data_2rpb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rpb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.6 155.76 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -123.73 152.02 42.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.1 146.72 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 115' ' ' ILE . 16.6 mt -106.53 133.47 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 111.96 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.7 p -117.9 128.21 26.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 111.134 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.4 Cg_endo -69.76 152.39 69.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 0.0 112.33 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.8 164.07 35.95 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.697 2.265 . . . . 0.0 112.337 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.96 121.47 11.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.26 106.68 5.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.13 136.94 58.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 53.4 mt -71.51 107.38 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.08 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -67.61 -43.99 79.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.58 35.25 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 49.1 t30 48.08 49.41 17.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.23 114.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.35 116.9 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 m -142.61 165.8 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 58.9 m -111.77 114.01 26.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.138 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.0 159.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -171.0 137.35 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 175.59 13.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 16.0 m -121.12 159.75 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.7 135.83 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.85 159.21 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.468 ' CD2' ' CE1' ' A' ' 111' ' ' PHE . 3.5 p90 -165.79 163.78 18.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -153.62 132.21 12.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.49 96.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 pt -82.26 -28.07 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 10.0 t0 -125.2 98.13 36.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.853 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.7 Cg_endo -69.68 -39.82 6.19 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.413 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 17.0 m -58.43 -18.28 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.06 -36.0 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.563 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -92.57 42.08 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.38 6.82 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.579 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 47.0 p90 -85.89 31.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.532 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.2 m120 47.35 42.09 13.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.579 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.7 m 26.83 43.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.2 t -96.73 -53.77 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.92 -40.24 75.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -61.52 -37.54 84.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.9 mt -61.79 -65.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.9 ptp -60.44 -37.18 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.54 -60.83 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.537 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 13.1 mm -41.77 -63.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.446 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 84.6 t -44.48 -53.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -56.19 -45.15 79.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 121' ' ' THR . 39.4 mt -61.38 -61.02 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -37.9 -40.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -57.33 -46.18 83.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 118' ' ' LEU . 91.4 m -70.87 -51.77 24.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -56.2 -60.64 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -49.98 -42.09 48.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 32.5 ttp180 -50.74 -35.55 32.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.72 -57.93 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.095 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -74.69 -59.86 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 123' ' ' LEU . 32.5 mm -47.81 -40.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.58 -31.94 15.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -120.46 114.24 21.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.94 -176.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 133' ' ' ASP . 42.3 mt-10 -122.58 130.81 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 131' ' ' GLU . 37.5 tp -34.96 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 131' ' ' GLU . 26.9 t0 -94.17 -56.99 2.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.453 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 1.8 tp10 -49.93 -18.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.0 p -63.54 -54.7 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 137' ' ' SER . 3.5 pp -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.469 ' N ' HD13 ' A' ' 136' ' ' LEU . 3.6 p -64.18 -50.55 67.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.7 71.38 2.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.63 -33.0 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.816 0.341 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.42 -39.84 74.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.6 mt -61.53 -49.49 84.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.14 -49.0 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' HG12 ' A' ' 166' ' ' ILE . 27.3 m-20 -57.67 -52.01 67.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 145' ' ' ARG . . . -51.38 -68.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 144' ' ' ALA . 24.6 mmt180 -35.18 -69.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -47.14 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 151' ' ' ASP . 57.6 ttp85 -41.29 -44.27 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.95 -55.27 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -47.51 -38.75 14.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.06 -40.49 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 9.8 t70 -58.0 -23.14 52.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -85.12 -27.79 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.459 ' CG2' ' O ' ' A' ' 153' ' ' ILE . 25.5 mt -91.4 -10.53 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.167 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 157' ' ' TRP . 23.4 p -95.97 -43.08 7.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -38.61 -34.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.568 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 3.9 ptm85 -70.1 -40.94 74.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.568 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 35.4 m0 -83.65 28.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 53.17 37.03 53.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 1.7 p -140.44 144.78 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.57 146.66 52.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.455 ' CG2' ' HG3' ' A' ' 147' ' ' ARG . 12.0 mm -73.8 91.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.01 -45.01 15.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.193 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -163.45 175.82 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -141.0 137.95 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 31.3 mp0 -132.33 146.14 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.454 HG12 ' ND2' ' A' ' 143' ' ' ASN . 11.9 mm -110.99 142.33 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.93 160.8 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -47.12 148.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -104.13 157.17 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 m-20 -110.39 118.48 49.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 169.99 17.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.241 . . . . 0.0 112.379 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.332 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -68.42 157.35 36.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 75.4 m-70 -126.6 128.45 46.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.14 132.81 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 27.2 mt -102.38 128.54 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.67 101.78 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 5.2 p -103.4 138.67 19.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.687 0.756 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.7 Cg_endo -69.78 147.42 62.72 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.69 2.26 . . . . 0.0 112.327 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.6 49.08 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.36 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -140.77 131.26 25.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.5 112.5 24.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.74 151.14 34.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 43.8 mt -79.63 110.3 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.36 -174.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.18 -39.37 75.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.05 24.72 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.5 m120 57.09 51.27 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.66 110.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 14.3 p -73.25 112.05 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.146 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.69 148.04 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.8 m -85.55 134.7 34.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.51 147.48 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -159.25 136.15 9.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.34 146.66 24.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.02 164.94 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.2 119.32 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -75.4 160.38 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 3.3 p90 -165.65 148.8 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -142.61 132.74 24.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.65 96.76 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 pt -74.56 -24.52 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.56 110.66 5.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -26.46 27.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.255 . . . . 0.0 112.317 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.32 -61.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -66.17 -39.42 89.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -89.3 50.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.82 37.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 30.2 p90 -116.83 30.39 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.8 m-80 58.85 27.25 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.548 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 7.2 m 35.28 41.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -94.61 -52.15 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -48.64 78.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -56.04 -32.74 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.64 -61.39 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.2 ptp -65.82 -10.08 34.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.49 -51.73 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 5.8 mm -47.83 -51.07 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.83 -22.97 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -90.18 -13.0 36.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.427 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 67.8 mt -89.67 -39.93 12.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.413 ' C ' HD23 ' A' ' 123' ' ' LEU . . . -64.76 -41.9 95.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.097 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.404 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 40.4 mm-40 -45.98 -39.48 9.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.6 m -83.34 -53.78 5.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 75.0 m-80 -52.78 -59.4 4.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 124' ' ' ARG . 3.1 pp -51.18 -41.13 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.468 ' N ' HD11 ' A' ' 123' ' ' LEU . 51.4 ttt180 -51.37 -35.84 40.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.57 -61.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.33 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 123' ' ' LEU . 49.8 mm -50.72 -47.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -43.31 -27.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -123.17 114.57 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -170.98 -175.38 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 44.4 mt-10 -121.47 125.76 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 59.6 tp -36.53 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 43.5 m-20 -84.57 -52.5 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 137' ' ' SER . 52.1 tt0 -56.53 -47.22 79.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.7 p -37.74 -34.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.07 -43.09 55.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 134' ' ' GLU . 71.2 m -112.8 73.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.78 25.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -68.29 -38.4 81.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.4 -21.52 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.2 mt -98.5 -26.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.8 mt -78.12 -34.43 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -81.44 -27.23 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.75 96.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' CD ' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.47 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.43 -28.17 52.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -73.94 -43.25 58.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.5 -8.91 58.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -93.82 -32.49 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -99.94 -6.44 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.39 -11.98 38.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -98.4 -26.2 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 153' ' ' ILE . 56.0 mt -92.24 15.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 57.5 p -122.4 -28.21 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.02 -24.96 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -19.89 23.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -94.55 2.51 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.25 24.79 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 160' ' ' LYS . 1.1 p -136.05 155.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -136.6 151.44 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.443 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 36.1 mm -88.45 94.35 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.69 -45.84 39.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -169.42 178.8 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.9 t -138.43 142.23 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -127.04 135.54 50.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.2 mm -104.48 138.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -95.22 160.28 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -50.38 149.6 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 169' ' ' ILE . 2.5 mp -101.37 146.17 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.52 122.69 50.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.883 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.04 17.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.356 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 21.4 mp0 -96.83 134.86 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.57 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 56.9 m-70 -106.46 132.99 51.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.84 137.79 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 116' ' ' VAL . 51.6 mt -104.46 121.64 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.08 100.15 10.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 11.4 t -100.92 136.01 19.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.79 145.96 58.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.317 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.3 66.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -132.26 119.63 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -74.74 109.91 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.11 131.11 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.97 105.06 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.37 177.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -65.85 -36.52 83.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.02 28.25 0.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.34 42.8 27.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.56 114.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.36 115.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.9 148.97 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.9 m -90.01 115.4 27.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.17 156.54 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.45 140.04 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.09 145.46 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.2 170.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -143.11 121.82 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.03 160.31 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 5.1 p90 -165.83 153.29 10.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.976 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 70' ' ' GLU . 3.5 pt20 -150.44 122.43 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.04 92.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.2 pt -76.2 -7.69 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.51 114.27 2.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -51.33 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 103' ' ' LYS . 5.4 p -42.98 -46.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.501 ' N ' ' CG1' ' A' ' 102' ' ' VAL . 10.8 mtpp -73.79 -39.32 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -95.07 54.95 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.57 0.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 29.1 p90 -85.69 28.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 6.2 m-80 52.93 31.17 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 47.1 t 33.64 41.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 m -93.19 -40.76 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.8 -52.24 32.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -52.19 -32.02 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.36 -60.68 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.0 ptp -69.95 -40.51 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 118' ' ' LEU . . . -57.03 -30.88 64.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 7.3 mm -74.95 -58.37 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.3 m -54.58 -29.97 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -83.37 -53.99 5.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 114' ' ' ALA . 10.4 mt -43.56 -55.29 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.402 ' C ' HD21 ' A' ' 123' ' ' LEU . . . -48.29 -52.55 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.9 mm-40 -37.53 -34.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 m -85.74 -61.14 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.46 -54.61 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.402 HD21 ' C ' ' A' ' 119' ' ' ALA . 2.5 pp -56.15 -40.02 73.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -53.4 -27.41 24.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.97 -62.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.48 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mt -48.49 -41.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.02 -28.92 6.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.487 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -121.69 114.32 20.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.28 -177.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 133' ' ' ASP . 16.1 mt-10 -118.84 129.34 55.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 23.4 tp -36.0 -30.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -94.49 -52.86 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 29.7 tt0 -54.26 -16.5 2.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -59.89 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.4 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.8 pp -60.39 -25.15 65.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -77.52 -50.71 12.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.91 74.63 2.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -103.92 -30.91 10.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.89 -23.7 62.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.68 -49.78 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -48.9 -33.36 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 23.8 p30 -86.34 -23.81 26.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -70.93 -56.23 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -50.92 -62.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -47.28 -55.38 8.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 151' ' ' ASP . 28.4 ttp180 -42.59 -51.21 5.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.78 -37.1 85.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -74.53 -19.52 60.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.85 -9.49 15.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -90.35 -18.6 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.76 -35.45 14.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 86.6 mt -77.84 -17.1 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 40.6 p -92.63 -42.28 9.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -44.04 -26.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' CG ' ' O ' ' A' ' 153' ' ' ILE . 0.0 OUTLIER -75.23 -37.2 61.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' A' ' 154' ' ' THR . 34.1 m0 -85.14 26.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 62.91 12.75 44.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 6.0 p -120.87 138.19 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.083 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.458 ' N ' HG23 ' A' ' 159' ' ' VAL . 0.2 OUTLIER -121.1 143.9 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mm -85.01 106.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.8 p -57.26 -61.47 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -156.11 179.31 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.87 149.65 32.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -131.61 137.2 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.44 141.71 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -99.45 158.88 15.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.92 144.73 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 31.4 mt -99.46 156.28 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -116.62 129.34 25.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.615 0.722 . . . . 0.0 110.919 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 164.73 33.44 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.788 0.327 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -70.73 157.5 37.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.544 ' CE1' ' O ' ' A' ' 69' ' ' ARG . 6.1 m-70 -129.03 147.58 50.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.26 145.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.439 ' CD1' HG23 ' A' ' 115' ' ' ILE . 26.9 mt -104.29 129.15 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.29 93.1 8.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.469 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 7.9 p -94.21 137.58 22.8 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.572 0.701 . . . . 0.0 111.152 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 146.98 61.99 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.741 2.294 . . . . 0.0 112.343 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 153.35 69.07 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -140.02 127.06 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.75 110.44 20.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -122.41 136.7 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.4 mt -68.35 108.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -53.42 -175.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -68.93 -40.67 78.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.42 27.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 47.0 t30 54.58 50.48 15.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -118.74 115.52 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.15 113.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.65 141.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -83.12 122.13 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.53 138.31 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -146.81 136.57 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.21 174.53 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.96 151.37 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.7 124.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -83.85 163.23 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.534 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 8.3 p90 -165.68 160.48 17.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -151.41 142.0 22.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.8 t -84.92 95.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.8 -15.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -146.61 106.29 4.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -12.74 33.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.238 . . . . 0.0 112.349 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -70.79 -55.81 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -72.97 -26.4 61.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -95.77 43.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 p -93.3 40.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.3 p90 -123.22 28.83 6.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.5 m-80 61.63 27.18 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.522 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 14.4 p 35.26 31.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.5 m -89.31 -49.2 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 10.8 m-20 -56.56 -45.64 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -62.52 -33.41 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.5 -53.73 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.472 ' O ' ' CD ' ' A' ' 117' ' ' LYS . 13.6 ptp -76.88 -21.38 55.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -78.63 -47.87 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.07 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.5 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 8.9 mm -50.39 -53.02 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.47 ' CG2' ' HD2' ' A' ' 117' ' ' LYS . 3.5 m -59.51 -43.0 89.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.472 ' CD ' ' O ' ' A' ' 113' ' ' MET . 0.8 OUTLIER -70.94 -10.72 60.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -95.01 -39.62 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.17 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -61.28 -34.62 75.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 m -80.59 -44.43 18.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.15 -46.06 85.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.2 pp -62.66 -40.68 97.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.468 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 44.8 mtt180 -52.71 -21.42 4.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.92 -59.69 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -75.82 -58.33 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.2 mm -50.17 -38.6 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.97 -23.09 14.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -131.26 114.13 14.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.47 -176.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 133' ' ' ASP . 19.0 mt-10 -122.0 120.48 34.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 41.8 tp -33.72 -34.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -86.0 -45.82 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 135' ' ' THR . 17.8 tp10 -58.64 -48.77 79.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 134' ' ' GLU . 20.2 p -31.9 -43.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.094 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.45 -52.48 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.5 m -64.4 -52.93 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.49 54.56 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.449 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -89.53 -37.88 14.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.472 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 3.8 p-10 -69.78 -21.54 63.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.68 -46.99 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.13 -45.7 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' HB3' ' CG1' ' A' ' 166' ' ' ILE . 2.4 p30 -71.66 -28.71 63.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.42 -58.28 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -47.57 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -46.84 -56.51 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.421 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 43.7 ttp85 -45.24 -47.02 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -64.17 -55.86 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -51.99 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.39 -34.26 64.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -23.28 62.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -93.2 -27.62 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mm -79.12 -18.09 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.3 p -99.16 -33.17 10.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.91 -18.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 9.8 ptt180 -92.13 -27.94 17.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.499 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.5 m0 -89.8 11.65 19.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 77.32 11.33 85.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.51 147.88 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.388 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 150.32 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.0 mm -84.71 96.55 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.465 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 47.9 p -48.96 -63.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -146.78 -179.36 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -141.08 144.25 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.112 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -137.16 139.48 41.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.473 ' CG1' ' HB3' ' A' ' 143' ' ' ASN . 4.2 mm -108.43 140.76 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -97.06 161.65 13.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -45.72 154.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.1 mp -105.13 152.55 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.7 m-20 -103.88 122.41 44.57 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 170.02 17.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.228 . . . . 0.0 112.371 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.787 0.327 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 23.4 mp0 -85.56 141.88 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 92.5 m-70 -110.38 132.26 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.22 138.26 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 115' ' ' ILE . 17.7 mt -102.33 125.9 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.24 112.43 24.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 5.1 p -118.21 138.76 25.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.593 0.711 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.72 150.95 69.13 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.274 . . . . 0.0 112.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.469 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 154.64 67.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.671 2.247 . . . . 0.0 112.395 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.433 ' CD ' HD12 ' A' ' 123' ' ' LEU . 3.2 pt20 -136.94 152.04 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.37 115.66 30.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 m -128.44 147.91 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 39.9 mt -79.65 108.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.13 -176.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -65.6 -45.45 83.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -83.75 34.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 16.2 t-20 49.69 49.82 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.9 t -116.57 109.44 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.1 p -74.21 116.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.63 155.03 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 24.5 m -96.89 126.24 41.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -115.09 151.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -154.48 133.0 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.88 152.17 30.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 28.8 m -101.87 165.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.8 t -135.51 126.12 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -85.42 158.86 20.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.2 p90 -165.6 154.09 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' NE2' ' OE2' ' A' ' 70' ' ' GLU . 3.8 pt20 -150.08 129.23 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.46 91.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 pt -73.57 -31.65 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.67 94.72 34.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.601 0.715 . . . . 0.0 110.859 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.49 10.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.3 -44.99 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -90.19 -21.11 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -96.84 43.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.42 40.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 39.7 p90 -117.93 35.12 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.6 m-80 50.93 36.56 15.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.52 ' C ' ' O ' ' A' ' 107' ' ' ASN . 3.7 p 27.72 41.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 107' ' ' ASN . 1.6 t -95.34 -57.72 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -49.73 -43.78 48.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.6 mt -58.94 -70.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.936 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 ptp -51.78 -38.16 54.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.54 -66.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 111' ' ' PHE . 15.6 mm -38.7 -63.89 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' ILE . 91.3 t -37.13 -51.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -67.73 -55.24 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ALA . 58.4 mt -46.28 -61.55 1.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' LEU . . . -36.52 -60.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 4.9 mt-30 -39.17 -47.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.1 m -67.92 -47.9 67.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.416 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 71.1 m-80 -63.29 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 1.6 pp -44.51 -39.25 4.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -53.84 -37.1 63.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.13 -47.91 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -84.9 -63.83 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 2.1 mp -51.84 -41.52 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.17 -30.21 7.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.8 pt-20 -118.54 113.05 20.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.21 -174.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 58.0 mt-10 -118.31 129.18 55.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 131' ' ' GLU . 64.6 tp -36.72 -29.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 3.8 p-10 -94.08 -46.08 7.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' SER . 2.6 tp10 -55.04 -44.97 75.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 1.1 p -34.24 -65.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.401 HD11 ' C ' ' A' ' 136' ' ' LEU . 1.5 pp -53.76 -34.99 60.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 134' ' ' GLU . 1.8 t -70.32 -70.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.21 69.69 0.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -97.94 -34.45 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -72.63 -33.0 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -68.53 -45.94 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.6 mt -54.27 -53.23 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -52.19 -41.0 62.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.97 -54.19 48.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -53.69 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.8 tp -41.36 -38.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -64.23 -44.87 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.83 -12.38 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 122' ' ' ASN . 28.2 mt-10 -87.95 -39.05 15.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.4 HD12 ' CB ' ' A' ' 118' ' ' LEU . 3.8 mm? -93.8 -13.56 27.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.55 -22.75 56.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 pttt -89.77 -30.07 18.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.73 -19.26 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 43.2 p -97.25 -28.17 14.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -47.37 -40.59 17.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.549 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.3 ptm180 -66.45 -32.06 73.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.549 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 42.2 m0 -83.71 14.09 4.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 65.8 33.96 87.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.448 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.16 145.69 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -128.83 135.44 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.71 86.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.43 ' CG2' ' NE2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -38.37 -47.43 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -169.54 179.99 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 165' ' ' GLU . 87.8 t -140.84 140.09 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.435 ' N ' HG12 ' A' ' 164' ' ' VAL . 68.9 mt-10 -123.83 147.12 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.65 142.15 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -103.16 161.05 14.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -41.68 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -113.75 156.5 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 11.4 m-20 -115.85 122.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.633 0.73 . . . . 0.0 110.822 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 170.55 16.28 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.817 0.341 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.2 155.39 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.56 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 51.0 m-70 -124.0 148.48 46.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.32 145.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.461 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 96.5 mt -113.3 124.45 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.32 107.23 18.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 6.2 p -105.65 138.3 19.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.76 144.94 55.64 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.717 2.278 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 159.94 51.54 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.633 2.222 . . . . 0.0 112.351 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.38 116.64 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 79' ' ' GLU . 14.7 mp0 -71.49 118.56 14.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.73 132.5 61.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 47.9 mm -60.9 113.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 130' ' ' MET . 0.7 OUTLIER -63.27 -178.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 130' ' ' MET . 17.5 tptt -61.41 -47.32 86.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.7 32.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 32.5 m-20 51.4 48.04 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.87 109.38 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.23 108.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.34 153.31 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -94.92 128.54 41.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.57 149.6 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.14 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -159.54 127.3 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.455 ' CB ' HD13 ' A' ' 166' ' ' ILE . . . -142.91 151.53 41.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.08 153.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.115 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.447 ' CG1' HD11 ' A' ' 161' ' ' ILE . 25.5 t -127.86 127.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -87.02 159.96 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.951 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 4.2 p90 -165.59 153.51 11.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.404 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.6 pt20 -149.74 128.8 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.5 91.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.096 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 pt -71.96 -12.75 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -158.4 105.66 1.67 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.901 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -13.44 34.81 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.388 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.26 -27.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.184 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -101.31 -20.57 15.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.53 48.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 m -83.0 3.2 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 38.1 p90 -84.22 24.53 0.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.2 m-80 62.1 31.2 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.567 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.3 t 33.79 40.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.5 p -95.11 -60.02 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.05 -36.56 29.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.461 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -65.18 -33.94 77.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.84 -57.03 7.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.5 ptp -67.43 -26.48 66.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.28 -49.45 16.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.445 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 2.6 mm -45.83 -62.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 m -53.0 -25.54 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -83.94 -25.51 30.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.84 -46.04 22.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.94 -53.35 56.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.41 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 37.3 mm-40 -40.99 -27.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 m -92.09 -37.14 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -75.45 -58.23 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 pp -51.05 -40.46 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -54.6 -22.99 15.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.61 -58.38 3.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.4 mp -76.09 -62.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.64 -40.84 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.79 -20.13 3.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.4 pt-20 -130.8 113.62 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.479 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -173.7 -175.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.854 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 24.4 mm-40 -123.17 120.4 33.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' GLU . 65.0 tp -35.35 -31.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.5 t70 -76.04 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -54.64 -46.49 73.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 136' ' ' LEU . 70.6 p -42.36 -52.88 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 135' ' ' THR . 41.4 mt -35.8 -49.94 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 t -121.95 87.64 2.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.83 35.06 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.98 -32.08 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -50.63 -36.97 37.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' ALA . 11.0 mt -87.45 -55.59 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.9 mt -42.69 -36.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 3.5 p30 -81.73 -31.54 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.451 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -60.78 -54.66 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -56.45 -63.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.0 mt -42.6 -52.4 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -45.22 -41.83 8.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.06 -25.0 32.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 8.0 mm-40 -79.81 -10.39 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 -39.27 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.98 -8.42 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.47 ' CG ' HD12 ' A' ' 153' ' ' ILE . 8.8 ptpt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.8 mp -87.1 -18.31 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -94.61 -14.93 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.104 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.54 -14.7 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.555 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 15.4 ptm180 -96.7 -22.38 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.555 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.3 m0 -93.87 5.27 52.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.25 22.8 67.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.16 135.47 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.073 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.32 130.41 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.447 HD11 ' CG1' ' A' ' 94' ' ' VAL . 18.5 mm -73.43 91.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 12.5 p -45.36 -44.6 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.402 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.9 OUTLIER -166.82 178.96 5.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 71.7 t -137.87 122.12 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.36 138.46 40.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.455 HD13 ' CB ' ' A' ' 92' ' ' ALA . 24.4 mm -112.67 142.34 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -103.11 159.57 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -47.42 160.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -108.01 156.66 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.7 m-20 -104.99 119.99 51.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.887 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 163.8 36.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.287 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.405 ' CD ' HD23 ' A' ' 132' ' ' LEU . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.178 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.798 0.332 . . . . 0.0 110.857 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -118.65 157.89 26.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.578 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 26.3 m-70 -123.98 146.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.467 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 8.1 p -95.4 145.93 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.418 ' CD1' HG22 ' A' ' 115' ' ' ILE . 19.5 mt -105.68 130.02 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.24 95.06 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 3.3 p -99.17 136.94 20.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.488 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.4 Cg_endo -69.71 149.44 67.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 0.0 112.38 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 168.78 20.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.38 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -146.73 118.12 7.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -76.83 102.65 6.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.81 148.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.5 mt -79.87 106.39 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.41 -174.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -67.88 -43.15 80.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.44 35.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 6.5 t30 51.01 43.25 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 110.82 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.86 113.95 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.1 150.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -89.38 109.67 20.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.57 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.14 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -168.67 144.09 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.83 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 72' ' ' VAL . 18.0 m -93.61 158.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' A' ' 150' ' ' LEU . 20.0 t -128.47 137.16 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.142 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -98.08 160.52 14.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.578 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 33.8 p90 -165.83 155.09 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.435 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.8 pt20 -141.96 121.12 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.97 93.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -80.81 -29.78 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -127.8 96.66 31.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 0.37 5.7 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 23.9 t -81.39 -44.37 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -86.58 -32.58 20.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -87.11 38.66 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 102' ' ' VAL . 4.8 m -85.83 12.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.1 p90 -93.02 35.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.4 m-80 52.18 31.81 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.488 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 43.1 t 34.63 40.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.1 p -97.27 -38.82 9.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.54 -45.22 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -61.75 -32.54 72.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.06 -59.51 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.5 ptp -70.3 -37.82 74.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.0 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.572 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 6.8 mm -63.22 -52.77 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' ' 117' ' ' LYS . 2.6 m -65.52 -20.23 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.419 ' N ' HG21 ' A' ' 116' ' ' VAL . 6.5 mtpm? -91.48 -15.55 28.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.413 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 17.0 mt -88.94 -39.3 13.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.06 81.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.4 mm-40 -44.98 -30.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.3 m -87.42 -49.63 7.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 72.4 m-80 -62.7 -59.27 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 127' ' ' ILE . 3.2 pp -48.84 -42.82 37.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -51.67 -41.67 61.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.72 -57.57 11.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.32 -62.36 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' LEU . 20.8 mt -49.3 -44.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 130' ' ' MET . 7.3 pt-20 -121.4 113.96 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.839 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.04 -175.29 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 37.9 mt-10 -121.7 130.63 53.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 31.2 tp -36.17 -29.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.1 p-10 -88.66 -63.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -40.99 -43.84 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.2 p -39.62 -69.81 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 pp -55.4 -29.4 58.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -107.54 40.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -166.58 64.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.4 ptt180 -104.78 -37.11 7.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -27.65 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -88.23 -48.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 64.9 mt -54.02 -48.02 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 11.3 p30 -69.76 -42.96 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -47.39 -48.33 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.047 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -64.0 -62.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.63 -58.94 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 26.0 ttm105 -40.67 -40.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.97 -45.92 22.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -57.89 -28.1 63.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.458 ' CD1' HG22 ' A' ' 94' ' ' VAL . 36.1 mt -96.39 -31.09 13.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -20.03 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.44 -26.01 16.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 153' ' ' ILE . 98.2 mt -86.58 -8.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.473 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 62.3 p -103.19 -36.67 8.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -42.62 -27.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.35 -38.18 31.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 154' ' ' THR . 36.1 m0 -84.48 34.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.62 23.61 4.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.478 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 2.1 p -130.59 143.35 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.46 ' N ' HG21 ' A' ' 159' ' ' VAL . 0.8 OUTLIER -130.86 147.14 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.405 HD12 ' CG1' ' A' ' 94' ' ' VAL . 12.7 mm -82.91 109.57 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.435 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 75.9 p -64.55 -43.33 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -165.93 -178.54 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.412 ' HB ' ' NH2' ' A' ' 147' ' ' ARG . 38.4 t -141.17 137.5 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.404 ' N ' HG11 ' A' ' 164' ' ' VAL . 19.3 mt-10 -123.34 136.97 54.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 mm -99.09 140.87 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -95.69 161.68 13.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -47.99 162.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.1 mp -118.75 157.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.503 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.3 t70 -127.16 133.64 25.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 0.0 110.806 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 168.76 20.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.309 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.794 0.33 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -76.91 151.08 35.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -120.55 151.7 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.56 HG12 ' CE1' ' A' ' 95' ' ' TYR . 17.5 m -98.16 156.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' CG2' HG21 ' A' ' 116' ' ' VAL . 31.4 mt -118.19 125.02 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.27 111.27 18.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 116' ' ' VAL . 85.9 t -120.53 132.19 24.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.95 69.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.75 166.93 25.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -146.44 117.49 7.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.83 107.03 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.76 145.22 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 41.0 mm -74.33 109.22 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.35 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -67.34 -45.09 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.15 32.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.1 m-20 50.69 44.3 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.48 110.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.11 115.19 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.94 150.0 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.145 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 95.1 m -97.64 130.55 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.34 157.44 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' CG ' ' HB2' ' A' ' 167' ' ' GLN . 18.4 p-10 -160.43 139.53 10.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.86 150.87 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.29 170.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 150' ' ' LEU . 19.8 t -135.14 131.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.56 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.8 m-30 -91.78 157.95 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -165.65 158.19 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -152.3 114.5 4.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.85 92.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.7 pt -76.05 -18.49 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -146.54 106.38 4.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.585 0.707 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -18.41 37.14 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.95 -25.75 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -101.47 -38.23 8.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -83.78 34.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.64 -5.99 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 40.1 p90 -85.13 26.44 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 109' ' ' SER . 14.8 m-80 56.37 37.05 28.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.561 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 11.1 p 32.8 36.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' ASN . 7.1 t -93.98 -52.25 4.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -51.4 -46.33 62.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.551 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -58.67 -37.45 76.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.63 -66.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 ptp -57.04 -26.08 59.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.23 -65.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.551 HG13 ' CE2' ' A' ' 111' ' ' PHE . 11.9 mm -39.63 -64.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.469 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 49.1 t -36.22 -40.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.03 -55.0 5.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.8 mt -45.69 -49.63 14.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.57 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 36.2 mm-40 -51.87 -39.53 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -76.71 -56.84 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -53.38 -57.42 10.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 127' ' ' ILE . 3.1 pp -51.21 -43.12 61.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.454 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.2 ttt85 -49.84 -38.69 36.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.85 -54.28 41.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.68 -62.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 123' ' ' LEU . 43.6 mm -48.7 -39.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.36 -30.14 24.85 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -122.02 114.02 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -172.19 -175.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 26.2 mt-10 -119.08 132.96 56.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 131' ' ' GLU . 48.8 tp -35.81 -30.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 21.6 t70 -90.21 -53.43 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -45.38 -37.51 5.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -65.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -28.85 67.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.0 p -103.15 39.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.2 60.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -89.97 -33.35 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.7 -43.35 99.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.0 mt -67.23 -50.7 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.51 -50.5 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -57.57 -55.33 36.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -45.43 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 145' ' ' ARG . 5.1 mmp_? -53.93 -69.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -55.64 -62.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 38.8 ttt-85 -41.69 -34.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.8 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.59 -56.47 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' A' ' 94' ' ' VAL . 94.4 mt -54.29 -35.86 63.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -15.82 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -84.57 -44.34 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.7 mt -72.03 -5.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.5 p -102.55 -37.66 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -48.51 -20.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.569 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.2 ptp180 -87.34 -34.09 18.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.569 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.4 m0 -86.11 19.25 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.77 19.12 62.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.55 148.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -128.66 148.46 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 27.9 mm -88.61 100.86 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.66 -51.17 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.203 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -163.98 -176.56 4.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 69.6 t -140.43 143.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.19 137.44 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.5 mm -107.24 123.22 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.5 mm-40 -78.11 157.71 29.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -42.43 157.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -110.8 155.72 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.6 m-20 -113.23 120.49 40.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.552 0.691 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 170.04 17.44 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.667 2.244 . . . . 0.0 112.358 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.379 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.09 148.15 24.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 16.0 m-70 -115.62 143.83 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.1 145.63 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.02 129.2 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.58 100.11 12.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.23 134.78 19.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.664 0.745 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.72 151.28 69.24 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.745 2.297 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 54.1 Cg_endo -69.67 161.08 47.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.476 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 5.2 mt-30 -139.67 117.82 11.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.06 110.69 11.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.65 142.95 41.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.6 mm -73.45 105.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.03 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -66.09 -36.47 83.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.2 29.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 60.1 t30 49.85 51.97 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.46 123.47 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 81' ' ' ILE . 3.6 t -82.57 116.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.57 155.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 m -100.71 122.96 44.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.433 ' C ' ' OD1' ' A' ' 91' ' ' ASP . 34.7 m -114.18 169.09 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -174.93 135.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.79 146.85 24.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -95.66 166.4 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.421 ' CG1' HD13 ' A' ' 161' ' ' ILE . 12.9 t -133.23 127.01 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -86.64 159.05 19.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 23.0 p90 -165.69 155.07 12.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.86 123.99 12.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.0 t -63.97 96.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.4 pt -80.58 -28.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -135.58 108.53 10.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.859 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.49 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -48.62 -23.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -103.83 -27.94 11.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.546 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.82 41.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.75 44.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 13.6 p90 -117.75 36.4 4.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.7 m-80 55.88 28.31 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 107' ' ' ASN . 14.0 p 33.26 39.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.162 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' ASN . 25.9 m -94.74 -48.19 6.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.2 -46.72 88.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -61.08 -41.02 95.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.0 -63.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -58.41 -29.17 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.39 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.459 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 3.1 mm -39.3 -62.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.45 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 55.8 t -34.86 -48.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.82 -50.05 22.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 47.9 mt -44.08 -49.12 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.7 90.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.476 ' OE1' ' CG ' ' A' ' 78' ' ' GLN . 35.3 mm-40 -48.35 -35.67 12.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 m -86.57 -63.31 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 69.7 m-80 -42.72 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -59.25 -43.68 92.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 19.4 ttt180 -51.28 -26.96 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mp -76.47 -60.37 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.6 mt -49.78 -41.64 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.06 -23.85 2.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.61 114.21 17.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.89 -176.79 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 mt-10 -115.86 119.81 37.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 21.5 tp -36.61 -29.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -86.99 -58.52 2.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.1 tp10 -48.0 -50.32 27.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' GLU . 40.6 p -35.05 -34.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 134' ' ' GLU . 54.3 mt -62.37 -57.78 10.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 m -77.62 -50.7 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.96 70.41 0.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.4 ptt85 -112.59 -9.73 13.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.97 -33.78 21.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -73.86 -37.65 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 44.5 mt -60.6 -43.91 95.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.462 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.8 p30 -79.98 -31.39 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.94 -34.12 74.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -79.08 -56.57 4.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.11 -42.67 29.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -53.8 -40.18 66.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.08 -57.16 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -44.36 -62.02 1.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.414 ' N ' HD11 ' A' ' 150' ' ' LEU . 9.4 mp -60.17 -36.09 76.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -11.53 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.76 -27.27 15.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 153' ' ' ILE . 39.4 mt -96.62 17.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 p -125.71 -34.05 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.8 -25.22 26.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.535 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 14.3 ptm180 -83.56 -20.11 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.535 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 52.9 m0 -96.85 1.57 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.97 12.32 77.15 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 160' ' ' LYS . 53.5 t -119.61 154.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.926 0.394 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -134.01 151.64 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.466 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 32.4 mm -89.81 92.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.12 -48.96 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -163.89 -175.98 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 84.2 t -139.74 141.89 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 164' ' ' VAL . 8.4 mt-10 -124.47 135.39 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 143' ' ' ASN . 3.7 mm -105.33 139.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.69 161.14 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -44.4 156.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.6 mp -108.96 156.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.6 m-20 -113.01 120.81 39.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 110.9 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.2 31.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.358 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.039 0 CA-C-O 120.784 0.326 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 2.2 pm0 -115.12 149.42 37.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 88.8 m-70 -106.9 143.73 34.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 140.3 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 115' ' ' ILE . 26.5 mt -102.92 125.08 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 94.0 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 5.7 p -97.62 133.68 23.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 111.181 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.74 144.66 54.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.73 157.82 59.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -140.94 118.51 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -71.45 109.57 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.45 132.52 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 45.5 mm -68.16 109.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.44 -175.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -69.71 -38.91 77.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -84.53 26.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 37.6 t30 52.83 48.72 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.87 117.83 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 81' ' ' ILE . 47.1 t -77.79 113.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.173 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -143.39 157.35 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 25.5 m -103.62 123.66 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.47 142.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.11 132.06 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -152.28 164.55 37.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.31 159.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.97 118.94 30.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.5 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 7.3 m-30 -79.38 159.64 27.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.5 p90 -165.71 147.89 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.954 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.453 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -140.24 131.72 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.3 t -71.71 91.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.095 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.14 -21.5 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.46 ' HB3' ' CA ' ' A' ' 158' ' ' GLY . 22.3 t70 -134.95 92.85 18.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.593 0.711 . . . . 0.0 110.871 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 -5.18 15.61 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.663 2.242 . . . . 0.0 112.294 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.64 -50.03 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -87.39 -18.06 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.545 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -99.44 43.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 p -89.41 14.19 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.545 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.5 p90 -97.47 29.8 3.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.2 m-80 58.75 28.06 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.497 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 10.0 m 35.94 38.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.4 p -92.33 -48.74 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -59.25 -42.76 91.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -61.39 -31.93 71.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.62 -54.3 10.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.8 ptp -74.15 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -93.2 -57.99 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.506 HG13 ' CE2' ' A' ' 111' ' ' PHE . 7.7 mm -39.68 -57.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 117' ' ' LYS . 1.7 m -57.79 -42.08 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 18.4 mtmt -67.4 -18.9 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 18.5 mt -88.16 -42.36 12.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.23 68.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.43 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.1 mm-40 -57.7 -28.28 63.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.6 m -89.9 -54.69 3.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -55.49 -52.39 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CD1' ' C ' ' A' ' 123' ' ' LEU . 1.3 pp -56.1 -40.18 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.455 ' N ' HD11 ' A' ' 123' ' ' LEU . 12.8 ttt180 -56.44 -18.14 10.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.68 -61.06 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -74.97 -50.8 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.4 mm -55.99 -38.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.34 -28.28 27.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.521 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.34 114.29 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.55 -177.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.0 mt-10 -122.14 128.85 51.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.1 tp -34.76 -32.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -86.37 -58.27 2.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 136' ' ' LEU . 2.5 tp10 -47.91 -47.05 32.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 28.6 p -33.5 -34.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 134' ' ' GLU . 14.1 mt -84.66 -57.78 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -52.78 -53.12 52.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.84 57.81 3.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -90.92 -36.86 13.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.459 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 18.4 t0 -69.1 -20.11 64.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.93 -58.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -42.57 -42.18 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 140' ' ' ASP . 1.4 p30 -76.76 -35.89 57.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.427 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -54.68 -48.63 72.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 148' ' ' GLU . 5.0 mmp_? -62.63 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 3.7 mm? -38.15 -37.56 0.28 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.469 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 40.7 ttt-85 -62.21 -44.11 97.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' ARG . 11.4 tp10 -74.49 -46.29 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.07 -54.09 50.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -7.62 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -97.92 -41.89 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.93 5.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.8 p -116.61 -28.86 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -58.3 -28.88 65.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.552 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 8.3 ptp180 -83.98 -16.33 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.845 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.552 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 54.7 m0 -98.87 0.63 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 84.78 9.34 81.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.63 141.64 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.22 129.17 51.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.44 109.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.453 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 70.1 p -62.06 -44.41 96.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.76 179.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 86.8 t -139.32 132.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -116.57 144.2 44.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 mm -109.16 142.26 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -102.14 159.58 15.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -47.53 146.12 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.5 mp -96.0 156.57 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.0 m-20 -108.66 119.23 49.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 168.37 21.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.381 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.77 145.14 36.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 81.5 m-70 -110.31 142.94 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.45 139.58 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.467 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 32.5 mt -106.45 119.58 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.89 124.26 29.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.479 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 14.5 p -121.1 136.84 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.652 0.739 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.74 147.98 64.18 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.71 51.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' OE1' ' CZ ' ' A' ' 124' ' ' ARG . 7.6 tt0 -126.86 126.84 43.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -93.37 96.43 9.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.405 ' CG1' ' OE1' ' A' ' 78' ' ' GLN . 15.2 m -108.54 145.27 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 74.3 mt -70.27 106.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.403 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.36 -175.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.54 -39.17 77.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.94 34.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.7 t-20 48.08 45.79 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' CG1' ' HG3' ' A' ' 172' ' ' PRO . 58.3 t -118.5 110.59 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.25 123.89 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.39 151.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -91.71 116.81 29.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.02 160.16 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.124 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.85 137.0 3.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.411 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 142.22 20.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.88 159.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.471 HG22 ' CD1' ' A' ' 150' ' ' LEU . 25.7 t -135.24 137.67 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -97.37 163.27 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 1.4 p90 -165.59 156.38 13.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -152.75 134.21 14.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.14 99.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.3 pt -83.44 -9.35 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' CG ' HG22 ' A' ' 102' ' ' VAL . 30.9 t0 -155.96 109.77 2.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.655 0.741 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.35 16.76 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' CG ' ' A' ' 100' ' ' ASP . 34.2 m -62.52 -14.99 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -103.58 -26.0 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -104.47 45.8 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.83 -2.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.7 p90 -86.49 38.44 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 49.2 27.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.2 t 36.09 40.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.8 t -96.85 -50.42 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.91 -40.42 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.4 t80 -61.51 -40.52 94.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.48 -67.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -55.81 -38.99 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -58.64 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.529 HG13 ' CE1' ' A' ' 111' ' ' PHE . 11.3 mm -46.31 -58.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.79 -23.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -93.57 -33.18 13.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.44 -51.84 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.26 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -67.14 -31.39 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 94.2 m -87.91 -29.4 20.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.9 -44.74 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 124' ' ' ARG . 1.8 pp -62.63 -40.94 98.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.464 ' N ' HD12 ' A' ' 123' ' ' LEU . 40.8 mtt-85 -52.15 -24.61 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.0 -57.0 3.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.74 -63.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.57 -44.78 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.6 -25.52 1.44 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.543 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -124.18 113.89 18.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.27 -178.03 1.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 132' ' ' LEU . 42.0 mt-10 -120.94 130.5 53.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 131' ' ' GLU . 13.3 tp -34.42 -35.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.2 m-20 -80.83 -51.03 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -54.44 -49.47 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.6 p -45.43 -31.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.1 mt -73.82 -49.46 25.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -106.48 37.27 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.3 21.3 5.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -74.19 -0.93 18.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.66 -27.38 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.32 -41.33 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.42 -58.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.55 ' CB ' ' CG2' ' A' ' 164' ' ' VAL . 14.4 p-10 -59.43 -33.26 71.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.31 73.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.062 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -84.69 -58.59 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.13 -53.21 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.469 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 24.7 ttp180 -44.33 -40.49 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -57.38 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -48.66 -23.37 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.471 ' CD1' HG22 ' A' ' 94' ' ' VAL . 82.8 mt -102.66 -23.99 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.49 -6.24 58.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.98 -33.28 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -79.02 -17.72 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 159' ' ' VAL . 82.0 p -97.18 -38.28 9.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -42.68 -44.38 4.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.5 ptm180 -60.55 -34.65 74.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.571 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 40.5 m0 -85.53 12.96 7.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.32 11.19 84.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 154' ' ' THR . 55.2 t -119.98 140.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 111.115 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.92 145.09 51.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 23.7 mm -75.85 106.48 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.12 -41.25 74.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -171.21 178.5 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.55 ' CG2' ' CB ' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -129.97 148.42 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -137.82 115.64 11.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.4 mm -93.18 141.53 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -100.06 160.54 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -51.52 159.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.0 mp -108.26 156.51 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.499 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 5.7 m-20 -115.72 129.66 24.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 161.93 44.01 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.447 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.375 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 141.6 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 96' ' ' TYR . 90.0 m-70 -101.39 159.05 15.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.33 144.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 115' ' ' ILE . 33.5 mt -106.31 134.79 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.74 108.12 20.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 4.6 p -114.86 136.16 22.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.595 0.712 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.458 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.77 146.12 59.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 159.38 53.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 120' ' ' GLN . 27.2 mt-30 -143.99 129.69 19.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.24 94.83 7.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 140.57 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CD1' HG22 ' A' ' 87' ' ' VAL . 31.3 mm -67.18 102.45 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.52 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -59.69 -42.95 94.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.98 30.04 0.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.845 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 5.7 t-20 51.98 50.62 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.06 120.36 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 81' ' ' ILE . 24.7 t -77.88 116.36 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.63 149.88 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 8.5 m -91.94 117.09 29.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.1 141.44 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -143.84 141.9 30.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.25 145.68 23.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.45 166.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.51 131.68 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.72 157.08 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.441 ' CG ' ' CZ ' ' A' ' 111' ' ' PHE . 8.7 p90 -165.84 156.34 13.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' CG2' ' A' ' 162' ' ' THR . 3.6 pt20 -153.03 121.31 6.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.8 100.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -86.21 -24.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 19.0 t0 -138.57 105.59 7.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.8 Cg_endo -69.79 -43.65 2.51 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.307 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -50.78 -19.23 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -107.91 -34.08 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.543 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -101.91 43.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.25 33.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.544 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 34.4 p90 -111.7 27.42 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 109' ' ' SER . 8.1 m-80 58.09 34.76 24.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.544 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.3 m 33.52 35.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.5 p -86.13 -60.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.823 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.46 -46.5 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -58.54 -39.67 80.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.07 -65.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -57.97 -31.66 67.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.59 -66.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 111' ' ' PHE . 16.7 mm -39.04 -63.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -41.61 -50.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -62.13 -50.5 71.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.14 -60.28 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.37 -61.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 78' ' ' GLN . 12.8 mm-40 -39.41 -33.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 m -88.1 -53.95 4.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -56.16 -56.8 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -51.53 -41.06 60.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' N ' HD11 ' A' ' 123' ' ' LEU . 41.5 ttp180 -55.98 -22.37 26.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 -59.58 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.17 -60.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.2 mt -54.97 -47.41 76.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.142 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -42.87 -27.34 0.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.8 pt-20 -120.58 113.33 20.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -173.12 -174.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 133' ' ' ASP . 15.8 mt-10 -116.96 127.84 54.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.462 ' C ' ' O ' ' A' ' 131' ' ' GLU . 20.7 tp -33.32 -35.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.1 t70 -84.15 -65.45 1.01 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 135' ' ' THR . 29.6 tt0 -41.69 -47.7 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 134' ' ' GLU . 72.9 p -33.18 -40.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 mt -73.83 -51.14 17.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 m -61.54 -58.36 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.89 65.39 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' CD ' ' C ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -97.06 -45.21 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.455 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 13.0 t70 -59.07 -29.01 67.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 144' ' ' ALA . 48.3 mt -73.81 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -39.73 -50.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.461 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.5 p30 -69.49 -33.39 72.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' ILE . . . -59.24 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -46.15 -63.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 mt -48.11 -51.3 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 163' ' ' ARG . 26.8 ttm180 -44.49 -40.57 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.5 -56.35 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -42.91 -55.23 3.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.01 -35.71 78.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -20.87 40.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -82.72 -29.95 29.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 mm -83.71 -17.62 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 157' ' ' TRP . 64.0 p -93.93 -39.96 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -41.51 -29.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.448 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 11.8 ptm180 -79.92 -36.44 36.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 154' ' ' THR . 35.6 m0 -84.16 30.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.26 33.74 39.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 1.5 p -141.49 144.25 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.151 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.413 ' HD2' ' C ' ' A' ' 160' ' ' LYS . 3.3 tmmm? -127.92 151.08 49.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.02 91.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.492 ' CG2' ' NE2' ' A' ' 97' ' ' GLN . 19.0 p -42.3 -46.68 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 147' ' ' ARG . 14.5 ptm180 -169.4 -175.03 2.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 73.8 t -139.72 147.28 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 167' ' ' GLN . 28.4 mm -102.92 142.32 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.401 ' N ' HG21 ' A' ' 166' ' ' ILE . 46.5 mt-30 -98.57 161.88 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -47.52 156.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -109.81 157.51 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 t70 -126.09 133.28 24.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.63 0.729 . . . . 0.0 110.885 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 170.15 17.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.177 0 C-N-CA 122.678 2.252 . . . . 0.0 112.318 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -104.74 144.33 31.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.96 145.66 39.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -94.21 140.39 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.562 HD12 ' CD2' ' A' ' 96' ' ' TYR . 21.0 mt -107.55 119.24 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 118.57 20.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 116' ' ' VAL . 88.8 t -117.41 132.68 23.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.729 . . . . 0.0 111.119 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.75 144.37 53.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.85 164.28 35.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.628 2.218 . . . . 0.0 112.316 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.424 ' CD ' HD13 ' A' ' 123' ' ' LEU . 1.3 pt20 -146.67 139.44 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.55 129.43 36.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.97 145.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.9 mt -74.73 114.59 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.2 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.15 23.55 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 27.7 m-20 60.41 50.68 5.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.7 t -118.82 111.16 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 p -75.27 115.41 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.19 162.2 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 31.9 m -102.84 125.04 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.83 162.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -171.01 134.71 0.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.08 35.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.96 164.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.93 134.28 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -96.77 154.4 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CD2' HD12 ' A' ' 73' ' ' ILE . 3.8 p90 -165.65 161.26 18.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -153.17 114.2 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.84 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.68 -24.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.468 ' HB3' ' CA ' ' A' ' 158' ' ' GLY . 29.3 t70 -133.64 90.12 29.16 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -40.61 5.09 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 0.0 112.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -38.39 -41.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -91.43 -35.65 14.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.546 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -84.45 41.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.087 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 6.1 p -87.66 47.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.7 p90 -130.37 32.21 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.3 m-80 60.93 28.06 17.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.467 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 6.4 t 36.1 35.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 107' ' ' ASN . 54.9 m -89.76 -58.75 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -47.46 -54.56 11.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.3 t80 -50.13 -48.38 53.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 mt -51.48 -68.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -60.95 -14.91 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.18 -34.51 23.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' A' ' 111' ' ' PHE . 14.1 mm -72.1 -54.83 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.474 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 2.0 m -56.68 -22.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.149 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -92.69 -45.21 8.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.38 -44.1 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.11 97.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.2 mm-40 -47.87 -33.09 6.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.1 m -87.0 -50.57 6.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -58.51 -58.25 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 127' ' ' ILE . 2.3 pp -51.72 -39.99 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.411 ' N ' HD12 ' A' ' 123' ' ' LEU . 65.8 ttt-85 -52.93 -31.99 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.81 -51.69 31.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.83 -60.12 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.461 ' CD1' HG23 ' A' ' 142' ' ' ILE . 47.0 mm -50.61 -38.01 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.11 -33.83 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 130' ' ' MET . 11.9 pt-20 -117.06 113.93 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.404 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -171.8 -177.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.44 121.92 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.8 tp -33.55 -34.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 131' ' ' GLU . 25.3 t0 -83.96 -51.71 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 135' ' ' THR . 49.1 tt0 -52.99 -47.55 68.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 134' ' ' GLU . 29.8 p -35.82 -50.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.51 -47.12 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -102.47 85.58 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.01 37.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.462 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.494 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.1 ttp180 -76.62 -31.42 57.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.18 -38.37 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -78.89 -60.11 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.461 HG23 ' CD1' ' A' ' 127' ' ' ILE . 20.3 mt -42.95 -51.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.72 -60.63 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -49.63 -68.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 149' ' ' GLU . 4.0 mm? -43.03 -59.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' LEU . 45.5 ttp180 -35.74 -43.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.66 -38.7 28.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 146' ' ' LEU . 39.7 mm-40 -62.23 -27.63 69.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.42 -29.72 12.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -15.22 60.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.33 -20.56 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.48 -12.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.0 p -101.31 -33.98 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -50.65 -23.3 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -88.2 -30.23 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -88.09 17.6 4.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 66.71 26.94 73.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.48 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.86 135.75 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 111.148 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.96 139.93 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 42.5 mm -84.98 109.48 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -55.09 37.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -163.0 -176.16 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.408 HG22 ' CA ' ' A' ' 147' ' ' ARG . 59.3 t -140.77 140.47 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.169 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -126.3 135.99 52.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 167' ' ' GLN . 22.0 mm -103.5 141.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.444 ' N ' HG23 ' A' ' 166' ' ' ILE . 81.4 mm-40 -99.14 161.65 13.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -51.59 154.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -104.53 156.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -109.11 120.66 45.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 166.15 28.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.642 2.228 . . . . 0.0 112.317 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.773 0.32 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 18.4 mp0 -114.59 144.97 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.573 ' CB ' ' CE2' ' A' ' 96' ' ' TYR . 65.7 m-70 -117.4 128.73 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.77 135.44 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mt -100.69 125.66 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.73 103.96 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 12.7 p -106.06 135.07 19.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.78 150.78 68.55 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.627 2.218 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.69 156.94 62.2 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.262 . . . . 0.0 112.348 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -142.99 121.34 12.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.77 105.66 11.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.12 148.78 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 69.3 mt -77.12 106.22 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.36 -174.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.67 -47.63 77.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.84 37.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.9 m120 47.61 54.8 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -124.38 110.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.35 108.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.46 146.63 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 1.8 m -80.52 113.52 18.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.41 143.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 15.8 p-10 -151.73 140.8 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.19 146.92 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.34 159.11 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 150' ' ' LEU . 40.5 t -131.9 129.12 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.17 159.82 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 71' ' ' HIS . 11.0 p90 -165.56 159.87 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' A' ' 70' ' ' GLU . 3.6 pt20 -152.36 128.72 10.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.32 93.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 100' ' ' ASP . 45.7 pt -73.07 -36.15 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' N ' HG13 ' A' ' 99' ' ' ILE . 24.8 t0 -125.4 99.24 33.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -7.52 21.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 54.2 t -76.88 -47.83 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -82.95 -33.36 26.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -88.2 46.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 102' ' ' VAL . 16.1 m -89.22 30.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 45.6 p90 -112.66 35.61 3.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m120 47.12 36.68 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.548 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.2 m 31.08 41.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.1 m -89.19 -59.27 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -52.81 -34.2 52.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -70.36 -40.16 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -62.15 -54.93 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 ptp -68.62 -33.64 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -66.87 -59.08 3.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.552 HG13 ' CE2' ' A' ' 111' ' ' PHE . 16.2 mm -46.33 -63.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.2 t -39.48 -40.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -74.04 -49.46 24.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.7 mt -55.72 -57.56 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.32 -51.38 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.424 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 46.4 mm-40 -42.85 -41.46 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 84.9 m -75.94 -59.3 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -45.77 -57.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 123' ' ' LEU . 3.3 pp -54.06 -43.65 70.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -53.01 -32.4 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.64 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.442 ' CG2' ' NH2' ' A' ' 145' ' ' ARG . 5.2 mp -76.35 -63.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.62 -45.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.12 -26.18 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.47 113.75 17.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.98 -175.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.3 mm-40 -122.76 123.31 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 131' ' ' GLU . 46.3 tp -34.39 -32.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.9 m-20 -83.93 -46.63 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 131' ' ' GLU . 37.0 tt0 -56.31 -50.58 71.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' LEU . 79.1 p -42.17 -56.35 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.131 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 97.4 mt -34.79 -51.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.9 m -117.76 87.21 2.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.81 39.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -82.97 -40.28 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.71 -44.02 63.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.96 -54.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.03 -36.81 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.497 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 80.5 m-20 -68.92 -19.14 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.4 -40.85 17.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.442 ' NH2' ' CG2' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -66.59 -55.84 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 146' ' ' LEU . 4.1 mm? -57.55 -32.7 67.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 31.6 ttt-85 -79.43 -40.55 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 9.9 tm-20 -63.28 -25.49 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -91.17 -62.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 94' ' ' VAL . 79.4 mt -54.13 -20.72 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 21.0 t0 -83.86 13.85 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -121.45 -40.87 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.1 mt -76.93 -8.42 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.6 p -100.65 -38.01 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -45.98 -37.66 6.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 6.4 ptp180 -66.74 -33.64 76.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.515 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.1 m0 -86.19 10.62 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.52 17.16 80.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.2 t -122.45 141.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -125.16 150.54 46.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.454 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 29.3 mm -85.82 113.88 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.469 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 25.7 p -68.02 -55.53 12.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 163' ' ' ARG . 4.5 ptp180 -156.01 178.0 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 99.4 t -141.41 145.86 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.26 145.1 51.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.497 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 19.9 mm -106.92 142.29 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.411 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 21.4 mm-40 -94.06 161.79 14.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -54.57 141.72 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.2 mp -91.22 157.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 t70 -128.34 133.78 25.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.36 24.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.312 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.794 0.331 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 11.8 mp0 -75.61 140.86 42.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 66.4 m-70 -108.46 134.46 51.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.543 HG12 ' CE1' ' A' ' 95' ' ' TYR . 11.3 m -93.96 151.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' A' ' 115' ' ' ILE . 20.8 mt -117.56 117.85 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.48 110.38 17.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 7.1 p -115.89 137.07 23.06 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.643 0.735 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.82 149.53 66.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 159.11 54.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.266 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -145.4 115.59 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.78 117.2 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.74 139.1 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.0 mt -70.29 105.52 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.5 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -64.94 -42.65 94.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.34 30.63 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.464 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER 53.46 44.72 29.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.82 114.21 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.18 114.29 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.089 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.84 144.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.5 m -87.34 124.48 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.26 163.98 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -174.86 136.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 166' ' ' ILE . . . -154.07 151.54 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.2 m -95.65 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.1 132.75 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.4 m-30 -91.05 157.6 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.542 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 7.7 p90 -165.7 146.23 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.476 ' NE2' ' CG2' ' A' ' 162' ' ' THR . 3.6 pt20 -141.92 123.14 14.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.54 124.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -111.11 -30.07 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 99' ' ' ILE . 34.5 t70 -124.38 101.67 34.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.908 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.401 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -41.45 -38.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -91.6 -37.82 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.553 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -91.3 45.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 p -90.73 40.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 28.7 p90 -119.99 32.83 5.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' SER . 2.9 m-80 49.8 38.02 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.481 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.9 t 34.41 33.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' ASN . 35.6 m -87.98 -51.17 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -47.57 75.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -60.2 -36.32 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.79 -60.54 3.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.9 -45.42 89.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.52 -55.14 37.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.556 HG13 ' CE2' ' A' ' 111' ' ' PHE . 10.9 mm -48.73 -62.96 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.6 t -42.01 -33.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -79.16 -53.97 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.4 mt -52.35 -58.9 5.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -38.84 -51.96 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -43.73 -41.17 4.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.8 m -78.18 -46.94 19.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -57.11 -61.12 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.9 pp -55.11 -42.14 72.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -54.59 -25.46 26.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.74 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -79.27 -64.22 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' A' ' 142' ' ' ILE . 2.9 mp -48.7 -42.66 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -46.91 -30.48 5.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -119.38 113.91 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.458 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -172.61 -175.19 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 133' ' ' ASP . 9.2 mt-10 -119.3 123.88 45.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 131' ' ' GLU . 51.8 tp -33.68 -34.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.3 m-20 -86.17 -54.1 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 135' ' ' THR . 70.7 tt0 -50.8 -49.81 57.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 134' ' ' GLU . 35.1 p -32.49 -51.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 mt -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 134' ' ' GLU . 2.2 m -93.86 41.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -146.84 49.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.465 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 45.8 ttt180 -95.37 -43.27 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.43 -19.4 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.1 mt -95.55 -56.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 46.3 mt -46.82 -41.77 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.465 ' ND2' ' HG2' ' A' ' 139' ' ' ARG . 16.9 p30 -77.69 -20.44 53.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.92 -37.1 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.15 -66.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.4 mt -42.92 -35.75 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -75.71 -41.16 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -18.07 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.26 -48.53 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.88 -35.73 79.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -58.11 -11.85 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -95.88 -45.36 6.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 153' ' ' ILE . 68.8 mt -75.31 -1.45 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 157' ' ' TRP . 26.6 p -109.02 -40.62 4.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.34 -34.88 3.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.562 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 10.2 ptm180 -70.04 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.562 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 51.4 m0 -88.08 11.88 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 69.87 35.12 72.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 20.5 t -138.8 136.62 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -116.3 141.0 48.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.95 96.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.476 ' CG2' ' NE2' ' A' ' 97' ' ' GLN . 12.0 p -47.75 -55.56 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -163.57 -175.95 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.16 137.07 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -119.08 143.72 46.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.407 ' HA ' ' CB ' ' A' ' 92' ' ' ALA . 15.3 mm -109.69 142.26 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.42 161.46 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -43.13 158.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 170' ' ' ASP . 45.4 mt -113.15 154.72 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.456 ' N ' HG21 ' A' ' 169' ' ' ILE . 38.2 m-20 -118.68 126.54 27.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.93 17.75 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.326 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 157.84 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.553 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 86.4 m-70 -124.37 156.74 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 95' ' ' TYR . 2.7 m -99.69 152.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.0 mt -110.03 131.59 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.76 105.99 18.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.2 p -118.3 127.36 26.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.3 Cg_endo -69.78 150.24 67.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.78 164.68 33.64 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.264 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -145.26 115.08 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.76 100.24 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -114.73 137.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.8 mt -70.2 105.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.11 -177.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -67.8 -35.94 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.91 28.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 13.8 m-20 54.32 45.42 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.82 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.04 108.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.436 ' CG1' ' HD3' ' A' ' 172' ' ' PRO . 15.0 m -135.63 152.81 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 3.6 m -88.89 130.87 35.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.21 132.06 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.1 138.33 33.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.78 171.55 18.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -121.66 159.08 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.5 t -130.73 130.42 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 72' ' ' VAL . 3.7 m-30 -91.27 160.81 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.6 p90 -165.85 157.0 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -152.17 132.36 13.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.452 ' CG2' HG13 ' A' ' 108' ' ' VAL . 20.3 t -73.54 98.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -76.55 -19.75 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.082 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -143.91 106.36 4.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.653 0.739 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -10.06 27.6 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.36 -29.65 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE2' ' N ' ' A' ' 158' ' ' GLY . 31.2 mtpt -94.65 -34.56 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -90.92 47.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.55 -5.57 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 33.9 p90 -83.11 16.86 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.5 m120 61.87 38.62 14.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 32.4 m 34.14 36.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 107' ' ' ASN . 8.3 t -89.43 -52.43 5.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.28 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -62.87 -33.28 74.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.23 -58.45 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.5 ptp -64.82 -39.12 93.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -54.59 39.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 111' ' ' PHE . 9.4 mm -50.59 -59.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.7 t -44.12 -42.86 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -69.15 -48.73 61.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.72 -59.77 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -41.32 -45.12 2.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.111 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 38.4 mm-40 -52.42 -41.59 63.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.2 m -80.08 -50.58 10.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -51.53 -52.81 43.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 1.7 pp -60.14 -41.67 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.479 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 57.0 ttt85 -54.31 -21.78 10.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.16 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.55 -55.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mm -51.07 -38.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.103 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.51 -27.31 11.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.449 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -123.24 114.19 19.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.17 -178.34 1.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 133' ' ' ASP . 20.6 mt-10 -122.66 121.56 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' GLU . 24.1 tp -33.73 -34.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' GLU . 58.0 m-20 -78.48 -50.38 11.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 tp10 -59.19 -46.98 86.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 p -40.57 -36.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.35 -55.47 21.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -101.54 46.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -132.79 43.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 139' ' ' ARG . 6.4 mtp-105 -87.89 -42.83 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.75 -11.31 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.7 mt -100.08 -56.0 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.37 -44.53 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.43 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 67.2 m-20 -56.57 -26.55 55.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.4 -48.59 15.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 145' ' ' ARG . 5.9 mpt_? -57.01 -64.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 149' ' ' GLU . 10.4 mt -52.74 -57.35 10.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 44.6 ttp180 -45.38 -38.27 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -82.86 -22.85 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 146' ' ' LEU . 32.7 mt-10 -83.31 -12.15 56.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.458 ' CD1' HD13 ' A' ' 115' ' ' ILE . 2.1 mm? -121.4 -5.87 9.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -24.32 23.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -86.59 -34.37 19.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.9 mt -81.54 -11.88 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 56.6 p -100.33 -40.44 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.176 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -46.59 -21.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 156' ' ' ARG . 0.8 OUTLIER -82.6 -37.2 25.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.41 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 32.2 m0 -84.04 24.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.41 ' N ' ' HE2' ' A' ' 103' ' ' LYS . . . 65.04 14.26 58.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 4.2 p -123.24 140.78 45.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.408 ' N ' HG21 ' A' ' 159' ' ' VAL . 3.5 tmtt? -126.78 140.13 52.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.53 93.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -55.04 7.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.435 ' HB3' ' NH1' ' A' ' 163' ' ' ARG . 2.8 ptp180 -158.59 -178.9 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 92.0 t -141.17 127.96 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.164 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -115.56 134.14 55.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.43 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 17.0 mm -102.52 142.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -101.22 159.13 15.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 19.5 mtt85 -45.03 157.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -111.58 155.8 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.473 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.2 m-20 -111.59 120.07 43.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.596 0.712 . . . . 0.0 110.922 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.28 19.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.436 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.794 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.96 143.72 32.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -112.53 145.27 40.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.35 137.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 96' ' ' TYR . 21.2 mt -103.11 126.92 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -112.51 132.01 22.38 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.5 Cg_endo -69.75 145.92 58.68 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.316 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.5 Cg_endo -69.78 162.57 41.58 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.706 2.27 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -142.97 117.09 9.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -69.04 106.65 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.38 142.62 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 19.5 mm -72.13 109.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -56.44 -177.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -65.68 -40.65 92.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -85.51 34.39 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.462 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 45.97 47.61 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 172' ' ' PRO . 31.8 t -115.37 122.28 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 81' ' ' ILE . 21.8 t -77.23 111.4 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 m -138.48 155.08 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.6 m -102.19 119.68 39.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.64 141.2 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -146.05 133.0 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.7 167.39 29.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 35.5 m -111.61 172.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.74 123.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -90.39 151.96 21.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.571 ' CD2' HD13 ' A' ' 73' ' ' ILE . 3.8 p90 -165.8 154.79 11.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 99' ' ' ILE . 2.5 pt20 -148.71 112.48 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.91 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.88 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 97' ' ' GLN . 2.7 pp -80.64 -26.53 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.414 ' OD1' ' CG2' ' A' ' 102' ' ' VAL . 28.5 t0 -134.97 97.51 13.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 104' ' ' ALA . 53.8 Cg_endo -69.79 -44.74 1.89 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 101' ' ' PRO . 4.0 m -36.41 -31.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' PRO . 11.7 mmmt -93.62 -35.54 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.565 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -82.27 41.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -73.86 4.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 30.2 p90 -97.34 27.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.8 m-80 56.87 32.99 22.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.525 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.0 m 32.97 39.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.0 t -96.28 -36.44 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 4.3 m-20 -71.05 -38.59 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 0.5 OUTLIER -67.8 -44.9 76.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -48.74 -54.3 15.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.457 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 7.9 ptp -77.3 -45.01 27.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -57.4 -14.99 5.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.094 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 2.0 mm -80.73 -51.55 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 117' ' ' LYS . 10.0 m -59.64 -25.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' N ' HG22 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -82.03 -32.82 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.5 -36.58 73.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' C ' HD21 ' A' ' 123' ' ' LEU . . . -65.87 -44.02 86.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 32.3 mm-40 -51.45 -38.17 52.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.1 m -82.88 -57.18 3.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.169 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -54.26 -56.44 18.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 124' ' ' ARG . 1.1 pp -53.72 -41.3 66.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' N ' HD13 ' A' ' 123' ' ' LEU . 41.5 ttt-85 -53.97 -20.35 6.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.13 -57.9 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.27 -62.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 3.0 mp -50.37 -41.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.3 -26.38 4.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.01 113.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.913 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -175.72 1.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.0 126.02 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' GLU . 42.5 tp -37.53 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.3 p30 -93.19 -43.39 8.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.829 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.6 tp10 -63.82 -20.66 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.1 p -73.54 -14.24 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 mt -82.17 -40.84 21.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 t -120.86 43.09 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -134.17 20.24 4.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -69.08 -32.08 71.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -51.72 -47.46 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.27 -43.43 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.9 mt -50.9 -49.9 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 76.0 m-20 -65.44 -52.24 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 148' ' ' GLU . . . -42.89 -48.58 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.101 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -61.23 -70.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.38 -62.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -40.26 -36.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 144' ' ' ALA . 0.3 OUTLIER -78.01 -56.98 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.92 -58.37 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.8 mt -56.24 -37.23 69.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -11.28 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -92.63 -37.17 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -76.13 -19.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 73.6 p -93.74 -38.41 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -52.11 -16.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.29 -31.75 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -88.97 11.47 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.69 10.98 85.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.57 145.42 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 111.128 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -118.48 141.2 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.84 92.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.92 -61.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -166.49 -178.06 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 62.9 t -135.18 147.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 13.7 mt-10 -135.55 143.31 45.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.481 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 24.6 mm -105.44 142.24 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -106.12 161.25 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -42.33 136.95 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -95.76 157.22 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.496 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 9.6 m-20 -107.87 120.93 45.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.843 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 169.14 19.58 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.433 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.251 . . . . 0.0 112.379 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.777 0.322 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -119.75 152.36 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 85.5 m-70 -121.86 143.85 49.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.35 139.66 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 HD13 ' CD2' ' A' ' 96' ' ' TYR . 27.4 mt -108.26 124.56 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.46 127.49 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.815 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 2.3 p -120.75 135.32 24.61 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.627 0.727 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.3 Cg_endo -69.78 150.29 67.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.2 Cg_endo -69.71 149.84 67.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -137.59 113.71 9.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.81 101.92 4.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 t -111.05 137.66 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.45 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 65.2 mt -68.16 104.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -49.78 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -65.12 -41.02 95.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 19.2 t70 -84.96 33.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 51.07 47.89 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.0 t -118.93 114.76 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.38 120.18 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -145.89 148.91 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 11.4 m -81.16 125.98 30.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' CG1' HG21 ' A' ' 127' ' ' ILE . 9.8 p -121.76 130.93 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 13.5 p-10 -140.95 145.47 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.82 150.34 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.33 155.15 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.77 141.76 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.39 162.53 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.1 p90 -165.9 157.53 14.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.48 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.0 pt20 -153.31 116.4 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.4 t -53.79 94.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.132 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.27 3.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -165.17 112.64 0.83 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.64 0.733 . . . . 0.0 110.841 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -51.22 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.244 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 p -44.68 -37.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -81.16 -37.08 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -96.73 56.01 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 p -92.66 3.25 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.166 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 31.0 p90 -87.94 24.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 23.4 m-80 61.97 27.4 16.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 3.3 t 36.66 40.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 t -96.16 -52.33 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -57.22 -39.2 74.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.493 ' CZ ' HD13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -62.88 -35.01 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.45 -64.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 ptp -61.64 -32.74 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -67.13 -57.22 7.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.485 HG13 ' CE2' ' A' ' 111' ' ' PHE . 8.1 mm -44.69 -56.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -53.79 -24.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.088 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -85.91 -37.77 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 121' ' ' THR . 10.4 mt -67.55 -57.07 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.73 -36.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -63.41 -40.85 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 118' ' ' LEU . 88.6 m -78.74 -38.77 38.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.26 -56.38 7.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -53.19 -44.18 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 45.5 ttt-85 -52.46 -22.04 4.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.92 -60.59 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.91 -60.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.402 HG21 ' CG1' ' A' ' 90' ' ' VAL . 1.9 mp -49.98 -38.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.62 -23.89 10.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.06 114.05 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.79 -175.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 133' ' ' ASP . 22.2 mt-10 -120.84 137.07 54.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.0 tp -38.29 -26.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -97.83 -59.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -41.93 -25.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' ASP . 1.5 p -64.2 -50.58 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -79.29 -13.95 59.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.935 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 m -92.78 -29.58 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.46 ' CA ' HD13 ' A' ' 141' ' ' ILE . . . -114.56 85.53 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.499 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -103.03 -43.45 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -16.84 63.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.46 HD13 ' CA ' ' A' ' 138' ' ' GLY . 3.8 mp -85.11 -48.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.48 -61.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.46 -37.67 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.97 -59.02 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -48.77 -66.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 tp -42.81 -48.77 5.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -55.31 -42.94 74.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.32 -9.83 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 13.2 mt-10 -98.35 -53.35 3.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.2 mt -64.6 -34.7 78.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -13.67 35.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -88.58 -49.84 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.4 mp -72.92 -21.61 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.0 p -91.21 -35.35 14.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -25.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -34.94 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -82.57 15.91 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.54 76.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.45 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.77 128.07 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.94 145.29 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -84.08 116.31 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.48 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 30.3 p -70.37 -62.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -146.65 167.13 24.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.96 115.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -99.16 147.21 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.62 137.21 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.408 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.9 mt-30 -88.74 159.61 17.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -50.58 156.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -110.99 157.26 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 10.0 t70 -125.45 133.26 24.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 168.47 21.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.211 0 C-N-CA 122.683 2.256 . . . . 0.0 112.316 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.764 0.316 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.38 152.87 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.563 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m-70 -113.85 149.26 35.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.2 p -96.49 145.31 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.452 ' CD1' HG22 ' A' ' 115' ' ' ILE . 18.7 mt -105.35 130.68 56.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.38 95.11 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.905 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 6.1 p -100.93 138.42 20.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.679 0.752 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.74 150.48 68.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.676 2.251 . . . . 0.0 112.327 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.2 Cg_endo -69.8 171.0 15.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.468 ' NE2' ' HG2' ' A' ' 120' ' ' GLN . 1.6 mp0 -142.97 145.88 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.37 101.22 11.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.05 145.83 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 66.9 mt -77.55 106.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.33 -178.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -62.87 -48.59 78.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -81.45 37.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.5 m120 46.67 44.84 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.6 t -111.23 110.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.61 120.86 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 m -144.83 150.3 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 6.9 m -93.52 125.05 37.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.9 148.98 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -152.81 138.45 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.831 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.08 153.44 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 m -101.22 163.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.39 132.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.26 161.31 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.6 p90 -165.91 152.37 9.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.443 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 4.3 pt20 -143.11 126.06 16.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.83 91.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.7 -31.89 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -132.07 102.6 14.49 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.846 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -10.14 27.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.637 2.224 . . . . 0.0 112.393 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.12 -50.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -77.02 -38.09 53.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.57 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -86.63 47.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.34 4.74 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 36.3 p90 -85.26 30.83 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m-80 49.63 37.07 11.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.556 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 23.6 m 32.57 41.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.4 m -94.96 -41.58 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -46.8 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.619 ' C ' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -57.05 -30.4 64.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.31 -60.67 3.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.0 ptp -67.75 -46.22 72.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.26 -35.93 63.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.571 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 5.2 mm -67.76 -64.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 2.7 m -52.29 -15.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -94.83 -34.32 12.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.8 mt -73.2 -54.23 8.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.08 -45.29 21.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 68.9 mt-30 -62.02 -36.13 80.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.5 m -74.16 -22.12 59.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 71.7 m-80 -91.53 -61.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 127' ' ' ILE . 4.1 pp -47.63 -39.83 18.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.441 ' N ' HD13 ' A' ' 123' ' ' LEU . 25.4 mtt-85 -52.72 -33.09 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.88 -54.43 15.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.56 -59.52 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.7 mt -50.25 -44.24 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.86 -24.02 0.68 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 130' ' ' MET . 10.4 pt-20 -125.86 112.76 16.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.42 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -175.54 -175.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 10.2 mm-40 -122.44 129.39 52.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.99 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 74.9 m-20 -85.74 -64.89 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.2 pt-20 -53.33 -46.02 69.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' GLU . 25.3 p -33.3 -33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 134' ' ' GLU . 39.6 mt -70.85 -69.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -54.14 -46.29 72.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.72 57.64 2.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -99.75 -26.41 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -78.12 -26.13 47.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.7 mt -78.73 -52.34 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -43.88 -50.51 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 0.9 OUTLIER -68.47 -41.01 80.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.473 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -50.86 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -55.09 -56.76 16.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 122' ' ' ASN . 7.2 tp -47.51 -62.12 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.469 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 25.9 ttp85 -43.85 -50.25 7.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -53.54 -31.37 46.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.58 -60.18 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.82 -31.75 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -66.85 -3.75 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -97.59 -43.84 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.45 HG23 ' CH2' ' A' ' 157' ' ' TRP . 4.5 mp -75.16 -18.78 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.8 p -92.04 -35.33 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.16 -38.62 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.6 ptp180 -69.93 -32.53 70.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . 0.571 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 31.7 m0 -88.23 34.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.57 23.39 4.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.72 143.32 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 111.115 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.75 141.92 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.54 97.56 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.443 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 62.6 p -51.27 -38.57 53.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -170.99 -179.93 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 147' ' ' ARG . 1.7 m -141.32 134.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -121.07 139.42 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.0 mm -104.12 142.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.171 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.48 161.95 13.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -49.32 145.38 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.3 mp -98.27 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.2 m-20 -112.72 120.46 40.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 110.87 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 170.23 17.12 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.629 2.22 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.29 138.6 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 99.1 m-70 -108.57 126.73 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -93.1 135.26 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.554 HD12 ' CZ ' ' A' ' 111' ' ' PHE . 20.4 mt -99.1 128.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.32 97.97 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.2 t -102.89 126.78 31.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 111.128 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 149.86 67.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.79 147.58 63.02 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -128.17 116.95 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.53 116.86 9.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.62 147.52 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.477 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 46.6 mm -83.56 108.67 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.4 m -53.11 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -67.32 -45.09 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 25.8 t70 -82.89 36.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.477 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.6 m-20 47.26 51.07 13.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.15 109.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.404 ' HB ' ' CD1' ' A' ' 81' ' ' ILE . 6.4 p -78.14 114.28 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.15 142.06 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 m -81.93 126.24 31.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.64 160.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.57 143.5 10.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.76 153.52 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 18.0 m -101.19 164.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.8 t -137.42 134.43 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.59 157.02 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 4.7 p90 -165.92 150.94 8.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.472 ' NE2' HG23 ' A' ' 162' ' ' THR . 3.0 pt20 -147.95 110.01 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.68 95.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.55 -8.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -161.22 109.59 1.25 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.569 0.699 . . . . 0.0 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -47.84 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' PRO . 2.2 t -34.83 -39.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -90.71 -37.86 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -94.23 49.83 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.8 m -86.12 8.17 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 35.7 p90 -90.47 26.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.5 m-80 56.56 33.97 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.5 t 33.65 41.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.3 m -97.45 -50.18 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.3 m-20 -57.6 -45.09 85.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.554 ' CZ ' HD12 ' A' ' 73' ' ' ILE . 1.1 t80 -61.09 -44.39 97.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -53.16 -64.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 21.0 ptp -62.24 -45.07 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -56.92 -32.31 65.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.511 HG13 ' CE2' ' A' ' 111' ' ' PHE . 3.9 mm -70.92 -59.81 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.184 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 8.7 m -44.06 -22.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 116' ' ' VAL . 77.1 mttt -94.77 -46.86 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.09 -53.04 62.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.46 -45.78 47.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 78.3 mt-30 -57.96 -37.9 75.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.7 m -70.17 -35.49 74.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.414 ' CG ' ' HB3' ' A' ' 149' ' ' GLU . 71.0 m-80 -80.31 -62.92 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 120' ' ' GLN . 4.0 pp -46.59 -43.79 17.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -47.73 -39.09 16.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.15 -52.03 66.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.42 -62.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 123' ' ' LEU . 5.2 mt -51.17 -43.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.61 -31.58 3.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.524 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -116.52 113.39 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -172.55 -175.09 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 133' ' ' ASP . 35.0 mt-10 -116.5 121.34 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 131' ' ' GLU . 57.5 tp -33.89 -33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 m-20 -83.45 -50.75 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 131' ' ' GLU . 24.8 tt0 -56.45 -48.58 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.0 p -40.1 -50.11 2.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.3 mt -47.02 -39.17 12.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -127.61 82.36 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -175.27 25.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 143' ' ' ASN . 5.0 ptt-85 -72.6 -35.33 67.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 1.5 m-20 -46.94 -32.21 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.09 -35.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.81 -50.64 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 2.3 p30 -61.77 -52.78 62.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.432 ' HA ' ' NH1' ' A' ' 147' ' ' ARG . . . -39.29 -49.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -58.8 -60.6 3.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 147' ' ' ARG . 3.9 mm? -54.37 -61.96 1.96 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 23.6 ttp-105 -36.19 -36.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.51 -55.5 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.474 ' HA ' ' CD ' ' A' ' 152' ' ' LYS . 70.2 mm-40 -50.24 -17.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.11 -40.07 5.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.1 -8.31 16.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.474 ' CD ' ' HA ' ' A' ' 149' ' ' GLU . 5.2 ptmt -100.83 -18.24 16.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.3 18.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.455 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 39.7 p -120.99 -32.29 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -25.56 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -84.1 -25.82 29.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -92.84 17.41 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 66.79 15.44 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 5.0 p -124.94 155.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.178 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -137.52 151.7 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.461 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 31.7 mm -88.94 98.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.472 HG23 ' NE2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -52.66 -48.84 66.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -166.15 -176.38 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.08 147.93 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.461 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 3.2 mm-40 -133.81 141.66 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.55 142.07 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -101.44 161.87 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.56 160.95 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -113.84 157.06 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.6 m-20 -111.42 123.54 34.75 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.666 0.746 . . . . 0.0 110.85 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 164.44 34.55 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.385 179.907 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 t -162.01 120.72 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -49.38 -54.25 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -74.68 119.75 19.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.27 40.3 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -102.94 116.86 33.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -88.78 41.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -55.19 129.25 37.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.6 155.76 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -123.73 152.02 42.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.1 146.72 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.447 ' CD1' HG21 ' A' ' 115' ' ' ILE . 16.6 mt -106.53 133.47 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 111.96 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.7 p -117.9 128.21 26.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 111.134 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.4 Cg_endo -69.76 152.39 69.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 0.0 112.33 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.8 164.07 35.95 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.697 2.265 . . . . 0.0 112.337 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.96 121.47 11.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.26 106.68 5.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.13 136.94 58.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 53.4 mt -71.51 107.38 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.08 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -67.61 -43.99 79.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.58 35.25 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 49.1 t30 48.08 49.41 17.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.2 t -113.23 114.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.35 116.9 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 m -142.61 165.8 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 58.9 m -111.77 114.01 26.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.138 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.0 159.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -171.0 137.35 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 175.59 13.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 16.0 m -121.12 159.75 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.7 135.83 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.85 159.21 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' CD2' ' CE1' ' A' ' 111' ' ' PHE . 3.5 p90 -165.79 163.78 18.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -153.62 132.21 12.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.49 96.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 pt -82.26 -28.07 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 10.0 t0 -125.2 98.13 36.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.853 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.7 Cg_endo -69.68 -39.82 6.19 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.413 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 17.0 m -58.43 -18.28 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.06 -36.0 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.563 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -92.57 42.08 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.38 6.82 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.579 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 47.0 p90 -85.89 31.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.532 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.2 m120 47.35 42.09 13.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.579 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.7 m 26.83 43.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.2 t -96.73 -53.77 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.92 -40.24 75.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.537 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -61.52 -37.54 84.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.9 mt -61.79 -65.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.9 ptp -60.44 -37.18 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.54 -60.83 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.537 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 13.1 mm -41.77 -63.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.446 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 84.6 t -44.48 -53.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -56.19 -45.15 79.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 121' ' ' THR . 39.4 mt -61.38 -61.02 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -37.9 -40.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -57.33 -46.18 83.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 118' ' ' LEU . 91.4 m -70.87 -51.77 24.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -56.2 -60.64 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -49.98 -42.09 48.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.458 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 32.5 ttp180 -50.74 -35.55 32.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.72 -57.93 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.095 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -74.69 -59.86 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 123' ' ' LEU . 32.5 mm -47.81 -40.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.58 -31.94 15.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -120.46 114.24 21.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.94 -176.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 133' ' ' ASP . 42.3 mt-10 -122.58 130.81 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 131' ' ' GLU . 37.5 tp -34.96 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 131' ' ' GLU . 26.9 t0 -94.17 -56.99 2.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.453 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 1.8 tp10 -49.93 -18.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.0 p -63.54 -54.7 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 137' ' ' SER . 3.5 pp -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.469 ' N ' HD13 ' A' ' 136' ' ' LEU . 3.6 p -64.18 -50.55 67.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.7 71.38 2.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.63 -33.0 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.816 0.341 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.42 -39.84 74.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.6 mt -61.53 -49.49 84.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.14 -49.0 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' HG12 ' A' ' 166' ' ' ILE . 27.3 m-20 -57.67 -52.01 67.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 145' ' ' ARG . . . -51.38 -68.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 144' ' ' ALA . 24.6 mmt180 -35.18 -69.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -47.14 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 151' ' ' ASP . 57.6 ttp85 -41.29 -44.27 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.95 -55.27 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -47.51 -38.75 14.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.06 -40.49 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 9.8 t70 -58.0 -23.14 52.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -85.12 -27.79 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.459 ' CG2' ' O ' ' A' ' 153' ' ' ILE . 25.5 mt -91.4 -10.53 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.167 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 157' ' ' TRP . 23.4 p -95.97 -43.08 7.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -38.61 -34.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.568 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 3.9 ptm85 -70.1 -40.94 74.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.568 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 35.4 m0 -83.65 28.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 53.17 37.03 53.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 1.7 p -140.44 144.78 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.57 146.66 52.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.455 ' CG2' ' HG3' ' A' ' 147' ' ' ARG . 12.0 mm -73.8 91.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.01 -45.01 15.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.193 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -163.45 175.82 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -141.0 137.95 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 31.3 mp0 -132.33 146.14 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.454 HG12 ' ND2' ' A' ' 143' ' ' ASN . 11.9 mm -110.99 142.33 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.93 160.8 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -47.12 148.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -104.13 157.17 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 m-20 -110.39 118.48 49.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 169.99 17.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.241 . . . . 0.0 112.379 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 132.91 24.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.79 164.99 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 179.836 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t -80.66 178.53 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.8 -60.05 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -76.28 114.67 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 120.15 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -124.74 144.85 50.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.67 36.24 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -52.73 123.28 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -68.42 157.35 36.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 75.4 m-70 -126.6 128.45 46.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.14 132.81 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 27.2 mt -102.38 128.54 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.67 101.78 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 5.2 p -103.4 138.67 19.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.687 0.756 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.7 Cg_endo -69.78 147.42 62.72 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.69 2.26 . . . . 0.0 112.327 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.6 49.08 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.36 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -140.77 131.26 25.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.5 112.5 24.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.74 151.14 34.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 43.8 mt -79.63 110.3 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.36 -174.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.18 -39.37 75.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.05 24.72 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.5 m120 57.09 51.27 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.66 110.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 14.3 p -73.25 112.05 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.146 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.69 148.04 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.8 m -85.55 134.7 34.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.51 147.48 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -159.25 136.15 9.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.34 146.66 24.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.02 164.94 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.2 119.32 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -75.4 160.38 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 3.3 p90 -165.65 148.8 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -142.61 132.74 24.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.65 96.76 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 pt -74.56 -24.52 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.56 110.66 5.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -26.46 27.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.255 . . . . 0.0 112.317 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.32 -61.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -66.17 -39.42 89.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -89.3 50.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.82 37.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 30.2 p90 -116.83 30.39 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.8 m-80 58.85 27.25 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.548 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 7.2 m 35.28 41.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -94.61 -52.15 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -48.64 78.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -56.04 -32.74 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.5 mt -69.64 -61.39 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.2 ptp -65.82 -10.08 34.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.49 -51.73 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 5.8 mm -47.83 -51.07 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -61.83 -22.97 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -90.18 -13.0 36.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.427 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 67.8 mt -89.67 -39.93 12.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.413 ' C ' HD23 ' A' ' 123' ' ' LEU . . . -64.76 -41.9 95.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.097 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.404 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 40.4 mm-40 -45.98 -39.48 9.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.6 m -83.34 -53.78 5.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 75.0 m-80 -52.78 -59.4 4.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 124' ' ' ARG . 3.1 pp -51.18 -41.13 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.468 ' N ' HD11 ' A' ' 123' ' ' LEU . 51.4 ttt180 -51.37 -35.84 40.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.57 -61.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.33 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 123' ' ' LEU . 49.8 mm -50.72 -47.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -43.31 -27.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -123.17 114.57 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -170.98 -175.38 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 44.4 mt-10 -121.47 125.76 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 59.6 tp -36.53 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 43.5 m-20 -84.57 -52.5 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 137' ' ' SER . 52.1 tt0 -56.53 -47.22 79.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.7 p -37.74 -34.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.07 -43.09 55.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 134' ' ' GLU . 71.2 m -112.8 73.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.78 25.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -68.29 -38.4 81.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.4 -21.52 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.2 mt -98.5 -26.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.8 mt -78.12 -34.43 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -81.44 -27.23 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.75 96.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' CD ' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.47 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.43 -28.17 52.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -73.94 -43.25 58.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.5 -8.91 58.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -93.82 -32.49 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -99.94 -6.44 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.39 -11.98 38.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -98.4 -26.2 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 153' ' ' ILE . 56.0 mt -92.24 15.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 57.5 p -122.4 -28.21 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.02 -24.96 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -19.89 23.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -94.55 2.51 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.25 24.79 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 160' ' ' LYS . 1.1 p -136.05 155.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -136.6 151.44 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.443 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 36.1 mm -88.45 94.35 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.69 -45.84 39.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -169.42 178.8 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 18.9 t -138.43 142.23 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -127.04 135.54 50.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.2 mm -104.48 138.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -95.22 160.28 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -50.38 149.6 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 169' ' ' ILE . 2.5 mp -101.37 146.17 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.52 122.69 50.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.883 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.04 17.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 129.84 18.24 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.356 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -63.12 -51.99 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -55.07 166.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.375 . . . . 0.0 110.874 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.72 -59.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -101.69 122.55 44.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -122.0 156.94 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.98 37.09 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 -37.9 133.98 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 21.4 mp0 -96.83 134.86 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.57 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 56.9 m-70 -106.46 132.99 51.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.84 137.79 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 116' ' ' VAL . 51.6 mt -104.46 121.64 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.08 100.15 10.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 11.4 t -100.92 136.01 19.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.79 145.96 58.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.317 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 149.3 66.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -132.26 119.63 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -74.74 109.91 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.11 131.11 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.97 105.06 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.37 177.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -65.85 -36.52 83.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.02 28.25 0.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.34 42.8 27.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.56 114.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.36 115.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.9 148.97 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.9 m -90.01 115.4 27.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.17 156.54 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.45 140.04 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.09 145.46 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.2 170.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -143.11 121.82 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.03 160.31 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 5.1 p90 -165.83 153.29 10.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.976 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 70' ' ' GLU . 3.5 pt20 -150.44 122.43 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -63.04 92.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.2 pt -76.2 -7.69 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.51 114.27 2.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -51.33 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 103' ' ' LYS . 5.4 p -42.98 -46.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.501 ' N ' ' CG1' ' A' ' 102' ' ' VAL . 10.8 mtpp -73.79 -39.32 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -95.07 54.95 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.57 0.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 29.1 p90 -85.69 28.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 6.2 m-80 52.93 31.17 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 47.1 t 33.64 41.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 m -93.19 -40.76 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.8 -52.24 32.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -52.19 -32.02 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 17.5 mt -57.36 -60.68 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.914 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.0 ptp -69.95 -40.51 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 118' ' ' LEU . . . -57.03 -30.88 64.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 7.3 mm -74.95 -58.37 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.3 m -54.58 -29.97 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -83.37 -53.99 5.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 114' ' ' ALA . 10.4 mt -43.56 -55.29 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' C ' HD21 ' A' ' 123' ' ' LEU . . . -48.29 -52.55 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.471 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.9 mm-40 -37.53 -34.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 m -85.74 -61.14 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.46 -54.61 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.402 HD21 ' C ' ' A' ' 119' ' ' ALA . 2.5 pp -56.15 -40.02 73.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -53.4 -27.41 24.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.97 -62.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.48 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mt -48.49 -41.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.02 -28.92 6.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.487 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -121.69 114.32 20.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.28 -177.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 133' ' ' ASP . 16.1 mt-10 -118.84 129.34 55.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 23.4 tp -36.0 -30.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -94.49 -52.86 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 29.7 tt0 -54.26 -16.5 2.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.2 -59.89 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.4 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.8 pp -60.39 -25.15 65.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -77.52 -50.71 12.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.91 74.63 2.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -103.92 -30.91 10.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.89 -23.7 62.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.68 -49.78 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -48.9 -33.36 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 23.8 p30 -86.34 -23.81 26.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -70.93 -56.23 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -50.92 -62.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -47.28 -55.38 8.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 151' ' ' ASP . 28.4 ttp180 -42.59 -51.21 5.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.78 -37.1 85.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -74.53 -19.52 60.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.85 -9.49 15.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -90.35 -18.6 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.76 -35.45 14.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 86.6 mt -77.84 -17.1 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 40.6 p -92.63 -42.28 9.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -44.04 -26.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' CG ' ' O ' ' A' ' 153' ' ' ILE . 0.0 OUTLIER -75.23 -37.2 61.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' A' ' 154' ' ' THR . 34.1 m0 -85.14 26.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 62.91 12.75 44.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 6.0 p -120.87 138.19 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.083 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.458 ' N ' HG23 ' A' ' 159' ' ' VAL . 0.2 OUTLIER -121.1 143.9 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 5.3 mm -85.01 106.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 18.8 p -57.26 -61.47 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -156.11 179.31 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 43.0 t -132.87 149.65 32.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -131.61 137.2 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.44 141.71 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -99.45 158.88 15.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.92 144.73 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 31.4 mt -99.46 156.28 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -116.62 129.34 25.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.615 0.722 . . . . 0.0 110.919 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 164.73 33.44 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.42 34.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -76.74 161.64 28.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.5 t -121.6 151.08 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -85.2 -57.42 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -71.06 138.32 49.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.75 123.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.48 -75.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' O ' ' CD2' ' A' ' 68' ' ' LEU . 1.9 tt 56.04 31.11 17.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.544 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -80.13 96.66 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -70.73 157.5 37.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.544 ' CE1' ' O ' ' A' ' 69' ' ' ARG . 6.1 m-70 -129.03 147.58 50.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.26 145.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.439 ' CD1' HG23 ' A' ' 115' ' ' ILE . 26.9 mt -104.29 129.15 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.29 93.1 8.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.469 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 7.9 p -94.21 137.58 22.8 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.572 0.701 . . . . 0.0 111.152 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 146.98 61.99 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.741 2.294 . . . . 0.0 112.343 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 153.35 69.07 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -140.02 127.06 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.75 110.44 20.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -122.41 136.7 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.4 mt -68.35 108.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -53.42 -175.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -68.93 -40.67 78.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.42 27.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 47.0 t30 54.58 50.48 15.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 97.5 t -118.74 115.52 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.1 p -80.15 113.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 m -141.65 141.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -83.12 122.13 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -108.53 138.31 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -146.81 136.57 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.21 174.53 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.96 151.37 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.7 124.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -83.85 163.23 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.534 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 8.3 p90 -165.68 160.48 17.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -151.41 142.0 22.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.8 t -84.92 95.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.8 -15.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -146.61 106.29 4.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -12.74 33.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.238 . . . . 0.0 112.349 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -70.79 -55.81 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -72.97 -26.4 61.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -95.77 43.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 p -93.3 40.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.3 p90 -123.22 28.83 6.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.5 m-80 61.63 27.18 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.522 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 14.4 p 35.26 31.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.5 m -89.31 -49.2 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 10.8 m-20 -56.56 -45.64 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.5 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -62.52 -33.41 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.5 -53.73 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.472 ' O ' ' CD ' ' A' ' 117' ' ' LYS . 13.6 ptp -76.88 -21.38 55.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -78.63 -47.87 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.07 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.5 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 8.9 mm -50.39 -53.02 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.47 ' CG2' ' HD2' ' A' ' 117' ' ' LYS . 3.5 m -59.51 -43.0 89.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.472 ' CD ' ' O ' ' A' ' 113' ' ' MET . 0.8 OUTLIER -70.94 -10.72 60.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -95.01 -39.62 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.17 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -61.28 -34.62 75.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 m -80.59 -44.43 18.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -64.15 -46.06 85.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.2 pp -62.66 -40.68 97.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.468 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 44.8 mtt180 -52.71 -21.42 4.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.92 -59.69 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 mp -75.82 -58.33 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.2 mm -50.17 -38.6 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.97 -23.09 14.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -131.26 114.13 14.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.47 -176.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 133' ' ' ASP . 19.0 mt-10 -122.0 120.48 34.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 41.8 tp -33.72 -34.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -86.0 -45.82 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 135' ' ' THR . 17.8 tp10 -58.64 -48.77 79.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 134' ' ' GLU . 20.2 p -31.9 -43.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.094 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.45 -52.48 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.5 m -64.4 -52.93 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.49 54.56 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.449 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -89.53 -37.88 14.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.472 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 3.8 p-10 -69.78 -21.54 63.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.68 -46.99 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.13 -45.7 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' HB3' ' CG1' ' A' ' 166' ' ' ILE . 2.4 p30 -71.66 -28.71 63.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.42 -58.28 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -47.57 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -46.84 -56.51 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.421 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 43.7 ttp85 -45.24 -47.02 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -64.17 -55.86 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -51.99 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.39 -34.26 64.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -23.28 62.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -93.2 -27.62 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mm -79.12 -18.09 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.3 p -99.16 -33.17 10.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.91 -18.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 9.8 ptt180 -92.13 -27.94 17.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.499 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.5 m0 -89.8 11.65 19.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 77.32 11.33 85.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.51 147.88 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.388 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 150.32 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.0 mm -84.71 96.55 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.465 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 47.9 p -48.96 -63.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -146.78 -179.36 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -141.08 144.25 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.112 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -137.16 139.48 41.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.473 ' CG1' ' HB3' ' A' ' 143' ' ' ASN . 4.2 mm -108.43 140.76 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -97.06 161.65 13.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -45.72 154.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.1 mp -105.13 152.55 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.7 m-20 -103.88 122.41 44.57 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 170.02 17.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.228 . . . . 0.0 112.371 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 145.99 59.02 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -66.55 162.65 20.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.878 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.9 m -145.5 158.67 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.79 172.09 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -81.12 146.31 30.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.9 m -154.93 145.31 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.65 -34.25 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 mp 62.85 35.43 13.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -68.42 137.98 54.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 23.4 mp0 -85.56 141.88 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 92.5 m-70 -110.38 132.26 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.22 138.26 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 115' ' ' ILE . 17.7 mt -102.33 125.9 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.24 112.43 24.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 5.1 p -118.21 138.76 25.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.593 0.711 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.72 150.95 69.13 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.274 . . . . 0.0 112.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.469 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 154.64 67.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.671 2.247 . . . . 0.0 112.395 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.433 ' CD ' HD12 ' A' ' 123' ' ' LEU . 3.2 pt20 -136.94 152.04 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.37 115.66 30.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 m -128.44 147.91 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 39.9 mt -79.65 108.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.13 -176.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -65.6 -45.45 83.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -83.75 34.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 16.2 t-20 49.69 49.82 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 84.9 t -116.57 109.44 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.1 p -74.21 116.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.63 155.03 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 24.5 m -96.89 126.24 41.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.5 p -115.09 151.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -154.48 133.0 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.88 152.17 30.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 28.8 m -101.87 165.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.8 t -135.51 126.12 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -85.42 158.86 20.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.2 p90 -165.6 154.09 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' NE2' ' OE2' ' A' ' 70' ' ' GLU . 3.8 pt20 -150.08 129.23 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.46 91.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 pt -73.57 -31.65 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -128.67 94.72 34.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.601 0.715 . . . . 0.0 110.859 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.49 10.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.3 -44.99 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -90.19 -21.11 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -96.84 43.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.42 40.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 39.7 p90 -117.93 35.12 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.6 m-80 50.93 36.56 15.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.52 ' C ' ' O ' ' A' ' 107' ' ' ASN . 3.7 p 27.72 41.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 107' ' ' ASN . 1.6 t -95.34 -57.72 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -49.73 -43.78 48.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.6 mt -58.94 -70.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.936 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 ptp -51.78 -38.16 54.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.54 -66.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 111' ' ' PHE . 15.6 mm -38.7 -63.89 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' ILE . 91.3 t -37.13 -51.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -67.73 -55.24 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ALA . 58.4 mt -46.28 -61.55 1.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' LEU . . . -36.52 -60.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.454 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 4.9 mt-30 -39.17 -47.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.1 m -67.92 -47.9 67.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.416 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 71.1 m-80 -63.29 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 1.6 pp -44.51 -39.25 4.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -53.84 -37.1 63.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.13 -47.91 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -84.9 -63.83 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 2.1 mp -51.84 -41.52 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.17 -30.21 7.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.8 pt-20 -118.54 113.05 20.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.21 -174.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 58.0 mt-10 -118.31 129.18 55.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 131' ' ' GLU . 64.6 tp -36.72 -29.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 3.8 p-10 -94.08 -46.08 7.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' SER . 2.6 tp10 -55.04 -44.97 75.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 1.1 p -34.24 -65.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD11 ' C ' ' A' ' 136' ' ' LEU . 1.5 pp -53.76 -34.99 60.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 134' ' ' GLU . 1.8 t -70.32 -70.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.21 69.69 0.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -97.94 -34.45 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -72.63 -33.0 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mp -68.53 -45.94 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.6 mt -54.27 -53.23 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -52.19 -41.0 62.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.97 -54.19 48.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -53.69 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.8 tp -41.36 -38.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -64.23 -44.87 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.83 -12.38 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 122' ' ' ASN . 28.2 mt-10 -87.95 -39.05 15.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.4 HD12 ' CB ' ' A' ' 118' ' ' LEU . 3.8 mm? -93.8 -13.56 27.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.55 -22.75 56.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 pttt -89.77 -30.07 18.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.73 -19.26 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 43.2 p -97.25 -28.17 14.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -47.37 -40.59 17.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.549 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.3 ptm180 -66.45 -32.06 73.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.549 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 42.2 m0 -83.71 14.09 4.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 65.8 33.96 87.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.448 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.16 145.69 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -128.83 135.44 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.71 86.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.43 ' CG2' ' NE2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -38.37 -47.43 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -169.54 179.99 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 165' ' ' GLU . 87.8 t -140.84 140.09 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.435 ' N ' HG12 ' A' ' 164' ' ' VAL . 68.9 mt-10 -123.83 147.12 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.65 142.15 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -103.16 161.05 14.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -41.68 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -113.75 156.5 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 11.4 m-20 -115.85 122.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.633 0.73 . . . . 0.0 110.822 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 170.55 16.28 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 141.38 44.92 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.11 166.7 22.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 t -79.0 -40.56 31.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.847 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 56.07 33.03 21.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.81 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' HIS . 2.7 p-80 -121.51 118.61 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 m -148.73 126.64 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -103.24 40.72 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mt 48.29 26.48 1.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 -61.75 114.61 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.2 155.39 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.56 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 51.0 m-70 -124.0 148.48 46.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.32 145.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.461 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 96.5 mt -113.3 124.45 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.32 107.23 18.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 6.2 p -105.65 138.3 19.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.76 144.94 55.64 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.717 2.278 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 159.94 51.54 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.633 2.222 . . . . 0.0 112.351 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.38 116.64 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 79' ' ' GLU . 14.7 mp0 -71.49 118.56 14.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.73 132.5 61.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 47.9 mm -60.9 113.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 130' ' ' MET . 0.7 OUTLIER -63.27 -178.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 130' ' ' MET . 17.5 tptt -61.41 -47.32 86.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.7 32.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 32.5 m-20 51.4 48.04 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.87 109.38 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.23 108.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.34 153.31 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -94.92 128.54 41.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.57 149.6 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.14 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -159.54 127.3 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.455 ' CB ' HD13 ' A' ' 166' ' ' ILE . . . -142.91 151.53 41.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.08 153.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.115 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.447 ' CG1' HD11 ' A' ' 161' ' ' ILE . 25.5 t -127.86 127.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -87.02 159.96 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.951 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 4.2 p90 -165.59 153.51 11.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.404 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.6 pt20 -149.74 128.8 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.5 91.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.096 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 pt -71.96 -12.75 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -158.4 105.66 1.67 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.901 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -13.44 34.81 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.388 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.26 -27.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.184 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -101.31 -20.57 15.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.53 48.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 m -83.0 3.2 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 38.1 p90 -84.22 24.53 0.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.2 m-80 62.1 31.2 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.567 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.3 t 33.79 40.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.5 p -95.11 -60.02 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.05 -36.56 29.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.461 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -65.18 -33.94 77.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.84 -57.03 7.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.5 ptp -67.43 -26.48 66.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.28 -49.45 16.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.445 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 2.6 mm -45.83 -62.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 m -53.0 -25.54 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -83.94 -25.51 30.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.84 -46.04 22.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.915 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.94 -53.35 56.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.41 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 37.3 mm-40 -40.99 -27.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 m -92.09 -37.14 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -75.45 -58.23 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 pp -51.05 -40.46 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -54.6 -22.99 15.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.61 -58.38 3.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.4 mp -76.09 -62.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.64 -40.84 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.79 -20.13 3.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.4 pt-20 -130.8 113.62 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.479 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -173.7 -175.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.854 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 24.4 mm-40 -123.17 120.4 33.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' GLU . 65.0 tp -35.35 -31.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.5 t70 -76.04 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -54.64 -46.49 73.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 136' ' ' LEU . 70.6 p -42.36 -52.88 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 135' ' ' THR . 41.4 mt -35.8 -49.94 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 t -121.95 87.64 2.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.83 35.06 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.98 -32.08 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -50.63 -36.97 37.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' ALA . 11.0 mt -87.45 -55.59 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.9 mt -42.69 -36.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 3.5 p30 -81.73 -31.54 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.451 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -60.78 -54.66 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -56.45 -63.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.0 mt -42.6 -52.4 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -45.22 -41.83 8.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.06 -25.0 32.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 8.0 mm-40 -79.81 -10.39 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 -39.27 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.98 -8.42 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.47 ' CG ' HD12 ' A' ' 153' ' ' ILE . 8.8 ptpt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.8 mp -87.1 -18.31 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -94.61 -14.93 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.104 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.54 -14.7 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.555 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 15.4 ptm180 -96.7 -22.38 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.555 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.3 m0 -93.87 5.27 52.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.25 22.8 67.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.4 t -123.16 135.47 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.073 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.32 130.41 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.447 HD11 ' CG1' ' A' ' 94' ' ' VAL . 18.5 mm -73.43 91.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 12.5 p -45.36 -44.6 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.402 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.9 OUTLIER -166.82 178.96 5.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 71.7 t -137.87 122.12 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -104.36 138.46 40.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.455 HD13 ' CB ' ' A' ' 92' ' ' ALA . 24.4 mm -112.67 142.34 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -103.11 159.57 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -47.42 160.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -108.01 156.66 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.7 m-20 -104.99 119.99 51.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.887 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 163.8 36.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.287 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.405 ' CD ' HD23 ' A' ' 132' ' ' LEU . 53.5 Cg_endo -69.78 121.87 8.55 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -47.91 156.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.843 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -162.41 135.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.854 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.68 165.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -92.59 145.74 24.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.3 39.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.31 130.93 22.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD22 ' NE2' ' A' ' 97' ' ' GLN . 11.8 mt -92.72 25.03 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -37.84 136.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -118.65 157.89 26.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.578 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 26.3 m-70 -123.98 146.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.467 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 8.1 p -95.4 145.93 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.418 ' CD1' HG22 ' A' ' 115' ' ' ILE . 19.5 mt -105.68 130.02 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.24 95.06 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 3.3 p -99.17 136.94 20.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.488 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.4 Cg_endo -69.71 149.44 67.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 0.0 112.38 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 168.78 20.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.38 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -146.73 118.12 7.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -76.83 102.65 6.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.81 148.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.5 mt -79.87 106.39 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.41 -174.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -67.88 -43.15 80.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.44 35.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 6.5 t30 51.01 43.25 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.36 110.82 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.86 113.95 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.1 150.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -89.38 109.67 20.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.57 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.14 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -168.67 144.09 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.83 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 72' ' ' VAL . 18.0 m -93.61 158.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.458 HG22 ' CD1' ' A' ' 150' ' ' LEU . 20.0 t -128.47 137.16 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.142 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -98.08 160.52 14.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.578 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 33.8 p90 -165.83 155.09 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.453 ' NE2' HD22 ' A' ' 68' ' ' LEU . 3.8 pt20 -141.96 121.12 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.97 93.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -80.81 -29.78 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -127.8 96.66 31.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 0.37 5.7 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 23.9 t -81.39 -44.37 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -86.58 -32.58 20.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -87.11 38.66 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 102' ' ' VAL . 4.8 m -85.83 12.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.1 p90 -93.02 35.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.4 m-80 52.18 31.81 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.488 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 43.1 t 34.63 40.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.1 p -97.27 -38.82 9.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.54 -45.22 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.603 ' C ' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -61.75 -32.54 72.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -61.06 -59.51 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.5 ptp -70.3 -37.82 74.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.0 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.572 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 6.8 mm -63.22 -52.77 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.419 HG21 ' N ' ' A' ' 117' ' ' LYS . 2.6 m -65.52 -20.23 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.419 ' N ' HG21 ' A' ' 116' ' ' VAL . 6.5 mtpm? -91.48 -15.55 28.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.413 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 17.0 mt -88.94 -39.3 13.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.06 81.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.4 mm-40 -44.98 -30.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.3 m -87.42 -49.63 7.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 72.4 m-80 -62.7 -59.27 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 127' ' ' ILE . 3.2 pp -48.84 -42.82 37.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -51.67 -41.67 61.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.72 -57.57 11.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -76.32 -62.36 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 123' ' ' LEU . 20.8 mt -49.3 -44.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 130' ' ' MET . 7.3 pt-20 -121.4 113.96 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.839 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.04 -175.29 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 37.9 mt-10 -121.7 130.63 53.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 31.2 tp -36.17 -29.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.1 p-10 -88.66 -63.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -40.99 -43.84 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.2 p -39.62 -69.81 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 pp -55.4 -29.4 58.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -107.54 40.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -166.58 64.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.4 ptt180 -104.78 -37.11 7.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.3 -27.65 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -88.23 -48.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 64.9 mt -54.02 -48.02 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 11.3 p30 -69.76 -42.96 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -47.39 -48.33 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.047 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -64.0 -62.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.63 -58.94 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 26.0 ttm105 -40.67 -40.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.97 -45.92 22.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -57.89 -28.1 63.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.458 ' CD1' HG22 ' A' ' 94' ' ' VAL . 36.1 mt -96.39 -31.09 13.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -20.03 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.44 -26.01 16.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 153' ' ' ILE . 98.2 mt -86.58 -8.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.473 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 62.3 p -103.19 -36.67 8.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -42.62 -27.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.35 -38.18 31.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 154' ' ' THR . 36.1 m0 -84.48 34.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.62 23.61 4.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.478 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 2.1 p -130.59 143.35 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.46 ' N ' HG21 ' A' ' 159' ' ' VAL . 0.8 OUTLIER -130.86 147.14 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.405 HD12 ' CG1' ' A' ' 94' ' ' VAL . 12.7 mm -82.91 109.57 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.435 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 75.9 p -64.55 -43.33 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -165.93 -178.54 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.412 ' HB ' ' NH2' ' A' ' 147' ' ' ARG . 38.4 t -141.17 137.5 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.404 ' N ' HG11 ' A' ' 164' ' ' VAL . 19.3 mt-10 -123.34 136.97 54.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 mm -99.09 140.87 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -95.69 161.68 13.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -47.99 162.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.1 mp -118.75 157.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.503 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.3 t70 -127.16 133.64 25.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 0.0 110.806 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 168.76 20.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 163.68 37.36 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -44.24 145.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.805 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 m -142.68 144.47 32.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.874 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -102.95 -52.86 2.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.9 107.91 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.34 178.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 69' ' ' ARG . 2.9 m-20 -132.02 40.81 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' ASP . 4.0 mm? 35.38 34.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 67' ' ' ASP . 35.1 mtt180 -36.14 109.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -76.91 151.08 35.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -120.55 151.7 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.56 HG12 ' CE1' ' A' ' 95' ' ' TYR . 17.5 m -98.16 156.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' CG2' HG21 ' A' ' 116' ' ' VAL . 31.4 mt -118.19 125.02 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.27 111.27 18.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.469 ' CG2' ' HA ' ' A' ' 116' ' ' VAL . 85.9 t -120.53 132.19 24.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.95 69.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.75 166.93 25.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -146.44 117.49 7.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.83 107.03 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.76 145.22 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 41.0 mm -74.33 109.22 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.35 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -67.34 -45.09 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.15 32.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.1 m-20 50.69 44.3 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.48 110.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.11 115.19 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.94 150.0 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.145 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 95.1 m -97.64 130.55 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.34 157.44 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' CG ' ' HB2' ' A' ' 167' ' ' GLN . 18.4 p-10 -160.43 139.53 10.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.86 150.87 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.29 170.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' A' ' 150' ' ' LEU . 19.8 t -135.14 131.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.56 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.8 m-30 -91.78 157.95 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -165.65 158.19 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -152.3 114.5 4.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.85 92.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.7 pt -76.05 -18.49 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -146.54 106.38 4.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.585 0.707 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -18.41 37.14 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.95 -25.75 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -101.47 -38.23 8.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.555 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -83.78 34.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.64 -5.99 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 40.1 p90 -85.13 26.44 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 109' ' ' SER . 14.8 m-80 56.37 37.05 28.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.561 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 11.1 p 32.8 36.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' ASN . 7.1 t -93.98 -52.25 4.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -51.4 -46.33 62.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.551 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.6 OUTLIER -58.67 -37.45 76.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.63 -66.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 ptp -57.04 -26.08 59.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.23 -65.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.551 HG13 ' CE2' ' A' ' 111' ' ' PHE . 11.9 mm -39.63 -64.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.469 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 49.1 t -36.22 -40.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.03 -55.0 5.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.8 mt -45.69 -49.63 14.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.57 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 36.2 mm-40 -51.87 -39.53 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -76.71 -56.84 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -53.38 -57.42 10.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 127' ' ' ILE . 3.1 pp -51.21 -43.12 61.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.2 ttt85 -49.84 -38.69 36.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.85 -54.28 41.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.68 -62.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 123' ' ' LEU . 43.6 mm -48.7 -39.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.36 -30.14 24.85 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -122.02 114.02 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -172.19 -175.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 26.2 mt-10 -119.08 132.96 56.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 131' ' ' GLU . 48.8 tp -35.81 -30.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 21.6 t70 -90.21 -53.43 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -45.38 -37.51 5.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -65.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -28.85 67.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.0 p -103.15 39.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.2 60.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -89.97 -33.35 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.7 -43.35 99.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.0 mt -67.23 -50.7 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.51 -50.5 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -57.57 -55.33 36.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -45.43 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 145' ' ' ARG . 5.1 mmp_? -53.93 -69.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -55.64 -62.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.461 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 38.8 ttt-85 -41.69 -34.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.8 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.59 -56.47 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' A' ' 94' ' ' VAL . 94.4 mt -54.29 -35.86 63.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -15.82 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -84.57 -44.34 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.7 mt -72.03 -5.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.5 p -102.55 -37.66 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -48.51 -20.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.569 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.2 ptp180 -87.34 -34.09 18.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.569 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.4 m0 -86.11 19.25 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.77 19.12 62.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.55 148.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.144 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -128.66 148.46 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 27.9 mm -88.61 100.86 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -51.66 -51.17 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.203 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -163.98 -176.56 4.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 69.6 t -140.43 143.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.19 137.44 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.5 mm -107.24 123.22 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.421 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.5 mm-40 -78.11 157.71 29.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -42.43 157.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -110.8 155.72 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.6 m-20 -113.23 120.49 40.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.552 0.691 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 170.04 17.44 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.667 2.244 . . . . 0.0 112.358 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 123.95 10.61 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.379 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -64.9 168.05 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.2 p -128.73 120.33 26.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.362 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.72 164.28 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -74.66 165.64 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.51 154.6 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.2 175.28 5.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 29.17 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 -74.29 125.9 29.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.09 148.15 24.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 16.0 m-70 -115.62 143.83 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.1 145.63 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.8 mt -109.02 129.2 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.58 100.11 12.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.6 t -106.23 134.78 19.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.664 0.745 . . . . 0.0 111.148 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.72 151.28 69.24 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.745 2.297 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 54.1 Cg_endo -69.67 161.08 47.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.476 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 5.2 mt-30 -139.67 117.82 11.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.06 110.69 11.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.65 142.95 41.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.6 mm -73.45 105.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.03 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -66.09 -36.47 83.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.2 29.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.46 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 60.1 t30 49.85 51.97 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.46 123.47 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' CG2' ' CD1' ' A' ' 81' ' ' ILE . 3.6 t -82.57 116.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.57 155.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 m -100.71 122.96 44.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.433 ' C ' ' OD1' ' A' ' 91' ' ' ASP . 34.7 m -114.18 169.09 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -174.93 135.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.79 146.85 24.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -95.66 166.4 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.421 ' CG1' HD13 ' A' ' 161' ' ' ILE . 12.9 t -133.23 127.01 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -86.64 159.05 19.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 23.0 p90 -165.69 155.07 12.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -145.86 123.99 12.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.0 t -63.97 96.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.4 pt -80.58 -28.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -135.58 108.53 10.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.859 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -48.49 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.371 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -48.62 -23.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -103.83 -27.94 11.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.546 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.82 41.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.75 44.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 13.6 p90 -117.75 36.4 4.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.7 m-80 55.88 28.31 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 107' ' ' ASN . 14.0 p 33.26 39.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.162 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' ASN . 25.9 m -94.74 -48.19 6.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.2 -46.72 88.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.459 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -61.08 -41.02 95.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.0 -63.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -58.41 -29.17 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.39 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.459 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 3.1 mm -39.3 -62.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.45 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 55.8 t -34.86 -48.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.82 -50.05 22.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 47.9 mt -44.08 -49.12 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.7 90.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.476 ' OE1' ' CG ' ' A' ' 78' ' ' GLN . 35.3 mm-40 -48.35 -35.67 12.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 m -86.57 -63.31 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 69.7 m-80 -42.72 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -59.25 -43.68 92.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.451 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 19.4 ttt180 -51.28 -26.96 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mp -76.47 -60.37 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.6 mt -49.78 -41.64 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.06 -23.85 2.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.61 114.21 17.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.89 -176.79 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 mt-10 -115.86 119.81 37.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 21.5 tp -36.61 -29.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -86.99 -58.52 2.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.1 tp10 -48.0 -50.32 27.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' GLU . 40.6 p -35.05 -34.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 134' ' ' GLU . 54.3 mt -62.37 -57.78 10.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 m -77.62 -50.7 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.96 70.41 0.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.4 ptt85 -112.59 -9.73 13.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.97 -33.78 21.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.6 mp -73.86 -37.65 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 44.5 mt -60.6 -43.91 95.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.462 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.8 p30 -79.98 -31.39 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.94 -34.12 74.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -79.08 -56.57 4.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.11 -42.67 29.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -53.8 -40.18 66.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.08 -57.16 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -44.36 -62.02 1.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.414 ' N ' HD11 ' A' ' 150' ' ' LEU . 9.4 mp -60.17 -36.09 76.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -11.53 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.76 -27.27 15.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 153' ' ' ILE . 39.4 mt -96.62 17.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 p -125.71 -34.05 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.8 -25.22 26.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.535 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 14.3 ptm180 -83.56 -20.11 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.535 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 52.9 m0 -96.85 1.57 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.97 12.32 77.15 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 160' ' ' LYS . 53.5 t -119.61 154.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.926 0.394 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -134.01 151.64 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.466 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 32.4 mm -89.81 92.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.12 -48.96 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -163.89 -175.98 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 84.2 t -139.74 141.89 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 164' ' ' VAL . 8.4 mt-10 -124.47 135.39 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.405 ' CD1' ' HB3' ' A' ' 143' ' ' ASN . 3.7 mm -105.33 139.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.69 161.14 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -44.4 156.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.6 mp -108.96 156.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.6 m-20 -113.01 120.81 39.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 110.9 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.2 31.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 153.92 68.61 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.358 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -93.15 167.44 11.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 64' ' ' ASP . 8.2 t -166.44 170.01 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' SER . 9.9 t70 -37.21 151.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -85.05 106.16 16.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.46 126.85 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.26 112.04 16.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 69' ' ' ARG . 4.6 mp -53.74 -21.9 8.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -34.37 142.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 2.2 pm0 -115.12 149.42 37.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 88.8 m-70 -106.9 143.73 34.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 140.3 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' CD1' HG22 ' A' ' 115' ' ' ILE . 26.5 mt -102.92 125.08 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 94.0 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 5.7 p -97.62 133.68 23.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 111.181 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.74 144.66 54.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.73 157.82 59.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -140.94 118.51 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -71.45 109.57 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.45 132.52 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 45.5 mm -68.16 109.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.44 -175.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -69.71 -38.91 77.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -84.53 26.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 37.6 t30 52.83 48.72 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.87 117.83 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 81' ' ' ILE . 47.1 t -77.79 113.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.173 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -143.39 157.35 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 25.5 m -103.62 123.66 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.47 142.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.11 132.06 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -152.28 164.55 37.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.31 159.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.97 118.94 30.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.5 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 7.3 m-30 -79.38 159.64 27.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.5 p90 -165.71 147.89 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.954 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.453 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -140.24 131.72 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.3 t -71.71 91.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.095 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.14 -21.5 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.46 ' HB3' ' CA ' ' A' ' 158' ' ' GLY . 22.3 t70 -134.95 92.85 18.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.593 0.711 . . . . 0.0 110.871 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 -5.18 15.61 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.663 2.242 . . . . 0.0 112.294 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.64 -50.03 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -87.39 -18.06 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.545 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -99.44 43.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 p -89.41 14.19 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.545 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.5 p90 -97.47 29.8 3.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.2 m-80 58.75 28.06 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.497 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 10.0 m 35.94 38.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.4 p -92.33 -48.74 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -59.25 -42.76 91.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.507 ' C ' ' CD1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -61.39 -31.93 71.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.62 -54.3 10.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.8 ptp -74.15 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -93.2 -57.99 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.506 HG13 ' CE2' ' A' ' 111' ' ' PHE . 7.7 mm -39.68 -57.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 117' ' ' LYS . 1.7 m -57.79 -42.08 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 18.4 mtmt -67.4 -18.9 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 18.5 mt -88.16 -42.36 12.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.23 68.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.43 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.1 mm-40 -57.7 -28.28 63.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.6 m -89.9 -54.69 3.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -55.49 -52.39 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' CD1' ' C ' ' A' ' 123' ' ' LEU . 1.3 pp -56.1 -40.18 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.455 ' N ' HD11 ' A' ' 123' ' ' LEU . 12.8 ttt180 -56.44 -18.14 10.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.68 -61.06 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -74.97 -50.8 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 34.4 mm -55.99 -38.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.34 -28.28 27.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.521 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.34 114.29 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.55 -177.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.0 mt-10 -122.14 128.85 51.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.1 tp -34.76 -32.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -86.37 -58.27 2.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 136' ' ' LEU . 2.5 tp10 -47.91 -47.05 32.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 28.6 p -33.5 -34.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 134' ' ' GLU . 14.1 mt -84.66 -57.78 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -52.78 -53.12 52.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.84 57.81 3.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -90.92 -36.86 13.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.459 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 18.4 t0 -69.1 -20.11 64.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.93 -58.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -42.57 -42.18 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 140' ' ' ASP . 1.4 p30 -76.76 -35.89 57.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.427 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -54.68 -48.63 72.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 148' ' ' GLU . 5.0 mmp_? -62.63 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 3.7 mm? -38.15 -37.56 0.28 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.469 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 40.7 ttt-85 -62.21 -44.11 97.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' ARG . 11.4 tp10 -74.49 -46.29 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.07 -54.09 50.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -7.62 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -97.92 -41.89 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.93 5.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.8 p -116.61 -28.86 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -58.3 -28.88 65.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.552 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 8.3 ptp180 -83.98 -16.33 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.845 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.552 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 54.7 m0 -98.87 0.63 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 84.78 9.34 81.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.63 141.64 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.22 129.17 51.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.44 109.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.453 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 70.1 p -62.06 -44.41 96.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.76 179.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 86.8 t -139.32 132.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -116.57 144.2 44.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 mm -109.16 142.26 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -102.14 159.58 15.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -47.53 146.12 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.5 mp -96.0 156.57 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.0 m-20 -108.66 119.23 49.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 168.37 21.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 161.14 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.381 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -102.07 -49.08 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.8 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 m -157.72 135.98 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -57.58 165.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -82.58 143.81 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.4 t -120.52 121.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -152.49 168.58 25.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLU . 1.6 tt -44.56 -26.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 -40.05 95.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -77.77 145.14 36.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 81.5 m-70 -110.31 142.94 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.45 139.58 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.467 HD11 ' CZ ' ' A' ' 111' ' ' PHE . 32.5 mt -106.45 119.58 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.89 124.26 29.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.479 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 14.5 p -121.1 136.84 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.652 0.739 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.74 147.98 64.18 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.71 51.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' OE1' ' CZ ' ' A' ' 124' ' ' ARG . 7.6 tt0 -126.86 126.84 43.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -93.37 96.43 9.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.405 ' CG1' ' OE1' ' A' ' 78' ' ' GLN . 15.2 m -108.54 145.27 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 74.3 mt -70.27 106.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.403 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.36 -175.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.54 -39.17 77.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.94 34.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.7 t-20 48.08 45.79 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' CG1' ' HG3' ' A' ' 172' ' ' PRO . 58.3 t -118.5 110.59 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.25 123.89 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.39 151.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -91.71 116.81 29.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.02 160.16 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.124 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.85 137.0 3.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.411 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 142.22 20.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.88 159.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.471 HG22 ' CD1' ' A' ' 150' ' ' LEU . 25.7 t -135.24 137.67 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -97.37 163.27 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 1.4 p90 -165.59 156.38 13.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -152.75 134.21 14.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.14 99.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.3 pt -83.44 -9.35 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' CG ' HG22 ' A' ' 102' ' ' VAL . 30.9 t0 -155.96 109.77 2.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.655 0.741 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.35 16.76 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.402 HG22 ' CG ' ' A' ' 100' ' ' ASP . 34.2 m -62.52 -14.99 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -103.58 -26.0 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -104.47 45.8 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.83 -2.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.564 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.7 p90 -86.49 38.44 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 49.2 27.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.564 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.2 t 36.09 40.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.8 t -96.85 -50.42 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.91 -40.42 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.4 t80 -61.51 -40.52 94.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.48 -67.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -55.81 -38.99 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -58.64 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.529 HG13 ' CE1' ' A' ' 111' ' ' PHE . 11.3 mm -46.31 -58.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.79 -23.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -93.57 -33.18 13.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.44 -51.84 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.26 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -67.14 -31.39 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 94.2 m -87.91 -29.4 20.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.9 -44.74 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 124' ' ' ARG . 1.8 pp -62.63 -40.94 98.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.464 ' N ' HD12 ' A' ' 123' ' ' LEU . 40.8 mtt-85 -52.15 -24.61 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.0 -57.0 3.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.74 -63.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.57 -44.78 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.6 -25.52 1.44 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.543 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -124.18 113.89 18.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.27 -178.03 1.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 132' ' ' LEU . 42.0 mt-10 -120.94 130.5 53.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 131' ' ' GLU . 13.3 tp -34.42 -35.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.2 m-20 -80.83 -51.03 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -54.44 -49.47 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.6 p -45.43 -31.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.1 mt -73.82 -49.46 25.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -106.48 37.27 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.3 21.3 5.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -74.19 -0.93 18.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.66 -27.38 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.4 mp -85.32 -41.33 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.42 -58.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.55 ' CB ' ' CG2' ' A' ' 164' ' ' VAL . 14.4 p-10 -59.43 -33.26 71.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.31 73.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.062 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -84.69 -58.59 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.13 -53.21 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.469 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 24.7 ttp180 -44.33 -40.49 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -57.38 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -48.66 -23.37 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.471 ' CD1' HG22 ' A' ' 94' ' ' VAL . 82.8 mt -102.66 -23.99 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.49 -6.24 58.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.98 -33.28 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -79.02 -17.72 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 159' ' ' VAL . 82.0 p -97.18 -38.28 9.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -42.68 -44.38 4.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.5 ptm180 -60.55 -34.65 74.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.571 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 40.5 m0 -85.53 12.96 7.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.32 11.19 84.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 154' ' ' THR . 55.2 t -119.98 140.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 111.115 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.92 145.09 51.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 23.7 mm -75.85 106.48 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.12 -41.25 74.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -171.21 178.5 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.55 ' CG2' ' CB ' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -129.97 148.42 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -137.82 115.64 11.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.4 mm -93.18 141.53 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.13 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -100.06 160.54 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -51.52 159.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.0 mp -108.26 156.51 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.499 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 5.7 m-20 -115.72 129.66 24.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 161.93 44.01 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.447 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 54.0 Cg_endo -69.74 122.95 9.63 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.375 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -87.11 164.31 16.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 m -62.76 137.67 58.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.843 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.17 -57.77 10.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -79.55 110.39 14.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -144.2 144.24 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -84.3 146.46 27.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 45.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -77.29 133.74 38.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.05 141.6 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 96' ' ' TYR . 90.0 m-70 -101.39 159.05 15.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.33 144.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 115' ' ' ILE . 33.5 mt -106.31 134.79 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.74 108.12 20.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 4.6 p -114.86 136.16 22.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.595 0.712 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.458 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.77 146.12 59.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 159.38 53.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 120' ' ' GLN . 27.2 mt-30 -143.99 129.69 19.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.24 94.83 7.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 140.57 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CD1' HG22 ' A' ' 87' ' ' VAL . 31.3 mm -67.18 102.45 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.52 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -59.69 -42.95 94.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.98 30.04 0.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.845 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 5.7 t-20 51.98 50.62 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.06 120.36 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 81' ' ' ILE . 24.7 t -77.88 116.36 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.63 149.88 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 8.5 m -91.94 117.09 29.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.1 141.44 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -143.84 141.9 30.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.25 145.68 23.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.45 166.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.51 131.68 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.72 157.08 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.441 ' CG ' ' CZ ' ' A' ' 111' ' ' PHE . 8.7 p90 -165.84 156.34 13.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' NE2' ' CG2' ' A' ' 162' ' ' THR . 3.6 pt20 -153.03 121.31 6.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.8 100.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -86.21 -24.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 19.0 t0 -138.57 105.59 7.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.8 Cg_endo -69.79 -43.65 2.51 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.307 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -50.78 -19.23 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -107.91 -34.08 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.543 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -101.91 43.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.1 p -87.25 33.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.544 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 34.4 p90 -111.7 27.42 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 109' ' ' SER . 8.1 m-80 58.09 34.76 24.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.544 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.3 m 33.52 35.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.5 p -86.13 -60.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.823 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.46 -46.5 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.532 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -58.54 -39.67 80.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.07 -65.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -57.97 -31.66 67.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.59 -66.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.532 HG13 ' CE2' ' A' ' 111' ' ' PHE . 16.7 mm -39.04 -63.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -41.61 -50.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -62.13 -50.5 71.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.14 -60.28 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.37 -61.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 78' ' ' GLN . 12.8 mm-40 -39.41 -33.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 m -88.1 -53.95 4.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -56.16 -56.8 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -51.53 -41.06 60.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' N ' HD11 ' A' ' 123' ' ' LEU . 41.5 ttp180 -55.98 -22.37 26.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 -59.58 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.17 -60.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.2 mt -54.97 -47.41 76.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.142 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -42.87 -27.34 0.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.8 pt-20 -120.58 113.33 20.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -173.12 -174.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 133' ' ' ASP . 15.8 mt-10 -116.96 127.84 54.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.462 ' C ' ' O ' ' A' ' 131' ' ' GLU . 20.7 tp -33.32 -35.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.1 t70 -84.15 -65.45 1.01 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 135' ' ' THR . 29.6 tt0 -41.69 -47.7 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 134' ' ' GLU . 72.9 p -33.18 -40.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 mt -73.83 -51.14 17.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 m -61.54 -58.36 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.89 65.39 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' CD ' ' C ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -97.06 -45.21 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.455 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 13.0 t70 -59.07 -29.01 67.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 144' ' ' ALA . 48.3 mt -73.81 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -39.73 -50.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.461 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.5 p30 -69.49 -33.39 72.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' ILE . . . -59.24 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -46.15 -63.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 mt -48.11 -51.3 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 163' ' ' ARG . 26.8 ttm180 -44.49 -40.57 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.5 -56.35 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -42.91 -55.23 3.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.8 mp -68.01 -35.71 78.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -20.87 40.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -82.72 -29.95 29.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 mm -83.71 -17.62 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 157' ' ' TRP . 64.0 p -93.93 -39.96 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -41.51 -29.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.448 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 11.8 ptm180 -79.92 -36.44 36.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 154' ' ' THR . 35.6 m0 -84.16 30.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.26 33.74 39.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 1.5 p -141.49 144.25 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.151 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.413 ' HD2' ' C ' ' A' ' 160' ' ' LYS . 3.3 tmmm? -127.92 151.08 49.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.02 91.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.492 ' CG2' ' NE2' ' A' ' 97' ' ' GLN . 19.0 p -42.3 -46.68 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 147' ' ' ARG . 14.5 ptm180 -169.4 -175.03 2.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 73.8 t -139.72 147.28 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 167' ' ' GLN . 28.4 mm -102.92 142.32 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.401 ' N ' HG21 ' A' ' 166' ' ' ILE . 46.5 mt-30 -98.57 161.88 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -47.52 156.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -109.81 157.51 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 t70 -126.09 133.28 24.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.63 0.729 . . . . 0.0 110.885 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 170.15 17.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 139.86 41.15 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.678 2.252 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -56.29 164.09 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.1 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.4 p -144.01 150.76 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -70.27 169.07 14.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -75.33 123.33 25.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.34 139.13 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -176.21 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.04 46.35 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 -60.83 123.53 17.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -104.74 144.33 31.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.96 145.66 39.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -94.21 140.39 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.562 HD12 ' CD2' ' A' ' 96' ' ' TYR . 21.0 mt -107.55 119.24 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 118.57 20.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' HA ' ' A' ' 116' ' ' VAL . 88.8 t -117.41 132.68 23.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.729 . . . . 0.0 111.119 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.75 144.37 53.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.85 164.28 35.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.628 2.218 . . . . 0.0 112.316 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.424 ' CD ' HD13 ' A' ' 123' ' ' LEU . 1.3 pt20 -146.67 139.44 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.55 129.43 36.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.97 145.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.9 mt -74.73 114.59 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.2 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.15 23.55 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 27.7 m-20 60.41 50.68 5.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.7 t -118.82 111.16 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.5 p -75.27 115.41 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.19 162.2 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 31.9 m -102.84 125.04 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.4 p -105.83 162.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -171.01 134.71 0.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.08 35.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.96 164.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.93 134.28 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -96.77 154.4 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CD2' HD12 ' A' ' 73' ' ' ILE . 3.8 p90 -165.65 161.26 18.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -153.17 114.2 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.84 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.68 -24.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.468 ' HB3' ' CA ' ' A' ' 158' ' ' GLY . 29.3 t70 -133.64 90.12 29.16 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -40.61 5.09 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 0.0 112.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.5 m -38.39 -41.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -91.43 -35.65 14.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.546 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -84.45 41.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.087 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 6.1 p -87.66 47.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.546 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.7 p90 -130.37 32.21 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.3 m-80 60.93 28.06 17.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.467 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 6.4 t 36.1 35.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 107' ' ' ASN . 54.9 m -89.76 -58.75 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -47.46 -54.56 11.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.558 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.3 t80 -50.13 -48.38 53.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.1 mt -51.48 -68.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -60.95 -14.91 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.18 -34.51 23.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.558 HG13 ' CE1' ' A' ' 111' ' ' PHE . 14.1 mm -72.1 -54.83 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.474 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 2.0 m -56.68 -22.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.149 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -92.69 -45.21 8.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.38 -44.1 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.11 97.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.2 mm-40 -47.87 -33.09 6.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.1 m -87.0 -50.57 6.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -58.51 -58.25 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 127' ' ' ILE . 2.3 pp -51.72 -39.99 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.411 ' N ' HD12 ' A' ' 123' ' ' LEU . 65.8 ttt-85 -52.93 -31.99 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.81 -51.69 31.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.83 -60.12 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.461 ' CD1' HG23 ' A' ' 142' ' ' ILE . 47.0 mm -50.61 -38.01 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.11 -33.83 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 130' ' ' MET . 11.9 pt-20 -117.06 113.93 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.404 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -171.8 -177.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.44 121.92 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.8 tp -33.55 -34.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 131' ' ' GLU . 25.3 t0 -83.96 -51.71 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 135' ' ' THR . 49.1 tt0 -52.99 -47.55 68.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 134' ' ' GLU . 29.8 p -35.82 -50.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.51 -47.12 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -102.47 85.58 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.01 37.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.462 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.494 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.1 ttp180 -76.62 -31.42 57.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.18 -38.37 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -78.89 -60.11 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.461 HG23 ' CD1' ' A' ' 127' ' ' ILE . 20.3 mt -42.95 -51.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.72 -60.63 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -49.63 -68.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 149' ' ' GLU . 4.0 mm? -43.03 -59.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' LEU . 45.5 ttp180 -35.74 -43.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.66 -38.7 28.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 146' ' ' LEU . 39.7 mm-40 -62.23 -27.63 69.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.42 -29.72 12.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -15.22 60.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.33 -20.56 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.48 -12.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.0 p -101.31 -33.98 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -50.65 -23.3 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -88.2 -30.23 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -88.09 17.6 4.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 66.71 26.94 73.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.48 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.86 135.75 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 111.148 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.96 139.93 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 42.5 mm -84.98 109.48 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -55.09 37.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -163.0 -176.16 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.408 HG22 ' CA ' ' A' ' 147' ' ' ARG . 59.3 t -140.77 140.47 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.169 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -126.3 135.99 52.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 167' ' ' GLN . 22.0 mm -103.5 141.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.444 ' N ' HG23 ' A' ' 166' ' ' ILE . 81.4 mm-40 -99.14 161.65 13.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -51.59 154.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -104.53 156.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -109.11 120.66 45.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 166.15 28.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 153.67 68.55 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.642 2.228 . . . . 0.0 112.317 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.22 157.91 7.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -107.29 109.71 21.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -88.18 -70.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.437 ' H ' ' CD2' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -118.36 106.76 13.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.818 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG23 ' N ' ' A' ' 67' ' ' ASP . 14.7 p -175.07 149.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.446 ' N ' HG23 ' A' ' 66' ' ' VAL . 6.0 m-20 -47.31 -75.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 67' ' ' ASP . 9.9 mp 35.72 34.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' ASP . 29.9 ptt180 -48.59 174.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 18.4 mp0 -114.59 144.97 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.573 ' CB ' ' CE2' ' A' ' 96' ' ' TYR . 65.7 m-70 -117.4 128.73 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.77 135.44 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.9 mt -100.69 125.66 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.73 103.96 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 12.7 p -106.06 135.07 19.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.78 150.78 68.55 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.627 2.218 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.69 156.94 62.2 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.262 . . . . 0.0 112.348 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -142.99 121.34 12.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.77 105.66 11.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.12 148.78 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 69.3 mt -77.12 106.22 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.36 -174.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.67 -47.63 77.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.84 37.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.9 m120 47.61 54.8 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.9 t -124.38 110.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.35 108.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.46 146.63 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 1.8 m -80.52 113.52 18.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -107.41 143.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 15.8 p-10 -151.73 140.8 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.19 146.92 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.34 159.11 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.462 HG23 ' CD1' ' A' ' 150' ' ' LEU . 40.5 t -131.9 129.12 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.17 159.82 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 71' ' ' HIS . 11.0 p90 -165.56 159.87 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' A' ' 70' ' ' GLU . 3.6 pt20 -152.36 128.72 10.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.32 93.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 100' ' ' ASP . 45.7 pt -73.07 -36.15 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' N ' HG13 ' A' ' 99' ' ' ILE . 24.8 t0 -125.4 99.24 33.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -7.52 21.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 105' ' ' VAL . 54.2 t -76.88 -47.83 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -82.95 -33.36 26.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -88.2 46.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 102' ' ' VAL . 16.1 m -89.22 30.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 45.6 p90 -112.66 35.61 3.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m120 47.12 36.68 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.548 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.2 m 31.08 41.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.1 m -89.19 -59.27 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -52.81 -34.2 52.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.9 OUTLIER -70.36 -40.16 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -62.15 -54.93 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 ptp -68.62 -33.64 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -66.87 -59.08 3.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.552 HG13 ' CE2' ' A' ' 111' ' ' PHE . 16.2 mm -46.33 -63.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.2 t -39.48 -40.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -74.04 -49.46 24.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.7 mt -55.72 -57.56 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.32 -51.38 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.424 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 46.4 mm-40 -42.85 -41.46 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 84.9 m -75.94 -59.3 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -45.77 -57.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 123' ' ' LEU . 3.3 pp -54.06 -43.65 70.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -53.01 -32.4 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.64 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.442 ' CG2' ' NH2' ' A' ' 145' ' ' ARG . 5.2 mp -76.35 -63.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.9 mp -49.62 -45.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.12 -26.18 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.47 113.75 17.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.98 -175.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.3 mm-40 -122.76 123.31 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 131' ' ' GLU . 46.3 tp -34.39 -32.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.9 m-20 -83.93 -46.63 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 131' ' ' GLU . 37.0 tt0 -56.31 -50.58 71.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' LEU . 79.1 p -42.17 -56.35 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.131 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 97.4 mt -34.79 -51.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.9 m -117.76 87.21 2.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.81 39.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -82.97 -40.28 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.71 -44.02 63.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.96 -54.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.03 -36.81 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.497 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 80.5 m-20 -68.92 -19.14 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.4 -40.85 17.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.442 ' NH2' ' CG2' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -66.59 -55.84 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 146' ' ' LEU . 4.1 mm? -57.55 -32.7 67.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 31.6 ttt-85 -79.43 -40.55 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 9.9 tm-20 -63.28 -25.49 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -91.17 -62.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 94' ' ' VAL . 79.4 mt -54.13 -20.72 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 21.0 t0 -83.86 13.85 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -121.45 -40.87 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.1 mt -76.93 -8.42 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.6 p -100.65 -38.01 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -45.98 -37.66 6.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 6.4 ptp180 -66.74 -33.64 76.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.515 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.1 m0 -86.19 10.62 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.52 17.16 80.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.2 t -122.45 141.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -125.16 150.54 46.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.454 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 29.3 mm -85.82 113.88 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.469 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 25.7 p -68.02 -55.53 12.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 163' ' ' ARG . 4.5 ptp180 -156.01 178.0 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 99.4 t -141.41 145.86 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.26 145.1 51.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.497 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 19.9 mm -106.92 142.29 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.411 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 21.4 mm-40 -94.06 161.79 14.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -54.57 141.72 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.2 mp -91.22 157.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 t70 -128.34 133.78 25.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.36 24.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.79 67.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -80.97 -57.83 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.844 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' ASP . 18.5 p -108.9 -60.56 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 63' ' ' SER . 7.4 t70 37.05 39.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -116.63 108.5 16.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -154.14 128.01 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -149.58 134.72 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 69' ' ' ARG . 3.3 mp -54.75 -31.75 58.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' LEU . 25.8 mtt-85 -33.62 125.87 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 11.8 mp0 -75.61 140.86 42.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 66.4 m-70 -108.46 134.46 51.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.543 HG12 ' CE1' ' A' ' 95' ' ' TYR . 11.3 m -93.96 151.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' A' ' 115' ' ' ILE . 20.8 mt -117.56 117.85 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.48 110.38 17.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 7.1 p -115.89 137.07 23.06 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.643 0.735 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.82 149.53 66.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 159.11 54.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.266 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -145.4 115.59 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.78 117.2 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.74 139.1 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.464 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.0 mt -70.29 105.52 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.5 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -64.94 -42.65 94.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.34 30.63 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.464 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER 53.46 44.72 29.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.82 114.21 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.18 114.29 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.089 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.1 m -142.84 144.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.5 m -87.34 124.48 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.26 163.98 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -174.86 136.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 166' ' ' ILE . . . -154.07 151.54 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.2 m -95.65 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.1 132.75 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.4 m-30 -91.05 157.6 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.542 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 7.7 p90 -165.7 146.23 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.476 ' NE2' ' CG2' ' A' ' 162' ' ' THR . 3.6 pt20 -141.92 123.14 14.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.54 124.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -111.11 -30.07 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 99' ' ' ILE . 34.5 t70 -124.38 101.67 34.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.908 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.401 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -41.45 -38.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -91.6 -37.82 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.553 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -91.3 45.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 p -90.73 40.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.553 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 28.7 p90 -119.99 32.83 5.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' SER . 2.9 m-80 49.8 38.02 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.481 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.9 t 34.41 33.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' ASN . 35.6 m -87.98 -51.17 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -47.57 75.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -60.2 -36.32 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.79 -60.54 3.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.9 -45.42 89.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.52 -55.14 37.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.556 HG13 ' CE2' ' A' ' 111' ' ' PHE . 10.9 mm -48.73 -62.96 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.6 t -42.01 -33.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -79.16 -53.97 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.4 mt -52.35 -58.9 5.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -38.84 -51.96 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -43.73 -41.17 4.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.8 m -78.18 -46.94 19.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -57.11 -61.12 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 ' C ' ' A' ' 123' ' ' LEU . 3.9 pp -55.11 -42.14 72.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -54.59 -25.46 26.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.74 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -79.27 -64.22 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.431 ' CD1' HG21 ' A' ' 142' ' ' ILE . 2.9 mp -48.7 -42.66 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -46.91 -30.48 5.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -119.38 113.91 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.458 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -172.61 -175.19 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 133' ' ' ASP . 9.2 mt-10 -119.3 123.88 45.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 131' ' ' GLU . 51.8 tp -33.68 -34.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.3 m-20 -86.17 -54.1 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 135' ' ' THR . 70.7 tt0 -50.8 -49.81 57.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 134' ' ' GLU . 35.1 p -32.49 -51.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 mt -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 134' ' ' GLU . 2.2 m -93.86 41.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -146.84 49.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.465 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 45.8 ttt180 -95.37 -43.27 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.43 -19.4 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.1 mt -95.55 -56.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 46.3 mt -46.82 -41.77 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.465 ' ND2' ' HG2' ' A' ' 139' ' ' ARG . 16.9 p30 -77.69 -20.44 53.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.92 -37.1 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.15 -66.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.4 mt -42.92 -35.75 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -75.71 -41.16 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -18.07 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.26 -48.53 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.88 -35.73 79.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -58.11 -11.85 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -95.88 -45.36 6.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 153' ' ' ILE . 68.8 mt -75.31 -1.45 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 157' ' ' TRP . 26.6 p -109.02 -40.62 4.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.34 -34.88 3.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.562 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 10.2 ptm180 -70.04 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.562 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 51.4 m0 -88.08 11.88 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 69.87 35.12 72.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 20.5 t -138.8 136.62 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -116.3 141.0 48.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.95 96.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.476 ' CG2' ' NE2' ' A' ' 97' ' ' GLN . 12.0 p -47.75 -55.56 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -163.57 -175.95 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.16 137.07 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -119.08 143.72 46.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.407 ' HA ' ' CB ' ' A' ' 92' ' ' ALA . 15.3 mm -109.69 142.26 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.42 161.46 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -43.13 158.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 170' ' ' ASP . 45.4 mt -113.15 154.72 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.456 ' N ' HG21 ' A' ' 169' ' ' ILE . 38.2 m-20 -118.68 126.54 27.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.93 17.75 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 131.56 21.46 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.326 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.55 165.5 11.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.912 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -44.04 -48.73 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.33 -58.5 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 65' ' ' HIS . 4.3 p80 -119.78 113.72 21.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.54 171.71 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -109.44 135.71 50.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mp -81.94 39.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -90.25 104.56 17.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 157.84 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.553 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 86.4 m-70 -124.37 156.74 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 95' ' ' TYR . 2.7 m -99.69 152.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.0 mt -110.03 131.59 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.76 105.99 18.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.2 p -118.3 127.36 26.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.3 Cg_endo -69.78 150.24 67.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.78 164.68 33.64 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.264 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -145.26 115.08 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.76 100.24 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -114.73 137.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.8 mt -70.2 105.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.11 -177.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -67.8 -35.94 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.91 28.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 13.8 m-20 54.32 45.42 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.6 t -114.82 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.04 108.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.436 ' CG1' ' HD3' ' A' ' 172' ' ' PRO . 15.0 m -135.63 152.81 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 3.6 m -88.89 130.87 35.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.21 132.06 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.1 138.33 33.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.78 171.55 18.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -121.66 159.08 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.5 t -130.73 130.42 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 72' ' ' VAL . 3.7 m-30 -91.27 160.81 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.6 p90 -165.85 157.0 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -152.17 132.36 13.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.452 ' CG2' HG13 ' A' ' 108' ' ' VAL . 20.3 t -73.54 98.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -76.55 -19.75 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.082 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -143.91 106.36 4.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.653 0.739 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -10.06 27.6 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.36 -29.65 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE2' ' N ' ' A' ' 158' ' ' GLY . 31.2 mtpt -94.65 -34.56 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -90.92 47.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.55 -5.57 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 33.9 p90 -83.11 16.86 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.5 m120 61.87 38.62 14.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 32.4 m 34.14 36.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 107' ' ' ASN . 8.3 t -89.43 -52.43 5.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.28 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -62.87 -33.28 74.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.23 -58.45 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.5 ptp -64.82 -39.12 93.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -54.59 39.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 111' ' ' PHE . 9.4 mm -50.59 -59.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.7 t -44.12 -42.86 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -69.15 -48.73 61.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.72 -59.77 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -41.32 -45.12 2.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.111 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 38.4 mm-40 -52.42 -41.59 63.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.2 m -80.08 -50.58 10.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -51.53 -52.81 43.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 1.7 pp -60.14 -41.67 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.479 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 57.0 ttt85 -54.31 -21.78 10.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.16 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.55 -55.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.7 mm -51.07 -38.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.103 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.51 -27.31 11.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.449 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -123.24 114.19 19.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.17 -178.34 1.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 133' ' ' ASP . 20.6 mt-10 -122.66 121.56 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' GLU . 24.1 tp -33.73 -34.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' GLU . 58.0 m-20 -78.48 -50.38 11.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 tp10 -59.19 -46.98 86.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 p -40.57 -36.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.35 -55.47 21.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -101.54 46.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -132.79 43.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 139' ' ' ARG . 6.4 mtp-105 -87.89 -42.83 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.75 -11.31 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.7 mt -100.08 -56.0 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.37 -44.53 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.43 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 67.2 m-20 -56.57 -26.55 55.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.4 -48.59 15.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 145' ' ' ARG . 5.9 mpt_? -57.01 -64.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 149' ' ' GLU . 10.4 mt -52.74 -57.35 10.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 44.6 ttp180 -45.38 -38.27 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -82.86 -22.85 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 146' ' ' LEU . 32.7 mt-10 -83.31 -12.15 56.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.458 ' CD1' HD13 ' A' ' 115' ' ' ILE . 2.1 mm? -121.4 -5.87 9.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -24.32 23.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -86.59 -34.37 19.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.9 mt -81.54 -11.88 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 56.6 p -100.33 -40.44 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.176 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -46.59 -21.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 156' ' ' ARG . 0.8 OUTLIER -82.6 -37.2 25.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.41 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 32.2 m0 -84.04 24.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.41 ' N ' ' HE2' ' A' ' 103' ' ' LYS . . . 65.04 14.26 58.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 4.2 p -123.24 140.78 45.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.408 ' N ' HG21 ' A' ' 159' ' ' VAL . 3.5 tmtt? -126.78 140.13 52.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.53 93.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -55.04 7.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.159 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.435 ' HB3' ' NH1' ' A' ' 163' ' ' ARG . 2.8 ptp180 -158.59 -178.9 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 92.0 t -141.17 127.96 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.164 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -115.56 134.14 55.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.43 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 17.0 mm -102.52 142.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -101.22 159.13 15.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 19.5 mtt85 -45.03 157.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -111.58 155.8 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.2 m-20 -111.59 120.07 43.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.596 0.712 . . . . 0.0 110.922 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.28 19.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.436 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.78 151.67 69.02 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -59.37 -35.19 73.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.457 ' N ' ' HG2' ' A' ' 173' ' ' LYS . 6.8 t70 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 m -109.79 119.69 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.866 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -63.65 -47.94 79.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.51 121.02 18.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -122.07 44.61 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.3 165.58 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 mt -78.6 69.19 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -102.36 114.04 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.96 143.72 32.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -112.53 145.27 40.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.35 137.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 96' ' ' TYR . 21.2 mt -103.11 126.92 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -112.51 132.01 22.38 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.5 Cg_endo -69.75 145.92 58.68 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.316 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.5 Cg_endo -69.78 162.57 41.58 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.706 2.27 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -142.97 117.09 9.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -69.04 106.65 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.38 142.62 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 19.5 mm -72.13 109.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -56.44 -177.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -65.68 -40.65 92.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -85.51 34.39 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.462 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 45.97 47.61 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 172' ' ' PRO . 31.8 t -115.37 122.28 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 81' ' ' ILE . 21.8 t -77.23 111.4 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 m -138.48 155.08 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.6 m -102.19 119.68 39.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.64 141.2 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -146.05 133.0 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.7 167.39 29.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 35.5 m -111.61 172.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.74 123.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -90.39 151.96 21.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.571 ' CD2' HD13 ' A' ' 73' ' ' ILE . 3.8 p90 -165.8 154.79 11.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 99' ' ' ILE . 2.5 pt20 -148.71 112.48 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.91 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.88 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 97' ' ' GLN . 2.7 pp -80.64 -26.53 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.414 ' OD1' ' CG2' ' A' ' 102' ' ' VAL . 28.5 t0 -134.97 97.51 13.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 104' ' ' ALA . 53.8 Cg_endo -69.79 -44.74 1.89 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 101' ' ' PRO . 4.0 m -36.41 -31.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 101' ' ' PRO . 11.7 mmmt -93.62 -35.54 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.565 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -82.27 41.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -73.86 4.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 30.2 p90 -97.34 27.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.8 m-80 56.87 32.99 22.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.525 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.0 m 32.97 39.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.0 t -96.28 -36.44 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 4.3 m-20 -71.05 -38.59 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.555 ' CE2' ' CD1' ' A' ' 115' ' ' ILE . 0.5 OUTLIER -67.8 -44.9 76.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -48.74 -54.3 15.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.457 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 7.9 ptp -77.3 -45.01 27.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -57.4 -14.99 5.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.094 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 111' ' ' PHE . 2.0 mm -80.73 -51.55 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 117' ' ' LYS . 10.0 m -59.64 -25.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' N ' HG22 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -82.03 -32.82 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.5 -36.58 73.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' C ' HD21 ' A' ' 123' ' ' LEU . . . -65.87 -44.02 86.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 32.3 mm-40 -51.45 -38.17 52.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.1 m -82.88 -57.18 3.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.169 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -54.26 -56.44 18.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 124' ' ' ARG . 1.1 pp -53.72 -41.3 66.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' N ' HD13 ' A' ' 123' ' ' LEU . 41.5 ttt-85 -53.97 -20.35 6.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.13 -57.9 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.27 -62.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 3.0 mp -50.37 -41.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.3 -26.38 4.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.01 113.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.913 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -175.72 1.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.0 126.02 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' GLU . 42.5 tp -37.53 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.3 p30 -93.19 -43.39 8.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.829 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.6 tp10 -63.82 -20.66 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.1 p -73.54 -14.24 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 mt -82.17 -40.84 21.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 t -120.86 43.09 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -134.17 20.24 4.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -69.08 -32.08 71.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -51.72 -47.46 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.27 -43.43 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.9 mt -50.9 -49.9 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 76.0 m-20 -65.44 -52.24 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 148' ' ' GLU . . . -42.89 -48.58 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.101 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -61.23 -70.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.38 -62.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -40.26 -36.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 144' ' ' ALA . 0.3 OUTLIER -78.01 -56.98 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.92 -58.37 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.8 mt -56.24 -37.23 69.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -11.28 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -92.63 -37.17 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -76.13 -19.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 73.6 p -93.74 -38.41 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -52.11 -16.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.29 -31.75 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -88.97 11.47 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.69 10.98 85.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.57 145.42 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 111.128 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -118.48 141.2 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.84 92.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.92 -61.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.414 ' HB3' ' NH1' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -166.49 -178.06 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 62.9 t -135.18 147.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 13.7 mt-10 -135.55 143.31 45.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.481 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 24.6 mm -105.44 142.24 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -106.12 161.25 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -42.33 136.95 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -95.76 157.22 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.496 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 9.6 m-20 -107.87 120.93 45.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.843 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 169.14 19.58 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.433 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 54.1 Cg_endo -69.75 128.49 16.11 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.251 . . . . 0.0 112.379 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -118.0 166.31 12.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 174' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.6 m -55.48 127.62 30.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.35 -55.93 23.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -82.29 122.0 27.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.49 132.77 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.48 156.73 37.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.88 39.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -54.87 118.59 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -119.75 152.36 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.566 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 85.5 m-70 -121.86 143.85 49.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.35 139.66 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 HD13 ' CD2' ' A' ' 96' ' ' TYR . 27.4 mt -108.26 124.56 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.46 127.49 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.815 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 2.3 p -120.75 135.32 24.61 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.627 0.727 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 53.3 Cg_endo -69.78 150.29 67.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.2 Cg_endo -69.71 149.84 67.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -137.59 113.71 9.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.81 101.92 4.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 t -111.05 137.66 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.45 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 65.2 mt -68.16 104.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -49.78 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -65.12 -41.02 95.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 19.2 t70 -84.96 33.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 51.07 47.89 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.0 t -118.93 114.76 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.38 120.18 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -145.89 148.91 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 11.4 m -81.16 125.98 30.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' CG1' HG21 ' A' ' 127' ' ' ILE . 9.8 p -121.76 130.93 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 13.5 p-10 -140.95 145.47 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.82 150.34 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.33 155.15 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.77 141.76 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.39 162.53 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.1 p90 -165.9 157.53 14.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.48 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.0 pt20 -153.31 116.4 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.4 t -53.79 94.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.132 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.27 3.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -165.17 112.64 0.83 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.64 0.733 . . . . 0.0 110.841 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -51.22 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.244 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 p -44.68 -37.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -81.16 -37.08 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -96.73 56.01 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 p -92.66 3.25 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.166 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 31.0 p90 -87.94 24.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 23.4 m-80 61.97 27.4 16.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 3.3 t 36.66 40.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 t -96.16 -52.33 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -57.22 -39.2 74.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.493 ' CZ ' HD13 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -62.88 -35.01 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.45 -64.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 ptp -61.64 -32.74 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -67.13 -57.22 7.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.485 HG13 ' CE2' ' A' ' 111' ' ' PHE . 8.1 mm -44.69 -56.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -53.79 -24.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.088 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -85.91 -37.77 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 121' ' ' THR . 10.4 mt -67.55 -57.07 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.73 -36.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -63.41 -40.85 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 118' ' ' LEU . 88.6 m -78.74 -38.77 38.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.26 -56.38 7.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -53.19 -44.18 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.438 ' N ' ' CD1' ' A' ' 123' ' ' LEU . 45.5 ttt-85 -52.46 -22.04 4.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.92 -60.59 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.91 -60.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.402 HG21 ' CG1' ' A' ' 90' ' ' VAL . 1.9 mp -49.98 -38.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.62 -23.89 10.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.06 114.05 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.79 -175.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 133' ' ' ASP . 22.2 mt-10 -120.84 137.07 54.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.0 tp -38.29 -26.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.6 OUTLIER -97.83 -59.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -41.93 -25.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' ASP . 1.5 p -64.2 -50.58 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -79.29 -13.95 59.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.935 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 m -92.78 -29.58 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.46 ' CA ' HD13 ' A' ' 141' ' ' ILE . . . -114.56 85.53 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.499 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -103.03 -43.45 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -16.84 63.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.46 HD13 ' CA ' ' A' ' 138' ' ' GLY . 3.8 mp -85.11 -48.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.48 -61.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.46 -37.67 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.97 -59.02 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -48.77 -66.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 tp -42.81 -48.77 5.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -55.31 -42.94 74.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.32 -9.83 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 13.2 mt-10 -98.35 -53.35 3.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.2 mt -64.6 -34.7 78.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -13.67 35.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -88.58 -49.84 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.4 mp -72.92 -21.61 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.0 p -91.21 -35.35 14.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -25.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -34.94 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -82.57 15.91 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.54 76.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.45 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.77 128.07 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.94 145.29 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -84.08 116.31 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.48 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 30.3 p -70.37 -62.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -146.65 167.13 24.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.96 115.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -99.16 147.21 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.62 137.21 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.408 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.9 mt-30 -88.74 159.61 17.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -50.58 156.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -110.99 157.26 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 10.0 t70 -125.45 133.26 24.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 168.47 21.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 170.62 16.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.683 2.256 . . . . 0.0 112.316 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 174' ' ' ASP . 31.9 pttt -95.45 -52.12 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' A' ' 173' ' ' LYS . 41.2 m-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.9 m -148.94 157.14 43.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -82.91 166.74 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -89.23 112.69 23.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -92.1 123.66 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.77 156.78 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 69' ' ' ARG . 5.1 tp -84.81 -21.56 29.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' LEU . 25.2 ptt-85 -36.58 137.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.38 152.87 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.563 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m-70 -113.85 149.26 35.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.2 p -96.49 145.31 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.452 ' CD1' HG22 ' A' ' 115' ' ' ILE . 18.7 mt -105.35 130.68 56.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.38 95.11 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.905 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 6.1 p -100.93 138.42 20.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.679 0.752 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 Cg_endo -69.74 150.48 68.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.676 2.251 . . . . 0.0 112.327 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.2 Cg_endo -69.8 171.0 15.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.468 ' NE2' ' HG2' ' A' ' 120' ' ' GLN . 1.6 mp0 -142.97 145.88 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.37 101.22 11.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -117.05 145.83 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 66.9 mt -77.55 106.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.33 -178.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -62.87 -48.59 78.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -81.45 37.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.5 m120 46.67 44.84 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.6 t -111.23 110.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.61 120.86 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 m -144.83 150.3 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 6.9 m -93.52 125.05 37.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.9 148.98 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -152.81 138.45 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.831 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.08 153.44 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 m -101.22 163.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.39 132.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -94.26 161.31 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.6 p90 -165.91 152.37 9.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.443 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 4.3 pt20 -143.11 126.06 16.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.83 91.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.7 -31.89 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -132.07 102.6 14.49 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.846 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -10.14 27.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.637 2.224 . . . . 0.0 112.393 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.12 -50.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -77.02 -38.09 53.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.57 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -86.63 47.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.34 4.74 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 36.3 p90 -85.26 30.83 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m-80 49.63 37.07 11.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.556 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 23.6 m 32.57 41.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.4 m -94.96 -41.58 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -46.8 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.619 ' C ' ' CD1' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -57.05 -30.4 64.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.31 -60.67 3.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.0 ptp -67.75 -46.22 72.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.26 -35.93 63.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.571 HG13 ' CZ ' ' A' ' 111' ' ' PHE . 5.2 mm -67.76 -64.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 2.7 m -52.29 -15.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -94.83 -34.32 12.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.8 mt -73.2 -54.23 8.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.08 -45.29 21.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 68.9 mt-30 -62.02 -36.13 80.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.5 m -74.16 -22.12 59.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 71.7 m-80 -91.53 -61.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 127' ' ' ILE . 4.1 pp -47.63 -39.83 18.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.441 ' N ' HD13 ' A' ' 123' ' ' LEU . 25.4 mtt-85 -52.72 -33.09 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.88 -54.43 15.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.56 -59.52 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.7 mt -50.25 -44.24 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.86 -24.02 0.68 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 130' ' ' MET . 10.4 pt-20 -125.86 112.76 16.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.42 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -175.54 -175.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 10.2 mm-40 -122.44 129.39 52.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.99 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 74.9 m-20 -85.74 -64.89 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.2 pt-20 -53.33 -46.02 69.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.457 ' C ' ' O ' ' A' ' 134' ' ' GLU . 25.3 p -33.3 -33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 134' ' ' GLU . 39.6 mt -70.85 -69.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -54.14 -46.29 72.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.72 57.64 2.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -99.75 -26.41 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -78.12 -26.13 47.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.7 mt -78.73 -52.34 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -43.88 -50.51 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 0.9 OUTLIER -68.47 -41.01 80.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -50.86 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -55.09 -56.76 16.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 122' ' ' ASN . 7.2 tp -47.51 -62.12 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.469 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 25.9 ttp85 -43.85 -50.25 7.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -53.54 -31.37 46.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.58 -60.18 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.82 -31.75 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -66.85 -3.75 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -97.59 -43.84 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.45 HG23 ' CH2' ' A' ' 157' ' ' TRP . 4.5 mp -75.16 -18.78 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.8 p -92.04 -35.33 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.16 -38.62 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.6 ptp180 -69.93 -32.53 70.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . 0.571 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 31.7 m0 -88.23 34.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.57 23.39 4.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.72 143.32 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 111.115 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.75 141.92 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.54 97.56 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.443 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 62.6 p -51.27 -38.57 53.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -170.99 -179.93 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 147' ' ' ARG . 1.7 m -141.32 134.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -121.07 139.42 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.0 mm -104.12 142.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.171 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.48 161.95 13.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -49.32 145.38 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.3 mp -98.27 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.447 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.2 m-20 -112.72 120.46 40.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 110.87 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 170.23 17.12 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.629 2.22 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 136.16 32.29 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -102.6 173.29 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.822 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.7 t -133.93 118.12 17.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.63 -60.25 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -71.69 126.02 28.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.18 128.29 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.179 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -155.87 176.19 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.23 36.49 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -65.04 141.11 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.29 138.6 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 99.1 m-70 -108.57 126.73 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -93.1 135.26 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.554 HD12 ' CZ ' ' A' ' 111' ' ' PHE . 20.4 mt -99.1 128.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.32 97.97 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.2 t -102.89 126.78 31.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 111.128 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 149.86 67.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.79 147.58 63.02 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -128.17 116.95 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.53 116.86 9.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.62 147.52 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.477 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 46.6 mm -83.56 108.67 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.4 m -53.11 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -67.32 -45.09 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 25.8 t70 -82.89 36.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.477 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.6 m-20 47.26 51.07 13.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.1 t -118.15 109.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.404 ' HB ' ' CD1' ' A' ' 81' ' ' ILE . 6.4 p -78.14 114.28 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.15 142.06 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 m -81.93 126.24 31.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.64 160.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.57 143.5 10.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.76 153.52 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 18.0 m -101.19 164.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.8 t -137.42 134.43 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.59 157.02 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 4.7 p90 -165.92 150.94 8.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.472 ' NE2' HG23 ' A' ' 162' ' ' THR . 3.0 pt20 -147.95 110.01 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.68 95.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.55 -8.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -161.22 109.59 1.25 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.569 0.699 . . . . 0.0 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -47.84 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' PRO . 2.2 t -34.83 -39.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -90.71 -37.86 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -94.23 49.83 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.8 m -86.12 8.17 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.559 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 35.7 p90 -90.47 26.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.5 m-80 56.56 33.97 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.5 t 33.65 41.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.3 m -97.45 -50.18 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.3 m-20 -57.6 -45.09 85.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.554 ' CZ ' HD12 ' A' ' 73' ' ' ILE . 1.1 t80 -61.09 -44.39 97.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -53.16 -64.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 21.0 ptp -62.24 -45.07 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -56.92 -32.31 65.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.511 HG13 ' CE2' ' A' ' 111' ' ' PHE . 3.9 mm -70.92 -59.81 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.184 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 8.7 m -44.06 -22.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 116' ' ' VAL . 77.1 mttt -94.77 -46.86 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.09 -53.04 62.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.46 -45.78 47.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 78.3 mt-30 -57.96 -37.9 75.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.7 m -70.17 -35.49 74.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.414 ' CG ' ' HB3' ' A' ' 149' ' ' GLU . 71.0 m-80 -80.31 -62.92 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 120' ' ' GLN . 4.0 pp -46.59 -43.79 17.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -47.73 -39.09 16.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.15 -52.03 66.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mp -80.42 -62.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.169 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 123' ' ' LEU . 5.2 mt -51.17 -43.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.61 -31.58 3.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.524 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -116.52 113.39 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -172.55 -175.09 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 133' ' ' ASP . 35.0 mt-10 -116.5 121.34 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 131' ' ' GLU . 57.5 tp -33.89 -33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 m-20 -83.45 -50.75 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 131' ' ' GLU . 24.8 tt0 -56.45 -48.58 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.0 p -40.1 -50.11 2.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.3 mt -47.02 -39.17 12.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -127.61 82.36 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -175.27 25.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 143' ' ' ASN . 5.0 ptt-85 -72.6 -35.33 67.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 1.5 m-20 -46.94 -32.21 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.09 -35.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.81 -50.64 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 2.3 p30 -61.77 -52.78 62.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.432 ' HA ' ' NH1' ' A' ' 147' ' ' ARG . . . -39.29 -49.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -58.8 -60.6 3.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 147' ' ' ARG . 3.9 mm? -54.37 -61.96 1.96 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.432 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 23.6 ttp-105 -36.19 -36.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.51 -55.5 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.474 ' HA ' ' CD ' ' A' ' 152' ' ' LYS . 70.2 mm-40 -50.24 -17.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.11 -40.07 5.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.1 -8.31 16.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.474 ' CD ' ' HA ' ' A' ' 149' ' ' GLU . 5.2 ptmt -100.83 -18.24 16.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.2 mt -107.3 18.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.455 ' HB ' ' CG1' ' A' ' 159' ' ' VAL . 39.7 p -120.99 -32.29 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -25.56 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -84.1 -25.82 29.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -92.84 17.41 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 66.79 15.44 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 154' ' ' THR . 5.0 p -124.94 155.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.178 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -137.52 151.7 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.461 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 31.7 mm -88.94 98.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.472 HG23 ' NE2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -52.66 -48.84 66.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -166.15 -176.38 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.08 147.93 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.461 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 3.2 mm-40 -133.81 141.66 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.55 142.07 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -101.44 161.87 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.56 160.95 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -113.84 157.06 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.6 m-20 -111.42 123.54 34.75 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.666 0.746 . . . . 0.0 110.85 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 164.44 34.55 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.64 40.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.385 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 153.4 24.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.1 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.884 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.6 155.76 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -123.73 152.02 42.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.1 146.72 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 115' ' ' ILE . 16.6 mt -106.53 133.47 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 111.96 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.7 p -117.9 128.21 26.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 111.134 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.4 Cg_endo -69.76 152.39 69.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 0.0 112.33 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.8 164.07 35.95 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.697 2.265 . . . . 0.0 112.337 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -144.96 121.47 11.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.26 106.68 5.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.13 136.94 58.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 53.4 mt -71.51 107.38 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.08 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -67.61 -43.99 79.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.58 35.25 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 49.1 t30 48.08 49.41 17.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG12 HG13 ' A' ' 88' ' ' VAL . 97.2 t -113.23 114.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -76.35 116.9 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 86' ' ' VAL . 25.2 m -142.61 165.8 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.494 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 58.9 m -111.77 114.01 26.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.138 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 127' ' ' ILE . 14.6 p -97.0 159.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.4 p-10 -171.0 137.35 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 175.59 13.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 165' ' ' GLU . 16.0 m -121.12 159.75 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.7 135.83 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 163' ' ' ARG . 5.4 m-85 -100.85 159.21 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.468 ' CD2' ' CE1' ' A' ' 111' ' ' PHE . 3.5 p90 -165.79 163.78 18.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.754 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.1 pt20 -153.62 132.21 12.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.49 96.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 pt -82.26 -28.07 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.585 ' OD1' HG22 ' A' ' 102' ' ' VAL . 10.0 t0 -125.2 98.13 36.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.853 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -39.82 6.19 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 ' OD1' ' A' ' 100' ' ' ASP . 17.0 m -58.43 -18.28 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.06 -36.0 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -92.57 42.08 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 105' ' ' VAL . 21.3 t -78.38 6.82 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 47.0 p90 -85.89 31.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.532 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.2 m120 47.35 42.09 13.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.7 m 26.83 43.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.2 t -96.73 -53.77 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.92 -40.24 75.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -61.52 -37.54 84.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.9 mt -61.79 -65.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.9 ptp -60.44 -37.18 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.54 -60.83 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.979 HG21 HD13 ' A' ' 73' ' ' ILE . 13.1 mm -41.77 -63.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 76' ' ' PRO . 84.6 t -44.48 -53.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -56.19 -45.15 79.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 121' ' ' THR . 39.4 mt -61.38 -61.02 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -37.9 -40.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -57.33 -46.18 83.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 118' ' ' LEU . 91.4 m -70.87 -51.77 24.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -56.2 -60.64 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -49.98 -42.09 48.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.5 ttp180 -50.74 -35.55 32.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.72 -57.93 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.095 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -74.69 -59.86 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 90' ' ' VAL . 32.5 mm -47.81 -40.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.58 -31.94 15.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -120.46 114.24 21.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.94 -176.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 133' ' ' ASP . 42.3 mt-10 -122.58 130.81 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.558 HD13 ' HD3' ' A' ' 172' ' ' PRO . 37.5 tp -34.96 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 131' ' ' GLU . 26.9 t0 -94.17 -56.99 2.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.461 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 1.8 tp10 -49.93 -18.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.0 p -63.54 -54.7 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 136' ' ' LEU . 3.5 pp -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.478 ' N ' HD12 ' A' ' 136' ' ' LEU . 3.6 p -64.18 -50.55 67.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.7 71.38 2.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.63 -33.0 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.816 0.341 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.42 -39.84 74.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.6 mt -61.53 -49.49 84.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.14 -49.0 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' HG12 ' A' ' 166' ' ' ILE . 27.3 m-20 -57.67 -52.01 67.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 145' ' ' ARG . . . -51.38 -68.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 144' ' ' ALA . 24.6 mmt180 -35.18 -69.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -47.14 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 151' ' ' ASP . 57.6 ttp85 -41.29 -44.27 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.95 -55.27 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -47.51 -38.75 14.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.676 HD12 HD13 ' A' ' 115' ' ' ILE . 3.2 mm? -87.06 -40.49 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 9.8 t70 -58.0 -23.14 52.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -85.12 -27.79 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 153' ' ' ILE . 25.5 mt -91.4 -10.53 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.167 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.975 ' HB ' HG13 ' A' ' 159' ' ' VAL . 23.4 p -95.97 -43.08 7.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -38.61 -34.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.585 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 3.9 ptm85 -70.1 -40.94 74.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.585 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 35.4 m0 -83.65 28.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 53.17 37.03 53.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.975 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.7 p -140.44 144.78 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.57 146.66 52.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.471 ' CG2' ' HG3' ' A' ' 147' ' ' ARG . 12.0 mm -73.8 91.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.754 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.01 -45.01 15.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.193 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 95' ' ' TYR . 9.9 ptp180 -163.45 175.82 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -141.0 137.95 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HB2' HG23 ' A' ' 93' ' ' VAL . 31.3 mp0 -132.33 146.14 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.466 HG12 ' ND2' ' A' ' 143' ' ' ASN . 11.9 mm -110.99 142.33 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.93 160.8 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -47.12 148.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -104.13 157.17 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 m-20 -110.39 118.48 49.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 169.99 17.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.241 . . . . 0.0 112.379 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.558 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -68.42 157.35 36.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 36.6 m80 -126.6 128.45 46.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.14 132.81 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 115' ' ' ILE . 27.2 mt -102.38 128.54 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.67 101.78 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.667 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.2 p -103.4 138.67 19.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.687 0.756 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.7 Cg_endo -69.78 147.42 62.72 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.69 2.26 . . . . 0.0 112.327 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.6 49.08 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.36 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -140.77 131.26 25.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.5 112.5 24.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.74 151.14 34.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 43.8 mt -79.63 110.3 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.36 -174.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.18 -39.37 75.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.05 24.72 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.5 m120 57.09 51.27 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 88' ' ' VAL . 75.0 t -120.66 110.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.3 p -73.25 112.05 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.146 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 86' ' ' VAL . 10.8 m -139.69 148.04 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.8 m -85.55 134.7 34.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 127' ' ' ILE . 9.9 p -123.51 147.48 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.1 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -159.25 136.15 9.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.34 146.66 24.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.02 164.94 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 164' ' ' VAL . 20.4 t -139.2 119.32 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -75.4 160.38 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 3.3 p90 -165.65 148.8 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.0 pt20 -142.61 132.74 24.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.65 96.76 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 pt -74.56 -24.52 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.56 110.66 5.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -26.46 27.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.255 . . . . 0.0 112.317 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.32 -61.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -66.17 -39.42 89.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.515 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -89.3 50.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 105' ' ' VAL . 8.7 p -95.82 37.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 30.2 p90 -116.83 30.39 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.8 m-80 58.85 27.25 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 7.2 m 35.28 41.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -94.61 -52.15 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -48.64 78.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -56.04 -32.74 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 116' ' ' VAL . 15.5 mt -69.64 -61.39 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.2 ptp -65.82 -10.08 34.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.49 -51.73 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 73' ' ' ILE . 5.8 mm -47.83 -51.07 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -61.83 -22.97 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -90.18 -13.0 36.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.427 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 67.8 mt -89.67 -39.93 12.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.9 95.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.097 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HA ' HD21 ' A' ' 123' ' ' LEU . 40.4 mm-40 -45.98 -39.48 9.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.6 m -83.34 -53.78 5.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 75.0 m-80 -52.78 -59.4 4.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.1 pp -51.18 -41.13 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' N ' HD12 ' A' ' 123' ' ' LEU . 51.4 ttt180 -51.37 -35.84 40.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.57 -61.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -72.33 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 142' ' ' ILE . 49.8 mm -50.72 -47.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -43.31 -27.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -123.17 114.57 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -170.98 -175.38 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 44.4 mt-10 -121.47 125.76 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 59.6 tp -36.53 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 43.5 m-20 -84.57 -52.5 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 137' ' ' SER . 52.1 tt0 -56.53 -47.22 79.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.7 p -37.74 -34.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.07 -43.09 55.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 134' ' ' GLU . 71.2 m -112.8 73.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.78 25.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 142' ' ' ILE . 83.9 mtm180 -68.29 -38.4 81.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.4 -21.52 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.2 mt -98.5 -26.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 127' ' ' ILE . 23.8 mt -78.12 -34.43 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -81.44 -27.23 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.75 96.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' N ' ' CD ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.47 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 123' ' ' LEU . 4.4 mm? -55.43 -28.17 52.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -73.94 -43.25 58.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.5 -8.91 58.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -93.82 -32.49 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -99.94 -6.44 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.39 -11.98 38.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -98.4 -26.2 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 153' ' ' ILE . 56.0 mt -92.24 15.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.985 ' HB ' HG13 ' A' ' 159' ' ' VAL . 57.5 p -122.4 -28.21 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.02 -24.96 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -19.89 23.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -94.55 2.51 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.25 24.79 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.1 p -136.05 155.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -136.6 151.44 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.46 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 36.1 mm -88.45 94.35 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -48.69 -45.84 39.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -169.42 178.8 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 94' ' ' VAL . 18.9 t -138.43 142.23 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -127.04 135.54 50.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 92' ' ' ALA . 7.2 mm -104.48 138.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -95.22 160.28 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -50.38 149.6 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.37 146.17 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.52 122.69 50.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.883 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.04 17.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.356 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.1 mtp-105 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' HG21 ' A' ' 162' ' ' THR . 21.4 mp0 -96.83 134.86 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 29.0 m80 -106.46 132.99 51.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.84 137.79 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 115' ' ' ILE . 51.6 mt -104.46 121.64 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.08 100.15 10.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 11.4 t -100.92 136.01 19.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.79 145.96 58.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.317 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.78 149.3 66.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -132.26 119.63 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -74.74 109.91 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.11 131.11 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.97 105.06 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.37 177.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -65.85 -36.52 83.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.02 28.25 0.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.34 42.8 27.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.56 114.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.5 p -82.36 115.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.9 148.97 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 77' ' ' PRO . 97.9 m -90.01 115.4 27.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 127' ' ' ILE . 10.7 p -110.17 156.54 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -159.45 140.04 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.09 145.46 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.2 170.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.441 ' CG1' HD12 ' A' ' 161' ' ' ILE . 19.5 t -143.11 121.82 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.03 160.31 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 5.1 p90 -165.83 153.29 10.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.976 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.672 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.9 pt20 -150.44 122.43 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 44.7 t -63.04 92.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.2 pt -76.2 -7.69 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.51 114.27 2.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -51.33 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 103' ' ' LYS . 5.4 p -42.98 -46.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 102' ' ' VAL . 10.8 mtpp -73.79 -39.32 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -95.07 54.95 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 105' ' ' VAL . 7.2 p -89.57 0.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 29.1 p90 -85.69 28.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 6.2 m-80 52.93 31.17 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 108' ' ' VAL . 47.1 t 33.64 41.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 m -93.19 -40.76 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.8 -52.24 32.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -52.19 -32.02 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.607 ' O ' HG13 ' A' ' 116' ' ' VAL . 17.5 mt -57.36 -60.68 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.0 ptp -69.95 -40.51 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.676 ' O ' HD12 ' A' ' 118' ' ' LEU . . . -57.03 -30.88 64.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.987 HG21 HD13 ' A' ' 73' ' ' ILE . 7.3 mm -74.95 -58.37 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.616 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.3 m -54.58 -29.97 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -83.37 -53.99 5.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 114' ' ' ALA . 10.4 mt -43.56 -55.29 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.29 -52.55 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.51 ' HA ' HD21 ' A' ' 123' ' ' LEU . 35.9 mm-40 -37.53 -34.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 m -85.74 -61.14 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.46 -54.61 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 127' ' ' ILE . 2.5 pp -56.15 -40.02 73.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -53.4 -27.41 24.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.97 -62.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.791 ' H ' HD12 ' A' ' 126' ' ' ILE . 2.5 mp -75.48 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 90' ' ' VAL . 4.1 mt -48.49 -41.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.02 -28.92 6.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.487 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -121.69 114.32 20.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.28 -177.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 133' ' ' ASP . 16.1 mt-10 -118.84 129.34 55.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 23.4 tp -36.0 -30.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -94.49 -52.86 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 29.7 tt0 -54.26 -16.5 2.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -64.2 -59.89 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.8 pp -60.39 -25.15 65.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -77.52 -50.71 12.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.91 74.63 2.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -103.92 -30.91 10.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.89 -23.7 62.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.3 mp -86.68 -49.78 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -48.9 -33.36 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 23.8 p30 -86.34 -23.81 26.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -70.93 -56.23 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -50.92 -62.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -47.28 -55.38 8.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 151' ' ' ASP . 28.4 ttp180 -42.59 -51.21 5.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.78 -37.1 85.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -74.53 -19.52 60.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 53.0 mt -107.85 -9.49 15.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -90.35 -18.6 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.76 -35.45 14.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 86.6 mt -77.84 -17.1 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 1.004 ' HB ' HG13 ' A' ' 159' ' ' VAL . 40.6 p -92.63 -42.28 9.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -44.04 -26.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' CG ' ' O ' ' A' ' 153' ' ' ILE . 0.0 OUTLIER -75.23 -37.2 61.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.514 ' HB2' HG12 ' A' ' 159' ' ' VAL . 34.1 m0 -85.14 26.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 62.91 12.75 44.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 1.004 HG13 ' HB ' ' A' ' 154' ' ' THR . 6.0 p -120.87 138.19 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.083 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.1 143.9 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 94' ' ' VAL . 5.3 mm -85.01 106.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.672 HG23 ' HG2' ' A' ' 97' ' ' GLN . 18.8 p -57.26 -61.47 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -156.11 179.31 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 143' ' ' ASN . 43.0 t -132.87 149.65 32.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -131.61 137.2 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 143' ' ' ASN . 22.8 mm -99.44 141.71 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -99.45 158.88 15.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.92 144.73 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 31.4 mt -99.46 156.28 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -116.62 129.34 25.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.615 0.722 . . . . 0.0 110.919 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 164.73 33.44 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.788 0.327 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -70.73 157.5 37.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.546 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 4.3 m80 -129.03 147.58 50.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' CE1' ' A' ' 95' ' ' TYR . 4.8 p -94.26 145.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.091 HD13 HG21 ' A' ' 115' ' ' ILE . 26.9 mt -104.29 129.15 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.29 93.1 8.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.597 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.9 p -94.21 137.58 22.8 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.572 0.701 . . . . 0.0 111.152 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 146.98 61.99 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.741 2.294 . . . . 0.0 112.343 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.7 Cg_endo -69.75 153.35 69.07 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -140.02 127.06 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.75 110.44 20.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -122.41 136.7 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.4 mt -68.35 108.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -53.42 -175.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -68.93 -40.67 78.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.42 27.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 47.0 t30 54.58 50.48 15.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 88' ' ' VAL . 97.5 t -118.74 115.52 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -80.15 113.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 86' ' ' VAL . 4.6 m -141.65 141.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 27.4 m -83.12 122.13 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 127' ' ' ILE . 2.9 p -108.53 138.31 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -146.81 136.57 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.21 174.53 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.96 151.37 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 164' ' ' VAL . 19.9 t -131.7 124.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.551 ' CE1' HG23 ' A' ' 72' ' ' VAL . 3.8 m-30 -83.85 163.23 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 8.3 p90 -165.68 160.48 17.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -151.41 142.0 22.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 98' ' ' VAL . 26.8 t -84.92 95.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.8 -15.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 30.7 t70 -146.61 106.29 4.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.867 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.9 Cg_endo -69.82 -12.74 33.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.238 . . . . 0.0 112.349 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -70.79 -55.81 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -72.97 -26.4 61.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -95.77 43.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.0 p -93.3 40.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.3 p90 -123.22 28.83 6.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.5 m-80 61.63 27.18 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.4 p 35.26 31.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.5 m -89.31 -49.2 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 10.8 m-20 -56.56 -45.64 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -62.52 -33.41 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.5 -53.73 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.472 ' O ' ' CD ' ' A' ' 117' ' ' LYS . 13.6 ptp -76.88 -21.38 55.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -78.63 -47.87 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.07 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 73' ' ' ILE . 8.9 mm -50.39 -53.02 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.477 ' CG2' ' HD2' ' A' ' 117' ' ' LYS . 3.5 m -59.51 -43.0 89.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HD2' ' CG2' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -70.94 -10.72 60.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -95.01 -39.62 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.17 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 34.7 mm-40 -61.28 -34.62 75.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 m -80.59 -44.43 18.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 78.6 m-20 -64.15 -46.06 85.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.2 pp -62.66 -40.68 97.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.797 ' N ' HD12 ' A' ' 123' ' ' LEU . 44.8 mtt180 -52.71 -21.42 4.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.92 -59.69 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -75.82 -58.33 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 90' ' ' VAL . 39.2 mm -50.17 -38.6 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.97 -23.09 14.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -131.26 114.13 14.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.47 -176.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 133' ' ' ASP . 19.0 mt-10 -122.0 120.48 34.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 41.8 tp -33.72 -34.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -86.0 -45.82 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 135' ' ' THR . 17.8 tp10 -58.64 -48.77 79.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 134' ' ' GLU . 20.2 p -31.9 -43.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.094 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.45 -52.48 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.5 m -64.4 -52.93 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.49 54.56 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.449 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -89.53 -37.88 14.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.483 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 3.8 p-10 -69.78 -21.54 63.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.68 -46.99 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 127' ' ' ILE . 41.5 mt -53.13 -45.7 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.491 ' HB3' ' CG1' ' A' ' 166' ' ' ILE . 2.4 p30 -71.66 -28.71 63.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.42 -58.28 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -47.57 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 122' ' ' ASN . 4.2 mm? -46.84 -56.51 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.573 ' HB2' HG21 ' A' ' 164' ' ' VAL . 43.7 ttp85 -45.24 -47.02 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -64.17 -55.86 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -51.99 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.39 -34.26 64.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -23.28 62.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -93.2 -27.62 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mm -79.12 -18.09 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.3 p -99.16 -33.17 10.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.91 -18.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 9.8 ptt180 -92.13 -27.94 17.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.5 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.5 m0 -89.8 11.65 19.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 77.32 11.33 85.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.51 147.88 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.388 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 150.32 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.496 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.0 mm -84.71 96.55 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.451 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 47.9 p -48.96 -63.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -146.78 -179.36 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -141.08 144.25 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.112 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -137.16 139.48 41.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 143' ' ' ASN . 4.2 mm -108.43 140.76 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -97.06 161.65 13.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -45.72 154.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 169' ' ' ILE . 2.1 mp -105.13 152.55 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.7 m-20 -103.88 122.41 44.57 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 170.02 17.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.228 . . . . 0.0 112.371 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.787 0.327 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HG3' HG21 ' A' ' 162' ' ' THR . 23.4 mp0 -85.56 141.88 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 92.5 m-70 -110.38 132.26 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.22 138.26 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 115' ' ' ILE . 17.7 mt -102.33 125.9 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.24 112.43 24.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.1 p -118.21 138.76 25.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.593 0.711 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.72 150.95 69.13 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.274 . . . . 0.0 112.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 154.64 67.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.671 2.247 . . . . 0.0 112.395 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' CD ' HD11 ' A' ' 123' ' ' LEU . 3.2 pt20 -136.94 152.04 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.37 115.66 30.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HG2' ' A' ' 124' ' ' ARG . 23.1 m -128.44 147.91 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.067 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 39.9 mt -79.65 108.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.13 -176.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -65.6 -45.45 83.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -83.75 34.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 16.2 t-20 49.69 49.82 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.591 HG12 HG13 ' A' ' 88' ' ' VAL . 84.9 t -116.57 109.44 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -74.21 116.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.591 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -142.63 155.03 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 24.5 m -96.89 126.24 41.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.8 HG11 HG21 ' A' ' 127' ' ' ILE . 12.5 p -115.09 151.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -154.48 133.0 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.88 152.17 30.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 28.8 m -101.87 165.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 HD12 ' A' ' 73' ' ' ILE . 24.8 t -135.51 126.12 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -85.42 158.86 20.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.2 p90 -165.6 154.09 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HG2' HG23 ' A' ' 162' ' ' THR . 12.2 pt20 -150.08 129.23 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 53.3 t -68.46 91.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 pt -73.57 -31.65 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 6.0 t70 -128.67 94.72 34.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.601 0.715 . . . . 0.0 110.859 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.525 ' O ' HG22 ' A' ' 105' ' ' VAL . 53.6 Cg_endo -69.75 -2.49 10.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 0.0 112.316 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 105' ' ' VAL . 19.4 t -80.3 -44.99 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -90.19 -21.11 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -96.84 43.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 102' ' ' VAL . 4.0 t -90.42 40.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 39.7 p90 -117.93 35.12 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 108' ' ' VAL . 5.6 m120 50.93 36.56 15.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.7 p 27.72 41.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 107' ' ' ASN . 1.6 t -95.34 -57.72 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -49.73 -43.78 48.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.6 mt -58.94 -70.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.936 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 ptp -51.78 -38.16 54.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.54 -66.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.943 HG21 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -38.7 -63.89 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 75' ' ' VAL . 91.3 t -37.13 -51.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -67.73 -55.24 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ALA . 58.4 mt -46.28 -61.55 1.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' LEU . . . -36.52 -60.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt-30 -39.17 -47.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.1 m -67.92 -47.9 67.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 71.1 m-80 -63.29 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.954 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.6 pp -44.51 -39.25 4.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HG2' HG11 ' A' ' 80' ' ' VAL . 19.5 mtp180 -53.84 -37.1 63.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.13 -47.91 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -84.9 -63.83 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.954 HD13 ' HB2' ' A' ' 123' ' ' LEU . 2.1 mp -51.84 -41.52 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.17 -30.21 7.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.8 pt-20 -118.54 113.05 20.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.21 -174.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 58.0 mt-10 -118.31 129.18 55.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 131' ' ' GLU . 64.6 tp -36.72 -29.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 3.8 p-10 -94.08 -46.08 7.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 2.6 tp10 -55.04 -44.97 75.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 1.1 p -34.24 -65.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.5 pp -53.76 -34.99 60.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 134' ' ' GLU . 1.8 t -70.32 -70.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.21 69.69 0.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -97.94 -34.45 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -72.63 -33.0 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 141' ' ' ILE . 5.3 mp -68.53 -45.94 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 127' ' ' ILE . 86.6 mt -54.27 -53.23 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.714 ' OD1' HG12 ' A' ' 164' ' ' VAL . 63.4 m-20 -52.19 -41.0 62.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.97 -54.19 48.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -53.69 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.8 tp -41.36 -38.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -64.23 -44.87 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.83 -12.38 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 122' ' ' ASN . 28.2 mt-10 -87.95 -39.05 15.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.659 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -93.8 -13.56 27.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.55 -22.75 56.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 pttt -89.77 -30.07 18.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.73 -19.26 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.494 ' CG2' HD11 ' A' ' 115' ' ' ILE . 43.2 p -97.25 -28.17 14.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -47.37 -40.59 17.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.567 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.3 ptm180 -66.45 -32.06 73.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.567 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 42.2 m0 -83.71 14.09 4.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 65.8 33.96 87.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.448 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.16 145.69 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -128.83 135.44 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.71 86.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.735 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -38.37 -47.43 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -169.54 179.99 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.714 HG12 ' OD1' ' A' ' 143' ' ' ASN . 87.8 t -140.84 140.09 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 68.9 mt-10 -123.83 147.12 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 143' ' ' ASN . 23.6 mm -109.65 142.15 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -103.16 161.05 14.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -41.68 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -113.75 156.5 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 11.4 m-20 -115.85 122.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.633 0.73 . . . . 0.0 110.822 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 170.55 16.28 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.412 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.817 0.341 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.2 155.39 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 51.0 m-70 -124.0 148.48 46.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.32 145.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.624 HD13 HG21 ' A' ' 115' ' ' ILE . 96.5 mt -113.3 124.45 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.32 107.23 18.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.2 p -105.65 138.3 19.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.76 144.94 55.64 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.717 2.278 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 159.94 51.54 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.633 2.222 . . . . 0.0 112.351 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.38 116.64 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 14.7 mp0 -71.49 118.56 14.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.73 132.5 61.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 47.9 mm -60.9 113.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.586 ' HG ' ' C ' ' A' ' 130' ' ' MET . 0.7 OUTLIER -63.27 -178.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 130' ' ' MET . 17.5 tptt -61.41 -47.32 86.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.7 32.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 32.5 m-20 51.4 48.04 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG12 HG13 ' A' ' 88' ' ' VAL . 46.5 t -112.87 109.38 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -75.23 108.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 86' ' ' VAL . 15.6 m -135.34 153.31 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 57.2 m -94.92 128.54 41.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.87 HG11 HG21 ' A' ' 127' ' ' ILE . 2.1 p -115.57 149.6 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.14 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -159.54 127.3 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -142.91 151.53 41.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 165' ' ' GLU . 3.7 m -97.08 153.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.598 ' CG1' HD12 ' A' ' 161' ' ' ILE . 25.5 t -127.86 127.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.0 m-30 -87.02 159.96 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.951 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 4.2 p90 -165.59 153.51 11.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.838 ' HG2' HG23 ' A' ' 162' ' ' THR . 9.6 pt20 -149.74 128.8 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.7 t -65.5 91.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.096 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 pt -71.96 -12.75 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 31.1 t0 -158.4 105.66 1.67 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.901 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.572 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.4 Cg_endo -69.7 -13.44 34.81 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.388 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.26 -27.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.184 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -101.31 -20.57 15.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.53 48.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 101' ' ' PRO . 4.0 m -83.0 3.2 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.1 p90 -84.22 24.53 0.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' VAL . 12.6 m120 62.1 31.2 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.3 t 33.79 40.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.5 p -95.11 -60.02 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.05 -36.56 29.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -65.18 -33.94 77.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.84 -57.03 7.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.5 ptp -67.43 -26.48 66.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.28 -49.45 16.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.624 HG21 HD13 ' A' ' 73' ' ' ILE . 2.6 mm -45.83 -62.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 m -53.0 -25.54 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -83.94 -25.51 30.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 115' ' ' ILE . 25.6 mt -77.84 -46.04 22.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.915 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.94 -53.35 56.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 37.3 mm-40 -40.99 -27.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 m -92.09 -37.14 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -75.45 -58.23 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.772 ' HB2' HD13 ' A' ' 127' ' ' ILE . 2.7 pp -51.05 -40.46 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.436 ' N ' HD12 ' A' ' 123' ' ' LEU . 35.6 ttt85 -54.6 -22.99 15.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.61 -58.38 3.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 126' ' ' ILE . 1.4 mp -76.09 -62.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.87 HG21 HG11 ' A' ' 90' ' ' VAL . 3.2 mp -52.64 -40.84 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.79 -20.13 3.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.4 pt-20 -130.8 113.62 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.586 ' C ' ' HG ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -173.7 -175.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.854 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 24.4 mm-40 -123.17 120.4 33.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' GLU . 65.0 tp -35.35 -31.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.5 t70 -76.04 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -54.64 -46.49 73.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 131' ' ' GLU . 70.6 p -42.36 -52.88 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 135' ' ' THR . 41.4 mt -35.8 -49.94 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 t -121.95 87.64 2.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.83 35.06 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.98 -32.08 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -50.63 -36.97 37.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' ALA . 11.0 mt -87.45 -55.59 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 51.9 mt -42.69 -36.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 3.5 p30 -81.73 -31.54 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.451 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -60.78 -54.66 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -56.45 -63.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 146' ' ' LEU . 12.0 mt -42.6 -52.4 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -45.22 -41.83 8.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.06 -25.0 32.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 8.0 mm-40 -79.81 -10.39 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 -39.27 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.98 -8.42 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 153' ' ' ILE . 8.8 ptpt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.8 mp -87.1 -18.31 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 111' ' ' PHE . 45.5 p -94.61 -14.93 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.54 -14.7 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.568 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 15.4 ptm180 -96.7 -22.38 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.568 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.3 m0 -93.87 5.27 52.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.25 22.8 67.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 111' ' ' PHE . 25.4 t -123.16 135.47 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.32 130.41 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.598 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.5 mm -73.43 91.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.838 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.5 p -45.36 -44.6 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.9 OUTLIER -166.82 178.96 5.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 71.7 t -137.87 122.12 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 93' ' ' VAL . 11.1 mt-10 -104.36 138.46 40.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.595 HD13 ' HB1' ' A' ' 92' ' ' ALA . 24.4 mm -112.67 142.34 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -103.11 159.57 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -47.42 160.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -108.01 156.66 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.7 m-20 -104.99 119.99 51.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.887 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 163.8 36.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.287 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.178 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.798 0.332 . . . . 0.0 110.857 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -118.65 157.89 26.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 26.3 m-70 -123.98 146.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.477 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 8.1 p -95.4 145.93 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 115' ' ' ILE . 19.5 mt -105.68 130.02 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.24 95.06 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' HD2' ' A' ' 76' ' ' PRO . 3.3 p -99.17 136.94 20.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.4 Cg_endo -69.71 149.44 67.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 0.0 112.38 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 168.78 20.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.38 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -146.73 118.12 7.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -76.83 102.65 6.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.81 148.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.5 mt -79.87 106.39 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.41 -174.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -67.88 -43.15 80.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.44 35.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 6.5 t30 51.01 43.25 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.703 HG13 ' HG3' ' A' ' 172' ' ' PRO . 60.6 t -113.36 110.82 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.86 113.95 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -134.1 150.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -89.38 109.67 20.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 127' ' ' ILE . 5.4 m -105.57 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.14 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -168.67 144.09 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.83 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 72' ' ' VAL . 18.0 m -93.61 158.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 161' ' ' ILE . 20.0 t -128.47 137.16 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.142 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.4 m-30 -98.08 160.52 14.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 33.8 p90 -165.83 155.09 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HG2' HG23 ' A' ' 162' ' ' THR . 9.6 pt20 -141.96 121.12 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 98' ' ' VAL . 42.2 t -64.97 93.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -80.81 -29.78 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -127.8 96.66 31.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.7 Cg_endo -69.71 0.37 5.7 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 105' ' ' VAL . 23.9 t -81.39 -44.37 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -86.58 -32.58 20.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.575 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -87.11 38.66 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 4.8 m -85.83 12.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.575 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.1 p90 -93.02 35.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.4 m-80 52.18 31.81 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 108' ' ' VAL . 43.1 t 34.63 40.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.1 p -97.27 -38.82 9.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.54 -45.22 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.75 -32.54 72.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.1 mt -61.06 -59.51 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 116' ' ' VAL . 15.5 ptp -70.3 -37.82 74.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.0 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.041 HG21 HD13 ' A' ' 73' ' ' ILE . 6.8 mm -63.22 -52.77 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.6 m -65.52 -20.23 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -91.48 -15.55 28.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.688 HD22 HD13 ' A' ' 153' ' ' ILE . 17.0 mt -88.94 -39.3 13.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.06 81.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.4 mm-40 -44.98 -30.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.3 m -87.42 -49.63 7.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -62.7 -59.27 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.746 HD13 HD12 ' A' ' 127' ' ' ILE . 3.2 pp -48.84 -42.82 37.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 123' ' ' LEU . 23.0 ttm180 -51.67 -41.67 61.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.72 -57.57 11.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -76.32 -62.36 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.89 HG21 HG21 ' A' ' 90' ' ' VAL . 20.8 mt -49.3 -44.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 130' ' ' MET . 7.3 pt-20 -121.4 113.96 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.839 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.42 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -173.04 -175.29 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 37.9 mt-10 -121.7 130.63 53.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 31.2 tp -36.17 -29.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.1 p-10 -88.66 -63.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -40.99 -43.84 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.2 p -39.62 -69.81 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.481 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.0 pp -55.4 -29.4 58.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -107.54 40.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -166.58 64.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.4 ptt180 -104.78 -37.11 7.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 0.5 OUTLIER -52.3 -27.65 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -88.23 -48.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 64.9 mt -54.02 -48.02 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 11.3 p30 -69.76 -42.96 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -47.39 -48.33 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.047 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -64.0 -62.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.63 -58.94 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 26.0 ttm105 -40.67 -40.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.97 -45.92 22.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -57.89 -28.1 63.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.723 ' O ' HG23 ' A' ' 154' ' ' THR . 36.1 mt -96.39 -31.09 13.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -20.03 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.44 -26.01 16.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.688 HD13 HD22 ' A' ' 118' ' ' LEU . 98.2 mt -86.58 -8.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.991 ' HB ' HG13 ' A' ' 159' ' ' VAL . 62.3 p -103.19 -36.67 8.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -42.62 -27.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.35 -38.18 31.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.556 ' HB2' HG12 ' A' ' 159' ' ' VAL . 36.1 m0 -84.48 34.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.62 23.61 4.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.478 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 154' ' ' THR . 2.1 p -130.59 143.35 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.86 147.14 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 95' ' ' TYR . 12.7 mm -82.91 109.57 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 97' ' ' GLN . 75.9 p -64.55 -43.33 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 1.6 ptp180 -165.93 -178.54 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.419 ' HB ' ' NH2' ' A' ' 147' ' ' ARG . 38.4 t -141.17 137.5 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -123.34 136.97 54.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.413 HD13 ' CB ' ' A' ' 92' ' ' ALA . 9.9 mm -99.09 140.87 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -95.69 161.68 13.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -47.99 162.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.1 mp -118.75 157.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.503 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.3 t70 -127.16 133.64 25.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 0.0 110.806 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 168.76 20.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.703 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.794 0.33 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -76.91 151.08 35.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -120.55 151.7 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.964 HG12 ' CE1' ' A' ' 95' ' ' TYR . 17.5 m -98.16 156.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 111' ' ' PHE . 31.4 mt -118.19 125.02 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.27 111.27 18.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 116' ' ' VAL . 85.9 t -120.53 132.19 24.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.73 152.95 69.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.75 166.93 25.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.415 ' OE1' HD11 ' A' ' 123' ' ' LEU . 9.0 tt0 -146.44 117.49 7.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.83 107.03 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.76 145.22 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.687 ' CD1' HG22 ' A' ' 87' ' ' VAL . 41.0 mm -74.33 109.22 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.35 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -67.34 -45.09 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.15 32.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.1 m-20 50.69 44.3 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.48 110.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 81' ' ' ILE . 6.6 t -70.11 115.19 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.94 150.0 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.145 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 95.1 m -97.64 130.55 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 127' ' ' ILE . 31.3 m -124.34 157.44 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 167' ' ' GLN . 18.4 p-10 -160.43 139.53 10.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.86 150.87 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.29 170.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -135.14 131.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.964 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.8 m-30 -91.78 157.95 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.572 ' CE1' HG21 ' A' ' 108' ' ' VAL . 13.0 p90 -165.65 158.19 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' A' ' 162' ' ' THR . 10.2 pt20 -152.3 114.5 4.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.85 92.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.7 pt -76.05 -18.49 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 11.7 t70 -146.54 106.38 4.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.585 0.707 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.1 Cg_endo -69.73 -18.41 37.14 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.95 -25.75 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -101.47 -38.23 8.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -83.78 34.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.64 -5.99 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 40.1 p90 -85.13 26.44 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 109' ' ' SER . 14.8 m-80 56.37 37.05 28.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 11.1 p 32.8 36.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' ASN . 7.1 t -93.98 -52.25 4.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -51.4 -46.33 62.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.748 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -58.67 -37.45 76.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 73' ' ' ILE . 39.5 mt -63.63 -66.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 ptp -57.04 -26.08 59.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.23 -65.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG13 ' CE2' ' A' ' 111' ' ' PHE . 11.9 mm -39.63 -64.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 75' ' ' VAL . 49.1 t -36.22 -40.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.03 -55.0 5.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.8 mt -45.69 -49.63 14.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.57 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.544 ' HA ' HD21 ' A' ' 123' ' ' LEU . 36.2 mm-40 -51.87 -39.53 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -76.71 -56.84 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -53.38 -57.42 10.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 124' ' ' ARG . 3.1 pp -51.21 -43.12 61.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.71 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.2 ttt85 -49.84 -38.69 36.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.85 -54.28 41.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.68 -62.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.946 HG21 HG21 ' A' ' 90' ' ' VAL . 43.6 mm -48.7 -39.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.36 -30.14 24.85 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -122.02 114.02 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -172.19 -175.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 26.2 mt-10 -119.08 132.96 56.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.473 HD13 ' HD3' ' A' ' 172' ' ' PRO . 48.8 tp -35.81 -30.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 21.6 t70 -90.21 -53.43 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -45.38 -37.51 5.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -65.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -67.83 -28.85 67.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.0 p -103.15 39.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.2 60.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -89.97 -33.35 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.7 -43.35 99.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.0 mt -67.23 -50.7 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.51 -50.5 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.504 ' OD1' HD11 ' A' ' 166' ' ' ILE . 82.2 m-20 -57.57 -55.33 36.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -45.43 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 145' ' ' ARG . 5.1 mmp_? -53.93 -69.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -55.64 -62.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 38.8 ttt-85 -41.69 -34.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.8 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.59 -56.47 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 154' ' ' THR . 94.4 mt -54.29 -35.86 63.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -15.82 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -84.57 -44.34 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 153' ' ' ILE . 8.7 mt -72.03 -5.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 159' ' ' VAL . 60.5 p -102.55 -37.66 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -48.51 -20.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.2 ptp180 -87.34 -34.09 18.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.4 m0 -86.11 19.25 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.77 19.12 62.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.4 p -124.55 148.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.144 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -128.66 148.46 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.9 mm -88.61 100.86 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -51.66 -51.17 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.203 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -163.98 -176.56 4.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 69.6 t -140.43 143.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.19 137.44 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.504 HD11 ' OD1' ' A' ' 143' ' ' ASN . 7.5 mm -107.24 123.22 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.5 mm-40 -78.11 157.71 29.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -42.43 157.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -110.8 155.72 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.6 m-20 -113.23 120.49 40.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.552 0.691 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 170.04 17.44 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.667 2.244 . . . . 0.0 112.358 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.473 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.379 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.09 148.15 24.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 16.0 m-70 -115.62 143.83 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.1 145.63 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 115' ' ' ILE . 54.8 mt -109.02 129.2 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.58 100.11 12.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 116' ' ' VAL . 19.6 t -106.23 134.78 19.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.664 0.745 . . . . 0.0 111.148 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.72 151.28 69.24 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.745 2.297 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 54.1 Cg_endo -69.67 161.08 47.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.476 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 5.2 mt-30 -139.67 117.82 11.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.06 110.69 11.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.65 142.95 41.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.985 ' CD1' HG22 ' A' ' 87' ' ' VAL . 49.6 mm -73.45 105.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.03 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -66.09 -36.47 83.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.2 29.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 60.1 t30 49.85 51.97 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.46 123.47 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.985 HG22 ' CD1' ' A' ' 81' ' ' ILE . 3.6 t -82.57 116.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.57 155.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 m -100.71 122.96 44.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 127' ' ' ILE . 34.7 m -114.18 169.09 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -174.93 135.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.79 146.85 24.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -95.66 166.4 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 161' ' ' ILE . 12.9 t -133.23 127.01 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -86.64 159.05 19.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 23.0 p90 -165.69 155.07 12.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.773 ' HG2' HG23 ' A' ' 162' ' ' THR . 7.7 pt20 -145.86 123.99 12.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 98' ' ' VAL . 38.0 t -63.97 96.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.4 pt -80.58 -28.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 23.3 t0 -135.58 108.53 10.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.859 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.7 Cg_endo -69.8 -48.49 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.371 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -48.62 -23.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -103.83 -27.94 11.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.82 41.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 105' ' ' VAL . 10.0 p -94.75 44.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 13.6 p90 -117.75 36.4 4.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 5.4 m120 55.88 28.31 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.0 p 33.26 39.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.162 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' ASN . 25.9 m -94.74 -48.19 6.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.2 -46.72 88.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.565 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -61.08 -41.02 95.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.0 -63.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -58.41 -29.17 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.39 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 73' ' ' ILE . 3.1 mm -39.3 -62.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 76' ' ' PRO . 55.8 t -34.86 -48.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.82 -50.05 22.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.9 mt -44.08 -49.12 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.7 90.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.476 ' OE1' ' CG ' ' A' ' 78' ' ' GLN . 35.3 mm-40 -48.35 -35.67 12.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 m -86.57 -63.31 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 149' ' ' GLU . 34.0 m120 -42.72 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -59.25 -43.68 92.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.755 ' N ' HD12 ' A' ' 123' ' ' LEU . 19.4 ttt180 -51.28 -26.96 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.653 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.1 mp -76.47 -60.37 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 mt -49.78 -41.64 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.06 -23.85 2.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.61 114.21 17.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -172.89 -176.79 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 mt-10 -115.86 119.81 37.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.518 HD13 ' HD3' ' A' ' 172' ' ' PRO . 21.5 tp -36.61 -29.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -86.99 -58.52 2.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.1 tp10 -48.0 -50.32 27.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' GLU . 40.6 p -35.05 -34.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 134' ' ' GLU . 54.3 mt -62.37 -57.78 10.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 m -77.62 -50.7 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.96 70.41 0.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.4 ptt85 -112.59 -9.73 13.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.97 -33.78 21.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 141' ' ' ILE . 4.6 mp -73.86 -37.65 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.575 HD11 ' SD ' ' A' ' 130' ' ' MET . 44.5 mt -60.6 -43.91 95.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.737 ' HB3' HD11 ' A' ' 166' ' ' ILE . 1.8 p30 -79.98 -31.39 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.94 -34.12 74.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -79.08 -56.57 4.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.11 -42.67 29.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -53.8 -40.18 66.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.08 -57.16 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.445 ' HB3' ' ND2' ' A' ' 122' ' ' ASN . 2.2 mp0 -44.36 -62.02 1.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 115' ' ' ILE . 9.4 mp -60.17 -36.09 76.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -11.53 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.76 -27.27 15.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 153' ' ' ILE . 39.4 mt -96.62 17.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 p -125.71 -34.05 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.8 -25.22 26.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 14.3 ptm180 -83.56 -20.11 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.537 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 52.9 m0 -96.85 1.57 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.97 12.32 77.15 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 160' ' ' LYS . 53.5 t -119.61 154.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.926 0.394 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -134.01 151.64 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.48 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 32.4 mm -89.81 92.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.773 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -49.12 -48.96 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -163.89 -175.98 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 84.2 t -139.74 141.89 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -124.47 135.39 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' A' ' 143' ' ' ASN . 3.7 mm -105.33 139.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.69 161.14 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -44.4 156.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.6 mp -108.96 156.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.6 m-20 -113.01 120.81 39.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 110.9 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.2 31.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.518 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.358 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.039 0 CA-C-O 120.784 0.326 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.52 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 2.2 pm0 -115.12 149.42 37.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m80 -106.9 143.73 34.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 140.3 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.948 HD13 HG21 ' A' ' 115' ' ' ILE . 26.5 mt -102.92 125.08 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 94.0 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.465 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.7 p -97.62 133.68 23.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 111.181 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 144.66 54.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.73 157.82 59.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -140.94 118.51 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -71.45 109.57 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.45 132.52 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.865 ' CD1' HG22 ' A' ' 87' ' ' VAL . 45.5 mm -68.16 109.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.44 -175.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -69.71 -38.91 77.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -84.53 26.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 37.6 t30 52.83 48.72 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 88' ' ' VAL . 43.8 t -113.87 117.83 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.161 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.865 HG22 ' CD1' ' A' ' 81' ' ' ILE . 47.1 t -77.79 113.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.173 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 HG12 ' A' ' 86' ' ' VAL . 29.2 m -143.39 157.35 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 25.5 m -103.62 123.66 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 127' ' ' ILE . 10.0 p -103.47 142.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.11 132.06 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -152.28 164.55 37.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.31 159.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.412 ' O ' HD12 ' A' ' 73' ' ' ILE . 74.3 t -133.97 118.94 30.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 7.3 m-30 -79.38 159.64 27.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.5 p90 -165.71 147.89 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.954 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.9 pt20 -140.24 131.72 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 98' ' ' VAL . 50.3 t -71.71 91.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.095 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -83.14 -21.5 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 99' ' ' ILE . 22.3 t70 -134.95 92.85 18.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.593 0.711 . . . . 0.0 110.871 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 -5.18 15.61 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.663 2.242 . . . . 0.0 112.294 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.64 -50.03 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -87.39 -18.06 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.554 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -99.44 43.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.5 p -89.41 14.19 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.5 p90 -97.47 29.8 3.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.2 m-80 58.75 28.06 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.513 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 10.0 m 35.94 38.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.4 p -92.33 -48.74 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -59.25 -42.76 91.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.514 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -61.39 -31.93 71.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 116' ' ' VAL . 33.1 mt -71.62 -54.3 10.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.8 ptp -74.15 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -93.2 -57.99 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 73' ' ' ILE . 7.7 mm -39.68 -57.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -57.79 -42.08 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 18.4 mtmt -67.4 -18.9 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 18.5 mt -88.16 -42.36 12.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.23 68.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.1 mm-40 -57.7 -28.28 63.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.6 m -89.9 -54.69 3.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -55.49 -52.39 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.724 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.3 pp -56.1 -40.18 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.704 ' N ' HD12 ' A' ' 123' ' ' LEU . 12.8 ttt180 -56.44 -18.14 10.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.68 -61.06 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -74.97 -50.8 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 90' ' ' VAL . 34.4 mm -55.99 -38.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.34 -28.28 27.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.521 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.34 114.29 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.55 -177.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.0 mt-10 -122.14 128.85 51.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.1 tp -34.76 -32.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -86.37 -58.27 2.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 136' ' ' LEU . 2.5 tp10 -47.91 -47.05 32.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 28.6 p -33.5 -34.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 134' ' ' GLU . 14.1 mt -84.66 -57.78 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -52.78 -53.12 52.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.84 57.81 3.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -90.92 -36.86 13.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 18.4 t0 -69.1 -20.11 64.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.93 -58.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -42.57 -42.18 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.47 ' ND2' ' HA ' ' A' ' 140' ' ' ASP . 1.4 p30 -76.76 -35.89 57.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.427 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -54.68 -48.63 72.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 148' ' ' GLU . 5.0 mmp_? -62.63 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 3.7 mm? -38.15 -37.56 0.28 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 40.7 ttt-85 -62.21 -44.11 97.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' ARG . 11.4 tp10 -74.49 -46.29 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.07 -54.09 50.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -7.62 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -97.92 -41.89 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 153' ' ' ILE . 17.0 mt -74.93 5.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.8 p -116.61 -28.86 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -58.3 -28.88 65.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 8.3 ptp180 -83.98 -16.33 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.845 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.561 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 54.7 m0 -98.87 0.63 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 84.78 9.34 81.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.63 141.64 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.22 129.17 51.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.44 109.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.526 HG23 ' HG2' ' A' ' 97' ' ' GLN . 70.1 p -62.06 -44.41 96.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.76 179.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 86.8 t -139.32 132.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -116.57 144.2 44.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 mm -109.16 142.26 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -102.14 159.58 15.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -47.53 146.12 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.5 mp -96.0 156.57 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.0 m-20 -108.66 119.23 49.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 168.37 21.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.381 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.77 145.14 36.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 81.5 m-70 -110.31 142.94 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.45 139.58 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 115' ' ' ILE . 32.5 mt -106.45 119.58 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.89 124.26 29.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.5 HG23 ' HD2' ' A' ' 76' ' ' PRO . 14.5 p -121.1 136.84 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.652 0.739 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.74 147.98 64.18 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 143.71 51.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' OE1' ' CZ ' ' A' ' 124' ' ' ARG . 7.6 tt0 -126.86 126.84 43.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 89' ' ' THR . 26.4 mp0 -93.37 96.43 9.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.405 ' CG1' ' OE1' ' A' ' 78' ' ' GLN . 15.2 m -108.54 145.27 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 74.3 mt -70.27 106.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.403 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.36 -175.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.54 -39.17 77.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 86' ' ' VAL . 38.9 t70 -86.94 34.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.7 t-20 48.08 45.79 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 84' ' ' ASP . 58.3 t -118.5 110.59 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 87' ' ' VAL . 7.3 p -75.25 123.89 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.39 151.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.554 HG23 ' OE2' ' A' ' 79' ' ' GLU . 19.7 m -91.71 116.81 29.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 127' ' ' ILE . 17.5 m -108.02 160.16 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.85 137.0 3.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.85 142.22 20.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 165' ' ' GLU . 15.4 m -93.88 159.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 150' ' ' LEU . 25.7 t -135.24 137.67 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 161' ' ' ILE . 4.7 m-30 -97.37 163.27 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 1.4 p90 -165.59 156.38 13.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.72 ' HG2' HG23 ' A' ' 162' ' ' THR . 10.4 pt20 -152.75 134.21 14.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.14 99.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.3 pt -83.44 -9.35 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 102' ' ' VAL . 30.9 t0 -155.96 109.77 2.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.655 0.741 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.35 16.76 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.604 HG22 ' OD1' ' A' ' 100' ' ' ASP . 34.2 m -62.52 -14.99 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -103.58 -26.0 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' A' ' 108' ' ' VAL . . . -104.47 45.8 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.83 -2.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.7 p90 -86.49 38.44 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 49.2 27.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' A' ' 104' ' ' ALA . 13.2 t 36.09 40.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.8 t -96.85 -50.42 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.91 -40.42 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.4 t80 -61.51 -40.52 94.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.48 -67.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -55.81 -38.99 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -58.64 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 73' ' ' ILE . 11.3 mm -46.31 -58.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.79 -23.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -93.57 -33.18 13.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.44 -51.84 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.26 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -67.14 -31.39 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 94.2 m -87.91 -29.4 20.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.564 ' O ' HD12 ' A' ' 126' ' ' ILE . 78.3 m-20 -78.9 -44.74 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.8 pp -62.63 -40.94 98.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.429 ' CZ ' ' OE1' ' A' ' 78' ' ' GLN . 40.8 mtt-85 -52.15 -24.61 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.0 -57.0 3.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.9 mp -79.74 -63.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 90' ' ' VAL . 3.4 mt -51.57 -44.78 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.6 -25.52 1.44 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.543 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -124.18 113.89 18.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.27 -178.03 1.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 132' ' ' LEU . 42.0 mt-10 -120.94 130.5 53.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 131' ' ' GLU . 13.3 tp -34.42 -35.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.2 m-20 -80.83 -51.03 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -54.44 -49.47 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.6 p -45.43 -31.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.1 mt -73.82 -49.46 25.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -106.48 37.27 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.3 21.3 5.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -74.19 -0.93 18.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.66 -27.38 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.604 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.4 mp -85.32 -41.33 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.42 -58.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 164' ' ' VAL . 14.4 p-10 -59.43 -33.26 71.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.31 73.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.062 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -84.69 -58.59 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.13 -53.21 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.481 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 24.7 ttp180 -44.33 -40.49 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -57.38 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -48.66 -23.37 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 94' ' ' VAL . 82.8 mt -102.66 -23.99 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.49 -6.24 58.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.98 -33.28 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -79.02 -17.72 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 159' ' ' VAL . 82.0 p -97.18 -38.28 9.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -42.68 -44.38 4.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.5 ptm180 -60.55 -34.65 74.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 40.5 m0 -85.53 12.96 7.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.32 11.19 84.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 154' ' ' THR . 55.2 t -119.98 140.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 111.115 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.92 145.09 51.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 95' ' ' TYR . 23.7 mm -75.85 106.48 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -56.12 -41.25 74.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -171.21 178.5 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.626 HG21 ' CB ' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -129.97 148.42 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.3 mm-40 -137.82 115.64 11.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.481 HD13 ' HB1' ' A' ' 92' ' ' ALA . 15.4 mm -93.18 141.53 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -100.06 160.54 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -51.52 159.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.0 mp -108.26 156.51 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.499 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 5.7 m-20 -115.72 129.66 24.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 161.93 44.01 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.436 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.375 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -115.05 141.6 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 96' ' ' TYR . 90.0 m-70 -101.39 159.05 15.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.33 144.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 115' ' ' ILE . 33.5 mt -106.31 134.79 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.74 108.12 20.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 76' ' ' PRO . 4.6 p -114.86 136.16 22.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.595 0.712 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.77 146.12 59.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 159.38 53.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 120' ' ' GLN . 27.2 mt-30 -143.99 129.69 19.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.24 94.83 7.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 140.57 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.614 HD13 HG22 ' A' ' 87' ' ' VAL . 31.3 mm -67.18 102.45 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.52 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -59.69 -42.95 94.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.98 30.04 0.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.845 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 51.98 50.62 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.06 120.36 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.614 HG22 HD13 ' A' ' 81' ' ' ILE . 24.7 t -77.88 116.36 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.63 149.88 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.507 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 8.5 m -91.94 117.09 29.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 127' ' ' ILE . 5.2 p -116.1 141.44 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -143.84 141.9 30.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.25 145.68 23.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.45 166.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.51 131.68 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.49 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.7 m-30 -92.72 157.08 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.441 ' CG ' ' CZ ' ' A' ' 111' ' ' PHE . 8.7 p90 -165.84 156.34 13.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.74 ' HG2' HG23 ' A' ' 162' ' ' THR . 12.3 pt20 -153.03 121.31 6.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.8 100.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -86.21 -24.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 19.0 t0 -138.57 105.59 7.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.8 Cg_endo -69.79 -43.65 2.51 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.307 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -50.78 -19.23 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -107.91 -34.08 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -101.91 43.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 105' ' ' VAL . 10.1 p -87.25 33.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 34.4 p90 -111.7 27.42 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 109' ' ' SER . 8.1 m-80 58.09 34.76 24.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.3 m 33.52 35.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.5 p -86.13 -60.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.823 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.46 -46.5 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -58.54 -39.67 80.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.07 -65.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -57.97 -31.66 67.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.59 -66.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 73' ' ' ILE . 16.7 mm -39.04 -63.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 75' ' ' VAL . 47.4 t -41.61 -50.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -62.13 -50.5 71.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.14 -60.28 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.37 -61.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 78' ' ' GLN . 12.8 mm-40 -39.41 -33.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 m -88.1 -53.95 4.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -56.16 -56.8 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 123' ' ' LEU . 2.6 pp -51.53 -41.06 60.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttp180 -55.98 -22.37 26.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 -59.58 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.8 mp -78.17 -60.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 90' ' ' VAL . 11.2 mt -54.97 -47.41 76.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -42.87 -27.34 0.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.8 pt-20 -120.58 113.33 20.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -173.12 -174.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 135' ' ' THR . 15.8 mt-10 -116.96 127.84 54.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.462 ' C ' ' O ' ' A' ' 131' ' ' GLU . 20.7 tp -33.32 -35.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.1 t70 -84.15 -65.45 1.01 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 135' ' ' THR . 29.6 tt0 -41.69 -47.7 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 131' ' ' GLU . 72.9 p -33.18 -40.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 mt -73.83 -51.14 17.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 m -61.54 -58.36 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.89 65.39 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' C ' ' CD ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -97.06 -45.21 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.467 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 13.0 t70 -59.07 -29.01 67.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 144' ' ' ALA . 48.3 mt -73.81 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -39.73 -50.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.5 p30 -69.49 -33.39 72.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' ILE . . . -59.24 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -46.15 -63.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 mt -48.11 -51.3 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 163' ' ' ARG . 26.8 ttm180 -44.49 -40.57 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.5 -56.35 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -42.91 -55.23 3.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 115' ' ' ILE . 9.8 mp -68.01 -35.71 78.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -20.87 40.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -82.72 -29.95 29.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 mm -83.71 -17.62 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.944 ' HB ' HG13 ' A' ' 159' ' ' VAL . 64.0 p -93.93 -39.96 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -41.51 -29.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.451 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 11.8 ptm180 -79.92 -36.44 36.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 154' ' ' THR . 35.6 m0 -84.16 30.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.26 33.74 39.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.944 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.5 p -141.49 144.25 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.151 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 3.3 tmmm? -127.92 151.08 49.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.0 mm -89.02 91.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 97' ' ' GLN . 19.0 p -42.3 -46.68 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 147' ' ' ARG . 14.5 ptm180 -169.4 -175.03 2.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 73.8 t -139.72 147.28 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 28.4 mm -102.92 142.32 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -98.57 161.88 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.951 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -47.52 156.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -109.81 157.51 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 t70 -126.09 133.28 24.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.63 0.729 . . . . 0.0 110.885 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 170.15 17.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.177 0 C-N-CA 122.678 2.252 . . . . 0.0 112.318 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -104.74 144.33 31.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.96 145.66 39.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.858 HG12 ' CE1' ' A' ' 95' ' ' TYR . 34.5 m -94.21 140.39 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 96' ' ' TYR . 21.0 mt -107.55 119.24 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 118.57 20.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 116' ' ' VAL . 88.8 t -117.41 132.68 23.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.729 . . . . 0.0 111.119 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.75 144.37 53.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.85 164.28 35.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.628 2.218 . . . . 0.0 112.316 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.541 ' CD ' HD11 ' A' ' 123' ' ' LEU . 1.3 pt20 -146.67 139.44 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.55 129.43 36.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.97 145.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.9 mt -74.73 114.59 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.2 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.15 23.55 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 27.7 m-20 60.41 50.68 5.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 88' ' ' VAL . 70.7 t -118.82 111.16 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -75.27 115.41 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.5 HG13 HG12 ' A' ' 86' ' ' VAL . 15.7 m -140.19 162.2 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.49 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 31.9 m -102.84 125.04 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 91' ' ' ASP . 11.4 p -105.83 162.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.9 p30 -171.01 134.71 0.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.08 35.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 165' ' ' GLU . 17.1 m -102.96 164.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.93 134.28 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.858 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.2 m-30 -96.77 154.4 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.481 ' CD2' HD11 ' A' ' 73' ' ' ILE . 3.8 p90 -165.65 161.26 18.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 99' ' ' ILE . 6.2 pt20 -153.17 114.2 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.84 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 97' ' ' GLN . 2.7 pp -89.68 -24.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 99' ' ' ILE . 29.3 t70 -133.64 90.12 29.16 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -40.61 5.09 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 0.0 112.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 103' ' ' LYS . 27.5 m -38.39 -41.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 102' ' ' VAL . 23.1 mtpp -91.43 -35.65 14.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -84.45 41.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.087 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 105' ' ' VAL . 6.1 p -87.66 47.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.7 p90 -130.37 32.21 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.3 m-80 60.93 28.06 17.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 6.4 t 36.1 35.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 107' ' ' ASN . 54.9 m -89.76 -58.75 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -47.46 -54.56 11.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.3 t80 -50.13 -48.38 53.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 73' ' ' ILE . 9.1 mt -51.48 -68.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -60.95 -14.91 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.18 -34.51 23.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.649 HD13 HD12 ' A' ' 150' ' ' LEU . 14.1 mm -72.1 -54.83 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.655 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.0 m -56.68 -22.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.149 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -92.69 -45.21 8.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.38 -44.1 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.11 97.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.2 mm-40 -47.87 -33.09 6.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.1 m -87.0 -50.57 6.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -58.51 -58.25 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.541 HD11 ' CD ' ' A' ' 78' ' ' GLN . 2.3 pp -51.72 -39.99 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -52.93 -31.99 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.81 -51.69 31.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.83 -60.12 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.505 HD11 HG23 ' A' ' 142' ' ' ILE . 47.0 mm -50.61 -38.01 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.11 -33.83 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 130' ' ' MET . 11.9 pt-20 -117.06 113.93 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.404 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -171.8 -177.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.44 121.92 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.8 tp -33.55 -34.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 131' ' ' GLU . 25.3 t0 -83.96 -51.71 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 135' ' ' THR . 49.1 tt0 -52.99 -47.55 68.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 134' ' ' GLU . 29.8 p -35.82 -50.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.51 -47.12 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -102.47 85.58 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 142' ' ' ILE . . . 171.01 37.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.494 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.1 ttp180 -76.62 -31.42 57.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 5.1 m-20 -60.18 -38.37 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -78.89 -60.11 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 127' ' ' ILE . 20.3 mt -42.95 -51.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 140' ' ' ASP . . . -57.72 -60.63 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -49.63 -68.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 149' ' ' GLU . 4.0 mm? -43.03 -59.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' LEU . 45.5 ttp180 -35.74 -43.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.66 -38.7 28.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 146' ' ' LEU . 39.7 mm-40 -62.23 -27.63 69.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.649 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -99.42 -29.72 12.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -15.22 60.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.33 -20.56 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.48 -12.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 161' ' ' ILE . 72.0 p -101.31 -33.98 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -50.65 -23.3 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -88.2 -30.23 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -88.09 17.6 4.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 66.71 26.94 73.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.48 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.86 135.75 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 111.148 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.96 139.93 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 154' ' ' THR . 42.5 mm -84.98 109.48 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -60.54 -55.09 37.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -163.0 -176.16 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.77 140.47 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.169 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 93' ' ' VAL . 2.7 mm-40 -126.3 135.99 52.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.5 141.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.14 161.65 13.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -51.59 154.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -104.53 156.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -109.11 120.66 45.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 166.15 28.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.642 2.228 . . . . 0.0 112.317 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.773 0.32 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' HG21 ' A' ' 162' ' ' THR . 18.4 mp0 -114.59 144.97 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 31.2 m80 -117.4 128.73 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.77 135.44 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.941 HD13 HG21 ' A' ' 115' ' ' ILE . 21.9 mt -100.69 125.66 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.73 103.96 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 12.7 p -106.06 135.07 19.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.78 150.78 68.55 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.627 2.218 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.485 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.69 156.94 62.2 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.262 . . . . 0.0 112.348 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -142.99 121.34 12.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.77 105.66 11.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 127' ' ' ILE . 17.5 m -116.12 148.78 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 69.3 mt -77.12 106.22 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.36 -174.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.67 -47.63 77.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 86' ' ' VAL . 26.3 t0 -82.84 37.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.9 m120 47.61 54.8 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.567 HG12 HG13 ' A' ' 88' ' ' VAL . 47.9 t -124.38 110.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.35 108.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.567 HG13 HG12 ' A' ' 86' ' ' VAL . 27.5 m -128.46 146.63 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 1.8 m -80.52 113.52 18.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.899 HG11 HG21 ' A' ' 127' ' ' ILE . 4.8 p -107.41 143.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 15.8 p-10 -151.73 140.8 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.19 146.92 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.34 159.11 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 150' ' ' LEU . 40.5 t -131.9 129.12 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.17 159.82 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.0 p90 -165.56 159.87 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.731 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.3 pt20 -152.36 128.72 10.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 98' ' ' VAL . 46.5 t -67.32 93.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 100' ' ' ASP . 45.7 pt -73.07 -36.15 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 99' ' ' ILE . 24.8 t0 -125.4 99.24 33.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.9 Cg_endo -69.77 -7.52 21.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 105' ' ' VAL . 54.2 t -76.88 -47.83 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -82.95 -33.36 26.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -88.2 46.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 102' ' ' VAL . 16.1 m -89.22 30.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 45.6 p90 -112.66 35.61 3.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m120 47.12 36.68 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.2 m 31.08 41.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.1 m -89.19 -59.27 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -52.81 -34.2 52.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -70.36 -40.16 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -62.15 -54.93 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 ptp -68.62 -33.64 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -66.87 -59.08 3.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.941 HG21 HD13 ' A' ' 73' ' ' ILE . 16.2 mm -46.33 -63.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.2 t -39.48 -40.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -74.04 -49.46 24.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.7 mt -55.72 -57.56 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.32 -51.38 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HA ' HD21 ' A' ' 123' ' ' LEU . 46.4 mm-40 -42.85 -41.46 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 84.9 m -75.94 -59.3 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -45.77 -57.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.3 pp -54.06 -43.65 70.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 123' ' ' LEU . 20.1 ttp180 -53.01 -32.4 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.64 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.2 mp -76.35 -63.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.899 HG21 HG11 ' A' ' 90' ' ' VAL . 2.9 mp -49.62 -45.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.12 -26.18 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.47 113.75 17.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.98 -175.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.3 mm-40 -122.76 123.31 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 131' ' ' GLU . 46.3 tp -34.39 -32.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.9 m-20 -83.93 -46.63 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 131' ' ' GLU . 37.0 tt0 -56.31 -50.58 71.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' LEU . 79.1 p -42.17 -56.35 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.131 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 97.4 mt -34.79 -51.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.9 m -117.76 87.21 2.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.81 39.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -82.97 -40.28 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.71 -44.02 63.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.708 HG22 ' NE ' ' A' ' 145' ' ' ARG . 26.5 mt -68.96 -54.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.03 -36.81 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.497 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 80.5 m-20 -68.92 -19.14 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.4 -40.85 17.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.708 ' NE ' HG22 ' A' ' 141' ' ' ILE . 0.5 OUTLIER -66.59 -55.84 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.55 -32.7 67.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 31.6 ttt-85 -79.43 -40.55 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' CD ' ' O ' ' A' ' 148' ' ' GLU . 9.9 tm-20 -63.28 -25.49 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -91.17 -62.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 94' ' ' VAL . 79.4 mt -54.13 -20.72 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 21.0 t0 -83.86 13.85 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -121.45 -40.87 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 153' ' ' ILE . 22.1 mt -76.93 -8.42 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.089 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.428 ' CG2' HD11 ' A' ' 115' ' ' ILE . 71.6 p -100.65 -38.01 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -45.98 -37.66 6.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.516 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 6.4 ptp180 -66.74 -33.64 76.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.516 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.1 m0 -86.19 10.62 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.52 17.16 80.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.2 t -122.45 141.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -125.16 150.54 46.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 29.3 mm -85.82 113.88 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.731 HG23 ' HG2' ' A' ' 97' ' ' GLN . 25.7 p -68.02 -55.53 12.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 163' ' ' ARG . 4.5 ptp180 -156.01 178.0 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 99.4 t -141.41 145.86 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.26 145.1 51.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.497 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 19.9 mm -106.92 142.29 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.429 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 21.4 mm-40 -94.06 161.79 14.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -54.57 141.72 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.2 mp -91.22 157.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 t70 -128.34 133.78 25.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.36 24.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.312 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.794 0.331 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 162' ' ' THR . 11.8 mp0 -75.61 140.86 42.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 66.4 m-70 -108.46 134.46 51.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.59 HG12 ' CE1' ' A' ' 95' ' ' TYR . 11.3 m -93.96 151.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 115' ' ' ILE . 20.8 mt -117.56 117.85 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.48 110.38 17.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.1 p -115.89 137.07 23.06 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.643 0.735 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.82 149.53 66.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 159.11 54.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.266 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -145.4 115.59 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.78 117.2 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.74 139.1 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.0 mt -70.29 105.52 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.5 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -64.94 -42.65 94.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.34 30.63 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER 53.46 44.72 29.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 HG13 ' A' ' 88' ' ' VAL . 41.1 t -111.82 114.21 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.8 p -77.18 114.29 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 HG12 ' A' ' 86' ' ' VAL . 27.1 m -142.84 144.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.5 m -87.34 124.48 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 127' ' ' ILE . 28.8 m -114.26 163.98 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -174.86 136.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 166' ' ' ILE . . . -154.07 151.54 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.2 m -95.65 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.1 132.75 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.4 m-30 -91.05 157.6 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 7.7 p90 -165.7 146.23 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.827 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.4 pt20 -141.92 123.14 14.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 159' ' ' VAL . 90.5 t -66.54 124.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -111.11 -30.07 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 99' ' ' ILE . 34.5 t70 -124.38 101.67 34.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.908 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.3 Cg_endo -69.74 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.401 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -41.45 -38.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -91.6 -37.82 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -91.3 45.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 105' ' ' VAL . 9.4 p -90.73 40.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 28.7 p90 -119.99 32.83 5.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' SER . 2.9 m-80 49.8 38.02 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 108' ' ' VAL . 13.9 t 34.41 33.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' ASN . 35.6 m -87.98 -51.17 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -47.57 75.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.728 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -60.2 -36.32 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.79 -60.54 3.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.9 -45.42 89.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.52 -55.14 37.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.005 HG21 HD13 ' A' ' 73' ' ' ILE . 10.9 mm -48.73 -62.96 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 76' ' ' PRO . 49.6 t -42.01 -33.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -79.16 -53.97 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 153' ' ' ILE . 14.4 mt -52.35 -58.9 5.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -38.84 -51.96 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -43.73 -41.17 4.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.8 m -78.18 -46.94 19.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -57.11 -61.12 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.9 pp -55.11 -42.14 72.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 123' ' ' LEU . 15.7 ttm180 -54.59 -25.46 26.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.74 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.3 mp -79.27 -64.22 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.83 HG21 HG21 ' A' ' 90' ' ' VAL . 2.9 mp -48.7 -42.66 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -46.91 -30.48 5.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -119.38 113.91 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.458 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -172.61 -175.19 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 133' ' ' ASP . 9.2 mt-10 -119.3 123.88 45.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 131' ' ' GLU . 51.8 tp -33.68 -34.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.3 m-20 -86.17 -54.1 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 135' ' ' THR . 70.7 tt0 -50.8 -49.81 57.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 134' ' ' GLU . 35.1 p -32.49 -51.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 mt -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 134' ' ' GLU . 2.2 m -93.86 41.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -146.84 49.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 45.8 ttt180 -95.37 -43.27 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.43 -19.4 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.1 mt -95.55 -56.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 127' ' ' ILE . 46.3 mt -46.82 -41.77 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' HG2' ' A' ' 139' ' ' ARG . 16.9 p30 -77.69 -20.44 53.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.92 -37.1 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.15 -66.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.4 mt -42.92 -35.75 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -75.71 -41.16 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -18.07 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.26 -48.53 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 115' ' ' ILE . 65.4 mt -67.88 -35.73 79.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -58.11 -11.85 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -95.88 -45.36 6.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 153' ' ' ILE . 68.8 mt -75.31 -1.45 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 161' ' ' ILE . 26.6 p -109.02 -40.62 4.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.34 -34.88 3.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 10.2 ptm180 -70.04 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.578 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 51.4 m0 -88.08 11.88 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 69.87 35.12 72.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 99' ' ' ILE . 20.5 t -138.8 136.62 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -116.3 141.0 48.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 154' ' ' THR . 46.9 mm -82.95 96.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.0 p -47.75 -55.56 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -163.57 -175.95 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.16 137.07 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -119.08 143.72 46.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 92' ' ' ALA . 15.3 mm -109.69 142.26 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.42 161.46 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -43.13 158.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 45.4 mt -113.15 154.72 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 38.2 m-20 -118.68 126.54 27.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.93 17.75 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.326 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 157.84 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 86.4 m-70 -124.37 156.74 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 95' ' ' TYR . 2.7 m -99.69 152.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 115' ' ' ILE . 20.0 mt -110.03 131.59 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.76 105.99 18.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.2 p -118.3 127.36 26.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.3 Cg_endo -69.78 150.24 67.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.78 164.68 33.64 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.264 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -145.26 115.08 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.76 100.24 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -114.73 137.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.8 mt -70.2 105.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.11 -177.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -67.8 -35.94 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.91 28.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 13.8 m-20 54.32 45.42 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 88' ' ' VAL . 55.6 t -114.82 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.3 p -84.04 108.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 86' ' ' VAL . 15.0 m -135.63 152.81 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 3.6 m -88.89 130.87 35.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 127' ' ' ILE . 8.2 p -120.21 132.06 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.1 138.33 33.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.78 171.55 18.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 165' ' ' GLU . 13.7 m -121.66 159.08 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 73' ' ' ILE . 38.5 t -130.73 130.42 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.7 m-30 -91.27 160.81 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.6 p90 -165.85 157.0 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.697 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.0 pt20 -152.17 132.36 13.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.3 t -73.54 98.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -76.55 -19.75 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.082 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -143.91 106.36 4.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.653 0.739 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -10.06 27.6 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.36 -29.65 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' A' ' 158' ' ' GLY . 31.2 mtpt -94.65 -34.56 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -90.92 47.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 105' ' ' VAL . 61.1 t -78.55 -5.57 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 33.9 p90 -83.11 16.86 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m-20 61.87 38.62 14.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 32.4 m 34.14 36.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 107' ' ' ASN . 8.3 t -89.43 -52.43 5.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.28 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -62.87 -33.28 74.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.23 -58.45 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.5 ptp -64.82 -39.12 93.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -54.59 39.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 73' ' ' ILE . 9.4 mm -50.59 -59.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.7 t -44.12 -42.86 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -69.15 -48.73 61.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.72 -59.77 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -41.32 -45.12 2.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.111 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 38.4 mm-40 -52.42 -41.59 63.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.2 m -80.08 -50.58 10.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -51.53 -52.81 43.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 124' ' ' ARG . 1.7 pp -60.14 -41.67 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.793 ' N ' HD12 ' A' ' 123' ' ' LEU . 57.0 ttt85 -54.31 -21.78 10.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.16 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.4 mp -76.55 -55.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.696 HG21 HG11 ' A' ' 90' ' ' VAL . 50.7 mm -51.07 -38.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.51 -27.31 11.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.449 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -123.24 114.19 19.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.17 -178.34 1.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 133' ' ' ASP . 20.6 mt-10 -122.66 121.56 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' GLU . 24.1 tp -33.73 -34.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' GLU . 58.0 m-20 -78.48 -50.38 11.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 tp10 -59.19 -46.98 86.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 p -40.57 -36.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.35 -55.47 21.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -101.54 46.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -132.79 43.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 mtp-105 -87.89 -42.83 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.75 -11.31 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.7 mt -100.08 -56.0 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.37 -44.53 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.529 ' OD1' HD11 ' A' ' 166' ' ' ILE . 67.2 m-20 -56.57 -26.55 55.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.4 -48.59 15.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 145' ' ' ARG . 5.9 mpt_? -57.01 -64.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 146' ' ' LEU . 10.4 mt -52.74 -57.35 10.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HB2' HG21 ' A' ' 164' ' ' VAL . 44.6 ttp180 -45.38 -38.27 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -82.86 -22.85 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 153' ' ' ILE . 32.7 mt-10 -83.31 -12.15 56.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.832 HD12 HD13 ' A' ' 115' ' ' ILE . 2.1 mm? -121.4 -5.87 9.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -24.32 23.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -86.59 -34.37 19.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 149' ' ' GLU . 22.9 mt -81.54 -11.88 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 1.013 ' HB ' HG13 ' A' ' 159' ' ' VAL . 56.6 p -100.33 -40.44 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.176 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -46.59 -21.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 156' ' ' ARG . 0.8 OUTLIER -82.6 -37.2 25.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.507 ' HB2' HG12 ' A' ' 159' ' ' VAL . 32.2 m0 -84.04 24.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.412 ' N ' ' HE2' ' A' ' 103' ' ' LYS . . . 65.04 14.26 58.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 1.013 HG13 ' HB ' ' A' ' 154' ' ' THR . 4.2 p -123.24 140.78 45.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD3' ' C ' ' A' ' 160' ' ' LYS . 3.5 tmtt? -126.78 140.13 52.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.53 93.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.697 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.28 -55.04 7.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.159 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 2.8 ptp180 -158.59 -178.9 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.501 HG12 ' OD1' ' A' ' 143' ' ' ASN . 92.0 t -141.17 127.96 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.164 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.5 mm-40 -115.56 134.14 55.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.529 HD11 ' OD1' ' A' ' 143' ' ' ASN . 17.0 mm -102.52 142.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -101.22 159.13 15.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 19.5 mtt85 -45.03 157.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -111.58 155.8 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.473 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.2 m-20 -111.59 120.07 43.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.596 0.712 . . . . 0.0 110.922 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.28 19.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.431 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.794 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 1.2 pm0 -103.96 143.72 32.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -112.53 145.27 40.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 93' ' ' VAL . 2.4 p -94.35 137.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 115' ' ' ILE . 21.2 mt -103.11 126.92 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -112.51 132.01 22.38 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.5 Cg_endo -69.75 145.92 58.68 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.316 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.5 Cg_endo -69.78 162.57 41.58 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.706 2.27 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -142.97 117.09 9.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -69.04 106.65 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.38 142.62 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 87' ' ' VAL . 19.5 mm -72.13 109.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -56.44 -177.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -65.68 -40.65 92.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -85.51 34.39 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 45.97 47.61 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ASP . 31.8 t -115.37 122.28 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 81' ' ' ILE . 21.8 t -77.23 111.4 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 m -138.48 155.08 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.6 m -102.19 119.68 39.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 127' ' ' ILE . 27.5 m -100.64 141.2 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -146.05 133.0 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.7 167.39 29.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 35.5 m -111.61 172.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.74 123.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 4.6 m-30 -90.39 151.96 21.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -165.8 154.79 11.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.514 ' O ' HG23 ' A' ' 99' ' ' ILE . 2.5 pt20 -148.71 112.48 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.91 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.88 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -80.64 -26.53 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.765 ' HB2' HD12 ' A' ' 99' ' ' ILE . 28.5 t0 -134.97 97.51 13.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 104' ' ' ALA . 53.8 Cg_endo -69.79 -44.74 1.89 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.706 HG23 ' HG2' ' A' ' 103' ' ' LYS . 4.0 m -36.41 -31.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.706 ' HG2' HG23 ' A' ' 102' ' ' VAL . 11.7 mmmt -93.62 -35.54 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -82.27 41.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -73.86 4.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 30.2 p90 -97.34 27.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.8 m-80 56.87 32.99 22.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.542 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.0 m 32.97 39.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.0 t -96.28 -36.44 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 4.3 m-20 -71.05 -38.59 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.792 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -67.8 -44.9 76.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -48.74 -54.3 15.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.633 ' O ' HG22 ' A' ' 116' ' ' VAL . 7.9 ptp -77.3 -45.01 27.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -57.4 -14.99 5.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.094 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 73' ' ' ILE . 2.0 mm -80.73 -51.55 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 113' ' ' MET . 10.0 m -59.64 -25.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -82.03 -32.82 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 114' ' ' ALA . 16.0 mt -70.5 -36.58 73.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.02 86.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 32.3 mm-40 -51.45 -38.17 52.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.1 m -82.88 -57.18 3.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.169 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -54.26 -56.44 18.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 1.005 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.1 pp -53.72 -41.3 66.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttt-85 -53.97 -20.35 6.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.13 -57.9 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -79.27 -62.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 1.005 HD13 ' HB2' ' A' ' 123' ' ' LEU . 3.0 mp -50.37 -41.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.3 -26.38 4.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.01 113.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.913 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -175.72 1.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.0 126.02 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' GLU . 42.5 tp -37.53 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.3 p30 -93.19 -43.39 8.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.829 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.6 tp10 -63.82 -20.66 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.1 p -73.54 -14.24 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 mt -82.17 -40.84 21.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 t -120.86 43.09 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -134.17 20.24 4.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 142' ' ' ILE . 14.6 ptt180 -69.08 -32.08 71.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -51.72 -47.46 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.27 -43.43 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 139' ' ' ARG . 48.9 mt -50.9 -49.9 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.541 ' OD1' HD11 ' A' ' 166' ' ' ILE . 76.0 m-20 -65.44 -52.24 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 148' ' ' GLU . . . -42.89 -48.58 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.101 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -61.23 -70.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.38 -62.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -40.26 -36.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 144' ' ' ALA . 0.3 OUTLIER -78.01 -56.98 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.92 -58.37 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.8 mt -56.24 -37.23 69.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -11.28 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -92.63 -37.17 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -76.13 -19.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 159' ' ' VAL . 73.6 p -93.74 -38.41 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -52.11 -16.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.29 -31.75 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.465 ' HB2' HG12 ' A' ' 159' ' ' VAL . 40.8 m0 -88.97 11.47 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.69 10.98 85.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -113.57 145.42 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 111.128 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -118.48 141.2 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 154' ' ' THR . 26.2 mm -79.84 92.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.92 -61.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -166.49 -178.06 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 ' OD1' ' A' ' 143' ' ' ASN . 62.9 t -135.18 147.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 13.7 mt-10 -135.55 143.31 45.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.541 HD11 ' OD1' ' A' ' 143' ' ' ASN . 24.6 mm -105.44 142.24 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -106.12 161.25 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -42.33 136.95 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -95.76 157.22 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.496 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 9.6 m-20 -107.87 120.93 45.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.843 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 169.14 19.58 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.451 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.251 . . . . 0.0 112.379 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.777 0.322 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -119.75 152.36 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 85.5 m-70 -121.86 143.85 49.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.35 139.66 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.71 HD11 ' CE1' ' A' ' 111' ' ' PHE . 27.4 mt -108.26 124.56 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.46 127.49 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.815 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 2.3 p -120.75 135.32 24.61 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.627 0.727 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.3 Cg_endo -69.78 150.29 67.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.2 Cg_endo -69.71 149.84 67.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' HD11 ' A' ' 123' ' ' LEU . 56.7 tt0 -137.59 113.71 9.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.81 101.92 4.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.472 HG11 ' HA2' ' A' ' 128' ' ' GLY . 15.1 t -111.05 137.66 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 65.2 mt -68.16 104.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -49.78 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -65.12 -41.02 95.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 19.2 t70 -84.96 33.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 51.07 47.89 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 172' ' ' PRO . 94.0 t -118.93 114.76 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.4 p -80.38 120.18 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -145.89 148.91 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 11.4 m -81.16 125.98 30.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.951 HG11 HG21 ' A' ' 127' ' ' ILE . 9.8 p -121.76 130.93 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 13.5 p-10 -140.95 145.47 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.82 150.34 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -100.33 155.15 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.77 141.76 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.39 162.53 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.1 p90 -165.9 157.53 14.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.468 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 11.8 pt20 -153.31 116.4 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 98' ' ' VAL . 34.4 t -53.79 94.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.132 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.27 3.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -165.17 112.64 0.83 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.64 0.733 . . . . 0.0 110.841 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -51.22 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.244 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 p -44.68 -37.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -81.16 -37.08 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -96.73 56.01 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 105' ' ' VAL . 12.8 p -92.66 3.25 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.166 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 31.0 p90 -87.94 24.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 23.4 m-80 61.97 27.4 16.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 3.3 t 36.66 40.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 t -96.16 -52.33 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -57.22 -39.2 74.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.71 ' CE1' HD11 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -62.88 -35.01 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.45 -64.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 ptp -61.64 -32.74 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -67.13 -57.22 7.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 154' ' ' THR . 8.1 mm -44.69 -56.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 76' ' ' PRO . 87.6 t -53.79 -24.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -85.91 -37.77 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 121' ' ' THR . 10.4 mt -67.55 -57.07 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.73 -36.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -63.41 -40.85 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 118' ' ' LEU . 88.6 m -78.74 -38.77 38.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 34.4 m120 -69.26 -56.38 7.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -53.19 -44.18 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.72 ' N ' HD12 ' A' ' 123' ' ' LEU . 45.5 ttt-85 -52.46 -22.04 4.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' ASN . . . -73.92 -60.59 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.0 mp -78.91 -60.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.951 HG21 HG11 ' A' ' 90' ' ' VAL . 1.9 mp -49.98 -38.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.472 ' HA2' HG11 ' A' ' 80' ' ' VAL . . . -51.62 -23.89 10.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.06 114.05 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.79 -175.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 133' ' ' ASP . 22.2 mt-10 -120.84 137.07 54.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.0 tp -38.29 -26.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.757 ' HA ' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -97.83 -59.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -41.93 -25.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' ASP . 1.5 p -64.2 -50.58 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.757 HD21 ' HA ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -79.29 -13.95 59.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.935 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 m -92.78 -29.58 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.477 ' CA ' HD13 ' A' ' 141' ' ' ILE . . . -114.56 85.53 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.499 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -103.03 -43.45 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -16.84 63.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.8 mp -85.11 -48.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.613 ' CG2' HD11 ' A' ' 127' ' ' ILE . 70.8 mt -55.48 -61.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.46 -37.67 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.97 -59.02 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -48.77 -66.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 tp -42.81 -48.77 5.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -55.31 -42.94 74.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.32 -9.83 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.701 ' O ' HD12 ' A' ' 153' ' ' ILE . 13.2 mt-10 -98.35 -53.35 3.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.2 mt -64.6 -34.7 78.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -13.67 35.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -88.58 -49.84 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 149' ' ' GLU . 4.4 mp -72.92 -21.61 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.533 ' CG2' HD11 ' A' ' 115' ' ' ILE . 60.0 p -91.21 -35.35 14.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -25.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CB ' HH11 ' A' ' 156' ' ' ARG . 0.0 OUTLIER -80.15 -34.94 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -82.57 15.91 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.54 76.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.45 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.77 128.07 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.94 145.29 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -84.08 116.31 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 30.3 p -70.37 -62.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -146.65 167.13 24.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.96 115.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 93' ' ' VAL . 20.0 mm-40 -99.16 147.21 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.559 HD13 ' HB1' ' A' ' 92' ' ' ALA . 22.6 mm -107.62 137.21 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.9 mt-30 -88.74 159.61 17.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -50.58 156.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -110.99 157.26 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 10.0 t70 -125.45 133.26 24.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 168.47 21.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.509 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.211 0 C-N-CA 122.683 2.256 . . . . 0.0 112.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.764 0.316 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.38 152.87 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m-70 -113.85 149.26 35.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.2 p -96.49 145.31 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.966 HD13 HG21 ' A' ' 115' ' ' ILE . 18.7 mt -105.35 130.68 56.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.38 95.11 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.905 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.1 p -100.93 138.42 20.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.679 0.752 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 150.48 68.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.676 2.251 . . . . 0.0 112.327 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.498 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.2 Cg_endo -69.8 171.0 15.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 13.7 mp0 -142.97 145.88 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.37 101.22 11.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.625 HG12 ' NH1' ' A' ' 124' ' ' ARG . 28.9 m -117.05 145.83 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 66.9 mt -77.55 106.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.33 -178.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -62.87 -48.59 78.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.3 t0 -81.45 37.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.5 m120 46.67 44.84 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 88' ' ' VAL . 76.6 t -111.23 110.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.61 120.86 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 86' ' ' VAL . 28.7 m -144.83 150.3 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 6.9 m -93.52 125.05 37.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 127' ' ' ILE . 34.4 m -112.9 148.98 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -152.81 138.45 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.831 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.08 153.44 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 165' ' ' GLU . 24.2 m -101.22 163.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.39 132.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.6 m-30 -94.26 161.31 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.6 p90 -165.91 152.37 9.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.601 ' HG2' HG23 ' A' ' 162' ' ' THR . 14.1 pt20 -143.11 126.06 16.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.83 91.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.7 -31.89 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -132.07 102.6 14.49 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.846 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -10.14 27.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.637 2.224 . . . . 0.0 112.393 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.12 -50.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -77.02 -38.09 53.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -86.63 47.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.34 4.74 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 36.3 p90 -85.26 30.83 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 108' ' ' VAL . 4.8 m120 49.63 37.07 11.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 23.6 m 32.57 41.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.4 m -94.96 -41.58 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -46.8 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.704 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -57.05 -30.4 64.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.0 mt -60.31 -60.67 3.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.4 ' O ' HG22 ' A' ' 116' ' ' VAL . 20.0 ptp -67.75 -46.22 72.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.26 -35.93 63.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.966 HG21 HD13 ' A' ' 73' ' ' ILE . 5.2 mm -67.76 -64.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.7 m -52.29 -15.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -94.83 -34.32 12.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 150' ' ' LEU . 10.8 mt -73.2 -54.23 8.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -47.08 -45.29 21.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.475 ' HG2' ' NE2' ' A' ' 78' ' ' GLN . 18.1 mt-30 -62.02 -36.13 80.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.5 m -74.16 -22.12 59.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 36.0 m120 -91.53 -61.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 124' ' ' ARG . 4.1 pp -47.63 -39.83 18.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.625 ' NH1' HG12 ' A' ' 80' ' ' VAL . 25.4 mtt-85 -52.72 -33.09 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.88 -54.43 15.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.56 -59.52 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 90' ' ' VAL . 3.7 mt -50.25 -44.24 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.86 -24.02 0.68 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' MET . 10.4 pt-20 -125.86 112.76 16.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -175.54 -175.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 135' ' ' THR . 10.2 mm-40 -122.44 129.39 52.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.99 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 74.9 m-20 -85.74 -64.89 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.2 pt-20 -53.33 -46.02 69.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 131' ' ' GLU . 25.3 p -33.3 -33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 134' ' ' GLU . 39.6 mt -70.85 -69.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -54.14 -46.29 72.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.72 57.64 2.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -99.75 -26.41 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -78.12 -26.13 47.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.7 mt -78.73 -52.34 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -43.88 -50.51 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.562 ' HB3' HD11 ' A' ' 166' ' ' ILE . 0.9 OUTLIER -68.47 -41.01 80.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.473 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -50.86 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -55.09 -56.76 16.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' HB1' ' A' ' 119' ' ' ALA . 7.2 tp -47.51 -62.12 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 25.9 ttp85 -43.85 -50.25 7.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -53.54 -31.37 46.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.58 -60.18 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 115' ' ' ILE . 3.3 mm? -54.82 -31.75 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -66.85 -3.75 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -97.59 -43.84 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.5 mp -75.16 -18.78 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.8 p -92.04 -35.33 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.16 -38.62 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.6 ptp180 -69.93 -32.53 70.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.672 ' O ' HG23 ' A' ' 159' ' ' VAL . 31.7 m0 -88.23 34.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.57 23.39 4.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 157' ' ' TRP . 91.2 t -126.72 143.32 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.75 141.92 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 95' ' ' TYR . 26.9 mm -77.54 97.56 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 97' ' ' GLN . 62.6 p -51.27 -38.57 53.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -170.99 -179.93 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 143' ' ' ASN . 1.7 m -141.32 134.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.445 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.7 mt-10 -121.07 139.42 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 143' ' ' ASN . 9.0 mm -104.12 142.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.171 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.48 161.95 13.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -49.32 145.38 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 170' ' ' ASP . 3.3 mp -98.27 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 169' ' ' ILE . 2.2 m-20 -112.72 120.46 40.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 110.87 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 170.23 17.12 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.629 2.22 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.29 138.6 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 47.2 m80 -108.57 126.73 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -93.1 135.26 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 115' ' ' ILE . 20.4 mt -99.1 128.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.32 97.97 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 116' ' ' VAL . 48.2 t -102.89 126.78 31.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 111.128 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 149.86 67.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.79 147.58 63.02 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -128.17 116.95 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.53 116.86 9.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.62 147.52 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 46.6 mm -83.56 108.67 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.4 m -53.11 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -67.32 -45.09 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 25.8 t70 -82.89 36.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.49 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.6 m-20 47.26 51.07 13.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 HG13 ' A' ' 88' ' ' VAL . 87.1 t -118.15 109.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 87' ' ' VAL . 6.4 p -78.14 114.28 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 86' ' ' VAL . 18.1 m -140.15 142.06 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 m -81.93 126.24 31.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 91' ' ' ASP . 7.2 p -119.64 160.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -162.57 143.5 10.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.76 153.52 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 165' ' ' GLU . 18.0 m -101.19 164.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.8 t -137.42 134.43 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 3.4 m-85 -96.59 157.02 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 4.7 p90 -165.92 150.94 8.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.762 ' HG2' HG23 ' A' ' 162' ' ' THR . 8.6 pt20 -147.95 110.01 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 108' ' ' VAL . 92.0 t -51.68 95.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.55 -8.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -161.22 109.59 1.25 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.569 0.699 . . . . 0.0 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -47.84 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' PRO . 2.2 t -34.83 -39.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -90.71 -37.86 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.565 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -94.23 49.83 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.8 m -86.12 8.17 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 35.7 p90 -90.47 26.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.5 m-80 56.56 33.97 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.5 t 33.65 41.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.3 m -97.45 -50.18 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.3 m-20 -57.6 -45.09 85.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 1.1 t80 -61.09 -44.39 97.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.527 HD23 HG12 ' A' ' 73' ' ' ILE . 19.0 mt -53.16 -64.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.786 ' O ' HG22 ' A' ' 116' ' ' VAL . 21.0 ptp -62.24 -45.07 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -56.92 -32.31 65.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 73' ' ' ILE . 3.9 mm -70.92 -59.81 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.184 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 113' ' ' MET . 8.7 m -44.06 -22.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 115' ' ' ILE . 77.1 mttt -94.77 -46.86 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.09 -53.04 62.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.46 -45.78 47.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.497 ' HA ' HD21 ' A' ' 123' ' ' LEU . 26.8 mt-30 -57.96 -37.9 75.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.7 m -70.17 -35.49 74.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.428 ' CG ' ' HB3' ' A' ' 149' ' ' GLU . 71.0 m-80 -80.31 -62.92 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.721 ' HB3' HD21 ' A' ' 146' ' ' LEU . 4.0 pp -46.59 -43.79 17.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.596 ' N ' HD12 ' A' ' 123' ' ' LEU . 9.7 ttm180 -47.73 -39.09 16.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.15 -52.03 66.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.1 mp -80.42 -62.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.169 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 123' ' ' LEU . 5.2 mt -51.17 -43.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.61 -31.58 3.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.524 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -116.52 113.39 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -172.55 -175.09 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 133' ' ' ASP . 35.0 mt-10 -116.5 121.34 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 131' ' ' GLU . 57.5 tp -33.89 -33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 m-20 -83.45 -50.75 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 131' ' ' GLU . 24.8 tt0 -56.45 -48.58 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.0 p -40.1 -50.11 2.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.3 mt -47.02 -39.17 12.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -127.61 82.36 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -175.27 25.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 5.0 ptt-85 -72.6 -35.33 67.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 1.5 m-20 -46.94 -32.21 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.09 -35.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 139' ' ' ARG . 71.4 mt -60.81 -50.64 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 2.3 p30 -61.77 -52.78 62.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' NH1' ' A' ' 147' ' ' ARG . . . -39.29 -49.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -58.8 -60.6 3.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 123' ' ' LEU . 3.9 mm? -54.37 -61.96 1.96 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 23.6 ttp-105 -36.19 -36.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.51 -55.5 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 152' ' ' LYS . 70.2 mm-40 -50.24 -17.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.11 -40.07 5.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.1 -8.31 16.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 149' ' ' GLU . 5.2 ptmt -100.83 -18.24 16.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 153' ' ' ILE . 7.2 mt -107.3 18.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.993 ' HB ' HG13 ' A' ' 159' ' ' VAL . 39.7 p -120.99 -32.29 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -25.56 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -84.1 -25.82 29.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TRP . . . . . 0.446 ' HB2' HG12 ' A' ' 159' ' ' VAL . 54.4 m0 -92.84 17.41 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 66.79 15.44 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.993 HG13 ' HB ' ' A' ' 154' ' ' THR . 5.0 p -124.94 155.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.178 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -137.52 151.7 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.477 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 31.7 mm -88.94 98.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -52.66 -48.84 66.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -166.15 -176.38 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.08 147.93 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.549 ' HB2' HG23 ' A' ' 93' ' ' VAL . 3.2 mm-40 -133.81 141.66 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.55 142.07 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -101.44 161.87 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.56 160.95 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -113.84 157.06 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.6 m-20 -111.42 123.54 34.75 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.666 0.746 . . . . 0.0 110.85 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 164.44 34.55 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.385 179.907 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 t -162.01 120.72 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -49.38 -54.25 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -74.68 119.75 19.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.27 40.3 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -102.94 116.86 33.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD12 HE22 ' A' ' 97' ' ' GLN . 4.0 mm? -88.78 41.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -55.19 129.25 37.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.6 155.76 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -123.73 152.02 42.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.1 146.72 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 115' ' ' ILE . 16.6 mt -106.53 133.47 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 111.96 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.7 p -117.9 128.21 26.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 111.134 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.4 Cg_endo -69.76 152.39 69.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 0.0 112.33 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.8 164.07 35.95 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.697 2.265 . . . . 0.0 112.337 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -144.96 121.47 11.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.26 106.68 5.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.13 136.94 58.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 53.4 mt -71.51 107.38 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.08 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -67.61 -43.99 79.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.58 35.25 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 49.1 t30 48.08 49.41 17.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG12 HG13 ' A' ' 88' ' ' VAL . 97.2 t -113.23 114.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -76.35 116.9 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 86' ' ' VAL . 25.2 m -142.61 165.8 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.494 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 58.9 m -111.77 114.01 26.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.138 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 127' ' ' ILE . 14.6 p -97.0 159.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.4 p-10 -171.0 137.35 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 175.59 13.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 165' ' ' GLU . 16.0 m -121.12 159.75 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.7 135.83 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 163' ' ' ARG . 5.4 m-85 -100.85 159.21 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' CD2' ' CE1' ' A' ' 111' ' ' PHE . 3.5 p90 -165.79 163.78 18.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.754 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.1 pt20 -153.62 132.21 12.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.49 96.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 pt -82.26 -28.07 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.585 ' OD1' HG22 ' A' ' 102' ' ' VAL . 10.0 t0 -125.2 98.13 36.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.853 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -39.82 6.19 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 ' OD1' ' A' ' 100' ' ' ASP . 17.0 m -58.43 -18.28 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.06 -36.0 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -92.57 42.08 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 105' ' ' VAL . 21.3 t -78.38 6.82 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 47.0 p90 -85.89 31.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.532 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.2 m120 47.35 42.09 13.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.7 m 26.83 43.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.2 t -96.73 -53.77 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.92 -40.24 75.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -61.52 -37.54 84.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.9 mt -61.79 -65.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.9 ptp -60.44 -37.18 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.54 -60.83 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.979 HG21 HD13 ' A' ' 73' ' ' ILE . 13.1 mm -41.77 -63.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 76' ' ' PRO . 84.6 t -44.48 -53.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -56.19 -45.15 79.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 121' ' ' THR . 39.4 mt -61.38 -61.02 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -37.9 -40.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -57.33 -46.18 83.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 118' ' ' LEU . 91.4 m -70.87 -51.77 24.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -56.2 -60.64 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -49.98 -42.09 48.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.5 ttp180 -50.74 -35.55 32.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.72 -57.93 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.095 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -74.69 -59.86 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 90' ' ' VAL . 32.5 mm -47.81 -40.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.58 -31.94 15.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -120.46 114.24 21.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.94 -176.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 133' ' ' ASP . 42.3 mt-10 -122.58 130.81 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.558 HD13 ' HD3' ' A' ' 172' ' ' PRO . 37.5 tp -34.96 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 131' ' ' GLU . 26.9 t0 -94.17 -56.99 2.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.461 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 1.8 tp10 -49.93 -18.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.0 p -63.54 -54.7 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 136' ' ' LEU . 3.5 pp -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.478 ' N ' HD12 ' A' ' 136' ' ' LEU . 3.6 p -64.18 -50.55 67.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.7 71.38 2.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.63 -33.0 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.816 0.341 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.42 -39.84 74.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.6 mt -61.53 -49.49 84.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.14 -49.0 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' HG12 ' A' ' 166' ' ' ILE . 27.3 m-20 -57.67 -52.01 67.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 145' ' ' ARG . . . -51.38 -68.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 144' ' ' ALA . 24.6 mmt180 -35.18 -69.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -47.14 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 151' ' ' ASP . 57.6 ttp85 -41.29 -44.27 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.95 -55.27 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -47.51 -38.75 14.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.676 HD12 HD13 ' A' ' 115' ' ' ILE . 3.2 mm? -87.06 -40.49 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 9.8 t70 -58.0 -23.14 52.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -85.12 -27.79 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 153' ' ' ILE . 25.5 mt -91.4 -10.53 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.167 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.975 ' HB ' HG13 ' A' ' 159' ' ' VAL . 23.4 p -95.97 -43.08 7.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -38.61 -34.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.585 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 3.9 ptm85 -70.1 -40.94 74.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.585 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 35.4 m0 -83.65 28.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 53.17 37.03 53.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.975 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.7 p -140.44 144.78 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.57 146.66 52.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.471 ' CG2' ' HG3' ' A' ' 147' ' ' ARG . 12.0 mm -73.8 91.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.754 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.01 -45.01 15.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.193 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 95' ' ' TYR . 9.9 ptp180 -163.45 175.82 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -141.0 137.95 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HB2' HG23 ' A' ' 93' ' ' VAL . 31.3 mp0 -132.33 146.14 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.466 HG12 ' ND2' ' A' ' 143' ' ' ASN . 11.9 mm -110.99 142.33 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.93 160.8 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -47.12 148.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -104.13 157.17 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 m-20 -110.39 118.48 49.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 169.99 17.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.241 . . . . 0.0 112.379 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.558 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.1 Cg_endo -69.74 132.91 24.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.332 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.79 164.99 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 179.836 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t -80.66 178.53 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.8 -60.05 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -76.28 114.67 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 120.15 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -124.74 144.85 50.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.67 36.24 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -52.73 123.28 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -68.42 157.35 36.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 36.6 m80 -126.6 128.45 46.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.14 132.81 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 115' ' ' ILE . 27.2 mt -102.38 128.54 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.67 101.78 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.667 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.2 p -103.4 138.67 19.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.687 0.756 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.7 Cg_endo -69.78 147.42 62.72 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.69 2.26 . . . . 0.0 112.327 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.6 49.08 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.36 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -140.77 131.26 25.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.5 112.5 24.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.74 151.14 34.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 43.8 mt -79.63 110.3 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.36 -174.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.18 -39.37 75.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.05 24.72 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.5 m120 57.09 51.27 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 88' ' ' VAL . 75.0 t -120.66 110.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.3 p -73.25 112.05 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.146 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 86' ' ' VAL . 10.8 m -139.69 148.04 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.8 m -85.55 134.7 34.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 127' ' ' ILE . 9.9 p -123.51 147.48 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.1 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -159.25 136.15 9.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.34 146.66 24.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.02 164.94 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 164' ' ' VAL . 20.4 t -139.2 119.32 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -75.4 160.38 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 3.3 p90 -165.65 148.8 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.0 pt20 -142.61 132.74 24.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.65 96.76 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 pt -74.56 -24.52 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.56 110.66 5.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -26.46 27.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.255 . . . . 0.0 112.317 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.32 -61.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -66.17 -39.42 89.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.515 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -89.3 50.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 105' ' ' VAL . 8.7 p -95.82 37.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 30.2 p90 -116.83 30.39 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.8 m-80 58.85 27.25 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 7.2 m 35.28 41.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -94.61 -52.15 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -48.64 78.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -56.04 -32.74 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 116' ' ' VAL . 15.5 mt -69.64 -61.39 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.2 ptp -65.82 -10.08 34.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.49 -51.73 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 73' ' ' ILE . 5.8 mm -47.83 -51.07 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -61.83 -22.97 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -90.18 -13.0 36.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.427 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 67.8 mt -89.67 -39.93 12.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.9 95.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.097 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HA ' HD21 ' A' ' 123' ' ' LEU . 40.4 mm-40 -45.98 -39.48 9.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.6 m -83.34 -53.78 5.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 75.0 m-80 -52.78 -59.4 4.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.1 pp -51.18 -41.13 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' N ' HD12 ' A' ' 123' ' ' LEU . 51.4 ttt180 -51.37 -35.84 40.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.57 -61.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -72.33 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 142' ' ' ILE . 49.8 mm -50.72 -47.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -43.31 -27.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -123.17 114.57 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -170.98 -175.38 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 44.4 mt-10 -121.47 125.76 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 59.6 tp -36.53 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 43.5 m-20 -84.57 -52.5 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 137' ' ' SER . 52.1 tt0 -56.53 -47.22 79.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.7 p -37.74 -34.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.07 -43.09 55.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 134' ' ' GLU . 71.2 m -112.8 73.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.78 25.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 142' ' ' ILE . 83.9 mtm180 -68.29 -38.4 81.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.4 -21.52 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.2 mt -98.5 -26.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 127' ' ' ILE . 23.8 mt -78.12 -34.43 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -81.44 -27.23 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.75 96.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' N ' ' CD ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.47 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 123' ' ' LEU . 4.4 mm? -55.43 -28.17 52.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -73.94 -43.25 58.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.5 -8.91 58.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -93.82 -32.49 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -99.94 -6.44 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.39 -11.98 38.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -98.4 -26.2 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 153' ' ' ILE . 56.0 mt -92.24 15.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.985 ' HB ' HG13 ' A' ' 159' ' ' VAL . 57.5 p -122.4 -28.21 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.02 -24.96 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -19.89 23.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -94.55 2.51 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.25 24.79 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.1 p -136.05 155.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -136.6 151.44 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.46 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 36.1 mm -88.45 94.35 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -48.69 -45.84 39.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -169.42 178.8 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 94' ' ' VAL . 18.9 t -138.43 142.23 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -127.04 135.54 50.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 92' ' ' ALA . 7.2 mm -104.48 138.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -95.22 160.28 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -50.38 149.6 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.37 146.17 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.52 122.69 50.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.883 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.04 17.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 129.84 18.24 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.356 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -63.12 -51.99 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -55.07 166.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.375 . . . . 0.0 110.874 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.72 -59.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -101.69 122.55 44.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -122.0 156.94 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.3 mm? -91.98 37.09 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.1 mtp-105 -37.9 133.98 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' HG21 ' A' ' 162' ' ' THR . 21.4 mp0 -96.83 134.86 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 29.0 m80 -106.46 132.99 51.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.84 137.79 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 115' ' ' ILE . 51.6 mt -104.46 121.64 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.08 100.15 10.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 11.4 t -100.92 136.01 19.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.79 145.96 58.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.317 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.78 149.3 66.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -132.26 119.63 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -74.74 109.91 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.11 131.11 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.97 105.06 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.37 177.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -65.85 -36.52 83.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.02 28.25 0.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.34 42.8 27.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.56 114.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.5 p -82.36 115.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.9 148.97 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 77' ' ' PRO . 97.9 m -90.01 115.4 27.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 127' ' ' ILE . 10.7 p -110.17 156.54 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -159.45 140.04 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.09 145.46 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.2 170.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.441 ' CG1' HD12 ' A' ' 161' ' ' ILE . 19.5 t -143.11 121.82 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.03 160.31 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 5.1 p90 -165.83 153.29 10.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.976 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.672 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.9 pt20 -150.44 122.43 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 44.7 t -63.04 92.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.2 pt -76.2 -7.69 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.51 114.27 2.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -51.33 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 103' ' ' LYS . 5.4 p -42.98 -46.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 102' ' ' VAL . 10.8 mtpp -73.79 -39.32 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -95.07 54.95 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 105' ' ' VAL . 7.2 p -89.57 0.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 29.1 p90 -85.69 28.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 6.2 m-80 52.93 31.17 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 108' ' ' VAL . 47.1 t 33.64 41.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 m -93.19 -40.76 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.8 -52.24 32.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -52.19 -32.02 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.607 ' O ' HG13 ' A' ' 116' ' ' VAL . 17.5 mt -57.36 -60.68 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.0 ptp -69.95 -40.51 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.676 ' O ' HD12 ' A' ' 118' ' ' LEU . . . -57.03 -30.88 64.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.987 HG21 HD13 ' A' ' 73' ' ' ILE . 7.3 mm -74.95 -58.37 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.616 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.3 m -54.58 -29.97 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -83.37 -53.99 5.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 114' ' ' ALA . 10.4 mt -43.56 -55.29 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.29 -52.55 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.51 ' HA ' HD21 ' A' ' 123' ' ' LEU . 35.9 mm-40 -37.53 -34.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 m -85.74 -61.14 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.46 -54.61 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 127' ' ' ILE . 2.5 pp -56.15 -40.02 73.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -53.4 -27.41 24.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.97 -62.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.791 ' H ' HD12 ' A' ' 126' ' ' ILE . 2.5 mp -75.48 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 90' ' ' VAL . 4.1 mt -48.49 -41.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.02 -28.92 6.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.487 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -121.69 114.32 20.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.28 -177.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 133' ' ' ASP . 16.1 mt-10 -118.84 129.34 55.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 23.4 tp -36.0 -30.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -94.49 -52.86 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 29.7 tt0 -54.26 -16.5 2.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -64.2 -59.89 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.8 pp -60.39 -25.15 65.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -77.52 -50.71 12.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.91 74.63 2.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -103.92 -30.91 10.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.89 -23.7 62.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.3 mp -86.68 -49.78 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -48.9 -33.36 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 23.8 p30 -86.34 -23.81 26.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -70.93 -56.23 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -50.92 -62.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -47.28 -55.38 8.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 151' ' ' ASP . 28.4 ttp180 -42.59 -51.21 5.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.78 -37.1 85.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -74.53 -19.52 60.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 53.0 mt -107.85 -9.49 15.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -90.35 -18.6 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.76 -35.45 14.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 86.6 mt -77.84 -17.1 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 1.004 ' HB ' HG13 ' A' ' 159' ' ' VAL . 40.6 p -92.63 -42.28 9.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -44.04 -26.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' CG ' ' O ' ' A' ' 153' ' ' ILE . 0.0 OUTLIER -75.23 -37.2 61.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.514 ' HB2' HG12 ' A' ' 159' ' ' VAL . 34.1 m0 -85.14 26.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 62.91 12.75 44.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 1.004 HG13 ' HB ' ' A' ' 154' ' ' THR . 6.0 p -120.87 138.19 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.083 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.1 143.9 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 94' ' ' VAL . 5.3 mm -85.01 106.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.672 HG23 ' HG2' ' A' ' 97' ' ' GLN . 18.8 p -57.26 -61.47 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -156.11 179.31 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 143' ' ' ASN . 43.0 t -132.87 149.65 32.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -131.61 137.2 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 143' ' ' ASN . 22.8 mm -99.44 141.71 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -99.45 158.88 15.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.92 144.73 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 31.4 mt -99.46 156.28 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -116.62 129.34 25.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.615 0.722 . . . . 0.0 110.919 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 164.73 33.44 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.42 34.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -76.74 161.64 28.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.836 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.5 t -121.6 151.08 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -85.2 -57.42 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -71.06 138.32 49.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.75 123.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.48 -75.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.9 tt 56.04 31.11 17.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.13 96.66 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -70.73 157.5 37.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.546 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 4.3 m80 -129.03 147.58 50.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' CE1' ' A' ' 95' ' ' TYR . 4.8 p -94.26 145.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.091 HD13 HG21 ' A' ' 115' ' ' ILE . 26.9 mt -104.29 129.15 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.29 93.1 8.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.597 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.9 p -94.21 137.58 22.8 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.572 0.701 . . . . 0.0 111.152 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 146.98 61.99 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.741 2.294 . . . . 0.0 112.343 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.7 Cg_endo -69.75 153.35 69.07 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -140.02 127.06 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.75 110.44 20.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -122.41 136.7 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.4 mt -68.35 108.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -53.42 -175.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -68.93 -40.67 78.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.42 27.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 47.0 t30 54.58 50.48 15.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 88' ' ' VAL . 97.5 t -118.74 115.52 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -80.15 113.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 86' ' ' VAL . 4.6 m -141.65 141.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 27.4 m -83.12 122.13 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 127' ' ' ILE . 2.9 p -108.53 138.31 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -146.81 136.57 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.21 174.53 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.96 151.37 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 164' ' ' VAL . 19.9 t -131.7 124.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.551 ' CE1' HG23 ' A' ' 72' ' ' VAL . 3.8 m-30 -83.85 163.23 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 8.3 p90 -165.68 160.48 17.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -151.41 142.0 22.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 98' ' ' VAL . 26.8 t -84.92 95.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.8 -15.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 30.7 t70 -146.61 106.29 4.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.867 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.9 Cg_endo -69.82 -12.74 33.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.238 . . . . 0.0 112.349 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -70.79 -55.81 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -72.97 -26.4 61.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -95.77 43.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.0 p -93.3 40.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.3 p90 -123.22 28.83 6.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.5 m-80 61.63 27.18 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.4 p 35.26 31.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.5 m -89.31 -49.2 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 10.8 m-20 -56.56 -45.64 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -62.52 -33.41 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.5 -53.73 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.472 ' O ' ' CD ' ' A' ' 117' ' ' LYS . 13.6 ptp -76.88 -21.38 55.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -78.63 -47.87 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.07 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 73' ' ' ILE . 8.9 mm -50.39 -53.02 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.477 ' CG2' ' HD2' ' A' ' 117' ' ' LYS . 3.5 m -59.51 -43.0 89.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HD2' ' CG2' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -70.94 -10.72 60.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -95.01 -39.62 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.17 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 34.7 mm-40 -61.28 -34.62 75.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 m -80.59 -44.43 18.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 78.6 m-20 -64.15 -46.06 85.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.2 pp -62.66 -40.68 97.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.797 ' N ' HD12 ' A' ' 123' ' ' LEU . 44.8 mtt180 -52.71 -21.42 4.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.92 -59.69 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -75.82 -58.33 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 90' ' ' VAL . 39.2 mm -50.17 -38.6 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.97 -23.09 14.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -131.26 114.13 14.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.47 -176.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 133' ' ' ASP . 19.0 mt-10 -122.0 120.48 34.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 41.8 tp -33.72 -34.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -86.0 -45.82 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 135' ' ' THR . 17.8 tp10 -58.64 -48.77 79.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 134' ' ' GLU . 20.2 p -31.9 -43.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.094 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.45 -52.48 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.5 m -64.4 -52.93 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.49 54.56 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.449 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -89.53 -37.88 14.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.483 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 3.8 p-10 -69.78 -21.54 63.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.68 -46.99 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 127' ' ' ILE . 41.5 mt -53.13 -45.7 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.491 ' HB3' ' CG1' ' A' ' 166' ' ' ILE . 2.4 p30 -71.66 -28.71 63.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.42 -58.28 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -47.57 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 122' ' ' ASN . 4.2 mm? -46.84 -56.51 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.573 ' HB2' HG21 ' A' ' 164' ' ' VAL . 43.7 ttp85 -45.24 -47.02 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -64.17 -55.86 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -51.99 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.39 -34.26 64.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -23.28 62.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -93.2 -27.62 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mm -79.12 -18.09 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.3 p -99.16 -33.17 10.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.91 -18.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 9.8 ptt180 -92.13 -27.94 17.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.5 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.5 m0 -89.8 11.65 19.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 77.32 11.33 85.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.51 147.88 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.388 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 150.32 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.496 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.0 mm -84.71 96.55 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.451 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 47.9 p -48.96 -63.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -146.78 -179.36 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -141.08 144.25 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.112 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -137.16 139.48 41.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 143' ' ' ASN . 4.2 mm -108.43 140.76 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -97.06 161.65 13.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -45.72 154.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 169' ' ' ILE . 2.1 mp -105.13 152.55 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.7 m-20 -103.88 122.41 44.57 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 170.02 17.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.228 . . . . 0.0 112.371 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 145.99 59.02 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -66.55 162.65 20.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.878 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.9 m -145.5 158.67 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.79 172.09 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -81.12 146.31 30.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.9 m -154.93 145.31 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.65 -34.25 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 mp 62.85 35.43 13.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -68.42 137.98 54.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HG3' HG21 ' A' ' 162' ' ' THR . 23.4 mp0 -85.56 141.88 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 92.5 m-70 -110.38 132.26 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.22 138.26 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 115' ' ' ILE . 17.7 mt -102.33 125.9 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.24 112.43 24.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.1 p -118.21 138.76 25.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.593 0.711 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.72 150.95 69.13 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.274 . . . . 0.0 112.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 154.64 67.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.671 2.247 . . . . 0.0 112.395 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' CD ' HD11 ' A' ' 123' ' ' LEU . 3.2 pt20 -136.94 152.04 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.37 115.66 30.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HG2' ' A' ' 124' ' ' ARG . 23.1 m -128.44 147.91 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.067 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 39.9 mt -79.65 108.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.13 -176.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -65.6 -45.45 83.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -83.75 34.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 16.2 t-20 49.69 49.82 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.591 HG12 HG13 ' A' ' 88' ' ' VAL . 84.9 t -116.57 109.44 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -74.21 116.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.591 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -142.63 155.03 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 24.5 m -96.89 126.24 41.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.8 HG11 HG21 ' A' ' 127' ' ' ILE . 12.5 p -115.09 151.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -154.48 133.0 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.88 152.17 30.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 28.8 m -101.87 165.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 HD12 ' A' ' 73' ' ' ILE . 24.8 t -135.51 126.12 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -85.42 158.86 20.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.2 p90 -165.6 154.09 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HG2' HG23 ' A' ' 162' ' ' THR . 12.2 pt20 -150.08 129.23 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 53.3 t -68.46 91.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 pt -73.57 -31.65 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 6.0 t70 -128.67 94.72 34.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.601 0.715 . . . . 0.0 110.859 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.525 ' O ' HG22 ' A' ' 105' ' ' VAL . 53.6 Cg_endo -69.75 -2.49 10.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 0.0 112.316 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 105' ' ' VAL . 19.4 t -80.3 -44.99 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -90.19 -21.11 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -96.84 43.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 102' ' ' VAL . 4.0 t -90.42 40.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 39.7 p90 -117.93 35.12 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 108' ' ' VAL . 5.6 m120 50.93 36.56 15.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.7 p 27.72 41.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 107' ' ' ASN . 1.6 t -95.34 -57.72 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -49.73 -43.78 48.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.6 mt -58.94 -70.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.936 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 ptp -51.78 -38.16 54.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.54 -66.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.943 HG21 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -38.7 -63.89 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 75' ' ' VAL . 91.3 t -37.13 -51.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -67.73 -55.24 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ALA . 58.4 mt -46.28 -61.55 1.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' LEU . . . -36.52 -60.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 2.1 mt-30 -39.17 -47.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.1 m -67.92 -47.9 67.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 71.1 m-80 -63.29 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.954 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.6 pp -44.51 -39.25 4.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HG2' HG11 ' A' ' 80' ' ' VAL . 19.5 mtp180 -53.84 -37.1 63.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.13 -47.91 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -84.9 -63.83 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.954 HD13 ' HB2' ' A' ' 123' ' ' LEU . 2.1 mp -51.84 -41.52 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.17 -30.21 7.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.8 pt-20 -118.54 113.05 20.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.21 -174.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 58.0 mt-10 -118.31 129.18 55.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 131' ' ' GLU . 64.6 tp -36.72 -29.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 3.8 p-10 -94.08 -46.08 7.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 2.6 tp10 -55.04 -44.97 75.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 1.1 p -34.24 -65.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.5 pp -53.76 -34.99 60.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 134' ' ' GLU . 1.8 t -70.32 -70.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.21 69.69 0.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -97.94 -34.45 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -72.63 -33.0 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 141' ' ' ILE . 5.3 mp -68.53 -45.94 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 127' ' ' ILE . 86.6 mt -54.27 -53.23 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.714 ' OD1' HG12 ' A' ' 164' ' ' VAL . 63.4 m-20 -52.19 -41.0 62.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.97 -54.19 48.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -53.69 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.8 tp -41.36 -38.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -64.23 -44.87 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.83 -12.38 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 122' ' ' ASN . 28.2 mt-10 -87.95 -39.05 15.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.659 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -93.8 -13.56 27.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.55 -22.75 56.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 pttt -89.77 -30.07 18.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.73 -19.26 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.494 ' CG2' HD11 ' A' ' 115' ' ' ILE . 43.2 p -97.25 -28.17 14.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -47.37 -40.59 17.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.567 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.3 ptm180 -66.45 -32.06 73.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.567 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 42.2 m0 -83.71 14.09 4.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 65.8 33.96 87.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.448 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.16 145.69 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -128.83 135.44 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.71 86.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.735 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -38.37 -47.43 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -169.54 179.99 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.714 HG12 ' OD1' ' A' ' 143' ' ' ASN . 87.8 t -140.84 140.09 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 68.9 mt-10 -123.83 147.12 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 143' ' ' ASN . 23.6 mm -109.65 142.15 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -103.16 161.05 14.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -41.68 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -113.75 156.5 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 11.4 m-20 -115.85 122.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.633 0.73 . . . . 0.0 110.822 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 170.55 16.28 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.412 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.3 Cg_endo -69.8 141.38 44.92 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.11 166.7 22.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.847 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 t -79.0 -40.56 31.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.847 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 56.07 33.03 21.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.81 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' HIS . 2.7 p-80 -121.51 118.61 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 m -148.73 126.64 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -103.24 40.72 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD23 HE22 ' A' ' 97' ' ' GLN . 3.5 mt 48.29 26.48 1.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 -61.75 114.61 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.2 155.39 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 51.0 m-70 -124.0 148.48 46.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.32 145.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.624 HD13 HG21 ' A' ' 115' ' ' ILE . 96.5 mt -113.3 124.45 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.32 107.23 18.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.2 p -105.65 138.3 19.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.76 144.94 55.64 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.717 2.278 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 159.94 51.54 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.633 2.222 . . . . 0.0 112.351 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.38 116.64 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 14.7 mp0 -71.49 118.56 14.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.73 132.5 61.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 47.9 mm -60.9 113.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.586 ' HG ' ' C ' ' A' ' 130' ' ' MET . 0.7 OUTLIER -63.27 -178.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 130' ' ' MET . 17.5 tptt -61.41 -47.32 86.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.7 32.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 32.5 m-20 51.4 48.04 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG12 HG13 ' A' ' 88' ' ' VAL . 46.5 t -112.87 109.38 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -75.23 108.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 86' ' ' VAL . 15.6 m -135.34 153.31 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 57.2 m -94.92 128.54 41.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.87 HG11 HG21 ' A' ' 127' ' ' ILE . 2.1 p -115.57 149.6 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.14 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -159.54 127.3 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -142.91 151.53 41.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 165' ' ' GLU . 3.7 m -97.08 153.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.598 ' CG1' HD12 ' A' ' 161' ' ' ILE . 25.5 t -127.86 127.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.0 m-30 -87.02 159.96 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.951 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 4.2 p90 -165.59 153.51 11.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.838 ' HG2' HG23 ' A' ' 162' ' ' THR . 9.6 pt20 -149.74 128.8 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.7 t -65.5 91.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.096 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 pt -71.96 -12.75 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 31.1 t0 -158.4 105.66 1.67 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.901 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.572 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.4 Cg_endo -69.7 -13.44 34.81 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.388 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.26 -27.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.184 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -101.31 -20.57 15.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.53 48.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 101' ' ' PRO . 4.0 m -83.0 3.2 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.1 p90 -84.22 24.53 0.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' VAL . 12.6 m120 62.1 31.2 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.3 t 33.79 40.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.5 p -95.11 -60.02 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.05 -36.56 29.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -65.18 -33.94 77.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.84 -57.03 7.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.5 ptp -67.43 -26.48 66.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.28 -49.45 16.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.624 HG21 HD13 ' A' ' 73' ' ' ILE . 2.6 mm -45.83 -62.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 m -53.0 -25.54 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -83.94 -25.51 30.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 115' ' ' ILE . 25.6 mt -77.84 -46.04 22.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.915 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.94 -53.35 56.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 37.3 mm-40 -40.99 -27.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 m -92.09 -37.14 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -75.45 -58.23 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.772 ' HB2' HD13 ' A' ' 127' ' ' ILE . 2.7 pp -51.05 -40.46 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' N ' HD12 ' A' ' 123' ' ' LEU . 35.6 ttt85 -54.6 -22.99 15.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.61 -58.38 3.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 126' ' ' ILE . 1.4 mp -76.09 -62.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.87 HG21 HG11 ' A' ' 90' ' ' VAL . 3.2 mp -52.64 -40.84 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.79 -20.13 3.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.4 pt-20 -130.8 113.62 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.586 ' C ' ' HG ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -173.7 -175.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.854 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 24.4 mm-40 -123.17 120.4 33.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' GLU . 65.0 tp -35.35 -31.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.5 t70 -76.04 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -54.64 -46.49 73.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 131' ' ' GLU . 70.6 p -42.36 -52.88 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 135' ' ' THR . 41.4 mt -35.8 -49.94 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 t -121.95 87.64 2.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.83 35.06 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.98 -32.08 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -50.63 -36.97 37.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' ALA . 11.0 mt -87.45 -55.59 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 51.9 mt -42.69 -36.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 3.5 p30 -81.73 -31.54 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.451 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -60.78 -54.66 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -56.45 -63.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 146' ' ' LEU . 12.0 mt -42.6 -52.4 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -45.22 -41.83 8.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.06 -25.0 32.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 8.0 mm-40 -79.81 -10.39 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 -39.27 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.98 -8.42 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 153' ' ' ILE . 8.8 ptpt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.8 mp -87.1 -18.31 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 111' ' ' PHE . 45.5 p -94.61 -14.93 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.54 -14.7 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.568 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 15.4 ptm180 -96.7 -22.38 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.568 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.3 m0 -93.87 5.27 52.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.25 22.8 67.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 111' ' ' PHE . 25.4 t -123.16 135.47 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.32 130.41 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.598 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.5 mm -73.43 91.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.838 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.5 p -45.36 -44.6 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.9 OUTLIER -166.82 178.96 5.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 71.7 t -137.87 122.12 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 93' ' ' VAL . 11.1 mt-10 -104.36 138.46 40.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.595 HD13 ' HB1' ' A' ' 92' ' ' ALA . 24.4 mm -112.67 142.34 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -103.11 159.57 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -47.42 160.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -108.01 156.66 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.7 m-20 -104.99 119.99 51.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.887 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 163.8 36.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.287 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 121.87 8.55 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -47.91 156.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.843 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -162.41 135.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.854 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.68 165.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -92.59 145.74 24.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.3 39.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.31 130.93 22.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 mt -92.72 25.03 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -37.84 136.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -118.65 157.89 26.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 26.3 m-70 -123.98 146.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.477 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 8.1 p -95.4 145.93 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 115' ' ' ILE . 19.5 mt -105.68 130.02 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.24 95.06 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' HD2' ' A' ' 76' ' ' PRO . 3.3 p -99.17 136.94 20.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.4 Cg_endo -69.71 149.44 67.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 0.0 112.38 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 168.78 20.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.38 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -146.73 118.12 7.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -76.83 102.65 6.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.81 148.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.5 mt -79.87 106.39 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.41 -174.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -67.88 -43.15 80.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.44 35.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 6.5 t30 51.01 43.25 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.703 HG13 ' HG3' ' A' ' 172' ' ' PRO . 60.6 t -113.36 110.82 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.86 113.95 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -134.1 150.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -89.38 109.67 20.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 127' ' ' ILE . 5.4 m -105.57 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.14 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -168.67 144.09 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.83 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 72' ' ' VAL . 18.0 m -93.61 158.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 161' ' ' ILE . 20.0 t -128.47 137.16 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.142 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.4 m-30 -98.08 160.52 14.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 33.8 p90 -165.83 155.09 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HG2' HG23 ' A' ' 162' ' ' THR . 9.6 pt20 -141.96 121.12 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 98' ' ' VAL . 42.2 t -64.97 93.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -80.81 -29.78 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -127.8 96.66 31.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.7 Cg_endo -69.71 0.37 5.7 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 105' ' ' VAL . 23.9 t -81.39 -44.37 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -86.58 -32.58 20.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.575 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -87.11 38.66 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 4.8 m -85.83 12.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.575 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.1 p90 -93.02 35.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.4 m-80 52.18 31.81 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 108' ' ' VAL . 43.1 t 34.63 40.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.1 p -97.27 -38.82 9.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.54 -45.22 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.75 -32.54 72.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.1 mt -61.06 -59.51 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 116' ' ' VAL . 15.5 ptp -70.3 -37.82 74.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.0 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.041 HG21 HD13 ' A' ' 73' ' ' ILE . 6.8 mm -63.22 -52.77 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.6 m -65.52 -20.23 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -91.48 -15.55 28.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.688 HD22 HD13 ' A' ' 153' ' ' ILE . 17.0 mt -88.94 -39.3 13.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.06 81.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.4 mm-40 -44.98 -30.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.3 m -87.42 -49.63 7.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -62.7 -59.27 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.746 HD13 HD12 ' A' ' 127' ' ' ILE . 3.2 pp -48.84 -42.82 37.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 123' ' ' LEU . 23.0 ttm180 -51.67 -41.67 61.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.72 -57.57 11.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -76.32 -62.36 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.89 HG21 HG21 ' A' ' 90' ' ' VAL . 20.8 mt -49.3 -44.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 130' ' ' MET . 7.3 pt-20 -121.4 113.96 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.839 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.42 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -173.04 -175.29 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 37.9 mt-10 -121.7 130.63 53.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 31.2 tp -36.17 -29.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.1 p-10 -88.66 -63.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -40.99 -43.84 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.2 p -39.62 -69.81 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.481 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.0 pp -55.4 -29.4 58.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -107.54 40.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -166.58 64.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.4 ptt180 -104.78 -37.11 7.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 0.5 OUTLIER -52.3 -27.65 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -88.23 -48.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 64.9 mt -54.02 -48.02 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 11.3 p30 -69.76 -42.96 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -47.39 -48.33 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.047 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -64.0 -62.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.63 -58.94 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 26.0 ttm105 -40.67 -40.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.97 -45.92 22.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -57.89 -28.1 63.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.723 ' O ' HG23 ' A' ' 154' ' ' THR . 36.1 mt -96.39 -31.09 13.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -20.03 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.44 -26.01 16.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.688 HD13 HD22 ' A' ' 118' ' ' LEU . 98.2 mt -86.58 -8.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.991 ' HB ' HG13 ' A' ' 159' ' ' VAL . 62.3 p -103.19 -36.67 8.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -42.62 -27.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.35 -38.18 31.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.556 ' HB2' HG12 ' A' ' 159' ' ' VAL . 36.1 m0 -84.48 34.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.62 23.61 4.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.478 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 154' ' ' THR . 2.1 p -130.59 143.35 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.86 147.14 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 95' ' ' TYR . 12.7 mm -82.91 109.57 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 97' ' ' GLN . 75.9 p -64.55 -43.33 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 1.6 ptp180 -165.93 -178.54 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.419 ' HB ' ' NH2' ' A' ' 147' ' ' ARG . 38.4 t -141.17 137.5 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -123.34 136.97 54.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.413 HD13 ' CB ' ' A' ' 92' ' ' ALA . 9.9 mm -99.09 140.87 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -95.69 161.68 13.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -47.99 162.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.1 mp -118.75 157.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.503 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.3 t70 -127.16 133.64 25.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 0.0 110.806 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 168.76 20.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.703 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.9 Cg_endo -69.77 163.68 37.36 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.309 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -44.24 145.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.805 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 m -142.68 144.47 32.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.874 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -102.95 -52.86 2.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.9 107.91 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.34 178.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 69' ' ' ARG . 2.9 m-20 -132.02 40.81 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' ASP . 4.0 mm? 35.38 34.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 67' ' ' ASP . 35.1 mtt180 -36.14 109.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -76.91 151.08 35.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -120.55 151.7 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.964 HG12 ' CE1' ' A' ' 95' ' ' TYR . 17.5 m -98.16 156.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 111' ' ' PHE . 31.4 mt -118.19 125.02 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.27 111.27 18.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 116' ' ' VAL . 85.9 t -120.53 132.19 24.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.73 152.95 69.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.75 166.93 25.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.415 ' OE1' HD11 ' A' ' 123' ' ' LEU . 9.0 tt0 -146.44 117.49 7.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.83 107.03 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.76 145.22 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.687 ' CD1' HG22 ' A' ' 87' ' ' VAL . 41.0 mm -74.33 109.22 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.35 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -67.34 -45.09 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.15 32.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.1 m-20 50.69 44.3 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.48 110.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 81' ' ' ILE . 6.6 t -70.11 115.19 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.94 150.0 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.145 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 95.1 m -97.64 130.55 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 127' ' ' ILE . 31.3 m -124.34 157.44 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 167' ' ' GLN . 18.4 p-10 -160.43 139.53 10.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.86 150.87 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.29 170.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -135.14 131.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.964 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.8 m-30 -91.78 157.95 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.572 ' CE1' HG21 ' A' ' 108' ' ' VAL . 13.0 p90 -165.65 158.19 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' A' ' 162' ' ' THR . 10.2 pt20 -152.3 114.5 4.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.85 92.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.7 pt -76.05 -18.49 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 11.7 t70 -146.54 106.38 4.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.585 0.707 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.1 Cg_endo -69.73 -18.41 37.14 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.95 -25.75 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -101.47 -38.23 8.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -83.78 34.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.64 -5.99 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 40.1 p90 -85.13 26.44 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 109' ' ' SER . 14.8 m-80 56.37 37.05 28.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 11.1 p 32.8 36.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' ASN . 7.1 t -93.98 -52.25 4.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -51.4 -46.33 62.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.748 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -58.67 -37.45 76.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 73' ' ' ILE . 39.5 mt -63.63 -66.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 ptp -57.04 -26.08 59.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.23 -65.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG13 ' CE2' ' A' ' 111' ' ' PHE . 11.9 mm -39.63 -64.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 75' ' ' VAL . 49.1 t -36.22 -40.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.03 -55.0 5.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.8 mt -45.69 -49.63 14.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.57 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.544 ' HA ' HD21 ' A' ' 123' ' ' LEU . 36.2 mm-40 -51.87 -39.53 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -76.71 -56.84 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -53.38 -57.42 10.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 124' ' ' ARG . 3.1 pp -51.21 -43.12 61.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.71 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.2 ttt85 -49.84 -38.69 36.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.85 -54.28 41.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.68 -62.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.946 HG21 HG21 ' A' ' 90' ' ' VAL . 43.6 mm -48.7 -39.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.36 -30.14 24.85 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -122.02 114.02 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -172.19 -175.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 26.2 mt-10 -119.08 132.96 56.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.473 HD13 ' HD3' ' A' ' 172' ' ' PRO . 48.8 tp -35.81 -30.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 21.6 t70 -90.21 -53.43 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -45.38 -37.51 5.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -65.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -67.83 -28.85 67.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.0 p -103.15 39.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.2 60.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -89.97 -33.35 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.7 -43.35 99.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.0 mt -67.23 -50.7 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.51 -50.5 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.504 ' OD1' HD11 ' A' ' 166' ' ' ILE . 82.2 m-20 -57.57 -55.33 36.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -45.43 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 145' ' ' ARG . 5.1 mmp_? -53.93 -69.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -55.64 -62.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 38.8 ttt-85 -41.69 -34.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.8 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.59 -56.47 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 154' ' ' THR . 94.4 mt -54.29 -35.86 63.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -15.82 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -84.57 -44.34 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 153' ' ' ILE . 8.7 mt -72.03 -5.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 159' ' ' VAL . 60.5 p -102.55 -37.66 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -48.51 -20.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.2 ptp180 -87.34 -34.09 18.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.4 m0 -86.11 19.25 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.77 19.12 62.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.4 p -124.55 148.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.144 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -128.66 148.46 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.9 mm -88.61 100.86 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -51.66 -51.17 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.203 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -163.98 -176.56 4.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 69.6 t -140.43 143.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.19 137.44 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.504 HD11 ' OD1' ' A' ' 143' ' ' ASN . 7.5 mm -107.24 123.22 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.5 mm-40 -78.11 157.71 29.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -42.43 157.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -110.8 155.72 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.6 m-20 -113.23 120.49 40.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.552 0.691 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 170.04 17.44 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.667 2.244 . . . . 0.0 112.358 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.473 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.0 Cg_endo -69.73 123.95 10.61 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.379 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -64.9 168.05 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.2 p -128.73 120.33 26.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.362 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.72 164.28 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -74.66 165.64 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.51 154.6 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.2 175.28 5.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 29.17 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 -74.29 125.9 29.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.09 148.15 24.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 16.0 m-70 -115.62 143.83 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.1 145.63 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 115' ' ' ILE . 54.8 mt -109.02 129.2 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.58 100.11 12.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 116' ' ' VAL . 19.6 t -106.23 134.78 19.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.664 0.745 . . . . 0.0 111.148 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.72 151.28 69.24 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.745 2.297 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 54.1 Cg_endo -69.67 161.08 47.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.476 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 5.2 mt-30 -139.67 117.82 11.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.06 110.69 11.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.65 142.95 41.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.985 ' CD1' HG22 ' A' ' 87' ' ' VAL . 49.6 mm -73.45 105.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.03 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -66.09 -36.47 83.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.2 29.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 60.1 t30 49.85 51.97 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.46 123.47 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.985 HG22 ' CD1' ' A' ' 81' ' ' ILE . 3.6 t -82.57 116.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.57 155.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 m -100.71 122.96 44.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 127' ' ' ILE . 34.7 m -114.18 169.09 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -174.93 135.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.79 146.85 24.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -95.66 166.4 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 161' ' ' ILE . 12.9 t -133.23 127.01 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -86.64 159.05 19.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 23.0 p90 -165.69 155.07 12.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.773 ' HG2' HG23 ' A' ' 162' ' ' THR . 7.7 pt20 -145.86 123.99 12.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 98' ' ' VAL . 38.0 t -63.97 96.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.4 pt -80.58 -28.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 23.3 t0 -135.58 108.53 10.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.859 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.7 Cg_endo -69.8 -48.49 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.371 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -48.62 -23.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -103.83 -27.94 11.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.82 41.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 105' ' ' VAL . 10.0 p -94.75 44.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 13.6 p90 -117.75 36.4 4.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 5.4 m120 55.88 28.31 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.0 p 33.26 39.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.162 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' ASN . 25.9 m -94.74 -48.19 6.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.2 -46.72 88.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.565 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -61.08 -41.02 95.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.0 -63.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -58.41 -29.17 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.39 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 73' ' ' ILE . 3.1 mm -39.3 -62.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 76' ' ' PRO . 55.8 t -34.86 -48.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.82 -50.05 22.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 47.9 mt -44.08 -49.12 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.7 90.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.476 ' OE1' ' CG ' ' A' ' 78' ' ' GLN . 35.3 mm-40 -48.35 -35.67 12.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 m -86.57 -63.31 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 149' ' ' GLU . 34.0 m120 -42.72 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -59.25 -43.68 92.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.755 ' N ' HD12 ' A' ' 123' ' ' LEU . 19.4 ttt180 -51.28 -26.96 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.653 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.1 mp -76.47 -60.37 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 mt -49.78 -41.64 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.06 -23.85 2.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.61 114.21 17.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -172.89 -176.79 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 mt-10 -115.86 119.81 37.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.518 HD13 ' HD3' ' A' ' 172' ' ' PRO . 21.5 tp -36.61 -29.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -86.99 -58.52 2.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.1 tp10 -48.0 -50.32 27.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' GLU . 40.6 p -35.05 -34.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 134' ' ' GLU . 54.3 mt -62.37 -57.78 10.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 m -77.62 -50.7 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.96 70.41 0.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.4 ptt85 -112.59 -9.73 13.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.97 -33.78 21.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 141' ' ' ILE . 4.6 mp -73.86 -37.65 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.575 HD11 ' SD ' ' A' ' 130' ' ' MET . 44.5 mt -60.6 -43.91 95.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.737 ' HB3' HD11 ' A' ' 166' ' ' ILE . 1.8 p30 -79.98 -31.39 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.94 -34.12 74.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -79.08 -56.57 4.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.11 -42.67 29.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -53.8 -40.18 66.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.08 -57.16 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.445 ' HB3' ' ND2' ' A' ' 122' ' ' ASN . 2.2 mp0 -44.36 -62.02 1.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 115' ' ' ILE . 9.4 mp -60.17 -36.09 76.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -11.53 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.76 -27.27 15.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 153' ' ' ILE . 39.4 mt -96.62 17.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 p -125.71 -34.05 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.8 -25.22 26.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 14.3 ptm180 -83.56 -20.11 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.537 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 52.9 m0 -96.85 1.57 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.97 12.32 77.15 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 160' ' ' LYS . 53.5 t -119.61 154.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.926 0.394 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -134.01 151.64 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.48 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 32.4 mm -89.81 92.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.773 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -49.12 -48.96 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -163.89 -175.98 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 84.2 t -139.74 141.89 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -124.47 135.39 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' A' ' 143' ' ' ASN . 3.7 mm -105.33 139.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.69 161.14 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -44.4 156.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.6 mp -108.96 156.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.6 m-20 -113.01 120.81 39.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 110.9 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.2 31.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.518 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.7 153.92 68.61 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.358 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -93.15 167.44 11.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 64' ' ' ASP . 8.2 t -166.44 170.01 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' SER . 9.9 t70 -37.21 151.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -85.05 106.16 16.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.46 126.85 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.26 112.04 16.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 69' ' ' ARG . 4.6 mp -53.74 -21.9 8.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -34.37 142.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.52 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 2.2 pm0 -115.12 149.42 37.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m80 -106.9 143.73 34.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 140.3 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.948 HD13 HG21 ' A' ' 115' ' ' ILE . 26.5 mt -102.92 125.08 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 94.0 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.7 p -97.62 133.68 23.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 111.181 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 144.66 54.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.73 157.82 59.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -140.94 118.51 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -71.45 109.57 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.45 132.52 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.865 ' CD1' HG22 ' A' ' 87' ' ' VAL . 45.5 mm -68.16 109.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.44 -175.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -69.71 -38.91 77.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -84.53 26.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 37.6 t30 52.83 48.72 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 88' ' ' VAL . 43.8 t -113.87 117.83 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.161 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.865 HG22 ' CD1' ' A' ' 81' ' ' ILE . 47.1 t -77.79 113.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.173 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 HG12 ' A' ' 86' ' ' VAL . 29.2 m -143.39 157.35 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 25.5 m -103.62 123.66 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 127' ' ' ILE . 10.0 p -103.47 142.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.11 132.06 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -152.28 164.55 37.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.31 159.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.412 ' O ' HD12 ' A' ' 73' ' ' ILE . 74.3 t -133.97 118.94 30.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 7.3 m-30 -79.38 159.64 27.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.5 p90 -165.71 147.89 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.954 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.9 pt20 -140.24 131.72 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 98' ' ' VAL . 50.3 t -71.71 91.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.095 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -83.14 -21.5 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 99' ' ' ILE . 22.3 t70 -134.95 92.85 18.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.593 0.711 . . . . 0.0 110.871 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 -5.18 15.61 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.663 2.242 . . . . 0.0 112.294 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.64 -50.03 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -87.39 -18.06 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.554 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -99.44 43.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.5 p -89.41 14.19 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.5 p90 -97.47 29.8 3.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.2 m-80 58.75 28.06 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.513 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 10.0 m 35.94 38.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.4 p -92.33 -48.74 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -59.25 -42.76 91.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.514 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -61.39 -31.93 71.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 116' ' ' VAL . 33.1 mt -71.62 -54.3 10.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.8 ptp -74.15 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -93.2 -57.99 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 73' ' ' ILE . 7.7 mm -39.68 -57.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -57.79 -42.08 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 18.4 mtmt -67.4 -18.9 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 18.5 mt -88.16 -42.36 12.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.23 68.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.1 mm-40 -57.7 -28.28 63.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.6 m -89.9 -54.69 3.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -55.49 -52.39 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.724 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.3 pp -56.1 -40.18 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.704 ' N ' HD12 ' A' ' 123' ' ' LEU . 12.8 ttt180 -56.44 -18.14 10.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.68 -61.06 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -74.97 -50.8 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 90' ' ' VAL . 34.4 mm -55.99 -38.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.34 -28.28 27.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.521 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.34 114.29 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.55 -177.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.0 mt-10 -122.14 128.85 51.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.1 tp -34.76 -32.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -86.37 -58.27 2.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 136' ' ' LEU . 2.5 tp10 -47.91 -47.05 32.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 28.6 p -33.5 -34.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 134' ' ' GLU . 14.1 mt -84.66 -57.78 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -52.78 -53.12 52.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.84 57.81 3.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -90.92 -36.86 13.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 18.4 t0 -69.1 -20.11 64.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.93 -58.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -42.57 -42.18 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.47 ' ND2' ' HA ' ' A' ' 140' ' ' ASP . 1.4 p30 -76.76 -35.89 57.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.427 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -54.68 -48.63 72.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 148' ' ' GLU . 5.0 mmp_? -62.63 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 3.7 mm? -38.15 -37.56 0.28 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 40.7 ttt-85 -62.21 -44.11 97.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' ARG . 11.4 tp10 -74.49 -46.29 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.07 -54.09 50.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -7.62 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -97.92 -41.89 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 153' ' ' ILE . 17.0 mt -74.93 5.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.8 p -116.61 -28.86 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -58.3 -28.88 65.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 8.3 ptp180 -83.98 -16.33 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.845 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.561 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 54.7 m0 -98.87 0.63 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 84.78 9.34 81.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.63 141.64 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.22 129.17 51.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.44 109.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.526 HG23 ' HG2' ' A' ' 97' ' ' GLN . 70.1 p -62.06 -44.41 96.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.76 179.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 86.8 t -139.32 132.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -116.57 144.2 44.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 mm -109.16 142.26 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -102.14 159.58 15.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -47.53 146.12 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.5 mp -96.0 156.57 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.0 m-20 -108.66 119.23 49.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 168.37 21.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 161.14 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.381 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -102.07 -49.08 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.8 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 m -157.72 135.98 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -57.58 165.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -82.58 143.81 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.4 t -120.52 121.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -152.49 168.58 25.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.6 tt -44.56 -26.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 -40.05 95.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -77.77 145.14 36.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 81.5 m-70 -110.31 142.94 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.45 139.58 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 115' ' ' ILE . 32.5 mt -106.45 119.58 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.89 124.26 29.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.5 HG23 ' HD2' ' A' ' 76' ' ' PRO . 14.5 p -121.1 136.84 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.652 0.739 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.74 147.98 64.18 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 143.71 51.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' OE1' ' CZ ' ' A' ' 124' ' ' ARG . 7.6 tt0 -126.86 126.84 43.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 89' ' ' THR . 26.4 mp0 -93.37 96.43 9.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.405 ' CG1' ' OE1' ' A' ' 78' ' ' GLN . 15.2 m -108.54 145.27 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 74.3 mt -70.27 106.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.403 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.36 -175.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.54 -39.17 77.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 86' ' ' VAL . 38.9 t70 -86.94 34.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.7 t-20 48.08 45.79 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 84' ' ' ASP . 58.3 t -118.5 110.59 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 87' ' ' VAL . 7.3 p -75.25 123.89 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.39 151.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.554 HG23 ' OE2' ' A' ' 79' ' ' GLU . 19.7 m -91.71 116.81 29.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 127' ' ' ILE . 17.5 m -108.02 160.16 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.85 137.0 3.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.85 142.22 20.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 165' ' ' GLU . 15.4 m -93.88 159.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 150' ' ' LEU . 25.7 t -135.24 137.67 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 161' ' ' ILE . 4.7 m-30 -97.37 163.27 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 1.4 p90 -165.59 156.38 13.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.72 ' HG2' HG23 ' A' ' 162' ' ' THR . 10.4 pt20 -152.75 134.21 14.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.14 99.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.3 pt -83.44 -9.35 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 102' ' ' VAL . 30.9 t0 -155.96 109.77 2.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.655 0.741 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.35 16.76 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.604 HG22 ' OD1' ' A' ' 100' ' ' ASP . 34.2 m -62.52 -14.99 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -103.58 -26.0 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' A' ' 108' ' ' VAL . . . -104.47 45.8 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.83 -2.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.7 p90 -86.49 38.44 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 49.2 27.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' A' ' 104' ' ' ALA . 13.2 t 36.09 40.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.8 t -96.85 -50.42 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.91 -40.42 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.4 t80 -61.51 -40.52 94.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.48 -67.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -55.81 -38.99 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -58.64 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 73' ' ' ILE . 11.3 mm -46.31 -58.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.79 -23.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -93.57 -33.18 13.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.44 -51.84 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.26 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -67.14 -31.39 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 94.2 m -87.91 -29.4 20.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.564 ' O ' HD12 ' A' ' 126' ' ' ILE . 78.3 m-20 -78.9 -44.74 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.8 pp -62.63 -40.94 98.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.429 ' CZ ' ' OE1' ' A' ' 78' ' ' GLN . 40.8 mtt-85 -52.15 -24.61 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.0 -57.0 3.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.9 mp -79.74 -63.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 90' ' ' VAL . 3.4 mt -51.57 -44.78 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.6 -25.52 1.44 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.543 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -124.18 113.89 18.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.27 -178.03 1.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 132' ' ' LEU . 42.0 mt-10 -120.94 130.5 53.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 131' ' ' GLU . 13.3 tp -34.42 -35.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.2 m-20 -80.83 -51.03 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -54.44 -49.47 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.6 p -45.43 -31.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.1 mt -73.82 -49.46 25.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -106.48 37.27 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.3 21.3 5.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -74.19 -0.93 18.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.66 -27.38 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.604 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.4 mp -85.32 -41.33 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.42 -58.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 164' ' ' VAL . 14.4 p-10 -59.43 -33.26 71.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.31 73.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.062 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -84.69 -58.59 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.13 -53.21 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.481 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 24.7 ttp180 -44.33 -40.49 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -57.38 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -48.66 -23.37 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 94' ' ' VAL . 82.8 mt -102.66 -23.99 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.49 -6.24 58.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.98 -33.28 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -79.02 -17.72 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 159' ' ' VAL . 82.0 p -97.18 -38.28 9.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -42.68 -44.38 4.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.5 ptm180 -60.55 -34.65 74.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 40.5 m0 -85.53 12.96 7.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.32 11.19 84.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 154' ' ' THR . 55.2 t -119.98 140.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 111.115 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.92 145.09 51.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 95' ' ' TYR . 23.7 mm -75.85 106.48 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -56.12 -41.25 74.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -171.21 178.5 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.626 HG21 ' CB ' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -129.97 148.42 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.3 mm-40 -137.82 115.64 11.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.481 HD13 ' HB1' ' A' ' 92' ' ' ALA . 15.4 mm -93.18 141.53 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -100.06 160.54 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -51.52 159.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.0 mp -108.26 156.51 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.499 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 5.7 m-20 -115.72 129.66 24.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 161.93 44.01 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.436 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 54.0 Cg_endo -69.74 122.95 9.63 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.375 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -87.11 164.31 16.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 m -62.76 137.67 58.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.843 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.17 -57.77 10.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -79.55 110.39 14.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -144.2 144.24 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -84.3 146.46 27.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 45.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -77.29 133.74 38.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -115.05 141.6 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 96' ' ' TYR . 90.0 m-70 -101.39 159.05 15.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.33 144.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 115' ' ' ILE . 33.5 mt -106.31 134.79 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.74 108.12 20.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 76' ' ' PRO . 4.6 p -114.86 136.16 22.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.595 0.712 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.77 146.12 59.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 159.38 53.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 120' ' ' GLN . 27.2 mt-30 -143.99 129.69 19.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.24 94.83 7.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 140.57 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.614 HD13 HG22 ' A' ' 87' ' ' VAL . 31.3 mm -67.18 102.45 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.52 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -59.69 -42.95 94.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.98 30.04 0.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.845 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 51.98 50.62 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.06 120.36 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.614 HG22 HD13 ' A' ' 81' ' ' ILE . 24.7 t -77.88 116.36 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.63 149.88 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.507 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 8.5 m -91.94 117.09 29.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 127' ' ' ILE . 5.2 p -116.1 141.44 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -143.84 141.9 30.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.25 145.68 23.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.45 166.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.51 131.68 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.49 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.7 m-30 -92.72 157.08 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.441 ' CG ' ' CZ ' ' A' ' 111' ' ' PHE . 8.7 p90 -165.84 156.34 13.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.74 ' HG2' HG23 ' A' ' 162' ' ' THR . 12.3 pt20 -153.03 121.31 6.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.8 100.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -86.21 -24.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 19.0 t0 -138.57 105.59 7.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.8 Cg_endo -69.79 -43.65 2.51 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.307 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -50.78 -19.23 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -107.91 -34.08 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -101.91 43.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 105' ' ' VAL . 10.1 p -87.25 33.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 34.4 p90 -111.7 27.42 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 109' ' ' SER . 8.1 m-80 58.09 34.76 24.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.3 m 33.52 35.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.5 p -86.13 -60.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.823 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.46 -46.5 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -58.54 -39.67 80.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.07 -65.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -57.97 -31.66 67.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.59 -66.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 73' ' ' ILE . 16.7 mm -39.04 -63.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 75' ' ' VAL . 47.4 t -41.61 -50.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -62.13 -50.5 71.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.14 -60.28 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.37 -61.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 78' ' ' GLN . 12.8 mm-40 -39.41 -33.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 m -88.1 -53.95 4.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -56.16 -56.8 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 123' ' ' LEU . 2.6 pp -51.53 -41.06 60.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttp180 -55.98 -22.37 26.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 -59.58 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.8 mp -78.17 -60.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 90' ' ' VAL . 11.2 mt -54.97 -47.41 76.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -42.87 -27.34 0.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.8 pt-20 -120.58 113.33 20.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -173.12 -174.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 135' ' ' THR . 15.8 mt-10 -116.96 127.84 54.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.462 ' C ' ' O ' ' A' ' 131' ' ' GLU . 20.7 tp -33.32 -35.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.1 t70 -84.15 -65.45 1.01 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 135' ' ' THR . 29.6 tt0 -41.69 -47.7 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 131' ' ' GLU . 72.9 p -33.18 -40.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 mt -73.83 -51.14 17.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 m -61.54 -58.36 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.89 65.39 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' C ' ' CD ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -97.06 -45.21 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.467 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 13.0 t70 -59.07 -29.01 67.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 144' ' ' ALA . 48.3 mt -73.81 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -39.73 -50.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.5 p30 -69.49 -33.39 72.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' ILE . . . -59.24 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -46.15 -63.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 mt -48.11 -51.3 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 163' ' ' ARG . 26.8 ttm180 -44.49 -40.57 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.5 -56.35 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -42.91 -55.23 3.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 115' ' ' ILE . 9.8 mp -68.01 -35.71 78.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -20.87 40.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -82.72 -29.95 29.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 mm -83.71 -17.62 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.944 ' HB ' HG13 ' A' ' 159' ' ' VAL . 64.0 p -93.93 -39.96 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -41.51 -29.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.451 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 11.8 ptm180 -79.92 -36.44 36.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 154' ' ' THR . 35.6 m0 -84.16 30.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.26 33.74 39.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.944 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.5 p -141.49 144.25 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.151 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 3.3 tmmm? -127.92 151.08 49.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.0 mm -89.02 91.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 97' ' ' GLN . 19.0 p -42.3 -46.68 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 147' ' ' ARG . 14.5 ptm180 -169.4 -175.03 2.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 73.8 t -139.72 147.28 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 28.4 mm -102.92 142.32 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -98.57 161.88 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.951 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -47.52 156.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -109.81 157.51 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 t70 -126.09 133.28 24.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.63 0.729 . . . . 0.0 110.885 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 170.15 17.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 139.86 41.15 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.678 2.252 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -56.29 164.09 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.1 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.4 p -144.01 150.76 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -70.27 169.07 14.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -75.33 123.33 25.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.34 139.13 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -176.21 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.04 46.35 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 -60.83 123.53 17.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -104.74 144.33 31.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.96 145.66 39.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.858 HG12 ' CE1' ' A' ' 95' ' ' TYR . 34.5 m -94.21 140.39 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 96' ' ' TYR . 21.0 mt -107.55 119.24 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 118.57 20.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 116' ' ' VAL . 88.8 t -117.41 132.68 23.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.729 . . . . 0.0 111.119 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.75 144.37 53.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.85 164.28 35.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.628 2.218 . . . . 0.0 112.316 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.541 ' CD ' HD11 ' A' ' 123' ' ' LEU . 1.3 pt20 -146.67 139.44 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.55 129.43 36.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.97 145.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.9 mt -74.73 114.59 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.2 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.15 23.55 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 27.7 m-20 60.41 50.68 5.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 88' ' ' VAL . 70.7 t -118.82 111.16 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -75.27 115.41 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.5 HG13 HG12 ' A' ' 86' ' ' VAL . 15.7 m -140.19 162.2 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.49 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 31.9 m -102.84 125.04 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 91' ' ' ASP . 11.4 p -105.83 162.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.9 p30 -171.01 134.71 0.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.08 35.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 165' ' ' GLU . 17.1 m -102.96 164.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.93 134.28 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.858 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.2 m-30 -96.77 154.4 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.481 ' CD2' HD11 ' A' ' 73' ' ' ILE . 3.8 p90 -165.65 161.26 18.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 99' ' ' ILE . 2.2 pt20 -153.17 114.2 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.84 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 97' ' ' GLN . 2.7 pp -89.68 -24.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 99' ' ' ILE . 29.3 t70 -133.64 90.12 29.16 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -40.61 5.09 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 0.0 112.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 103' ' ' LYS . 27.5 m -38.39 -41.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 102' ' ' VAL . 23.1 mtpp -91.43 -35.65 14.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -84.45 41.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.087 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 105' ' ' VAL . 6.1 p -87.66 47.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.7 p90 -130.37 32.21 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.3 m-80 60.93 28.06 17.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 6.4 t 36.1 35.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 107' ' ' ASN . 54.9 m -89.76 -58.75 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -47.46 -54.56 11.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.3 t80 -50.13 -48.38 53.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 73' ' ' ILE . 9.1 mt -51.48 -68.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -60.95 -14.91 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.18 -34.51 23.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.649 HD13 HD12 ' A' ' 150' ' ' LEU . 14.1 mm -72.1 -54.83 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.655 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.0 m -56.68 -22.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.149 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -92.69 -45.21 8.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.38 -44.1 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.11 97.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.2 mm-40 -47.87 -33.09 6.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.1 m -87.0 -50.57 6.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -58.51 -58.25 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.541 HD11 ' CD ' ' A' ' 78' ' ' GLN . 2.3 pp -51.72 -39.99 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -52.93 -31.99 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.81 -51.69 31.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.83 -60.12 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.505 HD11 HG23 ' A' ' 142' ' ' ILE . 47.0 mm -50.61 -38.01 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.11 -33.83 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 130' ' ' MET . 11.9 pt-20 -117.06 113.93 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.404 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -171.8 -177.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.44 121.92 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.8 tp -33.55 -34.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 131' ' ' GLU . 25.3 t0 -83.96 -51.71 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 135' ' ' THR . 49.1 tt0 -52.99 -47.55 68.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 134' ' ' GLU . 29.8 p -35.82 -50.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.51 -47.12 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -102.47 85.58 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 142' ' ' ILE . . . 171.01 37.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.494 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.1 ttp180 -76.62 -31.42 57.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 5.1 m-20 -60.18 -38.37 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -78.89 -60.11 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 127' ' ' ILE . 20.3 mt -42.95 -51.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 140' ' ' ASP . . . -57.72 -60.63 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -49.63 -68.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 149' ' ' GLU . 4.0 mm? -43.03 -59.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' LEU . 45.5 ttp180 -35.74 -43.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.66 -38.7 28.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 146' ' ' LEU . 39.7 mm-40 -62.23 -27.63 69.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.649 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -99.42 -29.72 12.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -15.22 60.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.33 -20.56 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.48 -12.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 161' ' ' ILE . 72.0 p -101.31 -33.98 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -50.65 -23.3 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -88.2 -30.23 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -88.09 17.6 4.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 66.71 26.94 73.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.48 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.86 135.75 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 111.148 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.96 139.93 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 154' ' ' THR . 42.5 mm -84.98 109.48 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -60.54 -55.09 37.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -163.0 -176.16 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.77 140.47 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.169 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 93' ' ' VAL . 2.7 mm-40 -126.3 135.99 52.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.5 141.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.14 161.65 13.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -51.59 154.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -104.53 156.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -109.11 120.66 45.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 166.15 28.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 153.67 68.55 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.642 2.228 . . . . 0.0 112.317 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.22 157.91 7.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -107.29 109.71 21.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -88.18 -70.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.36 106.76 13.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.818 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' CG2' HD13 ' A' ' 68' ' ' LEU . 14.7 p -175.07 149.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' LEU . 6.0 m-20 -47.31 -75.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.557 HD13 ' CG2' ' A' ' 66' ' ' VAL . 9.9 mp 35.72 34.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' ASP . 29.9 ptt180 -48.59 174.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' HG21 ' A' ' 162' ' ' THR . 18.4 mp0 -114.59 144.97 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 31.2 m80 -117.4 128.73 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.77 135.44 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.941 HD13 HG21 ' A' ' 115' ' ' ILE . 21.9 mt -100.69 125.66 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.73 103.96 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 12.7 p -106.06 135.07 19.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.78 150.78 68.55 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.627 2.218 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.485 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.69 156.94 62.2 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.262 . . . . 0.0 112.348 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -142.99 121.34 12.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.77 105.66 11.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 127' ' ' ILE . 17.5 m -116.12 148.78 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 69.3 mt -77.12 106.22 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.36 -174.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.67 -47.63 77.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 86' ' ' VAL . 26.3 t0 -82.84 37.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.9 m120 47.61 54.8 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.567 HG12 HG13 ' A' ' 88' ' ' VAL . 47.9 t -124.38 110.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.35 108.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.567 HG13 HG12 ' A' ' 86' ' ' VAL . 27.5 m -128.46 146.63 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 1.8 m -80.52 113.52 18.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.899 HG11 HG21 ' A' ' 127' ' ' ILE . 4.8 p -107.41 143.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 15.8 p-10 -151.73 140.8 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.19 146.92 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.34 159.11 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 150' ' ' LEU . 40.5 t -131.9 129.12 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.17 159.82 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.0 p90 -165.56 159.87 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.731 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.3 pt20 -152.36 128.72 10.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 98' ' ' VAL . 46.5 t -67.32 93.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 100' ' ' ASP . 45.7 pt -73.07 -36.15 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 99' ' ' ILE . 24.8 t0 -125.4 99.24 33.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.9 Cg_endo -69.77 -7.52 21.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 105' ' ' VAL . 54.2 t -76.88 -47.83 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -82.95 -33.36 26.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -88.2 46.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 102' ' ' VAL . 16.1 m -89.22 30.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 45.6 p90 -112.66 35.61 3.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m120 47.12 36.68 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.2 m 31.08 41.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.1 m -89.19 -59.27 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -52.81 -34.2 52.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -70.36 -40.16 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -62.15 -54.93 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 ptp -68.62 -33.64 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -66.87 -59.08 3.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.941 HG21 HD13 ' A' ' 73' ' ' ILE . 16.2 mm -46.33 -63.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.2 t -39.48 -40.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -74.04 -49.46 24.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.7 mt -55.72 -57.56 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.32 -51.38 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HA ' HD21 ' A' ' 123' ' ' LEU . 46.4 mm-40 -42.85 -41.46 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 84.9 m -75.94 -59.3 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -45.77 -57.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.3 pp -54.06 -43.65 70.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 123' ' ' LEU . 20.1 ttp180 -53.01 -32.4 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.64 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.2 mp -76.35 -63.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.899 HG21 HG11 ' A' ' 90' ' ' VAL . 2.9 mp -49.62 -45.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.12 -26.18 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.47 113.75 17.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.98 -175.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.3 mm-40 -122.76 123.31 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 131' ' ' GLU . 46.3 tp -34.39 -32.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.9 m-20 -83.93 -46.63 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 131' ' ' GLU . 37.0 tt0 -56.31 -50.58 71.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' LEU . 79.1 p -42.17 -56.35 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.131 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 97.4 mt -34.79 -51.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.9 m -117.76 87.21 2.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.81 39.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -82.97 -40.28 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.71 -44.02 63.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.708 HG22 ' NE ' ' A' ' 145' ' ' ARG . 26.5 mt -68.96 -54.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.03 -36.81 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.497 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 80.5 m-20 -68.92 -19.14 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.4 -40.85 17.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.708 ' NE ' HG22 ' A' ' 141' ' ' ILE . 0.5 OUTLIER -66.59 -55.84 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.55 -32.7 67.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 31.6 ttt-85 -79.43 -40.55 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' CD ' ' O ' ' A' ' 148' ' ' GLU . 9.9 tm-20 -63.28 -25.49 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -91.17 -62.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 94' ' ' VAL . 79.4 mt -54.13 -20.72 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 21.0 t0 -83.86 13.85 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -121.45 -40.87 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 153' ' ' ILE . 22.1 mt -76.93 -8.42 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.089 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.428 ' CG2' HD11 ' A' ' 115' ' ' ILE . 71.6 p -100.65 -38.01 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -45.98 -37.66 6.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.516 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 6.4 ptp180 -66.74 -33.64 76.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.516 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.1 m0 -86.19 10.62 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.52 17.16 80.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.2 t -122.45 141.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -125.16 150.54 46.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 29.3 mm -85.82 113.88 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.731 HG23 ' HG2' ' A' ' 97' ' ' GLN . 25.7 p -68.02 -55.53 12.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 163' ' ' ARG . 4.5 ptp180 -156.01 178.0 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 99.4 t -141.41 145.86 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.26 145.1 51.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.497 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 19.9 mm -106.92 142.29 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.429 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 21.4 mm-40 -94.06 161.79 14.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -54.57 141.72 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.2 mp -91.22 157.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 t70 -128.34 133.78 25.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.36 24.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.79 67.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -80.97 -57.83 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.844 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' ASP . 18.5 p -108.9 -60.56 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 63' ' ' SER . 7.4 t70 37.05 39.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -116.63 108.5 16.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -154.14 128.01 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -149.58 134.72 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 69' ' ' ARG . 3.3 mp -54.75 -31.75 58.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' LEU . 25.8 mtt-85 -33.62 125.87 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 162' ' ' THR . 11.8 mp0 -75.61 140.86 42.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 66.4 m-70 -108.46 134.46 51.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.59 HG12 ' CE1' ' A' ' 95' ' ' TYR . 11.3 m -93.96 151.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 115' ' ' ILE . 20.8 mt -117.56 117.85 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.48 110.38 17.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.1 p -115.89 137.07 23.06 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.643 0.735 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.82 149.53 66.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 159.11 54.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.266 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -145.4 115.59 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.78 117.2 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.74 139.1 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.0 mt -70.29 105.52 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.5 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -64.94 -42.65 94.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.34 30.63 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER 53.46 44.72 29.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 HG13 ' A' ' 88' ' ' VAL . 41.1 t -111.82 114.21 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.8 p -77.18 114.29 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 HG12 ' A' ' 86' ' ' VAL . 27.1 m -142.84 144.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.5 m -87.34 124.48 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 127' ' ' ILE . 28.8 m -114.26 163.98 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -174.86 136.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 166' ' ' ILE . . . -154.07 151.54 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.2 m -95.65 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.1 132.75 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.4 m-30 -91.05 157.6 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 7.7 p90 -165.7 146.23 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.827 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.4 pt20 -141.92 123.14 14.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 159' ' ' VAL . 90.5 t -66.54 124.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -111.11 -30.07 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 99' ' ' ILE . 34.5 t70 -124.38 101.67 34.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.908 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.3 Cg_endo -69.74 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.401 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -41.45 -38.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -91.6 -37.82 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -91.3 45.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 105' ' ' VAL . 9.4 p -90.73 40.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 28.7 p90 -119.99 32.83 5.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' SER . 2.9 m-80 49.8 38.02 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 108' ' ' VAL . 13.9 t 34.41 33.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' ASN . 35.6 m -87.98 -51.17 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -47.57 75.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.728 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -60.2 -36.32 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.79 -60.54 3.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.9 -45.42 89.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.52 -55.14 37.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.005 HG21 HD13 ' A' ' 73' ' ' ILE . 10.9 mm -48.73 -62.96 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 76' ' ' PRO . 49.6 t -42.01 -33.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -79.16 -53.97 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 153' ' ' ILE . 14.4 mt -52.35 -58.9 5.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -38.84 -51.96 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -43.73 -41.17 4.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.8 m -78.18 -46.94 19.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -57.11 -61.12 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.9 pp -55.11 -42.14 72.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 123' ' ' LEU . 15.7 ttm180 -54.59 -25.46 26.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.74 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.3 mp -79.27 -64.22 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.83 HG21 HG21 ' A' ' 90' ' ' VAL . 2.9 mp -48.7 -42.66 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -46.91 -30.48 5.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -119.38 113.91 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.458 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -172.61 -175.19 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 133' ' ' ASP . 9.2 mt-10 -119.3 123.88 45.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 131' ' ' GLU . 51.8 tp -33.68 -34.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.3 m-20 -86.17 -54.1 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 135' ' ' THR . 70.7 tt0 -50.8 -49.81 57.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 134' ' ' GLU . 35.1 p -32.49 -51.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 mt -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 134' ' ' GLU . 2.2 m -93.86 41.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -146.84 49.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 45.8 ttt180 -95.37 -43.27 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.43 -19.4 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.1 mt -95.55 -56.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 127' ' ' ILE . 46.3 mt -46.82 -41.77 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' HG2' ' A' ' 139' ' ' ARG . 16.9 p30 -77.69 -20.44 53.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.92 -37.1 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.15 -66.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.4 mt -42.92 -35.75 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -75.71 -41.16 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -18.07 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.26 -48.53 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 115' ' ' ILE . 65.4 mt -67.88 -35.73 79.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -58.11 -11.85 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -95.88 -45.36 6.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 153' ' ' ILE . 68.8 mt -75.31 -1.45 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 161' ' ' ILE . 26.6 p -109.02 -40.62 4.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.34 -34.88 3.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 10.2 ptm180 -70.04 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.578 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 51.4 m0 -88.08 11.88 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 69.87 35.12 72.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 99' ' ' ILE . 20.5 t -138.8 136.62 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -116.3 141.0 48.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 154' ' ' THR . 46.9 mm -82.95 96.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.0 p -47.75 -55.56 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -163.57 -175.95 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.16 137.07 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -119.08 143.72 46.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 92' ' ' ALA . 15.3 mm -109.69 142.26 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.42 161.46 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -43.13 158.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 45.4 mt -113.15 154.72 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 38.2 m-20 -118.68 126.54 27.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.93 17.75 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 131.56 21.46 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.326 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.55 165.5 11.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.912 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -44.04 -48.73 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.33 -58.5 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 65' ' ' HIS . 4.3 p80 -119.78 113.72 21.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.54 171.71 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -109.44 135.71 50.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mp -81.94 39.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -90.25 104.56 17.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 157.84 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 86.4 m-70 -124.37 156.74 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 95' ' ' TYR . 2.7 m -99.69 152.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 115' ' ' ILE . 20.0 mt -110.03 131.59 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.76 105.99 18.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.2 p -118.3 127.36 26.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.3 Cg_endo -69.78 150.24 67.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.78 164.68 33.64 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.264 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -145.26 115.08 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.76 100.24 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -114.73 137.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.8 mt -70.2 105.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.11 -177.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -67.8 -35.94 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.91 28.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 13.8 m-20 54.32 45.42 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 88' ' ' VAL . 55.6 t -114.82 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.3 p -84.04 108.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 86' ' ' VAL . 15.0 m -135.63 152.81 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 3.6 m -88.89 130.87 35.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 127' ' ' ILE . 8.2 p -120.21 132.06 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.1 138.33 33.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.78 171.55 18.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 165' ' ' GLU . 13.7 m -121.66 159.08 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 73' ' ' ILE . 38.5 t -130.73 130.42 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.7 m-30 -91.27 160.81 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.6 p90 -165.85 157.0 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.697 ' HG2' HG23 ' A' ' 162' ' ' THR . 11.0 pt20 -152.17 132.36 13.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.3 t -73.54 98.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -76.55 -19.75 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.082 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -143.91 106.36 4.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.653 0.739 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -10.06 27.6 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.36 -29.65 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' A' ' 158' ' ' GLY . 31.2 mtpt -94.65 -34.56 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -90.92 47.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 105' ' ' VAL . 61.1 t -78.55 -5.57 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 33.9 p90 -83.11 16.86 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m-20 61.87 38.62 14.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 32.4 m 34.14 36.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 107' ' ' ASN . 8.3 t -89.43 -52.43 5.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.28 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -62.87 -33.28 74.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.23 -58.45 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.5 ptp -64.82 -39.12 93.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -54.59 39.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 73' ' ' ILE . 9.4 mm -50.59 -59.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.7 t -44.12 -42.86 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -69.15 -48.73 61.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.72 -59.77 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -41.32 -45.12 2.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.111 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 38.4 mm-40 -52.42 -41.59 63.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.2 m -80.08 -50.58 10.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -51.53 -52.81 43.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 124' ' ' ARG . 1.7 pp -60.14 -41.67 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.793 ' N ' HD12 ' A' ' 123' ' ' LEU . 57.0 ttt85 -54.31 -21.78 10.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.16 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.4 mp -76.55 -55.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.696 HG21 HG11 ' A' ' 90' ' ' VAL . 50.7 mm -51.07 -38.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.51 -27.31 11.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.449 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -123.24 114.19 19.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.17 -178.34 1.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 133' ' ' ASP . 20.6 mt-10 -122.66 121.56 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' GLU . 24.1 tp -33.73 -34.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' GLU . 58.0 m-20 -78.48 -50.38 11.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 tp10 -59.19 -46.98 86.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 p -40.57 -36.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.35 -55.47 21.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -101.54 46.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -132.79 43.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 mtp-105 -87.89 -42.83 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.75 -11.31 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.7 mt -100.08 -56.0 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.37 -44.53 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.529 ' OD1' HD11 ' A' ' 166' ' ' ILE . 67.2 m-20 -56.57 -26.55 55.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.4 -48.59 15.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 145' ' ' ARG . 5.9 mpt_? -57.01 -64.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 146' ' ' LEU . 10.4 mt -52.74 -57.35 10.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HB2' HG21 ' A' ' 164' ' ' VAL . 44.6 ttp180 -45.38 -38.27 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -82.86 -22.85 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 153' ' ' ILE . 32.7 mt-10 -83.31 -12.15 56.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.832 HD12 HD13 ' A' ' 115' ' ' ILE . 2.1 mm? -121.4 -5.87 9.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -24.32 23.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -86.59 -34.37 19.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 149' ' ' GLU . 22.9 mt -81.54 -11.88 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 1.013 ' HB ' HG13 ' A' ' 159' ' ' VAL . 56.6 p -100.33 -40.44 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.176 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -46.59 -21.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 156' ' ' ARG . 0.8 OUTLIER -82.6 -37.2 25.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.507 ' HB2' HG12 ' A' ' 159' ' ' VAL . 32.2 m0 -84.04 24.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.412 ' N ' ' HE2' ' A' ' 103' ' ' LYS . . . 65.04 14.26 58.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 1.013 HG13 ' HB ' ' A' ' 154' ' ' THR . 4.2 p -123.24 140.78 45.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD3' ' C ' ' A' ' 160' ' ' LYS . 3.5 tmtt? -126.78 140.13 52.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.53 93.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.697 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.28 -55.04 7.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.159 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 2.8 ptp180 -158.59 -178.9 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.501 HG12 ' OD1' ' A' ' 143' ' ' ASN . 92.0 t -141.17 127.96 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.164 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.5 mm-40 -115.56 134.14 55.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.529 HD11 ' OD1' ' A' ' 143' ' ' ASN . 17.0 mm -102.52 142.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -101.22 159.13 15.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 19.5 mtt85 -45.03 157.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -111.58 155.8 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.2 m-20 -111.59 120.07 43.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.596 0.712 . . . . 0.0 110.922 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.28 19.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.431 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.78 151.67 69.02 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -59.37 -35.19 73.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 173' ' ' LYS . 6.8 t70 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 m -109.79 119.69 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.866 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -63.65 -47.94 79.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.51 121.02 18.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -122.07 44.61 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.3 165.58 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 mt -78.6 69.19 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -102.36 114.04 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 1.2 pm0 -103.96 143.72 32.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -112.53 145.27 40.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 93' ' ' VAL . 2.4 p -94.35 137.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 115' ' ' ILE . 21.2 mt -103.11 126.92 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -112.51 132.01 22.38 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.5 Cg_endo -69.75 145.92 58.68 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.316 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.5 Cg_endo -69.78 162.57 41.58 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.706 2.27 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -142.97 117.09 9.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -69.04 106.65 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.38 142.62 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 87' ' ' VAL . 19.5 mm -72.13 109.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -56.44 -177.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -65.68 -40.65 92.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -85.51 34.39 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 45.97 47.61 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ASP . 31.8 t -115.37 122.28 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 81' ' ' ILE . 21.8 t -77.23 111.4 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 m -138.48 155.08 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.6 m -102.19 119.68 39.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 127' ' ' ILE . 27.5 m -100.64 141.2 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -146.05 133.0 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.7 167.39 29.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 35.5 m -111.61 172.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.74 123.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 4.6 m-30 -90.39 151.96 21.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -165.8 154.79 11.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.602 HE21 HG22 ' A' ' 99' ' ' ILE . 5.0 pt20 -148.71 112.48 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.91 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.88 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -80.64 -26.53 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.765 ' HB2' HD12 ' A' ' 99' ' ' ILE . 28.5 t0 -134.97 97.51 13.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 104' ' ' ALA . 53.8 Cg_endo -69.79 -44.74 1.89 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.706 HG23 ' HG2' ' A' ' 103' ' ' LYS . 4.0 m -36.41 -31.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.706 ' HG2' HG23 ' A' ' 102' ' ' VAL . 11.7 mmmt -93.62 -35.54 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -82.27 41.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -73.86 4.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 30.2 p90 -97.34 27.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.8 m-80 56.87 32.99 22.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.542 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.0 m 32.97 39.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.0 t -96.28 -36.44 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 4.3 m-20 -71.05 -38.59 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.792 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -67.8 -44.9 76.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -48.74 -54.3 15.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.633 ' O ' HG22 ' A' ' 116' ' ' VAL . 7.9 ptp -77.3 -45.01 27.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -57.4 -14.99 5.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.094 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 73' ' ' ILE . 2.0 mm -80.73 -51.55 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 113' ' ' MET . 10.0 m -59.64 -25.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -82.03 -32.82 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 114' ' ' ALA . 16.0 mt -70.5 -36.58 73.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.02 86.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 32.3 mm-40 -51.45 -38.17 52.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.1 m -82.88 -57.18 3.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.169 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -54.26 -56.44 18.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 1.005 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.1 pp -53.72 -41.3 66.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttt-85 -53.97 -20.35 6.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.13 -57.9 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -79.27 -62.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 1.005 HD13 ' HB2' ' A' ' 123' ' ' LEU . 3.0 mp -50.37 -41.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.3 -26.38 4.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.01 113.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.913 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -175.72 1.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.0 126.02 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' GLU . 42.5 tp -37.53 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.3 p30 -93.19 -43.39 8.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.829 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.6 tp10 -63.82 -20.66 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.1 p -73.54 -14.24 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 mt -82.17 -40.84 21.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 t -120.86 43.09 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -134.17 20.24 4.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 142' ' ' ILE . 14.6 ptt180 -69.08 -32.08 71.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -51.72 -47.46 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.27 -43.43 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 139' ' ' ARG . 48.9 mt -50.9 -49.9 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.541 ' OD1' HD11 ' A' ' 166' ' ' ILE . 76.0 m-20 -65.44 -52.24 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 148' ' ' GLU . . . -42.89 -48.58 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.101 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -61.23 -70.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.38 -62.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -40.26 -36.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 144' ' ' ALA . 0.3 OUTLIER -78.01 -56.98 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.92 -58.37 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.8 mt -56.24 -37.23 69.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -11.28 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -92.63 -37.17 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -76.13 -19.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 159' ' ' VAL . 73.6 p -93.74 -38.41 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -52.11 -16.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.29 -31.75 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.465 ' HB2' HG12 ' A' ' 159' ' ' VAL . 40.8 m0 -88.97 11.47 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.69 10.98 85.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -113.57 145.42 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 111.128 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -118.48 141.2 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 154' ' ' THR . 26.2 mm -79.84 92.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.92 -61.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -166.49 -178.06 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 ' OD1' ' A' ' 143' ' ' ASN . 62.9 t -135.18 147.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 13.7 mt-10 -135.55 143.31 45.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.541 HD11 ' OD1' ' A' ' 143' ' ' ASN . 24.6 mm -105.44 142.24 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -106.12 161.25 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -42.33 136.95 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -95.76 157.22 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.496 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 9.6 m-20 -107.87 120.93 45.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.843 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 169.14 19.58 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.451 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 54.1 Cg_endo -69.75 128.49 16.11 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.251 . . . . 0.0 112.379 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -118.0 166.31 12.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 174' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.6 m -55.48 127.62 30.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.35 -55.93 23.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -82.29 122.0 27.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.49 132.77 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.48 156.73 37.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.88 39.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -54.87 118.59 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -119.75 152.36 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 85.5 m-70 -121.86 143.85 49.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.35 139.66 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.71 HD11 ' CE1' ' A' ' 111' ' ' PHE . 27.4 mt -108.26 124.56 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.46 127.49 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.815 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 2.3 p -120.75 135.32 24.61 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.627 0.727 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.3 Cg_endo -69.78 150.29 67.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.2 Cg_endo -69.71 149.84 67.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' HD11 ' A' ' 123' ' ' LEU . 56.7 tt0 -137.59 113.71 9.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.81 101.92 4.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG11 ' HA2' ' A' ' 128' ' ' GLY . 15.1 t -111.05 137.66 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 65.2 mt -68.16 104.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -49.78 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -65.12 -41.02 95.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 19.2 t70 -84.96 33.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 51.07 47.89 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 172' ' ' PRO . 94.0 t -118.93 114.76 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.4 p -80.38 120.18 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -145.89 148.91 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 11.4 m -81.16 125.98 30.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.951 HG11 HG21 ' A' ' 127' ' ' ILE . 9.8 p -121.76 130.93 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 13.5 p-10 -140.95 145.47 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.82 150.34 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -100.33 155.15 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.77 141.76 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.39 162.53 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.1 p90 -165.9 157.53 14.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.468 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 11.8 pt20 -153.31 116.4 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 98' ' ' VAL . 34.4 t -53.79 94.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.132 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.27 3.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -165.17 112.64 0.83 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.64 0.733 . . . . 0.0 110.841 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -51.22 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.244 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 p -44.68 -37.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -81.16 -37.08 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -96.73 56.01 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 105' ' ' VAL . 12.8 p -92.66 3.25 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.166 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 31.0 p90 -87.94 24.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 23.4 m-80 61.97 27.4 16.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 3.3 t 36.66 40.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 t -96.16 -52.33 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -57.22 -39.2 74.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.71 ' CE1' HD11 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -62.88 -35.01 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.45 -64.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 ptp -61.64 -32.74 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -67.13 -57.22 7.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 154' ' ' THR . 8.1 mm -44.69 -56.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 76' ' ' PRO . 87.6 t -53.79 -24.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -85.91 -37.77 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 121' ' ' THR . 10.4 mt -67.55 -57.07 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.73 -36.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -63.41 -40.85 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 118' ' ' LEU . 88.6 m -78.74 -38.77 38.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 34.4 m120 -69.26 -56.38 7.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -53.19 -44.18 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.72 ' N ' HD12 ' A' ' 123' ' ' LEU . 45.5 ttt-85 -52.46 -22.04 4.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' ASN . . . -73.92 -60.59 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.0 mp -78.91 -60.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.951 HG21 HG11 ' A' ' 90' ' ' VAL . 1.9 mp -49.98 -38.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.472 ' HA2' HG11 ' A' ' 80' ' ' VAL . . . -51.62 -23.89 10.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.06 114.05 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.79 -175.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 133' ' ' ASP . 22.2 mt-10 -120.84 137.07 54.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.0 tp -38.29 -26.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.757 ' HA ' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -97.83 -59.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -41.93 -25.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' ASP . 1.5 p -64.2 -50.58 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.757 HD21 ' HA ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -79.29 -13.95 59.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.935 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 m -92.78 -29.58 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.477 ' CA ' HD13 ' A' ' 141' ' ' ILE . . . -114.56 85.53 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.499 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -103.03 -43.45 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -16.84 63.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.8 mp -85.11 -48.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.613 ' CG2' HD11 ' A' ' 127' ' ' ILE . 70.8 mt -55.48 -61.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.46 -37.67 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.97 -59.02 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -48.77 -66.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 tp -42.81 -48.77 5.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -55.31 -42.94 74.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.32 -9.83 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.701 ' O ' HD12 ' A' ' 153' ' ' ILE . 13.2 mt-10 -98.35 -53.35 3.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.2 mt -64.6 -34.7 78.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -13.67 35.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -88.58 -49.84 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 149' ' ' GLU . 4.4 mp -72.92 -21.61 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.533 ' CG2' HD11 ' A' ' 115' ' ' ILE . 60.0 p -91.21 -35.35 14.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -25.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CB ' HH11 ' A' ' 156' ' ' ARG . 0.0 OUTLIER -80.15 -34.94 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -82.57 15.91 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.54 76.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.45 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.77 128.07 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.94 145.29 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -84.08 116.31 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 30.3 p -70.37 -62.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -146.65 167.13 24.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.96 115.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 93' ' ' VAL . 20.0 mm-40 -99.16 147.21 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.559 HD13 ' HB1' ' A' ' 92' ' ' ALA . 22.6 mm -107.62 137.21 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.9 mt-30 -88.74 159.61 17.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -50.58 156.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -110.99 157.26 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 10.0 t70 -125.45 133.26 24.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 168.47 21.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.509 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.5 Cg_endo -69.8 170.62 16.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.683 2.256 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 174' ' ' ASP . 31.9 pttt -95.45 -52.12 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' A' ' 173' ' ' LYS . 41.2 m-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.9 m -148.94 157.14 43.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -82.91 166.74 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -89.23 112.69 23.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 66' ' ' VAL . 17.4 m -92.1 123.66 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.77 156.78 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 69' ' ' ARG . 5.1 tp -84.81 -21.56 29.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' LEU . 25.2 ptt-85 -36.58 137.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.38 152.87 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m-70 -113.85 149.26 35.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.2 p -96.49 145.31 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.966 HD13 HG21 ' A' ' 115' ' ' ILE . 18.7 mt -105.35 130.68 56.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.38 95.11 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.905 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.1 p -100.93 138.42 20.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.679 0.752 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 150.48 68.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.676 2.251 . . . . 0.0 112.327 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.498 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.2 Cg_endo -69.8 171.0 15.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 13.7 mp0 -142.97 145.88 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.37 101.22 11.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.625 HG12 ' NH1' ' A' ' 124' ' ' ARG . 28.9 m -117.05 145.83 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 66.9 mt -77.55 106.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.33 -178.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -62.87 -48.59 78.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.3 t0 -81.45 37.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.5 m120 46.67 44.84 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 88' ' ' VAL . 76.6 t -111.23 110.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.61 120.86 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 86' ' ' VAL . 28.7 m -144.83 150.3 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 6.9 m -93.52 125.05 37.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 127' ' ' ILE . 34.4 m -112.9 148.98 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -152.81 138.45 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.831 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.08 153.44 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 165' ' ' GLU . 24.2 m -101.22 163.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.39 132.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.6 m-30 -94.26 161.31 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.6 p90 -165.91 152.37 9.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.601 ' HG2' HG23 ' A' ' 162' ' ' THR . 14.1 pt20 -143.11 126.06 16.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.83 91.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.408 ' O ' HG11 ' A' ' 66' ' ' VAL . 12.2 pt -71.7 -31.89 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -132.07 102.6 14.49 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.846 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -10.14 27.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.637 2.224 . . . . 0.0 112.393 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.12 -50.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -77.02 -38.09 53.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -86.63 47.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.34 4.74 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 36.3 p90 -85.26 30.83 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 108' ' ' VAL . 4.8 m120 49.63 37.07 11.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 23.6 m 32.57 41.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.4 m -94.96 -41.58 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -46.8 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.704 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -57.05 -30.4 64.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.0 mt -60.31 -60.67 3.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.4 ' O ' HG22 ' A' ' 116' ' ' VAL . 20.0 ptp -67.75 -46.22 72.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.26 -35.93 63.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.966 HG21 HD13 ' A' ' 73' ' ' ILE . 5.2 mm -67.76 -64.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.7 m -52.29 -15.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -94.83 -34.32 12.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 150' ' ' LEU . 10.8 mt -73.2 -54.23 8.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -47.08 -45.29 21.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.475 ' HG2' ' NE2' ' A' ' 78' ' ' GLN . 18.1 mt-30 -62.02 -36.13 80.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.5 m -74.16 -22.12 59.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 36.0 m120 -91.53 -61.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 124' ' ' ARG . 4.1 pp -47.63 -39.83 18.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.625 ' NH1' HG12 ' A' ' 80' ' ' VAL . 25.4 mtt-85 -52.72 -33.09 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.88 -54.43 15.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.56 -59.52 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 90' ' ' VAL . 3.7 mt -50.25 -44.24 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.86 -24.02 0.68 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' MET . 10.4 pt-20 -125.86 112.76 16.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -175.54 -175.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 135' ' ' THR . 10.2 mm-40 -122.44 129.39 52.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.99 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 74.9 m-20 -85.74 -64.89 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.2 pt-20 -53.33 -46.02 69.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 131' ' ' GLU . 25.3 p -33.3 -33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 134' ' ' GLU . 39.6 mt -70.85 -69.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -54.14 -46.29 72.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.72 57.64 2.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -99.75 -26.41 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -78.12 -26.13 47.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.7 mt -78.73 -52.34 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -43.88 -50.51 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.562 ' HB3' HD11 ' A' ' 166' ' ' ILE . 0.9 OUTLIER -68.47 -41.01 80.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -50.86 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -55.09 -56.76 16.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' HB1' ' A' ' 119' ' ' ALA . 7.2 tp -47.51 -62.12 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 25.9 ttp85 -43.85 -50.25 7.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -53.54 -31.37 46.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.58 -60.18 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 115' ' ' ILE . 3.3 mm? -54.82 -31.75 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -66.85 -3.75 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -97.59 -43.84 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.5 mp -75.16 -18.78 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.8 p -92.04 -35.33 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.16 -38.62 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.6 ptp180 -69.93 -32.53 70.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.672 ' O ' HG23 ' A' ' 159' ' ' VAL . 31.7 m0 -88.23 34.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.57 23.39 4.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 157' ' ' TRP . 91.2 t -126.72 143.32 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.75 141.92 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 95' ' ' TYR . 26.9 mm -77.54 97.56 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 97' ' ' GLN . 62.6 p -51.27 -38.57 53.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -170.99 -179.93 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 143' ' ' ASN . 1.7 m -141.32 134.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.445 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.7 mt-10 -121.07 139.42 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 143' ' ' ASN . 9.0 mm -104.12 142.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.171 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.48 161.95 13.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -49.32 145.38 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 170' ' ' ASP . 3.3 mp -98.27 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 169' ' ' ILE . 2.2 m-20 -112.72 120.46 40.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 110.87 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 170.23 17.12 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.629 2.22 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 136.16 32.29 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -102.6 173.29 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.822 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.7 t -133.93 118.12 17.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.63 -60.25 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -71.69 126.02 28.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.18 128.29 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.179 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -155.87 176.19 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.23 36.49 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -65.04 141.11 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.29 138.6 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 47.2 m80 -108.57 126.73 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -93.1 135.26 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 115' ' ' ILE . 20.4 mt -99.1 128.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.32 97.97 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 116' ' ' VAL . 48.2 t -102.89 126.78 31.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 111.128 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 149.86 67.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.79 147.58 63.02 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -128.17 116.95 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.53 116.86 9.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.62 147.52 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 46.6 mm -83.56 108.67 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.4 m -53.11 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -67.32 -45.09 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 25.8 t70 -82.89 36.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.49 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.6 m-20 47.26 51.07 13.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 HG13 ' A' ' 88' ' ' VAL . 87.1 t -118.15 109.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 87' ' ' VAL . 6.4 p -78.14 114.28 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 86' ' ' VAL . 18.1 m -140.15 142.06 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 m -81.93 126.24 31.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 91' ' ' ASP . 7.2 p -119.64 160.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -162.57 143.5 10.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.76 153.52 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 165' ' ' GLU . 18.0 m -101.19 164.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.8 t -137.42 134.43 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 3.4 m-85 -96.59 157.02 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 4.7 p90 -165.92 150.94 8.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.762 ' HG2' HG23 ' A' ' 162' ' ' THR . 8.6 pt20 -147.95 110.01 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 108' ' ' VAL . 92.0 t -51.68 95.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.55 -8.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -161.22 109.59 1.25 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.569 0.699 . . . . 0.0 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -47.84 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' PRO . 2.2 t -34.83 -39.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -90.71 -37.86 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.565 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -94.23 49.83 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.8 m -86.12 8.17 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 35.7 p90 -90.47 26.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.5 m-80 56.56 33.97 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.5 t 33.65 41.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.3 m -97.45 -50.18 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.3 m-20 -57.6 -45.09 85.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 1.1 t80 -61.09 -44.39 97.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.527 HD23 HG12 ' A' ' 73' ' ' ILE . 19.0 mt -53.16 -64.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.786 ' O ' HG22 ' A' ' 116' ' ' VAL . 21.0 ptp -62.24 -45.07 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -56.92 -32.31 65.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 73' ' ' ILE . 3.9 mm -70.92 -59.81 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.184 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 113' ' ' MET . 8.7 m -44.06 -22.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 115' ' ' ILE . 77.1 mttt -94.77 -46.86 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.09 -53.04 62.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.46 -45.78 47.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.497 ' HA ' HD21 ' A' ' 123' ' ' LEU . 26.8 mt-30 -57.96 -37.9 75.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.7 m -70.17 -35.49 74.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.428 ' CG ' ' HB3' ' A' ' 149' ' ' GLU . 71.0 m-80 -80.31 -62.92 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.721 ' HB3' HD21 ' A' ' 146' ' ' LEU . 4.0 pp -46.59 -43.79 17.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.596 ' N ' HD12 ' A' ' 123' ' ' LEU . 9.7 ttm180 -47.73 -39.09 16.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.15 -52.03 66.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.1 mp -80.42 -62.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.169 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 123' ' ' LEU . 5.2 mt -51.17 -43.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.61 -31.58 3.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.524 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -116.52 113.39 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -172.55 -175.09 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 133' ' ' ASP . 35.0 mt-10 -116.5 121.34 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 131' ' ' GLU . 57.5 tp -33.89 -33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 m-20 -83.45 -50.75 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 131' ' ' GLU . 24.8 tt0 -56.45 -48.58 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.0 p -40.1 -50.11 2.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.3 mt -47.02 -39.17 12.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -127.61 82.36 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -175.27 25.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 5.0 ptt-85 -72.6 -35.33 67.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 1.5 m-20 -46.94 -32.21 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.09 -35.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 139' ' ' ARG . 71.4 mt -60.81 -50.64 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 2.3 p30 -61.77 -52.78 62.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' NH1' ' A' ' 147' ' ' ARG . . . -39.29 -49.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -58.8 -60.6 3.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 123' ' ' LEU . 3.9 mm? -54.37 -61.96 1.96 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 23.6 ttp-105 -36.19 -36.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.51 -55.5 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 152' ' ' LYS . 70.2 mm-40 -50.24 -17.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.11 -40.07 5.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.1 -8.31 16.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 149' ' ' GLU . 5.2 ptmt -100.83 -18.24 16.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 153' ' ' ILE . 7.2 mt -107.3 18.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.993 ' HB ' HG13 ' A' ' 159' ' ' VAL . 39.7 p -120.99 -32.29 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -25.56 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -84.1 -25.82 29.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TRP . . . . . 0.446 ' HB2' HG12 ' A' ' 159' ' ' VAL . 54.4 m0 -92.84 17.41 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 66.79 15.44 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.993 HG13 ' HB ' ' A' ' 154' ' ' THR . 5.0 p -124.94 155.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.178 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -137.52 151.7 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.477 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 31.7 mm -88.94 98.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -52.66 -48.84 66.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -166.15 -176.38 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.08 147.93 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.549 ' HB2' HG23 ' A' ' 93' ' ' VAL . 3.2 mm-40 -133.81 141.66 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.55 142.07 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -101.44 161.87 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.56 160.95 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -113.84 157.06 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.6 m-20 -111.42 123.54 34.75 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.666 0.746 . . . . 0.0 110.85 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 164.44 34.55 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.64 40.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.385 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 153.4 24.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.1 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.6 155.76 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -123.73 152.02 42.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.1 146.72 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 115' ' ' ILE . 16.6 mt -106.53 133.47 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 111.96 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.7 p -117.9 128.21 26.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 111.134 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.4 Cg_endo -69.76 152.39 69.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 0.0 112.33 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.8 164.07 35.95 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.697 2.265 . . . . 0.0 112.337 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.96 121.47 11.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.26 106.68 5.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.13 136.94 58.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 53.4 mt -71.51 107.38 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.08 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -67.61 -43.99 79.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.58 35.25 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 49.1 t30 48.08 49.41 17.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG12 HG13 ' A' ' 88' ' ' VAL . 97.2 t -113.23 114.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -76.35 116.9 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 86' ' ' VAL . 25.2 m -142.61 165.8 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.494 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 58.9 m -111.77 114.01 26.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.138 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 127' ' ' ILE . 14.6 p -97.0 159.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.5 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.4 p-10 -171.0 137.35 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 175.59 13.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 165' ' ' GLU . 16.0 m -121.12 159.75 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.7 135.83 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 163' ' ' ARG . 5.4 m-85 -100.85 159.21 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.468 ' CD2' ' CE1' ' A' ' 111' ' ' PHE . 3.5 p90 -165.79 163.78 18.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.754 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -153.62 132.21 12.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.49 96.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 pt -82.26 -28.07 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.585 ' OD1' HG22 ' A' ' 102' ' ' VAL . 10.0 t0 -125.2 98.13 36.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.853 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -39.82 6.19 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 ' OD1' ' A' ' 100' ' ' ASP . 17.0 m -58.43 -18.28 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.06 -36.0 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -92.57 42.08 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 105' ' ' VAL . 21.3 t -78.38 6.82 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 47.0 p90 -85.89 31.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.532 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.2 m120 47.35 42.09 13.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.7 m 26.83 43.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.2 t -96.73 -53.77 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.92 -40.24 75.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -61.52 -37.54 84.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.9 mt -61.79 -65.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.9 ptp -60.44 -37.18 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.54 -60.83 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.979 HG21 HD13 ' A' ' 73' ' ' ILE . 13.1 mm -41.77 -63.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 76' ' ' PRO . 84.6 t -44.48 -53.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -56.19 -45.15 79.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 121' ' ' THR . 39.4 mt -61.38 -61.02 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -37.9 -40.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -57.33 -46.18 83.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 118' ' ' LEU . 91.4 m -70.87 -51.77 24.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -56.2 -60.64 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -49.98 -42.09 48.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.5 ttp180 -50.74 -35.55 32.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.72 -57.93 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.095 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -74.69 -59.86 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 90' ' ' VAL . 32.5 mm -47.81 -40.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.58 -31.94 15.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -120.46 114.24 21.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.94 -176.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 133' ' ' ASP . 42.3 mt-10 -122.58 130.81 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.558 HD13 ' HD3' ' A' ' 172' ' ' PRO . 37.5 tp -34.96 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 131' ' ' GLU . 26.9 t0 -94.17 -56.99 2.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.461 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 1.8 tp10 -49.93 -18.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.0 p -63.54 -54.7 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 136' ' ' LEU . 3.5 pp -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.478 ' N ' HD12 ' A' ' 136' ' ' LEU . 3.6 p -64.18 -50.55 67.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.7 71.38 2.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.63 -33.0 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.816 0.341 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.42 -39.84 74.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.6 mt -61.53 -49.49 84.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.14 -49.0 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' HG12 ' A' ' 166' ' ' ILE . 27.3 m-20 -57.67 -52.01 67.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 145' ' ' ARG . . . -51.38 -68.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 144' ' ' ALA . 24.6 mmt180 -35.18 -69.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -47.14 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 151' ' ' ASP . 57.6 ttp85 -41.29 -44.27 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.95 -55.27 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -47.51 -38.75 14.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.676 HD12 HD13 ' A' ' 115' ' ' ILE . 3.2 mm? -87.06 -40.49 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 9.8 t70 -58.0 -23.14 52.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -85.12 -27.79 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 153' ' ' ILE . 25.5 mt -91.4 -10.53 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.167 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.975 ' HB ' HG13 ' A' ' 159' ' ' VAL . 23.4 p -95.97 -43.08 7.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -38.61 -34.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.585 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 3.9 ptm85 -70.1 -40.94 74.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.585 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 35.4 m0 -83.65 28.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 53.17 37.03 53.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.975 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.7 p -140.44 144.78 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.57 146.66 52.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.471 ' CG2' ' HG3' ' A' ' 147' ' ' ARG . 12.0 mm -73.8 91.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.754 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.01 -45.01 15.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.193 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 95' ' ' TYR . 9.9 ptp180 -163.45 175.82 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -141.0 137.95 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HB2' HG23 ' A' ' 93' ' ' VAL . 31.3 mp0 -132.33 146.14 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.466 HG12 ' ND2' ' A' ' 143' ' ' ASN . 11.9 mm -110.99 142.33 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.93 160.8 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -47.12 148.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -104.13 157.17 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.489 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 m-20 -110.39 118.48 49.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 169.99 17.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.241 . . . . 0.0 112.379 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.558 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -68.42 157.35 36.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 75.4 m-70 -126.6 128.45 46.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.14 132.81 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 115' ' ' ILE . 27.2 mt -102.38 128.54 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.67 101.78 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.667 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.2 p -103.4 138.67 19.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.687 0.756 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.7 Cg_endo -69.78 147.42 62.72 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.69 2.26 . . . . 0.0 112.327 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.6 49.08 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.36 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -140.77 131.26 25.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.5 112.5 24.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.74 151.14 34.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 43.8 mt -79.63 110.3 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.36 -174.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.18 -39.37 75.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.05 24.72 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.5 m120 57.09 51.27 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 88' ' ' VAL . 75.0 t -120.66 110.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.3 p -73.25 112.05 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.146 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 86' ' ' VAL . 10.8 m -139.69 148.04 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.8 m -85.55 134.7 34.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 127' ' ' ILE . 9.9 p -123.51 147.48 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.1 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -159.25 136.15 9.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.34 146.66 24.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.02 164.94 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 164' ' ' VAL . 20.4 t -139.2 119.32 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -75.4 160.38 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 3.3 p90 -165.65 148.8 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 162' ' ' THR . 4.0 pt20 -142.61 132.74 24.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.65 96.76 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 pt -74.56 -24.52 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.56 110.66 5.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -26.46 27.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.255 . . . . 0.0 112.317 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.32 -61.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -66.17 -39.42 89.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.515 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -89.3 50.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 105' ' ' VAL . 8.7 p -95.82 37.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 30.2 p90 -116.83 30.39 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.8 m-80 58.85 27.25 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 7.2 m 35.28 41.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -94.61 -52.15 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -48.64 78.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -56.04 -32.74 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 116' ' ' VAL . 15.5 mt -69.64 -61.39 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.2 ptp -65.82 -10.08 34.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.49 -51.73 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 73' ' ' ILE . 5.8 mm -47.83 -51.07 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -61.83 -22.97 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -90.18 -13.0 36.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.427 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 67.8 mt -89.67 -39.93 12.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.9 95.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.097 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HA ' HD21 ' A' ' 123' ' ' LEU . 40.4 mm-40 -45.98 -39.48 9.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.6 m -83.34 -53.78 5.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 75.0 m-80 -52.78 -59.4 4.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.1 pp -51.18 -41.13 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' N ' HD12 ' A' ' 123' ' ' LEU . 51.4 ttt180 -51.37 -35.84 40.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.57 -61.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -72.33 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 142' ' ' ILE . 49.8 mm -50.72 -47.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -43.31 -27.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -123.17 114.57 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -170.98 -175.38 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 44.4 mt-10 -121.47 125.76 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 59.6 tp -36.53 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 43.5 m-20 -84.57 -52.5 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 137' ' ' SER . 52.1 tt0 -56.53 -47.22 79.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.7 p -37.74 -34.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.07 -43.09 55.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 134' ' ' GLU . 71.2 m -112.8 73.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.78 25.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 142' ' ' ILE . 83.9 mtm180 -68.29 -38.4 81.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.4 -21.52 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.2 mt -98.5 -26.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 127' ' ' ILE . 23.8 mt -78.12 -34.43 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -81.44 -27.23 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.75 96.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.542 ' N ' ' CD ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.47 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 123' ' ' LEU . 4.4 mm? -55.43 -28.17 52.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -73.94 -43.25 58.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.5 -8.91 58.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -93.82 -32.49 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -99.94 -6.44 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.39 -11.98 38.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -98.4 -26.2 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 153' ' ' ILE . 56.0 mt -92.24 15.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.985 ' HB ' HG13 ' A' ' 159' ' ' VAL . 57.5 p -122.4 -28.21 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.02 -24.96 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -19.89 23.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -94.55 2.51 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.25 24.79 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.1 p -136.05 155.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -136.6 151.44 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.46 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 36.1 mm -88.45 94.35 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -48.69 -45.84 39.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -169.42 178.8 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 94' ' ' VAL . 18.9 t -138.43 142.23 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -127.04 135.54 50.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 92' ' ' ALA . 7.2 mm -104.48 138.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -95.22 160.28 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -50.38 149.6 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.37 146.17 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.52 122.69 50.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.883 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.04 17.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.356 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.1 mtp-105 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.766 0.317 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' HG21 ' A' ' 162' ' ' THR . 21.4 mp0 -96.83 134.86 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 56.9 m-70 -106.46 132.99 51.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.84 137.79 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 115' ' ' ILE . 51.6 mt -104.46 121.64 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.08 100.15 10.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 11.4 t -100.92 136.01 19.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.79 145.96 58.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.317 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.78 149.3 66.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -132.26 119.63 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -74.74 109.91 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.11 131.11 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.97 105.06 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.37 177.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -65.85 -36.52 83.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.02 28.25 0.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.34 42.8 27.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.56 114.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.5 p -82.36 115.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.9 148.97 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 77' ' ' PRO . 97.9 m -90.01 115.4 27.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 127' ' ' ILE . 10.7 p -110.17 156.54 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -159.45 140.04 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.09 145.46 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.2 170.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.441 ' CG1' HD12 ' A' ' 161' ' ' ILE . 19.5 t -143.11 121.82 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.03 160.31 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 5.1 p90 -165.83 153.29 10.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.976 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.672 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.5 pt20 -150.44 122.43 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 44.7 t -63.04 92.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.2 pt -76.2 -7.69 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.51 114.27 2.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -51.33 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 103' ' ' LYS . 5.4 p -42.98 -46.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 102' ' ' VAL . 10.8 mtpp -73.79 -39.32 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -95.07 54.95 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 105' ' ' VAL . 7.2 p -89.57 0.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 29.1 p90 -85.69 28.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 6.2 m-80 52.93 31.17 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 108' ' ' VAL . 47.1 t 33.64 41.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 m -93.19 -40.76 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.8 -52.24 32.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -52.19 -32.02 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.607 ' O ' HG13 ' A' ' 116' ' ' VAL . 17.5 mt -57.36 -60.68 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.0 ptp -69.95 -40.51 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.676 ' O ' HD12 ' A' ' 118' ' ' LEU . . . -57.03 -30.88 64.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.987 HG21 HD13 ' A' ' 73' ' ' ILE . 7.3 mm -74.95 -58.37 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.616 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.3 m -54.58 -29.97 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -83.37 -53.99 5.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 114' ' ' ALA . 10.4 mt -43.56 -55.29 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.29 -52.55 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.51 ' HA ' HD21 ' A' ' 123' ' ' LEU . 35.9 mm-40 -37.53 -34.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 m -85.74 -61.14 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.46 -54.61 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 127' ' ' ILE . 2.5 pp -56.15 -40.02 73.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -53.4 -27.41 24.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.97 -62.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.791 ' H ' HD12 ' A' ' 126' ' ' ILE . 2.5 mp -75.48 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 90' ' ' VAL . 4.1 mt -48.49 -41.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.02 -28.92 6.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.487 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -121.69 114.32 20.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.28 -177.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 133' ' ' ASP . 16.1 mt-10 -118.84 129.34 55.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 23.4 tp -36.0 -30.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -94.49 -52.86 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 29.7 tt0 -54.26 -16.5 2.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -64.2 -59.89 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.8 pp -60.39 -25.15 65.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -77.52 -50.71 12.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.91 74.63 2.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -103.92 -30.91 10.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.89 -23.7 62.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.3 mp -86.68 -49.78 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -48.9 -33.36 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 23.8 p30 -86.34 -23.81 26.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -70.93 -56.23 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -50.92 -62.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -47.28 -55.38 8.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 151' ' ' ASP . 28.4 ttp180 -42.59 -51.21 5.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.78 -37.1 85.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -74.53 -19.52 60.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 53.0 mt -107.85 -9.49 15.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -90.35 -18.6 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.76 -35.45 14.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 86.6 mt -77.84 -17.1 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 1.004 ' HB ' HG13 ' A' ' 159' ' ' VAL . 40.6 p -92.63 -42.28 9.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -44.04 -26.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.442 ' CG ' ' O ' ' A' ' 153' ' ' ILE . 0.0 OUTLIER -75.23 -37.2 61.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.514 ' HB2' HG12 ' A' ' 159' ' ' VAL . 34.1 m0 -85.14 26.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 62.91 12.75 44.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 1.004 HG13 ' HB ' ' A' ' 154' ' ' THR . 6.0 p -120.87 138.19 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.083 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.1 143.9 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 94' ' ' VAL . 5.3 mm -85.01 106.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.672 HG23 ' HG2' ' A' ' 97' ' ' GLN . 18.8 p -57.26 -61.47 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -156.11 179.31 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 143' ' ' ASN . 43.0 t -132.87 149.65 32.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -131.61 137.2 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 143' ' ' ASN . 22.8 mm -99.44 141.71 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -99.45 158.88 15.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.92 144.73 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 31.4 mt -99.46 156.28 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -116.62 129.34 25.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.615 0.722 . . . . 0.0 110.919 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 164.73 33.44 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.788 0.327 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -70.73 157.5 37.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.546 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 6.1 m-70 -129.03 147.58 50.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' CE1' ' A' ' 95' ' ' TYR . 4.8 p -94.26 145.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.091 HD13 HG21 ' A' ' 115' ' ' ILE . 26.9 mt -104.29 129.15 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.29 93.1 8.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.597 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.9 p -94.21 137.58 22.8 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.572 0.701 . . . . 0.0 111.152 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 146.98 61.99 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.741 2.294 . . . . 0.0 112.343 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.7 Cg_endo -69.75 153.35 69.07 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -140.02 127.06 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.75 110.44 20.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -122.41 136.7 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.4 mt -68.35 108.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -53.42 -175.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -68.93 -40.67 78.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.42 27.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 47.0 t30 54.58 50.48 15.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 88' ' ' VAL . 97.5 t -118.74 115.52 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -80.15 113.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 86' ' ' VAL . 4.6 m -141.65 141.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 27.4 m -83.12 122.13 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 127' ' ' ILE . 2.9 p -108.53 138.31 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -146.81 136.57 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.21 174.53 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.96 151.37 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 164' ' ' VAL . 19.9 t -131.7 124.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.551 ' CE1' HG23 ' A' ' 72' ' ' VAL . 3.8 m-30 -83.85 163.23 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 8.3 p90 -165.68 160.48 17.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -151.41 142.0 22.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 98' ' ' VAL . 26.8 t -84.92 95.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.8 -15.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 30.7 t70 -146.61 106.29 4.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.867 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.9 Cg_endo -69.82 -12.74 33.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.238 . . . . 0.0 112.349 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -70.79 -55.81 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -72.97 -26.4 61.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -95.77 43.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.0 p -93.3 40.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.3 p90 -123.22 28.83 6.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.5 m-80 61.63 27.18 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.4 p 35.26 31.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.5 m -89.31 -49.2 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 10.8 m-20 -56.56 -45.64 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -62.52 -33.41 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.5 -53.73 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.472 ' O ' ' CD ' ' A' ' 117' ' ' LYS . 13.6 ptp -76.88 -21.38 55.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -78.63 -47.87 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.07 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 73' ' ' ILE . 8.9 mm -50.39 -53.02 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.477 ' CG2' ' HD2' ' A' ' 117' ' ' LYS . 3.5 m -59.51 -43.0 89.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HD2' ' CG2' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -70.94 -10.72 60.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -95.01 -39.62 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.17 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 34.7 mm-40 -61.28 -34.62 75.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 m -80.59 -44.43 18.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 78.6 m-20 -64.15 -46.06 85.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.2 pp -62.66 -40.68 97.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.797 ' N ' HD12 ' A' ' 123' ' ' LEU . 44.8 mtt180 -52.71 -21.42 4.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.92 -59.69 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -75.82 -58.33 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 90' ' ' VAL . 39.2 mm -50.17 -38.6 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.97 -23.09 14.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -131.26 114.13 14.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.47 -176.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 133' ' ' ASP . 19.0 mt-10 -122.0 120.48 34.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 41.8 tp -33.72 -34.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -86.0 -45.82 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 135' ' ' THR . 17.8 tp10 -58.64 -48.77 79.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 134' ' ' GLU . 20.2 p -31.9 -43.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.094 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.45 -52.48 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.5 m -64.4 -52.93 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.49 54.56 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.449 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -89.53 -37.88 14.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.483 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 3.8 p-10 -69.78 -21.54 63.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.68 -46.99 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 127' ' ' ILE . 41.5 mt -53.13 -45.7 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.491 ' HB3' ' CG1' ' A' ' 166' ' ' ILE . 2.4 p30 -71.66 -28.71 63.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.42 -58.28 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -47.57 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 122' ' ' ASN . 4.2 mm? -46.84 -56.51 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.573 ' HB2' HG21 ' A' ' 164' ' ' VAL . 43.7 ttp85 -45.24 -47.02 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -64.17 -55.86 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -51.99 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.39 -34.26 64.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -23.28 62.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -93.2 -27.62 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mm -79.12 -18.09 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.3 p -99.16 -33.17 10.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.91 -18.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 9.8 ptt180 -92.13 -27.94 17.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.5 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.5 m0 -89.8 11.65 19.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 77.32 11.33 85.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.51 147.88 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.388 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 150.32 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.496 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.0 mm -84.71 96.55 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.451 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 47.9 p -48.96 -63.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -146.78 -179.36 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -141.08 144.25 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.112 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -137.16 139.48 41.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 143' ' ' ASN . 4.2 mm -108.43 140.76 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -97.06 161.65 13.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -45.72 154.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 169' ' ' ILE . 2.1 mp -105.13 152.55 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.7 m-20 -103.88 122.41 44.57 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 170.02 17.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.228 . . . . 0.0 112.371 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.787 0.327 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HG3' HG21 ' A' ' 162' ' ' THR . 23.4 mp0 -85.56 141.88 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 92.5 m-70 -110.38 132.26 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.22 138.26 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 115' ' ' ILE . 17.7 mt -102.33 125.9 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.24 112.43 24.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.1 p -118.21 138.76 25.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.593 0.711 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.72 150.95 69.13 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.274 . . . . 0.0 112.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 154.64 67.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.671 2.247 . . . . 0.0 112.395 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' CD ' HD11 ' A' ' 123' ' ' LEU . 3.2 pt20 -136.94 152.04 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.37 115.66 30.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HG2' ' A' ' 124' ' ' ARG . 23.1 m -128.44 147.91 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.067 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 39.9 mt -79.65 108.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.13 -176.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -65.6 -45.45 83.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -83.75 34.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 16.2 t-20 49.69 49.82 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.591 HG12 HG13 ' A' ' 88' ' ' VAL . 84.9 t -116.57 109.44 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -74.21 116.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.591 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -142.63 155.03 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 24.5 m -96.89 126.24 41.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.8 HG11 HG21 ' A' ' 127' ' ' ILE . 12.5 p -115.09 151.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -154.48 133.0 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.88 152.17 30.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 28.8 m -101.87 165.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 HD12 ' A' ' 73' ' ' ILE . 24.8 t -135.51 126.12 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -85.42 158.86 20.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.2 p90 -165.6 154.09 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -150.08 129.23 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 53.3 t -68.46 91.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 pt -73.57 -31.65 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 6.0 t70 -128.67 94.72 34.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.601 0.715 . . . . 0.0 110.859 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.525 ' O ' HG22 ' A' ' 105' ' ' VAL . 53.6 Cg_endo -69.75 -2.49 10.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 0.0 112.316 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 105' ' ' VAL . 19.4 t -80.3 -44.99 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -90.19 -21.11 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -96.84 43.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 102' ' ' VAL . 4.0 t -90.42 40.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 39.7 p90 -117.93 35.12 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.6 m-80 50.93 36.56 15.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.7 p 27.72 41.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 107' ' ' ASN . 1.6 t -95.34 -57.72 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -49.73 -43.78 48.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.6 mt -58.94 -70.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.936 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 ptp -51.78 -38.16 54.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.54 -66.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.943 HG21 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -38.7 -63.89 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 75' ' ' VAL . 91.3 t -37.13 -51.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -67.73 -55.24 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ALA . 58.4 mt -46.28 -61.55 1.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' LEU . . . -36.52 -60.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 4.9 mt-30 -39.17 -47.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.1 m -67.92 -47.9 67.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 71.1 m-80 -63.29 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.954 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.6 pp -44.51 -39.25 4.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HG2' HG11 ' A' ' 80' ' ' VAL . 19.5 mtp180 -53.84 -37.1 63.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.13 -47.91 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -84.9 -63.83 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.954 HD13 ' HB2' ' A' ' 123' ' ' LEU . 2.1 mp -51.84 -41.52 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.17 -30.21 7.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.8 pt-20 -118.54 113.05 20.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.21 -174.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 58.0 mt-10 -118.31 129.18 55.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 131' ' ' GLU . 64.6 tp -36.72 -29.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 3.8 p-10 -94.08 -46.08 7.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 2.6 tp10 -55.04 -44.97 75.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 1.1 p -34.24 -65.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.5 pp -53.76 -34.99 60.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 134' ' ' GLU . 1.8 t -70.32 -70.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.21 69.69 0.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -97.94 -34.45 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -72.63 -33.0 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 141' ' ' ILE . 5.3 mp -68.53 -45.94 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 127' ' ' ILE . 86.6 mt -54.27 -53.23 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.714 ' OD1' HG12 ' A' ' 164' ' ' VAL . 63.4 m-20 -52.19 -41.0 62.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.97 -54.19 48.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -53.69 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.8 tp -41.36 -38.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -64.23 -44.87 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.83 -12.38 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 122' ' ' ASN . 28.2 mt-10 -87.95 -39.05 15.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.659 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -93.8 -13.56 27.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.55 -22.75 56.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 pttt -89.77 -30.07 18.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.73 -19.26 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.494 ' CG2' HD11 ' A' ' 115' ' ' ILE . 43.2 p -97.25 -28.17 14.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -47.37 -40.59 17.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.567 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.3 ptm180 -66.45 -32.06 73.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.567 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 42.2 m0 -83.71 14.09 4.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 65.8 33.96 87.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.448 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.16 145.69 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -128.83 135.44 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.71 86.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.735 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -38.37 -47.43 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -169.54 179.99 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.714 HG12 ' OD1' ' A' ' 143' ' ' ASN . 87.8 t -140.84 140.09 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 68.9 mt-10 -123.83 147.12 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 143' ' ' ASN . 23.6 mm -109.65 142.15 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -103.16 161.05 14.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -41.68 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -113.75 156.5 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 11.4 m-20 -115.85 122.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.633 0.73 . . . . 0.0 110.822 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 170.55 16.28 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.412 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.817 0.341 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.2 155.39 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 51.0 m-70 -124.0 148.48 46.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.32 145.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.624 HD13 HG21 ' A' ' 115' ' ' ILE . 96.5 mt -113.3 124.45 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.32 107.23 18.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.2 p -105.65 138.3 19.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.76 144.94 55.64 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.717 2.278 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 159.94 51.54 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.633 2.222 . . . . 0.0 112.351 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.38 116.64 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 14.7 mp0 -71.49 118.56 14.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.73 132.5 61.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 47.9 mm -60.9 113.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.586 ' HG ' ' C ' ' A' ' 130' ' ' MET . 0.7 OUTLIER -63.27 -178.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 130' ' ' MET . 17.5 tptt -61.41 -47.32 86.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.7 32.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 32.5 m-20 51.4 48.04 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG12 HG13 ' A' ' 88' ' ' VAL . 46.5 t -112.87 109.38 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -75.23 108.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 86' ' ' VAL . 15.6 m -135.34 153.31 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 57.2 m -94.92 128.54 41.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.87 HG11 HG21 ' A' ' 127' ' ' ILE . 2.1 p -115.57 149.6 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.14 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -159.54 127.3 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -142.91 151.53 41.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 165' ' ' GLU . 3.7 m -97.08 153.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.598 ' CG1' HD12 ' A' ' 161' ' ' ILE . 25.5 t -127.86 127.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.0 m-30 -87.02 159.96 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.951 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 4.2 p90 -165.59 153.51 11.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.838 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -149.74 128.8 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.7 t -65.5 91.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.096 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 pt -71.96 -12.75 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 31.1 t0 -158.4 105.66 1.67 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.901 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.572 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.4 Cg_endo -69.7 -13.44 34.81 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.388 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.26 -27.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.184 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -101.31 -20.57 15.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.53 48.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 101' ' ' PRO . 4.0 m -83.0 3.2 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.1 p90 -84.22 24.53 0.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.2 m-80 62.1 31.2 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.3 t 33.79 40.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.5 p -95.11 -60.02 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.05 -36.56 29.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -65.18 -33.94 77.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.84 -57.03 7.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.5 ptp -67.43 -26.48 66.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.28 -49.45 16.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.624 HG21 HD13 ' A' ' 73' ' ' ILE . 2.6 mm -45.83 -62.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 m -53.0 -25.54 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -83.94 -25.51 30.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 115' ' ' ILE . 25.6 mt -77.84 -46.04 22.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.915 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.94 -53.35 56.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 37.3 mm-40 -40.99 -27.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 m -92.09 -37.14 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -75.45 -58.23 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.772 ' HB2' HD13 ' A' ' 127' ' ' ILE . 2.7 pp -51.05 -40.46 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.436 ' N ' HD12 ' A' ' 123' ' ' LEU . 35.6 ttt85 -54.6 -22.99 15.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.61 -58.38 3.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 126' ' ' ILE . 1.4 mp -76.09 -62.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.87 HG21 HG11 ' A' ' 90' ' ' VAL . 3.2 mp -52.64 -40.84 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.79 -20.13 3.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.4 pt-20 -130.8 113.62 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.586 ' C ' ' HG ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -173.7 -175.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.854 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 24.4 mm-40 -123.17 120.4 33.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' GLU . 65.0 tp -35.35 -31.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.5 t70 -76.04 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -54.64 -46.49 73.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 131' ' ' GLU . 70.6 p -42.36 -52.88 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 135' ' ' THR . 41.4 mt -35.8 -49.94 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 t -121.95 87.64 2.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.83 35.06 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.98 -32.08 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -50.63 -36.97 37.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' ALA . 11.0 mt -87.45 -55.59 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 51.9 mt -42.69 -36.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 3.5 p30 -81.73 -31.54 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.451 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -60.78 -54.66 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -56.45 -63.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 146' ' ' LEU . 12.0 mt -42.6 -52.4 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -45.22 -41.83 8.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.06 -25.0 32.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 8.0 mm-40 -79.81 -10.39 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 -39.27 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.98 -8.42 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 153' ' ' ILE . 8.8 ptpt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.8 mp -87.1 -18.31 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 111' ' ' PHE . 45.5 p -94.61 -14.93 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.54 -14.7 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.568 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 15.4 ptm180 -96.7 -22.38 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.568 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.3 m0 -93.87 5.27 52.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.25 22.8 67.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 111' ' ' PHE . 25.4 t -123.16 135.47 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.32 130.41 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.598 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.5 mm -73.43 91.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.838 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.5 p -45.36 -44.6 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.9 OUTLIER -166.82 178.96 5.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 71.7 t -137.87 122.12 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 93' ' ' VAL . 11.1 mt-10 -104.36 138.46 40.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.595 HD13 ' HB1' ' A' ' 92' ' ' ALA . 24.4 mm -112.67 142.34 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -103.11 159.57 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -47.42 160.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -108.01 156.66 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.7 m-20 -104.99 119.99 51.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.887 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 163.8 36.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.287 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.232 0.178 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.798 0.332 . . . . 0.0 110.857 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -118.65 157.89 26.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 26.3 m-70 -123.98 146.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.477 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 8.1 p -95.4 145.93 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 115' ' ' ILE . 19.5 mt -105.68 130.02 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.24 95.06 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' HD2' ' A' ' 76' ' ' PRO . 3.3 p -99.17 136.94 20.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.4 Cg_endo -69.71 149.44 67.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 0.0 112.38 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 168.78 20.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.38 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -146.73 118.12 7.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -76.83 102.65 6.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.81 148.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.5 mt -79.87 106.39 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.41 -174.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -67.88 -43.15 80.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.44 35.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 6.5 t30 51.01 43.25 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.703 HG13 ' HG3' ' A' ' 172' ' ' PRO . 60.6 t -113.36 110.82 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.86 113.95 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -134.1 150.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -89.38 109.67 20.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 127' ' ' ILE . 5.4 m -105.57 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.14 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -168.67 144.09 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.83 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 72' ' ' VAL . 18.0 m -93.61 158.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 161' ' ' ILE . 20.0 t -128.47 137.16 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.142 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.4 m-30 -98.08 160.52 14.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 33.8 p90 -165.83 155.09 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -141.96 121.12 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 98' ' ' VAL . 42.2 t -64.97 93.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -80.81 -29.78 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -127.8 96.66 31.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.7 Cg_endo -69.71 0.37 5.7 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 105' ' ' VAL . 23.9 t -81.39 -44.37 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -86.58 -32.58 20.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.575 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -87.11 38.66 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 4.8 m -85.83 12.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.575 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.1 p90 -93.02 35.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.4 m-80 52.18 31.81 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 108' ' ' VAL . 43.1 t 34.63 40.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.1 p -97.27 -38.82 9.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.54 -45.22 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.75 -32.54 72.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.1 mt -61.06 -59.51 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 116' ' ' VAL . 15.5 ptp -70.3 -37.82 74.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.0 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.041 HG21 HD13 ' A' ' 73' ' ' ILE . 6.8 mm -63.22 -52.77 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.6 m -65.52 -20.23 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -91.48 -15.55 28.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.688 HD22 HD13 ' A' ' 153' ' ' ILE . 17.0 mt -88.94 -39.3 13.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.06 81.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.4 mm-40 -44.98 -30.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.3 m -87.42 -49.63 7.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 72.4 m-80 -62.7 -59.27 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.746 HD13 HD12 ' A' ' 127' ' ' ILE . 3.2 pp -48.84 -42.82 37.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 123' ' ' LEU . 23.0 ttm180 -51.67 -41.67 61.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.72 -57.57 11.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -76.32 -62.36 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.89 HG21 HG21 ' A' ' 90' ' ' VAL . 20.8 mt -49.3 -44.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 130' ' ' MET . 7.3 pt-20 -121.4 113.96 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.839 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.42 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -173.04 -175.29 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 37.9 mt-10 -121.7 130.63 53.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 31.2 tp -36.17 -29.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.1 p-10 -88.66 -63.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -40.99 -43.84 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.2 p -39.62 -69.81 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.481 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.0 pp -55.4 -29.4 58.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -107.54 40.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -166.58 64.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.4 ptt180 -104.78 -37.11 7.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 0.5 OUTLIER -52.3 -27.65 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -88.23 -48.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 64.9 mt -54.02 -48.02 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 11.3 p30 -69.76 -42.96 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -47.39 -48.33 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.047 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -64.0 -62.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.63 -58.94 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 26.0 ttm105 -40.67 -40.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.97 -45.92 22.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -57.89 -28.1 63.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.723 ' O ' HG23 ' A' ' 154' ' ' THR . 36.1 mt -96.39 -31.09 13.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -20.03 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.44 -26.01 16.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.688 HD13 HD22 ' A' ' 118' ' ' LEU . 98.2 mt -86.58 -8.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.991 ' HB ' HG13 ' A' ' 159' ' ' VAL . 62.3 p -103.19 -36.67 8.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -42.62 -27.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.35 -38.18 31.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.556 ' HB2' HG12 ' A' ' 159' ' ' VAL . 36.1 m0 -84.48 34.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.62 23.61 4.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.478 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 154' ' ' THR . 2.1 p -130.59 143.35 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.86 147.14 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 95' ' ' TYR . 12.7 mm -82.91 109.57 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 97' ' ' GLN . 75.9 p -64.55 -43.33 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 1.6 ptp180 -165.93 -178.54 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.419 ' HB ' ' NH2' ' A' ' 147' ' ' ARG . 38.4 t -141.17 137.5 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -123.34 136.97 54.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.413 HD13 ' CB ' ' A' ' 92' ' ' ALA . 9.9 mm -99.09 140.87 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -95.69 161.68 13.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -47.99 162.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.1 mp -118.75 157.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.503 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.3 t70 -127.16 133.64 25.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 0.0 110.806 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 168.76 20.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.703 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.794 0.33 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -76.91 151.08 35.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -120.55 151.7 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.964 HG12 ' CE1' ' A' ' 95' ' ' TYR . 17.5 m -98.16 156.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 111' ' ' PHE . 31.4 mt -118.19 125.02 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.27 111.27 18.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 116' ' ' VAL . 85.9 t -120.53 132.19 24.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.73 152.95 69.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.75 166.93 25.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.57 ' NE2' HD11 ' A' ' 123' ' ' LEU . 2.4 tt0 -146.44 117.49 7.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.83 107.03 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.76 145.22 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.687 ' CD1' HG22 ' A' ' 87' ' ' VAL . 41.0 mm -74.33 109.22 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.35 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -67.34 -45.09 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.15 32.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.1 m-20 50.69 44.3 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.48 110.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 81' ' ' ILE . 6.6 t -70.11 115.19 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.94 150.0 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.145 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 95.1 m -97.64 130.55 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 127' ' ' ILE . 31.3 m -124.34 157.44 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 167' ' ' GLN . 18.4 p-10 -160.43 139.53 10.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.86 150.87 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.29 170.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -135.14 131.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.964 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.8 m-30 -91.78 157.95 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.572 ' CE1' HG21 ' A' ' 108' ' ' VAL . 13.0 p90 -165.65 158.19 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.1 pt20 -152.3 114.5 4.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.85 92.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.7 pt -76.05 -18.49 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 11.7 t70 -146.54 106.38 4.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.585 0.707 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.1 Cg_endo -69.73 -18.41 37.14 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.95 -25.75 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -101.47 -38.23 8.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -83.78 34.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.64 -5.99 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 40.1 p90 -85.13 26.44 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 109' ' ' SER . 14.8 m-80 56.37 37.05 28.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 11.1 p 32.8 36.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' ASN . 7.1 t -93.98 -52.25 4.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -51.4 -46.33 62.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.748 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -58.67 -37.45 76.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 73' ' ' ILE . 39.5 mt -63.63 -66.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 ptp -57.04 -26.08 59.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.23 -65.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG13 ' CE2' ' A' ' 111' ' ' PHE . 11.9 mm -39.63 -64.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 75' ' ' VAL . 49.1 t -36.22 -40.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.03 -55.0 5.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.8 mt -45.69 -49.63 14.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.57 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.544 ' HA ' HD21 ' A' ' 123' ' ' LEU . 36.2 mm-40 -51.87 -39.53 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -76.71 -56.84 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -53.38 -57.42 10.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 124' ' ' ARG . 3.1 pp -51.21 -43.12 61.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.71 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.2 ttt85 -49.84 -38.69 36.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.85 -54.28 41.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.68 -62.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.946 HG21 HG21 ' A' ' 90' ' ' VAL . 43.6 mm -48.7 -39.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.36 -30.14 24.85 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -122.02 114.02 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -172.19 -175.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 26.2 mt-10 -119.08 132.96 56.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.473 HD13 ' HD3' ' A' ' 172' ' ' PRO . 48.8 tp -35.81 -30.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 21.6 t70 -90.21 -53.43 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -45.38 -37.51 5.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -65.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -67.83 -28.85 67.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.0 p -103.15 39.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.2 60.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -89.97 -33.35 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.7 -43.35 99.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.0 mt -67.23 -50.7 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.51 -50.5 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.504 ' OD1' HD11 ' A' ' 166' ' ' ILE . 82.2 m-20 -57.57 -55.33 36.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -45.43 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 145' ' ' ARG . 5.1 mmp_? -53.93 -69.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -55.64 -62.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 38.8 ttt-85 -41.69 -34.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.8 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.59 -56.47 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 154' ' ' THR . 94.4 mt -54.29 -35.86 63.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -15.82 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -84.57 -44.34 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 153' ' ' ILE . 8.7 mt -72.03 -5.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 159' ' ' VAL . 60.5 p -102.55 -37.66 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -48.51 -20.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.2 ptp180 -87.34 -34.09 18.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.4 m0 -86.11 19.25 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.77 19.12 62.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.4 p -124.55 148.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.144 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -128.66 148.46 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.9 mm -88.61 100.86 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -51.66 -51.17 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.203 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -163.98 -176.56 4.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 69.6 t -140.43 143.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.19 137.44 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.504 HD11 ' OD1' ' A' ' 143' ' ' ASN . 7.5 mm -107.24 123.22 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.5 mm-40 -78.11 157.71 29.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -42.43 157.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -110.8 155.72 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.6 m-20 -113.23 120.49 40.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.552 0.691 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 170.04 17.44 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.667 2.244 . . . . 0.0 112.358 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.473 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.379 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.09 148.15 24.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 16.0 m-70 -115.62 143.83 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.1 145.63 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 115' ' ' ILE . 54.8 mt -109.02 129.2 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.58 100.11 12.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 116' ' ' VAL . 19.6 t -106.23 134.78 19.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.664 0.745 . . . . 0.0 111.148 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.72 151.28 69.24 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.745 2.297 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 54.1 Cg_endo -69.67 161.08 47.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.476 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 5.2 mt-30 -139.67 117.82 11.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.06 110.69 11.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.65 142.95 41.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.985 ' CD1' HG22 ' A' ' 87' ' ' VAL . 49.6 mm -73.45 105.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.03 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -66.09 -36.47 83.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.2 29.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 60.1 t30 49.85 51.97 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.46 123.47 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.985 HG22 ' CD1' ' A' ' 81' ' ' ILE . 3.6 t -82.57 116.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.57 155.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 m -100.71 122.96 44.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 127' ' ' ILE . 34.7 m -114.18 169.09 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -174.93 135.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.79 146.85 24.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -95.66 166.4 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 161' ' ' ILE . 12.9 t -133.23 127.01 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -86.64 159.05 19.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 23.0 p90 -165.69 155.07 12.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.773 ' HG2' HG23 ' A' ' 162' ' ' THR . 2.9 pt20 -145.86 123.99 12.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 98' ' ' VAL . 38.0 t -63.97 96.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.4 pt -80.58 -28.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 23.3 t0 -135.58 108.53 10.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.859 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.7 Cg_endo -69.8 -48.49 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.371 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -48.62 -23.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -103.83 -27.94 11.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.82 41.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 105' ' ' VAL . 10.0 p -94.75 44.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 13.6 p90 -117.75 36.4 4.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.7 m-80 55.88 28.31 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.0 p 33.26 39.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.162 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' ASN . 25.9 m -94.74 -48.19 6.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.2 -46.72 88.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.565 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -61.08 -41.02 95.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.0 -63.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -58.41 -29.17 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.39 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 73' ' ' ILE . 3.1 mm -39.3 -62.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 76' ' ' PRO . 55.8 t -34.86 -48.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.82 -50.05 22.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 47.9 mt -44.08 -49.12 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.7 90.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.476 ' OE1' ' CG ' ' A' ' 78' ' ' GLN . 35.3 mm-40 -48.35 -35.67 12.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 m -86.57 -63.31 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 69.7 m-80 -42.72 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -59.25 -43.68 92.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.755 ' N ' HD12 ' A' ' 123' ' ' LEU . 19.4 ttt180 -51.28 -26.96 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.653 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.1 mp -76.47 -60.37 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 mt -49.78 -41.64 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.06 -23.85 2.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.61 114.21 17.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -172.89 -176.79 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 mt-10 -115.86 119.81 37.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.518 HD13 ' HD3' ' A' ' 172' ' ' PRO . 21.5 tp -36.61 -29.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -86.99 -58.52 2.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.1 tp10 -48.0 -50.32 27.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' GLU . 40.6 p -35.05 -34.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 134' ' ' GLU . 54.3 mt -62.37 -57.78 10.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 m -77.62 -50.7 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.96 70.41 0.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.4 ptt85 -112.59 -9.73 13.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.97 -33.78 21.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 141' ' ' ILE . 4.6 mp -73.86 -37.65 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.575 HD11 ' SD ' ' A' ' 130' ' ' MET . 44.5 mt -60.6 -43.91 95.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.737 ' HB3' HD11 ' A' ' 166' ' ' ILE . 1.8 p30 -79.98 -31.39 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.94 -34.12 74.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -79.08 -56.57 4.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.11 -42.67 29.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -53.8 -40.18 66.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.08 -57.16 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -44.36 -62.02 1.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 115' ' ' ILE . 9.4 mp -60.17 -36.09 76.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -11.53 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.76 -27.27 15.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 153' ' ' ILE . 39.4 mt -96.62 17.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 p -125.71 -34.05 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.8 -25.22 26.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 14.3 ptm180 -83.56 -20.11 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.537 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 52.9 m0 -96.85 1.57 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.97 12.32 77.15 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 160' ' ' LYS . 53.5 t -119.61 154.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.926 0.394 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -134.01 151.64 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.48 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 32.4 mm -89.81 92.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.773 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -49.12 -48.96 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -163.89 -175.98 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 84.2 t -139.74 141.89 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -124.47 135.39 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' A' ' 143' ' ' ASN . 3.7 mm -105.33 139.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.69 161.14 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -44.4 156.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.6 mp -108.96 156.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.6 m-20 -113.01 120.81 39.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 110.9 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.2 31.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.518 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.358 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.039 0 CA-C-O 120.784 0.326 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.52 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 2.2 pm0 -115.12 149.42 37.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 88.8 m-70 -106.9 143.73 34.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 140.3 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.948 HD13 HG21 ' A' ' 115' ' ' ILE . 26.5 mt -102.92 125.08 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 94.0 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.465 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.7 p -97.62 133.68 23.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 111.181 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 144.66 54.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.73 157.82 59.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.451 HE21 HD11 ' A' ' 123' ' ' LEU . 10.3 tt0 -140.94 118.51 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -71.45 109.57 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.45 132.52 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.865 ' CD1' HG22 ' A' ' 87' ' ' VAL . 45.5 mm -68.16 109.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.44 -175.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -69.71 -38.91 77.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -84.53 26.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 37.6 t30 52.83 48.72 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 88' ' ' VAL . 43.8 t -113.87 117.83 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.161 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.865 HG22 ' CD1' ' A' ' 81' ' ' ILE . 47.1 t -77.79 113.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.173 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 HG12 ' A' ' 86' ' ' VAL . 29.2 m -143.39 157.35 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 25.5 m -103.62 123.66 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 127' ' ' ILE . 10.0 p -103.47 142.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.11 132.06 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -152.28 164.55 37.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.31 159.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.412 ' O ' HD12 ' A' ' 73' ' ' ILE . 74.3 t -133.97 118.94 30.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 7.3 m-30 -79.38 159.64 27.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.5 p90 -165.71 147.89 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.954 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.9 pt20 -140.24 131.72 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 98' ' ' VAL . 50.3 t -71.71 91.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.095 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -83.14 -21.5 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 99' ' ' ILE . 22.3 t70 -134.95 92.85 18.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.593 0.711 . . . . 0.0 110.871 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 -5.18 15.61 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.663 2.242 . . . . 0.0 112.294 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.64 -50.03 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -87.39 -18.06 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.554 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -99.44 43.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.5 p -89.41 14.19 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.5 p90 -97.47 29.8 3.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.2 m-80 58.75 28.06 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.513 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 10.0 m 35.94 38.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.4 p -92.33 -48.74 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -59.25 -42.76 91.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.514 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -61.39 -31.93 71.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 116' ' ' VAL . 33.1 mt -71.62 -54.3 10.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.8 ptp -74.15 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -93.2 -57.99 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 73' ' ' ILE . 7.7 mm -39.68 -57.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -57.79 -42.08 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 18.4 mtmt -67.4 -18.9 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 18.5 mt -88.16 -42.36 12.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.23 68.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.1 mm-40 -57.7 -28.28 63.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.6 m -89.9 -54.69 3.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -55.49 -52.39 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.724 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.3 pp -56.1 -40.18 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.704 ' N ' HD12 ' A' ' 123' ' ' LEU . 12.8 ttt180 -56.44 -18.14 10.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.68 -61.06 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -74.97 -50.8 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 90' ' ' VAL . 34.4 mm -55.99 -38.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.34 -28.28 27.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.521 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.34 114.29 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.55 -177.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.0 mt-10 -122.14 128.85 51.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.1 tp -34.76 -32.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -86.37 -58.27 2.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 136' ' ' LEU . 2.5 tp10 -47.91 -47.05 32.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 28.6 p -33.5 -34.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 134' ' ' GLU . 14.1 mt -84.66 -57.78 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -52.78 -53.12 52.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.84 57.81 3.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -90.92 -36.86 13.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 18.4 t0 -69.1 -20.11 64.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.93 -58.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -42.57 -42.18 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.47 ' ND2' ' HA ' ' A' ' 140' ' ' ASP . 1.4 p30 -76.76 -35.89 57.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.427 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -54.68 -48.63 72.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 148' ' ' GLU . 5.0 mmp_? -62.63 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 3.7 mm? -38.15 -37.56 0.28 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 40.7 ttt-85 -62.21 -44.11 97.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' ARG . 11.4 tp10 -74.49 -46.29 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.07 -54.09 50.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -7.62 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -97.92 -41.89 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 153' ' ' ILE . 17.0 mt -74.93 5.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.8 p -116.61 -28.86 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -58.3 -28.88 65.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 8.3 ptp180 -83.98 -16.33 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.845 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.561 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 54.7 m0 -98.87 0.63 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 84.78 9.34 81.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.63 141.64 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.22 129.17 51.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.44 109.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.526 HG23 ' HG2' ' A' ' 97' ' ' GLN . 70.1 p -62.06 -44.41 96.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.76 179.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 86.8 t -139.32 132.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -116.57 144.2 44.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 mm -109.16 142.26 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -102.14 159.58 15.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -47.53 146.12 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.5 mp -96.0 156.57 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.0 m-20 -108.66 119.23 49.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 168.37 21.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.381 179.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.77 145.14 36.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 81.5 m-70 -110.31 142.94 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.45 139.58 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 115' ' ' ILE . 32.5 mt -106.45 119.58 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.89 124.26 29.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.5 HG23 ' HD2' ' A' ' 76' ' ' PRO . 14.5 p -121.1 136.84 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.652 0.739 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.74 147.98 64.18 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 143.71 51.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' OE1' ' CZ ' ' A' ' 124' ' ' ARG . 7.6 tt0 -126.86 126.84 43.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 89' ' ' THR . 26.4 mp0 -93.37 96.43 9.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.405 ' CG1' ' OE1' ' A' ' 78' ' ' GLN . 15.2 m -108.54 145.27 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 74.3 mt -70.27 106.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.403 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.36 -175.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.54 -39.17 77.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 86' ' ' VAL . 38.9 t70 -86.94 34.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.7 t-20 48.08 45.79 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 84' ' ' ASP . 58.3 t -118.5 110.59 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 87' ' ' VAL . 7.3 p -75.25 123.89 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.39 151.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.554 HG23 ' OE2' ' A' ' 79' ' ' GLU . 19.7 m -91.71 116.81 29.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 127' ' ' ILE . 17.5 m -108.02 160.16 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.85 137.0 3.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.85 142.22 20.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 165' ' ' GLU . 15.4 m -93.88 159.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 150' ' ' LEU . 25.7 t -135.24 137.67 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 161' ' ' ILE . 4.7 m-30 -97.37 163.27 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 1.4 p90 -165.59 156.38 13.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.72 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -152.75 134.21 14.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.14 99.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.3 pt -83.44 -9.35 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 102' ' ' VAL . 30.9 t0 -155.96 109.77 2.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.655 0.741 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.35 16.76 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.604 HG22 ' OD1' ' A' ' 100' ' ' ASP . 34.2 m -62.52 -14.99 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -103.58 -26.0 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' A' ' 108' ' ' VAL . . . -104.47 45.8 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.83 -2.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.7 p90 -86.49 38.44 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 49.2 27.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' A' ' 104' ' ' ALA . 13.2 t 36.09 40.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.8 t -96.85 -50.42 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.91 -40.42 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.4 t80 -61.51 -40.52 94.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.48 -67.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -55.81 -38.99 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -58.64 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 73' ' ' ILE . 11.3 mm -46.31 -58.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.79 -23.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -93.57 -33.18 13.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.44 -51.84 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.26 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -67.14 -31.39 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 94.2 m -87.91 -29.4 20.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.564 ' O ' HD12 ' A' ' 126' ' ' ILE . 78.3 m-20 -78.9 -44.74 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.8 pp -62.63 -40.94 98.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.429 ' CZ ' ' OE1' ' A' ' 78' ' ' GLN . 40.8 mtt-85 -52.15 -24.61 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.0 -57.0 3.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.9 mp -79.74 -63.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 90' ' ' VAL . 3.4 mt -51.57 -44.78 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.6 -25.52 1.44 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.543 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -124.18 113.89 18.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.27 -178.03 1.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 132' ' ' LEU . 42.0 mt-10 -120.94 130.5 53.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 131' ' ' GLU . 13.3 tp -34.42 -35.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.2 m-20 -80.83 -51.03 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -54.44 -49.47 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.6 p -45.43 -31.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.1 mt -73.82 -49.46 25.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -106.48 37.27 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.3 21.3 5.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -74.19 -0.93 18.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.66 -27.38 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.604 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.4 mp -85.32 -41.33 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.42 -58.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 164' ' ' VAL . 14.4 p-10 -59.43 -33.26 71.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.31 73.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.062 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -84.69 -58.59 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.13 -53.21 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.481 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 24.7 ttp180 -44.33 -40.49 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -57.38 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -48.66 -23.37 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 94' ' ' VAL . 82.8 mt -102.66 -23.99 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.49 -6.24 58.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.98 -33.28 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -79.02 -17.72 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 159' ' ' VAL . 82.0 p -97.18 -38.28 9.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -42.68 -44.38 4.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.5 ptm180 -60.55 -34.65 74.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 40.5 m0 -85.53 12.96 7.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.32 11.19 84.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 154' ' ' THR . 55.2 t -119.98 140.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 111.115 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.92 145.09 51.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 95' ' ' TYR . 23.7 mm -75.85 106.48 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -56.12 -41.25 74.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -171.21 178.5 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.626 HG21 ' CB ' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -129.97 148.42 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.3 mm-40 -137.82 115.64 11.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.481 HD13 ' HB1' ' A' ' 92' ' ' ALA . 15.4 mm -93.18 141.53 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -100.06 160.54 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -51.52 159.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.0 mp -108.26 156.51 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.499 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 5.7 m-20 -115.72 129.66 24.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 161.93 44.01 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.436 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.375 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.789 0.328 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -115.05 141.6 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 96' ' ' TYR . 90.0 m-70 -101.39 159.05 15.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.33 144.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 115' ' ' ILE . 33.5 mt -106.31 134.79 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.74 108.12 20.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 76' ' ' PRO . 4.6 p -114.86 136.16 22.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.595 0.712 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.77 146.12 59.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 159.38 53.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 120' ' ' GLN . 27.2 mt-30 -143.99 129.69 19.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.24 94.83 7.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 140.57 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.614 HD13 HG22 ' A' ' 87' ' ' VAL . 31.3 mm -67.18 102.45 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.52 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -59.69 -42.95 94.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.98 30.04 0.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.845 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 5.7 t-20 51.98 50.62 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.06 120.36 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.614 HG22 HD13 ' A' ' 81' ' ' ILE . 24.7 t -77.88 116.36 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.63 149.88 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.507 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 8.5 m -91.94 117.09 29.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 127' ' ' ILE . 5.2 p -116.1 141.44 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -143.84 141.9 30.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.25 145.68 23.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.45 166.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.51 131.68 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.49 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.7 m-30 -92.72 157.08 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.441 ' CG ' ' CZ ' ' A' ' 111' ' ' PHE . 8.7 p90 -165.84 156.34 13.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.74 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -153.03 121.31 6.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.8 100.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -86.21 -24.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 19.0 t0 -138.57 105.59 7.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.8 Cg_endo -69.79 -43.65 2.51 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.307 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -50.78 -19.23 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -107.91 -34.08 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -101.91 43.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 105' ' ' VAL . 10.1 p -87.25 33.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 34.4 p90 -111.7 27.42 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 109' ' ' SER . 8.1 m-80 58.09 34.76 24.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.3 m 33.52 35.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.5 p -86.13 -60.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.823 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.46 -46.5 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -58.54 -39.67 80.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.07 -65.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -57.97 -31.66 67.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.59 -66.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 73' ' ' ILE . 16.7 mm -39.04 -63.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 75' ' ' VAL . 47.4 t -41.61 -50.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -62.13 -50.5 71.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.14 -60.28 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.37 -61.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 78' ' ' GLN . 12.8 mm-40 -39.41 -33.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 m -88.1 -53.95 4.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -56.16 -56.8 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 123' ' ' LEU . 2.6 pp -51.53 -41.06 60.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttp180 -55.98 -22.37 26.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 -59.58 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.8 mp -78.17 -60.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 90' ' ' VAL . 11.2 mt -54.97 -47.41 76.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -42.87 -27.34 0.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.8 pt-20 -120.58 113.33 20.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -173.12 -174.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 135' ' ' THR . 15.8 mt-10 -116.96 127.84 54.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.462 ' C ' ' O ' ' A' ' 131' ' ' GLU . 20.7 tp -33.32 -35.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.1 t70 -84.15 -65.45 1.01 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 135' ' ' THR . 29.6 tt0 -41.69 -47.7 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 131' ' ' GLU . 72.9 p -33.18 -40.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 mt -73.83 -51.14 17.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 m -61.54 -58.36 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.89 65.39 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' C ' ' CD ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -97.06 -45.21 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.467 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 13.0 t70 -59.07 -29.01 67.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 144' ' ' ALA . 48.3 mt -73.81 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -39.73 -50.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.474 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.5 p30 -69.49 -33.39 72.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' ILE . . . -59.24 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -46.15 -63.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 mt -48.11 -51.3 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 163' ' ' ARG . 26.8 ttm180 -44.49 -40.57 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.5 -56.35 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -42.91 -55.23 3.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 115' ' ' ILE . 9.8 mp -68.01 -35.71 78.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -20.87 40.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -82.72 -29.95 29.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 mm -83.71 -17.62 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.944 ' HB ' HG13 ' A' ' 159' ' ' VAL . 64.0 p -93.93 -39.96 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -41.51 -29.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.451 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 11.8 ptm180 -79.92 -36.44 36.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 154' ' ' THR . 35.6 m0 -84.16 30.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.26 33.74 39.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.944 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.5 p -141.49 144.25 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.151 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 3.3 tmmm? -127.92 151.08 49.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.0 mm -89.02 91.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 97' ' ' GLN . 19.0 p -42.3 -46.68 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 147' ' ' ARG . 14.5 ptm180 -169.4 -175.03 2.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 73.8 t -139.72 147.28 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 28.4 mm -102.92 142.32 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.57 161.88 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.951 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -47.52 156.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -109.81 157.51 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 t70 -126.09 133.28 24.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.63 0.729 . . . . 0.0 110.885 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 170.15 17.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.177 0 C-N-CA 122.678 2.252 . . . . 0.0 112.318 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -104.74 144.33 31.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.96 145.66 39.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.858 HG12 ' CE1' ' A' ' 95' ' ' TYR . 34.5 m -94.21 140.39 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 96' ' ' TYR . 21.0 mt -107.55 119.24 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 118.57 20.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 116' ' ' VAL . 88.8 t -117.41 132.68 23.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.729 . . . . 0.0 111.119 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.75 144.37 53.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.85 164.28 35.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.628 2.218 . . . . 0.0 112.316 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.541 ' CD ' HD11 ' A' ' 123' ' ' LEU . 1.3 pt20 -146.67 139.44 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.55 129.43 36.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.97 145.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.9 mt -74.73 114.59 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.2 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.15 23.55 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 27.7 m-20 60.41 50.68 5.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 88' ' ' VAL . 70.7 t -118.82 111.16 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -75.27 115.41 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.5 HG13 HG12 ' A' ' 86' ' ' VAL . 15.7 m -140.19 162.2 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.49 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 31.9 m -102.84 125.04 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 91' ' ' ASP . 11.4 p -105.83 162.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.9 p30 -171.01 134.71 0.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.08 35.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 165' ' ' GLU . 17.1 m -102.96 164.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.93 134.28 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.858 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.2 m-30 -96.77 154.4 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.481 ' CD2' HD11 ' A' ' 73' ' ' ILE . 3.8 p90 -165.65 161.26 18.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 99' ' ' ILE . 2.2 pt20 -153.17 114.2 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.84 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 97' ' ' GLN . 2.7 pp -89.68 -24.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 99' ' ' ILE . 29.3 t70 -133.64 90.12 29.16 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -40.61 5.09 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 0.0 112.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 103' ' ' LYS . 27.5 m -38.39 -41.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 102' ' ' VAL . 23.1 mtpp -91.43 -35.65 14.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -84.45 41.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.087 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 105' ' ' VAL . 6.1 p -87.66 47.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.7 p90 -130.37 32.21 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.3 m-80 60.93 28.06 17.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 6.4 t 36.1 35.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 107' ' ' ASN . 54.9 m -89.76 -58.75 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -47.46 -54.56 11.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.566 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.3 t80 -50.13 -48.38 53.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 73' ' ' ILE . 9.1 mt -51.48 -68.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -60.95 -14.91 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.18 -34.51 23.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.649 HD13 HD12 ' A' ' 150' ' ' LEU . 14.1 mm -72.1 -54.83 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.655 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.0 m -56.68 -22.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.149 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -92.69 -45.21 8.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.38 -44.1 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.11 97.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.2 mm-40 -47.87 -33.09 6.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.1 m -87.0 -50.57 6.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -58.51 -58.25 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.541 HD11 ' CD ' ' A' ' 78' ' ' GLN . 2.3 pp -51.72 -39.99 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -52.93 -31.99 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.81 -51.69 31.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.83 -60.12 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.505 HD11 HG23 ' A' ' 142' ' ' ILE . 47.0 mm -50.61 -38.01 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.11 -33.83 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 130' ' ' MET . 11.9 pt-20 -117.06 113.93 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.404 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -171.8 -177.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.44 121.92 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.8 tp -33.55 -34.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 131' ' ' GLU . 25.3 t0 -83.96 -51.71 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 135' ' ' THR . 49.1 tt0 -52.99 -47.55 68.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 134' ' ' GLU . 29.8 p -35.82 -50.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.51 -47.12 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -102.47 85.58 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 142' ' ' ILE . . . 171.01 37.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.494 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.1 ttp180 -76.62 -31.42 57.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 5.1 m-20 -60.18 -38.37 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -78.89 -60.11 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 127' ' ' ILE . 20.3 mt -42.95 -51.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 140' ' ' ASP . . . -57.72 -60.63 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -49.63 -68.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 149' ' ' GLU . 4.0 mm? -43.03 -59.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' LEU . 45.5 ttp180 -35.74 -43.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.66 -38.7 28.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 146' ' ' LEU . 39.7 mm-40 -62.23 -27.63 69.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.649 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -99.42 -29.72 12.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -15.22 60.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.33 -20.56 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.48 -12.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 161' ' ' ILE . 72.0 p -101.31 -33.98 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -50.65 -23.3 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -88.2 -30.23 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -88.09 17.6 4.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 66.71 26.94 73.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.48 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.86 135.75 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 111.148 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.96 139.93 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 154' ' ' THR . 42.5 mm -84.98 109.48 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -60.54 -55.09 37.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -163.0 -176.16 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.77 140.47 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.169 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 93' ' ' VAL . 2.7 mm-40 -126.3 135.99 52.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.5 141.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.14 161.65 13.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -51.59 154.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -104.53 156.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -109.11 120.66 45.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 166.15 28.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.642 2.228 . . . . 0.0 112.317 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.773 0.32 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 18.4 mp0 -114.59 144.97 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 65.7 m-70 -117.4 128.73 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.77 135.44 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.941 HD13 HG21 ' A' ' 115' ' ' ILE . 21.9 mt -100.69 125.66 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.73 103.96 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 12.7 p -106.06 135.07 19.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.78 150.78 68.55 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.627 2.218 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.485 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.69 156.94 62.2 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.262 . . . . 0.0 112.348 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -142.99 121.34 12.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.77 105.66 11.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 127' ' ' ILE . 17.5 m -116.12 148.78 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 69.3 mt -77.12 106.22 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.36 -174.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.67 -47.63 77.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 86' ' ' VAL . 26.3 t0 -82.84 37.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.9 m120 47.61 54.8 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.567 HG12 HG13 ' A' ' 88' ' ' VAL . 47.9 t -124.38 110.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.35 108.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.567 HG13 HG12 ' A' ' 86' ' ' VAL . 27.5 m -128.46 146.63 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 1.8 m -80.52 113.52 18.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.899 HG11 HG21 ' A' ' 127' ' ' ILE . 4.8 p -107.41 143.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 15.8 p-10 -151.73 140.8 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.459 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.19 146.92 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.34 159.11 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 150' ' ' LEU . 40.5 t -131.9 129.12 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.17 159.82 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.0 p90 -165.56 159.87 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.731 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -152.36 128.72 10.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 98' ' ' VAL . 46.5 t -67.32 93.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 100' ' ' ASP . 45.7 pt -73.07 -36.15 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 99' ' ' ILE . 24.8 t0 -125.4 99.24 33.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.9 Cg_endo -69.77 -7.52 21.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 105' ' ' VAL . 54.2 t -76.88 -47.83 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -82.95 -33.36 26.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -88.2 46.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 102' ' ' VAL . 16.1 m -89.22 30.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 45.6 p90 -112.66 35.61 3.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m120 47.12 36.68 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.2 m 31.08 41.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.1 m -89.19 -59.27 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -52.81 -34.2 52.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -70.36 -40.16 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -62.15 -54.93 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 ptp -68.62 -33.64 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -66.87 -59.08 3.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.941 HG21 HD13 ' A' ' 73' ' ' ILE . 16.2 mm -46.33 -63.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.2 t -39.48 -40.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -74.04 -49.46 24.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.7 mt -55.72 -57.56 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.32 -51.38 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HA ' HD21 ' A' ' 123' ' ' LEU . 46.4 mm-40 -42.85 -41.46 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 84.9 m -75.94 -59.3 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -45.77 -57.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.3 pp -54.06 -43.65 70.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 123' ' ' LEU . 20.1 ttp180 -53.01 -32.4 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.64 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.2 mp -76.35 -63.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.899 HG21 HG11 ' A' ' 90' ' ' VAL . 2.9 mp -49.62 -45.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.12 -26.18 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.47 113.75 17.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.98 -175.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.3 mm-40 -122.76 123.31 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 131' ' ' GLU . 46.3 tp -34.39 -32.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.9 m-20 -83.93 -46.63 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 131' ' ' GLU . 37.0 tt0 -56.31 -50.58 71.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' LEU . 79.1 p -42.17 -56.35 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.131 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 97.4 mt -34.79 -51.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.9 m -117.76 87.21 2.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.81 39.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -82.97 -40.28 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.71 -44.02 63.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.708 HG22 ' NE ' ' A' ' 145' ' ' ARG . 26.5 mt -68.96 -54.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.03 -36.81 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.497 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 80.5 m-20 -68.92 -19.14 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.4 -40.85 17.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.708 ' NE ' HG22 ' A' ' 141' ' ' ILE . 0.5 OUTLIER -66.59 -55.84 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.55 -32.7 67.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 31.6 ttt-85 -79.43 -40.55 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.452 ' CD ' ' O ' ' A' ' 148' ' ' GLU . 9.9 tm-20 -63.28 -25.49 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -91.17 -62.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 94' ' ' VAL . 79.4 mt -54.13 -20.72 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 21.0 t0 -83.86 13.85 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -121.45 -40.87 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 153' ' ' ILE . 22.1 mt -76.93 -8.42 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.089 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.428 ' CG2' HD11 ' A' ' 115' ' ' ILE . 71.6 p -100.65 -38.01 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -45.98 -37.66 6.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.516 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 6.4 ptp180 -66.74 -33.64 76.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.516 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.1 m0 -86.19 10.62 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.52 17.16 80.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.2 t -122.45 141.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -125.16 150.54 46.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 29.3 mm -85.82 113.88 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.731 HG23 ' HG2' ' A' ' 97' ' ' GLN . 25.7 p -68.02 -55.53 12.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 163' ' ' ARG . 4.5 ptp180 -156.01 178.0 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 99.4 t -141.41 145.86 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.26 145.1 51.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.497 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 19.9 mm -106.92 142.29 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.429 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 21.4 mm-40 -94.06 161.79 14.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -54.57 141.72 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.2 mp -91.22 157.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 t70 -128.34 133.78 25.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.36 24.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.312 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.794 0.331 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 162' ' ' THR . 11.8 mp0 -75.61 140.86 42.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 66.4 m-70 -108.46 134.46 51.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.59 HG12 ' CE1' ' A' ' 95' ' ' TYR . 11.3 m -93.96 151.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 115' ' ' ILE . 20.8 mt -117.56 117.85 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.48 110.38 17.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.1 p -115.89 137.07 23.06 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.643 0.735 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.82 149.53 66.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 159.11 54.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.266 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -145.4 115.59 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.78 117.2 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.74 139.1 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.0 mt -70.29 105.52 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.5 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -64.94 -42.65 94.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.34 30.63 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER 53.46 44.72 29.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 HG13 ' A' ' 88' ' ' VAL . 41.1 t -111.82 114.21 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.8 p -77.18 114.29 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 HG12 ' A' ' 86' ' ' VAL . 27.1 m -142.84 144.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.5 m -87.34 124.48 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 127' ' ' ILE . 28.8 m -114.26 163.98 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -174.86 136.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 166' ' ' ILE . . . -154.07 151.54 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.2 m -95.65 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.1 132.75 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.4 m-30 -91.05 157.6 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 7.7 p90 -165.7 146.23 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.827 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -141.92 123.14 14.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 159' ' ' VAL . 90.5 t -66.54 124.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -111.11 -30.07 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 99' ' ' ILE . 34.5 t70 -124.38 101.67 34.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.908 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.3 Cg_endo -69.74 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.401 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -41.45 -38.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -91.6 -37.82 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -91.3 45.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 105' ' ' VAL . 9.4 p -90.73 40.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 28.7 p90 -119.99 32.83 5.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' SER . 2.9 m-80 49.8 38.02 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 108' ' ' VAL . 13.9 t 34.41 33.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' ASN . 35.6 m -87.98 -51.17 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -47.57 75.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.728 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -60.2 -36.32 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.79 -60.54 3.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.9 -45.42 89.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.52 -55.14 37.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.005 HG21 HD13 ' A' ' 73' ' ' ILE . 10.9 mm -48.73 -62.96 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 76' ' ' PRO . 49.6 t -42.01 -33.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -79.16 -53.97 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 153' ' ' ILE . 14.4 mt -52.35 -58.9 5.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -38.84 -51.96 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -43.73 -41.17 4.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.8 m -78.18 -46.94 19.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -57.11 -61.12 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.9 pp -55.11 -42.14 72.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 123' ' ' LEU . 15.7 ttm180 -54.59 -25.46 26.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.74 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.3 mp -79.27 -64.22 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.83 HG21 HG21 ' A' ' 90' ' ' VAL . 2.9 mp -48.7 -42.66 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -46.91 -30.48 5.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -119.38 113.91 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.458 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -172.61 -175.19 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 133' ' ' ASP . 9.2 mt-10 -119.3 123.88 45.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 131' ' ' GLU . 51.8 tp -33.68 -34.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.3 m-20 -86.17 -54.1 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 135' ' ' THR . 70.7 tt0 -50.8 -49.81 57.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 134' ' ' GLU . 35.1 p -32.49 -51.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 mt -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 134' ' ' GLU . 2.2 m -93.86 41.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -146.84 49.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 45.8 ttt180 -95.37 -43.27 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.43 -19.4 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.1 mt -95.55 -56.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 127' ' ' ILE . 46.3 mt -46.82 -41.77 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' HG2' ' A' ' 139' ' ' ARG . 16.9 p30 -77.69 -20.44 53.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.92 -37.1 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.15 -66.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.4 mt -42.92 -35.75 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -75.71 -41.16 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -18.07 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.26 -48.53 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 115' ' ' ILE . 65.4 mt -67.88 -35.73 79.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -58.11 -11.85 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -95.88 -45.36 6.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 153' ' ' ILE . 68.8 mt -75.31 -1.45 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 161' ' ' ILE . 26.6 p -109.02 -40.62 4.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.34 -34.88 3.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 10.2 ptm180 -70.04 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.578 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 51.4 m0 -88.08 11.88 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 69.87 35.12 72.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 99' ' ' ILE . 20.5 t -138.8 136.62 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -116.3 141.0 48.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 154' ' ' THR . 46.9 mm -82.95 96.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.0 p -47.75 -55.56 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -163.57 -175.95 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.16 137.07 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -119.08 143.72 46.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 92' ' ' ALA . 15.3 mm -109.69 142.26 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.42 161.46 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -43.13 158.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 45.4 mt -113.15 154.72 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 38.2 m-20 -118.68 126.54 27.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.93 17.75 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.326 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.762 0.315 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 157.84 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 86.4 m-70 -124.37 156.74 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 95' ' ' TYR . 2.7 m -99.69 152.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 115' ' ' ILE . 20.0 mt -110.03 131.59 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.76 105.99 18.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.2 p -118.3 127.36 26.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.3 Cg_endo -69.78 150.24 67.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.78 164.68 33.64 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.264 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -145.26 115.08 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.76 100.24 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -114.73 137.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.8 mt -70.2 105.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.11 -177.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -67.8 -35.94 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.91 28.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 13.8 m-20 54.32 45.42 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 88' ' ' VAL . 55.6 t -114.82 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.3 p -84.04 108.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 86' ' ' VAL . 15.0 m -135.63 152.81 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 3.6 m -88.89 130.87 35.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 127' ' ' ILE . 8.2 p -120.21 132.06 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.1 138.33 33.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.78 171.55 18.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 165' ' ' GLU . 13.7 m -121.66 159.08 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 73' ' ' ILE . 38.5 t -130.73 130.42 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.7 m-30 -91.27 160.81 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.6 p90 -165.85 157.0 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.697 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.9 pt20 -152.17 132.36 13.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.3 t -73.54 98.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -76.55 -19.75 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.082 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -143.91 106.36 4.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.653 0.739 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -10.06 27.6 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.36 -29.65 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' A' ' 158' ' ' GLY . 31.2 mtpt -94.65 -34.56 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -90.92 47.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 105' ' ' VAL . 61.1 t -78.55 -5.57 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 33.9 p90 -83.11 16.86 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.5 m120 61.87 38.62 14.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 32.4 m 34.14 36.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 107' ' ' ASN . 8.3 t -89.43 -52.43 5.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.28 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -62.87 -33.28 74.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.23 -58.45 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.5 ptp -64.82 -39.12 93.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -54.59 39.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 73' ' ' ILE . 9.4 mm -50.59 -59.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.7 t -44.12 -42.86 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -69.15 -48.73 61.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.72 -59.77 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -41.32 -45.12 2.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.111 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 38.4 mm-40 -52.42 -41.59 63.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.2 m -80.08 -50.58 10.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -51.53 -52.81 43.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 124' ' ' ARG . 1.7 pp -60.14 -41.67 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.793 ' N ' HD12 ' A' ' 123' ' ' LEU . 57.0 ttt85 -54.31 -21.78 10.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.16 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.4 mp -76.55 -55.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.696 HG21 HG11 ' A' ' 90' ' ' VAL . 50.7 mm -51.07 -38.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.51 -27.31 11.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.449 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -123.24 114.19 19.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.17 -178.34 1.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 133' ' ' ASP . 20.6 mt-10 -122.66 121.56 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' GLU . 24.1 tp -33.73 -34.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' GLU . 58.0 m-20 -78.48 -50.38 11.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 tp10 -59.19 -46.98 86.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 p -40.57 -36.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.35 -55.47 21.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -101.54 46.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -132.79 43.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 mtp-105 -87.89 -42.83 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.75 -11.31 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.7 mt -100.08 -56.0 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.37 -44.53 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.529 ' OD1' HD11 ' A' ' 166' ' ' ILE . 67.2 m-20 -56.57 -26.55 55.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.4 -48.59 15.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 145' ' ' ARG . 5.9 mpt_? -57.01 -64.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 146' ' ' LEU . 10.4 mt -52.74 -57.35 10.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HB2' HG21 ' A' ' 164' ' ' VAL . 44.6 ttp180 -45.38 -38.27 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -82.86 -22.85 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 153' ' ' ILE . 32.7 mt-10 -83.31 -12.15 56.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.832 HD12 HD13 ' A' ' 115' ' ' ILE . 2.1 mm? -121.4 -5.87 9.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -24.32 23.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -86.59 -34.37 19.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 149' ' ' GLU . 22.9 mt -81.54 -11.88 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 1.013 ' HB ' HG13 ' A' ' 159' ' ' VAL . 56.6 p -100.33 -40.44 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.176 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -46.59 -21.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 156' ' ' ARG . 0.8 OUTLIER -82.6 -37.2 25.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.507 ' HB2' HG12 ' A' ' 159' ' ' VAL . 32.2 m0 -84.04 24.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.412 ' N ' ' HE2' ' A' ' 103' ' ' LYS . . . 65.04 14.26 58.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 1.013 HG13 ' HB ' ' A' ' 154' ' ' THR . 4.2 p -123.24 140.78 45.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD3' ' C ' ' A' ' 160' ' ' LYS . 3.5 tmtt? -126.78 140.13 52.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.53 93.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.697 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.28 -55.04 7.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.159 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 2.8 ptp180 -158.59 -178.9 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.501 HG12 ' OD1' ' A' ' 143' ' ' ASN . 92.0 t -141.17 127.96 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.164 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.5 mm-40 -115.56 134.14 55.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.529 HD11 ' OD1' ' A' ' 143' ' ' ASN . 17.0 mm -102.52 142.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -101.22 159.13 15.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 19.5 mtt85 -45.03 157.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -111.58 155.8 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.473 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.2 m-20 -111.59 120.07 43.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.596 0.712 . . . . 0.0 110.922 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.28 19.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.431 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.218 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.794 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 1.2 pm0 -103.96 143.72 32.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -112.53 145.27 40.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 93' ' ' VAL . 2.4 p -94.35 137.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 115' ' ' ILE . 21.2 mt -103.11 126.92 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -112.51 132.01 22.38 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.5 Cg_endo -69.75 145.92 58.68 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.316 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.5 Cg_endo -69.78 162.57 41.58 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.706 2.27 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -142.97 117.09 9.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -69.04 106.65 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.38 142.62 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 87' ' ' VAL . 19.5 mm -72.13 109.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -56.44 -177.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -65.68 -40.65 92.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -85.51 34.39 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 45.97 47.61 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ASP . 31.8 t -115.37 122.28 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 81' ' ' ILE . 21.8 t -77.23 111.4 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 m -138.48 155.08 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.6 m -102.19 119.68 39.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 127' ' ' ILE . 27.5 m -100.64 141.2 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -146.05 133.0 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.7 167.39 29.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 35.5 m -111.61 172.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.74 123.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 4.6 m-30 -90.39 151.96 21.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -165.8 154.79 11.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.514 ' O ' HG23 ' A' ' 99' ' ' ILE . 2.5 pt20 -148.71 112.48 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.91 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.88 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -80.64 -26.53 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.765 ' HB2' HD12 ' A' ' 99' ' ' ILE . 28.5 t0 -134.97 97.51 13.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 104' ' ' ALA . 53.8 Cg_endo -69.79 -44.74 1.89 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.706 HG23 ' HG2' ' A' ' 103' ' ' LYS . 4.0 m -36.41 -31.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.706 ' HG2' HG23 ' A' ' 102' ' ' VAL . 11.7 mmmt -93.62 -35.54 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -82.27 41.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -73.86 4.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 30.2 p90 -97.34 27.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.8 m-80 56.87 32.99 22.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.542 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.0 m 32.97 39.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.0 t -96.28 -36.44 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 4.3 m-20 -71.05 -38.59 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.792 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -67.8 -44.9 76.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -48.74 -54.3 15.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.633 ' O ' HG22 ' A' ' 116' ' ' VAL . 7.9 ptp -77.3 -45.01 27.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -57.4 -14.99 5.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.094 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 73' ' ' ILE . 2.0 mm -80.73 -51.55 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 113' ' ' MET . 10.0 m -59.64 -25.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -82.03 -32.82 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 114' ' ' ALA . 16.0 mt -70.5 -36.58 73.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.02 86.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 32.3 mm-40 -51.45 -38.17 52.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.1 m -82.88 -57.18 3.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.169 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -54.26 -56.44 18.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 1.005 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.1 pp -53.72 -41.3 66.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttt-85 -53.97 -20.35 6.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.13 -57.9 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -79.27 -62.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 1.005 HD13 ' HB2' ' A' ' 123' ' ' LEU . 3.0 mp -50.37 -41.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.3 -26.38 4.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.01 113.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.913 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -175.72 1.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.0 126.02 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' GLU . 42.5 tp -37.53 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.3 p30 -93.19 -43.39 8.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.829 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.6 tp10 -63.82 -20.66 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.1 p -73.54 -14.24 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 mt -82.17 -40.84 21.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 t -120.86 43.09 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -134.17 20.24 4.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 142' ' ' ILE . 14.6 ptt180 -69.08 -32.08 71.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -51.72 -47.46 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.27 -43.43 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 139' ' ' ARG . 48.9 mt -50.9 -49.9 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.541 ' OD1' HD11 ' A' ' 166' ' ' ILE . 76.0 m-20 -65.44 -52.24 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 148' ' ' GLU . . . -42.89 -48.58 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.101 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -61.23 -70.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.38 -62.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -40.26 -36.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 144' ' ' ALA . 0.3 OUTLIER -78.01 -56.98 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.92 -58.37 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.8 mt -56.24 -37.23 69.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -11.28 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -92.63 -37.17 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -76.13 -19.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 159' ' ' VAL . 73.6 p -93.74 -38.41 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -52.11 -16.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.29 -31.75 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.465 ' HB2' HG12 ' A' ' 159' ' ' VAL . 40.8 m0 -88.97 11.47 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.69 10.98 85.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -113.57 145.42 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 111.128 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -118.48 141.2 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 154' ' ' THR . 26.2 mm -79.84 92.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.92 -61.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -166.49 -178.06 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 ' OD1' ' A' ' 143' ' ' ASN . 62.9 t -135.18 147.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 13.7 mt-10 -135.55 143.31 45.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.541 HD11 ' OD1' ' A' ' 143' ' ' ASN . 24.6 mm -105.44 142.24 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -106.12 161.25 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -42.33 136.95 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -95.76 157.22 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.496 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 9.6 m-20 -107.87 120.93 45.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.843 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 169.14 19.58 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.451 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.251 . . . . 0.0 112.379 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.777 0.322 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -119.75 152.36 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 85.5 m-70 -121.86 143.85 49.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.35 139.66 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.71 HD11 ' CE1' ' A' ' 111' ' ' PHE . 27.4 mt -108.26 124.56 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.46 127.49 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.815 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 2.3 p -120.75 135.32 24.61 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.627 0.727 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.3 Cg_endo -69.78 150.29 67.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.2 Cg_endo -69.71 149.84 67.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.73 HE21 HD11 ' A' ' 123' ' ' LEU . 12.9 tt0 -137.59 113.71 9.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.81 101.92 4.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.472 HG11 ' HA2' ' A' ' 128' ' ' GLY . 15.1 t -111.05 137.66 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 65.2 mt -68.16 104.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -49.78 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -65.12 -41.02 95.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 19.2 t70 -84.96 33.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 51.07 47.89 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 172' ' ' PRO . 94.0 t -118.93 114.76 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.4 p -80.38 120.18 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -145.89 148.91 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 11.4 m -81.16 125.98 30.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.951 HG11 HG21 ' A' ' 127' ' ' ILE . 9.8 p -121.76 130.93 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 13.5 p-10 -140.95 145.47 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.82 150.34 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -100.33 155.15 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.77 141.76 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.39 162.53 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.1 p90 -165.9 157.53 14.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.517 ' NE2' HG21 ' A' ' 162' ' ' THR . 3.0 pt20 -153.31 116.4 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 98' ' ' VAL . 34.4 t -53.79 94.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.132 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.27 3.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -165.17 112.64 0.83 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.64 0.733 . . . . 0.0 110.841 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -51.22 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.244 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 p -44.68 -37.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -81.16 -37.08 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -96.73 56.01 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 105' ' ' VAL . 12.8 p -92.66 3.25 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.166 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 31.0 p90 -87.94 24.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 23.4 m-80 61.97 27.4 16.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 3.3 t 36.66 40.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 t -96.16 -52.33 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -57.22 -39.2 74.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.71 ' CE1' HD11 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -62.88 -35.01 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.45 -64.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 ptp -61.64 -32.74 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -67.13 -57.22 7.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 154' ' ' THR . 8.1 mm -44.69 -56.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 76' ' ' PRO . 87.6 t -53.79 -24.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -85.91 -37.77 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 121' ' ' THR . 10.4 mt -67.55 -57.07 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.73 -36.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -63.41 -40.85 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 118' ' ' LEU . 88.6 m -78.74 -38.77 38.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 72.2 m-80 -69.26 -56.38 7.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.73 HD11 HE21 ' A' ' 78' ' ' GLN . 2.1 pp -53.19 -44.18 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.72 ' N ' HD12 ' A' ' 123' ' ' LEU . 45.5 ttt-85 -52.46 -22.04 4.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' ASN . . . -73.92 -60.59 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.0 mp -78.91 -60.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.951 HG21 HG11 ' A' ' 90' ' ' VAL . 1.9 mp -49.98 -38.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.472 ' HA2' HG11 ' A' ' 80' ' ' VAL . . . -51.62 -23.89 10.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.06 114.05 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.79 -175.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 133' ' ' ASP . 22.2 mt-10 -120.84 137.07 54.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.0 tp -38.29 -26.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.757 ' HA ' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -97.83 -59.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -41.93 -25.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' ASP . 1.5 p -64.2 -50.58 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.757 HD21 ' HA ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -79.29 -13.95 59.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.935 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 m -92.78 -29.58 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.477 ' CA ' HD13 ' A' ' 141' ' ' ILE . . . -114.56 85.53 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.499 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -103.03 -43.45 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -16.84 63.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.8 mp -85.11 -48.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.613 ' CG2' HD11 ' A' ' 127' ' ' ILE . 70.8 mt -55.48 -61.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.46 -37.67 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.97 -59.02 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -48.77 -66.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 tp -42.81 -48.77 5.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -55.31 -42.94 74.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.32 -9.83 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.701 ' O ' HD12 ' A' ' 153' ' ' ILE . 13.2 mt-10 -98.35 -53.35 3.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.2 mt -64.6 -34.7 78.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -13.67 35.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -88.58 -49.84 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 149' ' ' GLU . 4.4 mp -72.92 -21.61 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.533 ' CG2' HD11 ' A' ' 115' ' ' ILE . 60.0 p -91.21 -35.35 14.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -25.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CB ' HH11 ' A' ' 156' ' ' ARG . 0.0 OUTLIER -80.15 -34.94 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -82.57 15.91 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.54 76.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.45 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.77 128.07 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.94 145.29 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -84.08 116.31 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.517 HG21 ' NE2' ' A' ' 97' ' ' GLN . 30.3 p -70.37 -62.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -146.65 167.13 24.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.96 115.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 93' ' ' VAL . 20.0 mm-40 -99.16 147.21 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.559 HD13 ' HB1' ' A' ' 92' ' ' ALA . 22.6 mm -107.62 137.21 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.9 mt-30 -88.74 159.61 17.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -50.58 156.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -110.99 157.26 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 10.0 t70 -125.45 133.26 24.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 168.47 21.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.509 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.211 0 C-N-CA 122.683 2.256 . . . . 0.0 112.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.764 0.316 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.38 152.87 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m-70 -113.85 149.26 35.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.2 p -96.49 145.31 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.966 HD13 HG21 ' A' ' 115' ' ' ILE . 18.7 mt -105.35 130.68 56.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.38 95.11 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.905 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.1 p -100.93 138.42 20.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.679 0.752 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 150.48 68.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.676 2.251 . . . . 0.0 112.327 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.498 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.2 Cg_endo -69.8 171.0 15.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.47 ' NE2' ' HG2' ' A' ' 120' ' ' GLN . 1.6 mp0 -142.97 145.88 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.37 101.22 11.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.625 HG12 ' NH1' ' A' ' 124' ' ' ARG . 28.9 m -117.05 145.83 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 66.9 mt -77.55 106.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.33 -178.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -62.87 -48.59 78.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.3 t0 -81.45 37.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.5 m120 46.67 44.84 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 88' ' ' VAL . 76.6 t -111.23 110.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.61 120.86 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 86' ' ' VAL . 28.7 m -144.83 150.3 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 6.9 m -93.52 125.05 37.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 127' ' ' ILE . 34.4 m -112.9 148.98 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -152.81 138.45 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.831 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.08 153.44 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 165' ' ' GLU . 24.2 m -101.22 163.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.39 132.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.6 m-30 -94.26 161.31 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.6 p90 -165.91 152.37 9.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.601 ' HG2' HG23 ' A' ' 162' ' ' THR . 4.3 pt20 -143.11 126.06 16.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.83 91.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.2 pt -71.7 -31.89 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -132.07 102.6 14.49 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.846 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -10.14 27.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.637 2.224 . . . . 0.0 112.393 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.12 -50.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -77.02 -38.09 53.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -86.63 47.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.34 4.74 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 36.3 p90 -85.26 30.83 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m-80 49.63 37.07 11.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 23.6 m 32.57 41.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.4 m -94.96 -41.58 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -46.8 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.704 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -57.05 -30.4 64.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.0 mt -60.31 -60.67 3.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.4 ' O ' HG22 ' A' ' 116' ' ' VAL . 20.0 ptp -67.75 -46.22 72.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.26 -35.93 63.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.966 HG21 HD13 ' A' ' 73' ' ' ILE . 5.2 mm -67.76 -64.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 2.7 m -52.29 -15.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -94.83 -34.32 12.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 150' ' ' LEU . 10.8 mt -73.2 -54.23 8.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -47.08 -45.29 21.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 68.9 mt-30 -62.02 -36.13 80.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.5 m -74.16 -22.12 59.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 71.7 m-80 -91.53 -61.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 124' ' ' ARG . 4.1 pp -47.63 -39.83 18.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.625 ' NH1' HG12 ' A' ' 80' ' ' VAL . 25.4 mtt-85 -52.72 -33.09 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.88 -54.43 15.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.56 -59.52 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 90' ' ' VAL . 3.7 mt -50.25 -44.24 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.86 -24.02 0.68 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' MET . 10.4 pt-20 -125.86 112.76 16.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -175.54 -175.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 135' ' ' THR . 10.2 mm-40 -122.44 129.39 52.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.99 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 74.9 m-20 -85.74 -64.89 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.2 pt-20 -53.33 -46.02 69.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 131' ' ' GLU . 25.3 p -33.3 -33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 134' ' ' GLU . 39.6 mt -70.85 -69.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -54.14 -46.29 72.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.72 57.64 2.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -99.75 -26.41 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -78.12 -26.13 47.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.7 mt -78.73 -52.34 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -43.88 -50.51 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.562 ' HB3' HD11 ' A' ' 166' ' ' ILE . 0.9 OUTLIER -68.47 -41.01 80.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.473 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -50.86 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -55.09 -56.76 16.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' HB1' ' A' ' 119' ' ' ALA . 7.2 tp -47.51 -62.12 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 25.9 ttp85 -43.85 -50.25 7.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -53.54 -31.37 46.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.58 -60.18 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 115' ' ' ILE . 3.3 mm? -54.82 -31.75 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -66.85 -3.75 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -97.59 -43.84 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.5 mp -75.16 -18.78 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.8 p -92.04 -35.33 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.16 -38.62 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.6 ptp180 -69.93 -32.53 70.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.672 ' O ' HG23 ' A' ' 159' ' ' VAL . 31.7 m0 -88.23 34.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.57 23.39 4.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 157' ' ' TRP . 91.2 t -126.72 143.32 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.75 141.92 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 95' ' ' TYR . 26.9 mm -77.54 97.56 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 97' ' ' GLN . 62.6 p -51.27 -38.57 53.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -170.99 -179.93 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 143' ' ' ASN . 1.7 m -141.32 134.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.445 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.7 mt-10 -121.07 139.42 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 143' ' ' ASN . 9.0 mm -104.12 142.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.171 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.48 161.95 13.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -49.32 145.38 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 170' ' ' ASP . 3.3 mp -98.27 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 169' ' ' ILE . 2.2 m-20 -112.72 120.46 40.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 110.87 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 170.23 17.12 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.629 2.22 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.787 0.327 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.29 138.6 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 99.1 m-70 -108.57 126.73 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -93.1 135.26 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 115' ' ' ILE . 20.4 mt -99.1 128.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.32 97.97 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 116' ' ' VAL . 48.2 t -102.89 126.78 31.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 111.128 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 149.86 67.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.79 147.58 63.02 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -128.17 116.95 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.53 116.86 9.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.62 147.52 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 46.6 mm -83.56 108.67 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.4 m -53.11 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -67.32 -45.09 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 25.8 t70 -82.89 36.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.49 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.6 m-20 47.26 51.07 13.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 HG13 ' A' ' 88' ' ' VAL . 87.1 t -118.15 109.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 87' ' ' VAL . 6.4 p -78.14 114.28 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 86' ' ' VAL . 18.1 m -140.15 142.06 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 m -81.93 126.24 31.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 91' ' ' ASP . 7.2 p -119.64 160.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -162.57 143.5 10.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.76 153.52 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 165' ' ' GLU . 18.0 m -101.19 164.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.8 t -137.42 134.43 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 3.4 m-85 -96.59 157.02 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 4.7 p90 -165.92 150.94 8.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.762 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.0 pt20 -147.95 110.01 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 108' ' ' VAL . 92.0 t -51.68 95.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.55 -8.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -161.22 109.59 1.25 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.569 0.699 . . . . 0.0 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -47.84 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' PRO . 2.2 t -34.83 -39.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -90.71 -37.86 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.565 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -94.23 49.83 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.8 m -86.12 8.17 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 35.7 p90 -90.47 26.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.5 m-80 56.56 33.97 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.5 t 33.65 41.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.3 m -97.45 -50.18 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.3 m-20 -57.6 -45.09 85.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 1.1 t80 -61.09 -44.39 97.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.527 HD23 HG12 ' A' ' 73' ' ' ILE . 19.0 mt -53.16 -64.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.786 ' O ' HG22 ' A' ' 116' ' ' VAL . 21.0 ptp -62.24 -45.07 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -56.92 -32.31 65.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 73' ' ' ILE . 3.9 mm -70.92 -59.81 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.184 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 113' ' ' MET . 8.7 m -44.06 -22.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 115' ' ' ILE . 77.1 mttt -94.77 -46.86 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.09 -53.04 62.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.46 -45.78 47.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 78.3 mt-30 -57.96 -37.9 75.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.7 m -70.17 -35.49 74.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.428 ' CG ' ' HB3' ' A' ' 149' ' ' GLU . 71.0 m-80 -80.31 -62.92 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.721 ' HB3' HD21 ' A' ' 146' ' ' LEU . 4.0 pp -46.59 -43.79 17.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.596 ' N ' HD12 ' A' ' 123' ' ' LEU . 9.7 ttm180 -47.73 -39.09 16.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.15 -52.03 66.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.1 mp -80.42 -62.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.169 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 123' ' ' LEU . 5.2 mt -51.17 -43.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.61 -31.58 3.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.524 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -116.52 113.39 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -172.55 -175.09 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 133' ' ' ASP . 35.0 mt-10 -116.5 121.34 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 131' ' ' GLU . 57.5 tp -33.89 -33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 m-20 -83.45 -50.75 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 131' ' ' GLU . 24.8 tt0 -56.45 -48.58 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.0 p -40.1 -50.11 2.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.3 mt -47.02 -39.17 12.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -127.61 82.36 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -175.27 25.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 5.0 ptt-85 -72.6 -35.33 67.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 1.5 m-20 -46.94 -32.21 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.09 -35.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 139' ' ' ARG . 71.4 mt -60.81 -50.64 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 2.3 p30 -61.77 -52.78 62.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' NH1' ' A' ' 147' ' ' ARG . . . -39.29 -49.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -58.8 -60.6 3.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 123' ' ' LEU . 3.9 mm? -54.37 -61.96 1.96 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 23.6 ttp-105 -36.19 -36.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.51 -55.5 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 152' ' ' LYS . 70.2 mm-40 -50.24 -17.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.11 -40.07 5.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.1 -8.31 16.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 149' ' ' GLU . 5.2 ptmt -100.83 -18.24 16.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 153' ' ' ILE . 7.2 mt -107.3 18.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.993 ' HB ' HG13 ' A' ' 159' ' ' VAL . 39.7 p -120.99 -32.29 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -25.56 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -84.1 -25.82 29.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TRP . . . . . 0.446 ' HB2' HG12 ' A' ' 159' ' ' VAL . 54.4 m0 -92.84 17.41 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 66.79 15.44 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.993 HG13 ' HB ' ' A' ' 154' ' ' THR . 5.0 p -124.94 155.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.178 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -137.52 151.7 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.477 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 31.7 mm -88.94 98.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -52.66 -48.84 66.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -166.15 -176.38 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.08 147.93 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.549 ' HB2' HG23 ' A' ' 93' ' ' VAL . 3.2 mm-40 -133.81 141.66 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.55 142.07 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -101.44 161.87 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.56 160.95 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -113.84 157.06 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.6 m-20 -111.42 123.54 34.75 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.666 0.746 . . . . 0.0 110.85 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 164.44 34.55 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.385 179.907 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 t -162.01 120.72 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -49.38 -54.25 18.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -74.68 119.75 19.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.826 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.27 40.3 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -102.94 116.86 33.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 68' ' ' LEU . 4.0 mm? -88.78 41.69 1.04 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -55.19 129.25 37.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.6 155.76 22.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -123.73 152.02 42.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.1 146.72 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.979 HD13 HG21 ' A' ' 115' ' ' ILE . 16.6 mt -106.53 133.47 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.48 111.96 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.7 p -117.9 128.21 26.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 111.134 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.4 Cg_endo -69.76 152.39 69.3 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 0.0 112.33 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.8 164.07 35.95 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.697 2.265 . . . . 0.0 112.337 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.96 121.47 11.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.26 106.68 5.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.13 136.94 58.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 53.4 mt -71.51 107.38 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.08 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -67.61 -43.99 79.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -84.58 35.25 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 49.1 t30 48.08 49.41 17.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG12 HG13 ' A' ' 88' ' ' VAL . 97.2 t -113.23 114.31 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -76.35 116.9 20.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 86' ' ' VAL . 25.2 m -142.61 165.8 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.121 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.494 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 58.9 m -111.77 114.01 26.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.138 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 127' ' ' ILE . 14.6 p -97.0 159.3 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.5 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.4 p-10 -171.0 137.35 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.85 175.59 13.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 165' ' ' GLU . 16.0 m -121.12 159.75 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.7 135.83 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.42 ' CB ' ' HG2' ' A' ' 163' ' ' ARG . 5.4 m-85 -100.85 159.21 15.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.468 ' CD2' ' CE1' ' A' ' 111' ' ' PHE . 3.5 p90 -165.79 163.78 18.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.754 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -153.62 132.21 12.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.49 96.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 pt -82.26 -28.07 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.585 ' OD1' HG22 ' A' ' 102' ' ' VAL . 10.0 t0 -125.2 98.13 36.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.0 110.853 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -39.82 6.19 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.585 HG22 ' OD1' ' A' ' 100' ' ' ASP . 17.0 m -58.43 -18.28 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.099 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -106.06 -36.0 7.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -92.57 42.08 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 105' ' ' VAL . 21.3 t -78.38 6.82 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.592 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 47.0 p90 -85.89 31.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.532 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.2 m120 47.35 42.09 13.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.865 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.592 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.7 m 26.83 43.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.2 t -96.73 -53.77 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.92 -40.24 75.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.592 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -61.52 -37.54 84.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.88 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 20.9 mt -61.79 -65.11 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.9 ptp -60.44 -37.18 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.54 -60.83 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.979 HG21 HD13 ' A' ' 73' ' ' ILE . 13.1 mm -41.77 -63.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 76' ' ' PRO . 84.6 t -44.48 -53.23 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -56.19 -45.15 79.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 121' ' ' THR . 39.4 mt -61.38 -61.02 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -37.9 -40.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -57.33 -46.18 83.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 118' ' ' LEU . 91.4 m -70.87 -51.77 24.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -56.2 -60.64 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.1 pp -49.98 -42.09 48.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.763 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.5 ttp180 -50.74 -35.55 32.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.72 -57.93 6.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.095 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -74.69 -59.86 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 90' ' ' VAL . 32.5 mm -47.81 -40.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -49.58 -31.94 15.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.485 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -120.46 114.24 21.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.898 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.94 -176.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 133' ' ' ASP . 42.3 mt-10 -122.58 130.81 53.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.558 HD13 ' HD3' ' A' ' 172' ' ' PRO . 37.5 tp -34.96 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 131' ' ' GLU . 26.9 t0 -94.17 -56.99 2.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.902 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.461 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 1.8 tp10 -49.93 -18.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.0 p -63.54 -54.7 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.18 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 136' ' ' LEU . 3.5 pp -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.478 ' N ' HD12 ' A' ' 136' ' ' LEU . 3.6 p -64.18 -50.55 67.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.7 71.38 2.97 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.508 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.63 -33.0 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.816 0.341 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.42 -39.84 74.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 34.6 mt -61.53 -49.49 84.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.14 -49.0 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.127 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' HG12 ' A' ' 166' ' ' ILE . 27.3 m-20 -57.67 -52.01 67.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 145' ' ' ARG . . . -51.38 -68.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 144' ' ' ALA . 24.6 mmt180 -35.18 -69.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -47.14 -57.05 5.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 151' ' ' ASP . 57.6 ttp85 -41.29 -44.27 2.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.95 -55.27 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -47.51 -38.75 14.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.676 HD12 HD13 ' A' ' 115' ' ' ILE . 3.2 mm? -87.06 -40.49 14.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 9.8 t70 -58.0 -23.14 52.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.894 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -85.12 -27.79 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 153' ' ' ILE . 25.5 mt -91.4 -10.53 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.167 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.975 ' HB ' HG13 ' A' ' 159' ' ' VAL . 23.4 p -95.97 -43.08 7.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -38.61 -34.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.585 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 3.9 ptm85 -70.1 -40.94 74.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.585 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 35.4 m0 -83.65 28.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 53.17 37.03 53.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.975 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.7 p -140.44 144.78 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 111.086 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.57 146.66 52.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.471 ' CG2' ' HG3' ' A' ' 147' ' ' ARG . 12.0 mm -73.8 91.29 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.154 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.754 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.01 -45.01 15.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.193 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 95' ' ' TYR . 9.9 ptp180 -163.45 175.82 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -141.0 137.95 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.574 ' HB2' HG23 ' A' ' 93' ' ' VAL . 31.3 mp0 -132.33 146.14 51.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.466 HG12 ' ND2' ' A' ' 143' ' ' ASN . 11.9 mm -110.99 142.33 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -98.93 160.8 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -47.12 148.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -104.13 157.17 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.489 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.8 m-20 -110.39 118.48 49.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.621 0.724 . . . . 0.0 110.812 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 169.99 17.68 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.241 . . . . 0.0 112.379 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.558 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.1 Cg_endo -69.74 132.91 24.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.725 2.283 . . . . 0.0 112.332 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -69.79 164.99 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.885 179.836 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t -80.66 178.53 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.381 . . . . 0.0 110.859 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.8 -60.05 1.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -76.28 114.67 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 120.15 60.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -124.74 144.85 50.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.67 36.24 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -52.73 123.28 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -68.42 157.35 36.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 75.4 m-70 -126.6 128.45 46.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.14 132.81 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.789 HD13 HG21 ' A' ' 115' ' ' ILE . 27.2 mt -102.38 128.54 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.67 101.78 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.667 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.2 p -103.4 138.67 19.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.687 0.756 . . . . 0.0 111.122 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.7 Cg_endo -69.78 147.42 62.72 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.69 2.26 . . . . 0.0 112.327 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.6 49.08 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 0.0 112.36 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -140.77 131.26 25.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -91.5 112.5 24.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.74 151.14 34.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 43.8 mt -79.63 110.3 15.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.36 -174.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -70.18 -39.37 75.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.05 24.72 1.04 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.5 m120 57.09 51.27 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 88' ' ' VAL . 75.0 t -120.66 110.12 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 87' ' ' VAL . 14.3 p -73.25 112.05 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.146 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 86' ' ' VAL . 10.8 m -139.69 148.04 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.8 m -85.55 134.7 34.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 127' ' ' ILE . 9.9 p -123.51 147.48 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.1 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -159.25 136.15 9.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.489 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.34 146.66 24.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.101 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.02 164.94 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 164' ' ' VAL . 20.4 t -139.2 119.32 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -75.4 160.38 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 3.3 p90 -165.65 148.8 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.719 ' HG2' HG23 ' A' ' 162' ' ' THR . 4.0 pt20 -142.61 132.74 24.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.65 96.76 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 pt -74.56 -24.52 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.56 110.66 5.33 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -26.46 27.71 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.683 2.255 . . . . 0.0 112.317 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 t -57.32 -61.51 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -66.17 -39.42 89.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.515 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -89.3 50.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 105' ' ' VAL . 8.7 p -95.82 37.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 30.2 p90 -116.83 30.39 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.8 m-80 58.85 27.25 15.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 7.2 m 35.28 41.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.106 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -94.61 -52.15 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -48.64 78.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -56.04 -32.74 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 116' ' ' VAL . 15.5 mt -69.64 -61.39 1.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.2 ptp -65.82 -10.08 34.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.863 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.49 -51.73 4.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.789 HG21 HD13 ' A' ' 73' ' ' ILE . 5.8 mm -47.83 -51.07 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -61.83 -22.97 29.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -90.18 -13.0 36.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.427 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 67.8 mt -89.67 -39.93 12.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.9 95.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.097 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.409 ' HA ' HD21 ' A' ' 123' ' ' LEU . 40.4 mm-40 -45.98 -39.48 9.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.6 m -83.34 -53.78 5.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.144 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 75.0 m-80 -52.78 -59.4 4.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.886 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 146' ' ' LEU . 3.1 pp -51.18 -41.13 59.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' N ' HD12 ' A' ' 123' ' ' LEU . 51.4 ttt180 -51.37 -35.84 40.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.57 -61.96 1.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.762 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -72.33 -60.05 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 142' ' ' ILE . 49.8 mm -50.72 -47.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -43.31 -27.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.499 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -123.17 114.57 20.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -170.98 -175.38 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 44.4 mt-10 -121.47 125.76 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' GLU . 59.6 tp -36.53 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 43.5 m-20 -84.57 -52.5 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 137' ' ' SER . 52.1 tt0 -56.53 -47.22 79.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.7 p -37.74 -34.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.07 -43.09 55.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 134' ' ' GLU . 71.2 m -112.8 73.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.78 25.13 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.438 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 142' ' ' ILE . 83.9 mtm180 -68.29 -38.4 81.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -56.4 -21.52 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.2 mt -98.5 -26.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 127' ' ' ILE . 23.8 mt -78.12 -34.43 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.165 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -81.44 -27.23 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.44 -40.75 96.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.542 ' N ' ' CD ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.47 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 123' ' ' LEU . 4.4 mm? -55.43 -28.17 52.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -73.94 -43.25 58.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.5 -8.91 58.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -93.82 -32.49 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -99.94 -6.44 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.903 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.39 -11.98 38.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -98.4 -26.2 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 153' ' ' ILE . 56.0 mt -92.24 15.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.985 ' HB ' HG13 ' A' ' 159' ' ' VAL . 57.5 p -122.4 -28.21 4.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -55.02 -24.96 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -19.89 23.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -94.55 2.51 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 79.25 24.79 60.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.985 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.1 p -136.05 155.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 159' ' ' VAL . 0.0 OUTLIER -136.6 151.44 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.46 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 36.1 mm -88.45 94.35 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.719 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -48.69 -45.84 39.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -169.42 178.8 4.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 94' ' ' VAL . 18.9 t -138.43 142.23 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -127.04 135.54 50.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 92' ' ' ALA . 7.2 mm -104.48 138.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -95.22 160.28 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -50.38 149.6 2.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.37 146.17 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.52 122.69 50.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.883 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.04 17.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 129.84 18.24 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.253 . . . . 0.0 112.356 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -63.12 -51.99 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 t70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -55.07 166.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.375 . . . . 0.0 110.874 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.72 -59.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -101.69 122.55 44.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.5 136.95 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -122.0 156.94 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.3 mm? -91.98 37.09 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 8.1 mtp-105 -37.9 133.98 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' HG21 ' A' ' 162' ' ' THR . 21.4 mp0 -96.83 134.86 39.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 56.9 m-70 -106.46 132.99 51.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -93.84 137.79 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.987 HD13 HG21 ' A' ' 115' ' ' ILE . 51.6 mt -104.46 121.64 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.08 100.15 10.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 11.4 t -100.92 136.01 19.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 0.0 111.122 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HG2' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.79 145.96 58.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.317 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.78 149.3 66.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.655 2.237 . . . . 0.0 112.32 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -132.26 119.63 21.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -74.74 109.91 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -119.11 131.11 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 44.7 mm -63.97 105.06 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.37 177.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -65.85 -36.52 83.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.02 28.25 0.93 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.34 42.8 27.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.2 t -114.56 114.9 47.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.5 p -82.36 115.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.9 148.97 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 77' ' ' PRO . 97.9 m -90.01 115.4 27.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.627 HG11 HG21 ' A' ' 127' ' ' ILE . 10.7 p -110.17 156.54 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.9 OUTLIER -159.45 140.04 12.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.84 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.09 145.46 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.2 170.09 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.441 ' CG1' HD12 ' A' ' 161' ' ' ILE . 19.5 t -143.11 121.82 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -79.03 160.31 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 5.1 p90 -165.83 153.29 10.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.976 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.672 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.5 pt20 -150.44 122.43 8.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 44.7 t -63.04 92.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.2 pt -76.2 -7.69 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.51 114.27 2.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -51.33 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 103' ' ' LYS . 5.4 p -42.98 -46.4 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 102' ' ' VAL . 10.8 mtpp -73.79 -39.32 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -95.07 54.95 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 105' ' ' VAL . 7.2 p -89.57 0.75 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 29.1 p90 -85.69 28.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 6.2 m-80 52.93 31.17 10.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.707 HG12 ' O ' ' A' ' 108' ' ' VAL . 47.1 t 33.64 41.63 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.5 m -93.19 -40.76 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.8 -52.24 32.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -52.19 -32.02 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.607 ' O ' HG13 ' A' ' 116' ' ' VAL . 17.5 mt -57.36 -60.68 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.0 ptp -69.95 -40.51 75.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.676 ' O ' HD12 ' A' ' 118' ' ' LEU . . . -57.03 -30.88 64.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.088 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.987 HG21 HD13 ' A' ' 73' ' ' ILE . 7.3 mm -74.95 -58.37 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.106 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.616 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.3 m -54.58 -29.97 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -83.37 -53.99 5.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 114' ' ' ALA . 10.4 mt -43.56 -55.29 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.29 -52.55 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.097 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.51 ' HA ' HD21 ' A' ' 123' ' ' LEU . 35.9 mm-40 -37.53 -34.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 m -85.74 -61.14 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -47.46 -54.61 10.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 127' ' ' ILE . 2.5 pp -56.15 -40.02 73.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -53.4 -27.41 24.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.97 -62.82 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.052 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.791 ' H ' HD12 ' A' ' 126' ' ' ILE . 2.5 mp -75.48 -61.38 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.627 HG21 HG11 ' A' ' 90' ' ' VAL . 4.1 mt -48.49 -41.35 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.02 -28.92 6.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.487 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -121.69 114.32 20.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.28 -177.38 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 133' ' ' ASP . 16.1 mt-10 -118.84 129.34 55.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 131' ' ' GLU . 23.4 tp -36.0 -30.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.9 OUTLIER -94.49 -52.86 4.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 29.7 tt0 -54.26 -16.5 2.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.402 ' HB ' HD13 ' A' ' 169' ' ' ILE . 1.0 OUTLIER -64.2 -59.89 3.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.142 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.8 pp -60.39 -25.15 65.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.959 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -77.52 -50.71 12.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.91 74.63 2.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.532 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -103.92 -30.91 10.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.873 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -70.89 -23.7 62.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.613 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.3 mp -86.68 -49.78 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.177 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -48.9 -33.36 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.118 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 23.8 p30 -86.34 -23.81 26.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.516 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -70.93 -56.23 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -50.92 -62.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 mt -47.28 -55.38 8.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 151' ' ' ASP . 28.4 ttp180 -42.59 -51.21 5.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.78 -37.1 85.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -74.53 -19.52 60.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 53.0 mt -107.85 -9.49 15.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -90.35 -18.6 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.76 -35.45 14.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.442 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 86.6 mt -77.84 -17.1 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 1.004 ' HB ' HG13 ' A' ' 159' ' ' VAL . 40.6 p -92.63 -42.28 9.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.151 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -44.04 -26.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' CG ' ' O ' ' A' ' 153' ' ' ILE . 0.0 OUTLIER -75.23 -37.2 61.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.514 ' HB2' HG12 ' A' ' 159' ' ' VAL . 34.1 m0 -85.14 26.53 0.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 62.91 12.75 44.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 1.004 HG13 ' HB ' ' A' ' 154' ' ' THR . 6.0 p -120.87 138.19 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.083 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.1 143.9 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 94' ' ' VAL . 5.3 mm -85.01 106.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.672 HG23 ' HG2' ' A' ' 97' ' ' GLN . 18.8 p -57.26 -61.47 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -156.11 179.31 9.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 143' ' ' ASN . 43.0 t -132.87 149.65 32.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -131.61 137.2 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 143' ' ' ASN . 22.8 mm -99.44 141.71 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -99.45 158.88 15.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.456 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -48.92 144.73 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 31.4 mt -99.46 156.28 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -116.62 129.34 25.35 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.615 0.722 . . . . 0.0 110.919 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 164.73 33.44 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.42 34.66 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.328 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -76.74 161.64 28.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.836 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.5 t -121.6 151.08 40.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -85.2 -57.42 3.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -71.06 138.32 49.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.75 123.53 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.087 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.48 -75.26 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.664 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.9 tt 56.04 31.11 17.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.544 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -80.13 96.66 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -70.73 157.5 37.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.896 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.546 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 6.1 m-70 -129.03 147.58 50.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' CE1' ' A' ' 95' ' ' TYR . 4.8 p -94.26 145.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.091 HD13 HG21 ' A' ' 115' ' ' ILE . 26.9 mt -104.29 129.15 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.29 93.1 8.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.899 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.597 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.9 p -94.21 137.58 22.8 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.572 0.701 . . . . 0.0 111.152 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.597 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 146.98 61.99 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.741 2.294 . . . . 0.0 112.343 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.7 Cg_endo -69.75 153.35 69.07 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -140.02 127.06 20.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.75 110.44 20.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -122.41 136.7 58.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.4 mt -68.35 108.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -53.42 -175.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -68.93 -40.67 78.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.42 27.77 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 47.0 t30 54.58 50.48 15.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG12 HG13 ' A' ' 88' ' ' VAL . 97.5 t -118.74 115.52 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -80.15 113.99 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 86' ' ' VAL . 4.6 m -141.65 141.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 27.4 m -83.12 122.13 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 127' ' ' ILE . 2.9 p -108.53 138.31 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -146.81 136.57 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.21 174.53 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -124.96 151.37 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 164' ' ' VAL . 19.9 t -131.7 124.64 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.551 ' CE1' HG23 ' A' ' 72' ' ' VAL . 3.8 m-30 -83.85 163.23 20.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.546 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 8.3 p90 -165.68 160.48 17.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.914 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HG2' ' CG2' ' A' ' 162' ' ' THR . 3.9 pt20 -151.41 142.0 22.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 98' ' ' VAL . 26.8 t -84.92 95.75 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.8 -15.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 30.7 t70 -146.61 106.29 4.03 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.867 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.9 Cg_endo -69.82 -12.74 33.39 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.238 . . . . 0.0 112.349 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -70.79 -55.81 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -72.97 -26.4 61.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -95.77 43.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.0 p -93.3 40.26 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.193 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.3 p90 -123.22 28.83 6.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 109' ' ' SER . 4.5 m-80 61.63 27.18 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.682 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.4 p 35.26 31.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.5 m -89.31 -49.2 6.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 10.8 m-20 -56.56 -45.64 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.513 ' CZ ' HG13 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -62.52 -33.41 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.0 mt -65.5 -53.73 38.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.472 ' O ' ' CD ' ' A' ' 117' ' ' LYS . 13.6 ptp -76.88 -21.38 55.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -78.63 -47.87 16.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.07 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.091 HG21 HD13 ' A' ' 73' ' ' ILE . 8.9 mm -50.39 -53.02 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.477 ' CG2' ' HD2' ' A' ' 117' ' ' LYS . 3.5 m -59.51 -43.0 89.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.477 ' HD2' ' CG2' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -70.94 -10.72 60.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -95.01 -39.62 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.17 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 34.7 mm-40 -61.28 -34.62 75.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 m -80.59 -44.43 18.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 78.6 m-20 -64.15 -46.06 85.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.2 pp -62.66 -40.68 97.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.797 ' N ' HD12 ' A' ' 123' ' ' LEU . 44.8 mtt180 -52.71 -21.42 4.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.92 -59.69 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.0 mp -75.82 -58.33 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.176 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 90' ' ' VAL . 39.2 mm -50.17 -38.6 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.97 -23.09 14.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.488 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -131.26 114.13 14.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.47 -176.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 133' ' ' ASP . 19.0 mt-10 -122.0 120.48 34.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 41.8 tp -33.72 -34.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.0 OUTLIER -86.0 -45.82 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 135' ' ' THR . 17.8 tp10 -58.64 -48.77 79.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 134' ' ' GLU . 20.2 p -31.9 -43.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.094 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.45 -52.48 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.5 m -64.4 -52.93 55.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.49 54.56 2.84 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.449 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -89.53 -37.88 14.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.483 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 3.8 p-10 -69.78 -21.54 63.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.9 mt -82.68 -46.99 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.415 HG23 HD11 ' A' ' 127' ' ' ILE . 41.5 mt -53.13 -45.7 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.491 ' HB3' ' CG1' ' A' ' 166' ' ' ILE . 2.4 p30 -71.66 -28.71 63.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.42 -58.28 7.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -47.57 -65.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.83 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 122' ' ' ASN . 4.2 mm? -46.84 -56.51 6.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.573 ' HB2' HG21 ' A' ' 164' ' ' VAL . 43.7 ttp85 -45.24 -47.02 12.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -64.17 -55.86 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -51.99 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.39 -34.26 64.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -23.28 62.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -93.2 -27.62 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mm -79.12 -18.09 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.3 p -99.16 -33.17 10.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.91 -18.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.5 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 9.8 ptt180 -92.13 -27.94 17.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.834 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.5 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.5 m0 -89.8 11.65 19.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 77.32 11.33 85.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.5 t -121.51 147.88 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.914 0.388 . . . . 0.0 111.104 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.57 150.32 50.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.496 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.0 mm -84.71 96.55 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.451 ' CG2' ' HG2' ' A' ' 97' ' ' GLN . 47.9 p -48.96 -63.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -146.78 -179.36 6.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -141.08 144.25 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.112 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -137.16 139.48 41.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 143' ' ' ASN . 4.2 mm -108.43 140.76 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -97.06 161.65 13.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -45.72 154.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 169' ' ' ILE . 2.1 mp -105.13 152.55 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.419 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 1.7 m-20 -103.88 122.41 44.57 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.588 0.709 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 170.02 17.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.228 . . . . 0.0 112.371 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 145.99 59.02 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 0.0 112.361 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -66.55 162.65 20.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.878 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.9 m -145.5 158.67 43.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.841 0.353 . . . . 0.0 110.888 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.79 172.09 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -81.12 146.31 30.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.9 m -154.93 145.31 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.65 -34.25 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 mp 62.85 35.43 13.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -68.42 137.98 54.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.811 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HG3' HG21 ' A' ' 162' ' ' THR . 23.4 mp0 -85.56 141.88 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.595 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 92.5 m-70 -110.38 132.26 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -94.22 138.26 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 115' ' ' ILE . 17.7 mt -102.33 125.9 56.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.24 112.43 24.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.1 p -118.21 138.76 25.91 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.593 0.711 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.662 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.72 150.95 69.13 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.71 2.274 . . . . 0.0 112.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 154.64 67.56 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.671 2.247 . . . . 0.0 112.395 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' CD ' HD11 ' A' ' 123' ' ' LEU . 3.2 pt20 -136.94 152.04 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -105.37 115.66 30.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HG2' ' A' ' 124' ' ' ARG . 23.1 m -128.44 147.91 32.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.067 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 39.9 mt -79.65 108.71 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.13 -176.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -65.6 -45.45 83.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -83.75 34.35 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 16.2 t-20 49.69 49.82 19.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.591 HG12 HG13 ' A' ' 88' ' ' VAL . 84.9 t -116.57 109.44 28.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -74.21 116.93 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.591 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -142.63 155.03 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 24.5 m -96.89 126.24 41.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.182 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.8 HG11 HG21 ' A' ' 127' ' ' ILE . 12.5 p -115.09 151.54 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -154.48 133.0 12.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.88 152.17 30.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.111 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 28.8 m -101.87 165.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 HD12 ' A' ' 73' ' ' ILE . 24.8 t -135.51 126.12 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -85.42 158.86 20.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.2 p90 -165.6 154.09 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.735 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -150.08 129.23 12.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 98' ' ' VAL . 53.3 t -68.46 91.2 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 pt -73.57 -31.65 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 6.0 t70 -128.67 94.72 34.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.601 0.715 . . . . 0.0 110.859 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.525 ' O ' HG22 ' A' ' 105' ' ' VAL . 53.6 Cg_endo -69.75 -2.49 10.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 0.0 112.316 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 105' ' ' VAL . 19.4 t -80.3 -44.99 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.119 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -90.19 -21.11 22.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -96.84 43.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 102' ' ' VAL . 4.0 t -90.42 40.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.154 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 39.7 p90 -117.93 35.12 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.6 m-80 50.93 36.56 15.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.882 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.767 ' O ' HG13 ' A' ' 108' ' ' VAL . 3.7 p 27.72 41.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 107' ' ' ASN . 1.6 t -95.34 -57.72 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -49.73 -43.78 48.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -59.27 -42.11 90.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.6 mt -58.94 -70.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.936 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 ptp -51.78 -38.16 54.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.54 -66.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.137 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.943 HG21 HD13 ' A' ' 73' ' ' ILE . 15.6 mm -38.7 -63.89 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 75' ' ' VAL . 91.3 t -37.13 -51.62 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -67.73 -55.24 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' ALA . 58.4 mt -46.28 -61.55 1.73 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.902 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' LEU . . . -36.52 -60.97 0.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 123' ' ' LEU . 4.9 mt-30 -39.17 -47.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.1 m -67.92 -47.9 67.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.417 ' HB3' ' CD ' ' A' ' 149' ' ' GLU . 71.1 m-80 -63.29 -65.54 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.954 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.6 pp -44.51 -39.25 4.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.414 ' HG2' HG11 ' A' ' 80' ' ' VAL . 19.5 mtp180 -53.84 -37.1 63.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.13 -47.91 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mp -84.9 -63.83 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.954 HD13 ' HB2' ' A' ' 123' ' ' LEU . 2.1 mp -51.84 -41.52 30.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.17 -30.21 7.46 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.8 pt-20 -118.54 113.05 20.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.824 0.345 . . . . 0.0 110.884 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.408 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -173.21 -174.99 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 58.0 mt-10 -118.31 129.18 55.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 131' ' ' GLU . 64.6 tp -36.72 -29.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 3.8 p-10 -94.08 -46.08 7.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 131' ' ' GLU . 2.6 tp10 -55.04 -44.97 75.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 1.1 p -34.24 -65.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.181 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.5 pp -53.76 -34.99 60.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 134' ' ' GLU . 1.8 t -70.32 -70.3 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.21 69.69 0.65 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 -97.94 -34.45 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.873 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -72.63 -33.0 66.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 141' ' ' ILE . 5.3 mp -68.53 -45.94 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 127' ' ' ILE . 86.6 mt -54.27 -53.23 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.714 ' OD1' HG12 ' A' ' 164' ' ' VAL . 63.4 m-20 -52.19 -41.0 62.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.97 -54.19 48.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.15 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.3 mmt-85 -53.69 -72.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.8 tp -41.36 -38.12 1.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -64.23 -44.87 90.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -75.83 -12.38 60.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 122' ' ' ASN . 28.2 mt-10 -87.95 -39.05 15.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.659 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -93.8 -13.56 27.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.55 -22.75 56.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.1 pttt -89.77 -30.07 18.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.7 mt -82.73 -19.26 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.494 ' CG2' HD11 ' A' ' 115' ' ' ILE . 43.2 p -97.25 -28.17 14.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -47.37 -40.59 17.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.567 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.3 ptm180 -66.45 -32.06 73.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.567 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 42.2 m0 -83.71 14.09 4.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.943 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 65.8 33.96 87.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.448 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.9 t -137.16 145.69 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.135 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -128.83 135.44 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 45.8 mm -70.71 86.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.735 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -38.37 -47.43 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -169.54 179.99 3.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.714 HG12 ' OD1' ' A' ' 143' ' ' ASN . 87.8 t -140.84 140.09 33.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 68.9 mt-10 -123.83 147.12 47.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 143' ' ' ASN . 23.6 mm -109.65 142.15 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -103.16 161.05 14.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -41.68 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -113.75 156.5 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 11.4 m-20 -115.85 122.82 31.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.633 0.73 . . . . 0.0 110.822 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 170.55 16.28 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.269 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.412 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.3 Cg_endo -69.8 141.38 44.92 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 0.0 112.32 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -73.11 166.7 22.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.7 t -79.0 -40.56 31.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.847 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 56.07 33.03 21.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.81 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' HIS . 2.7 p-80 -121.51 118.61 29.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.2 m -148.73 126.64 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -103.24 40.72 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.514 HD23 HE22 ' A' ' 97' ' ' GLN . 3.5 mt 48.29 26.48 1.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 -61.75 114.61 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -103.2 155.39 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 51.0 m-70 -124.0 148.48 46.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.32 145.67 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.624 HD13 HG21 ' A' ' 115' ' ' ILE . 96.5 mt -113.3 124.45 69.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.32 107.23 18.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.647 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.2 p -105.65 138.3 19.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.647 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.76 144.94 55.64 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.717 2.278 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.421 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.75 159.94 51.54 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.633 2.222 . . . . 0.0 112.351 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.38 116.64 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 14.7 mp0 -71.49 118.56 14.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.73 132.5 61.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 47.9 mm -60.9 113.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.586 ' HG ' ' C ' ' A' ' 130' ' ' MET . 0.7 OUTLIER -63.27 -178.4 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 130' ' ' MET . 17.5 tptt -61.41 -47.32 86.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.7 32.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 32.5 m-20 51.4 48.04 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG12 HG13 ' A' ' 88' ' ' VAL . 46.5 t -112.87 109.38 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.9 p -75.23 108.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.132 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.545 HG13 HG12 ' A' ' 86' ' ' VAL . 15.6 m -135.34 153.31 33.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 57.2 m -94.92 128.54 41.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.87 HG11 HG21 ' A' ' 127' ' ' ILE . 2.1 p -115.57 149.6 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.14 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -159.54 127.3 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -142.91 151.53 41.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.746 HG23 ' HB2' ' A' ' 165' ' ' GLU . 3.7 m -97.08 153.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.598 ' CG1' HD12 ' A' ' 161' ' ' ILE . 25.5 t -127.86 127.18 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.121 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.0 m-30 -87.02 159.96 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.951 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 4.2 p90 -165.59 153.51 11.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.838 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -149.74 128.8 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.7 t -65.5 91.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.096 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 pt -71.96 -12.75 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 31.1 t0 -158.4 105.66 1.67 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 0.0 110.901 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.572 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.4 Cg_endo -69.7 -13.44 34.81 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.728 2.285 . . . . 0.0 112.388 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.26 -27.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.184 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -101.31 -20.57 15.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.576 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.53 48.37 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 101' ' ' PRO . 4.0 m -83.0 3.2 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.1 p90 -84.22 24.53 0.94 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.2 m-80 62.1 31.2 17.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.583 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.3 t 33.79 40.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.5 p -95.11 -60.02 1.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.05 -36.56 29.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -65.18 -33.94 77.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.84 -57.03 7.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.5 ptp -67.43 -26.48 66.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.28 -49.45 16.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.624 HG21 HD13 ' A' ' 73' ' ' ILE . 2.6 mm -45.83 -62.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.088 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 m -53.0 -25.54 9.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -83.94 -25.51 30.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 115' ' ' ILE . 25.6 mt -77.84 -46.04 22.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.915 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.94 -53.35 56.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 37.3 mm-40 -40.99 -27.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.2 m -92.09 -37.14 12.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -75.45 -58.23 3.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.772 ' HB2' HD13 ' A' ' 127' ' ' ILE . 2.7 pp -51.05 -40.46 58.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.436 ' N ' HD12 ' A' ' 123' ' ' LEU . 35.6 ttt85 -54.6 -22.99 15.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.61 -58.38 3.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 126' ' ' ILE . 1.4 mp -76.09 -62.82 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.156 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.87 HG21 HG11 ' A' ' 90' ' ' VAL . 3.2 mp -52.64 -40.84 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.79 -20.13 3.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.516 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.4 pt-20 -130.8 113.62 14.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 110.849 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.586 ' C ' ' HG ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -173.7 -175.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.854 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 133' ' ' ASP . 24.4 mm-40 -123.17 120.4 33.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' GLU . 65.0 tp -35.35 -31.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.5 t70 -76.04 -62.34 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -54.64 -46.49 73.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 131' ' ' GLU . 70.6 p -42.36 -52.88 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.162 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 135' ' ' THR . 41.4 mt -35.8 -49.94 0.62 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 28.6 t -121.95 87.64 2.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.83 35.06 0.12 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -78.98 -32.08 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -50.63 -36.97 37.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' ALA . 11.0 mt -87.45 -55.59 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 51.9 mt -42.69 -36.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 144' ' ' ALA . 3.5 p30 -81.73 -31.54 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.451 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -60.78 -54.66 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -56.45 -63.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 146' ' ' LEU . 12.0 mt -42.6 -52.4 4.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -45.22 -41.83 8.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -83.06 -25.0 32.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.492 ' O ' ' CD1' ' A' ' 153' ' ' ILE . 8.0 mm-40 -79.81 -10.39 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 -39.27 3.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.98 -8.42 5.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 153' ' ' ILE . 8.8 ptpt -90.63 -31.79 16.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' A' ' 149' ' ' GLU . 4.8 mp -87.1 -18.31 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.146 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.4 HG21 ' HE2' ' A' ' 111' ' ' PHE . 45.5 p -94.61 -14.93 24.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.104 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -66.54 -14.7 62.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.568 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 15.4 ptm180 -96.7 -22.38 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.568 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 49.3 m0 -93.87 5.27 52.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 78.25 22.8 67.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 111' ' ' PHE . 25.4 t -123.16 135.47 63.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.073 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.32 130.41 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.598 HD12 ' CG1' ' A' ' 94' ' ' VAL . 18.5 mm -73.43 91.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.838 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.5 p -45.36 -44.6 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.414 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.9 OUTLIER -166.82 178.96 5.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 71.7 t -137.87 122.12 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 93' ' ' VAL . 11.1 mt-10 -104.36 138.46 40.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.595 HD13 ' HB1' ' A' ' 92' ' ' ALA . 24.4 mm -112.67 142.34 25.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.084 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -103.11 159.57 15.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -47.42 160.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -108.01 156.66 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.128 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.7 m-20 -104.99 119.99 51.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.723 . . . . 0.0 110.887 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 163.8 36.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 0.0 112.287 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 121.87 8.55 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -47.91 156.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.843 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.4 m -162.41 135.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.854 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -44.68 165.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -92.59 145.74 24.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.3 39.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.31 130.93 22.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' NE2' ' A' ' 97' ' ' GLN . 11.8 mt -92.72 25.03 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -37.84 136.5 0.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -118.65 157.89 26.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 26.3 m-70 -123.98 146.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.477 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 8.1 p -95.4 145.93 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 HG21 ' A' ' 115' ' ' ILE . 19.5 mt -105.68 130.02 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.24 95.06 9.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' HD2' ' A' ' 76' ' ' PRO . 3.3 p -99.17 136.94 20.36 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 111.162 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.4 Cg_endo -69.71 149.44 67.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.688 2.259 . . . . 0.0 112.38 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 168.78 20.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.635 2.223 . . . . 0.0 112.38 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -146.73 118.12 7.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -76.83 102.65 6.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.81 148.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.1 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.5 mt -79.87 106.39 10.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.092 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.406 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.41 -174.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -67.88 -43.15 80.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -84.44 35.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 6.5 t30 51.01 43.25 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.916 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.703 HG13 ' HG3' ' A' ' 172' ' ' PRO . 60.6 t -113.36 110.82 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.86 113.95 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG13 HG12 ' A' ' 86' ' ' VAL . 20.5 m -134.1 150.44 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -89.38 109.67 20.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 127' ' ' ILE . 5.4 m -105.57 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.14 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -168.67 144.09 3.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.503 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.83 146.63 24.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 72' ' ' VAL . 18.0 m -93.61 158.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 161' ' ' ILE . 20.0 t -128.47 137.16 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.142 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.4 m-30 -98.08 160.52 14.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 33.8 p90 -165.83 155.09 11.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.539 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -141.96 121.12 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 98' ' ' VAL . 42.2 t -64.97 93.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -80.81 -29.78 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -127.8 96.66 31.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.7 Cg_endo -69.71 0.37 5.7 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.706 2.271 . . . . 0.0 112.342 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 105' ' ' VAL . 23.9 t -81.39 -44.37 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.134 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -86.58 -32.58 20.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.575 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -87.11 38.66 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.11 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 4.8 m -85.83 12.0 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.575 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.1 p90 -93.02 35.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.4 m-80 52.18 31.81 9.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 108' ' ' VAL . 43.1 t 34.63 40.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.1 p -97.27 -38.82 9.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.54 -45.22 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -61.75 -32.54 72.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.1 mt -61.06 -59.51 5.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 116' ' ' VAL . 15.5 ptp -70.3 -37.82 74.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.0 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.041 HG21 HD13 ' A' ' 73' ' ' ILE . 6.8 mm -63.22 -52.77 54.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 112' ' ' LEU . 2.6 m -65.52 -20.23 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -91.48 -15.55 28.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.688 HD22 HD13 ' A' ' 153' ' ' ILE . 17.0 mt -88.94 -39.3 13.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.956 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.06 81.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.1 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.4 mm-40 -44.98 -30.93 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.3 m -87.42 -49.63 7.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 72.4 m-80 -62.7 -59.27 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.746 HD13 HD12 ' A' ' 127' ' ' ILE . 3.2 pp -48.84 -42.82 37.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 123' ' ' LEU . 23.0 ttm180 -51.67 -41.67 61.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.72 -57.57 11.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.7 mp -76.32 -62.36 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.89 HG21 HG21 ' A' ' 90' ' ' VAL . 20.8 mt -49.3 -44.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.1 -29.11 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.47 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' A' ' 130' ' ' MET . 7.3 pt-20 -121.4 113.96 20.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.863 0.363 . . . . 0.0 110.839 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.42 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -173.04 -175.29 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 133' ' ' ASP . 37.9 mt-10 -121.7 130.63 53.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 131' ' ' GLU . 31.2 tp -36.17 -29.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.1 p-10 -88.66 -63.32 1.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -40.99 -43.84 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.2 p -39.62 -69.81 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.481 HD12 ' C ' ' A' ' 136' ' ' LEU . 2.0 pp -55.4 -29.4 58.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.912 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -107.54 40.89 1.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -166.58 64.94 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.486 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.492 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 20.4 ptt180 -104.78 -37.11 7.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.361 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 0.5 OUTLIER -52.3 -27.65 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.1 mt -88.23 -48.54 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.181 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 138' ' ' GLY . 64.9 mt -54.02 -48.02 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 11.3 p30 -69.76 -42.96 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -47.39 -48.33 26.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.047 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -64.0 -62.79 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.63 -58.94 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 26.0 ttm105 -40.67 -40.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.97 -45.92 22.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -57.89 -28.1 63.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.723 ' O ' HG23 ' A' ' 154' ' ' THR . 36.1 mt -96.39 -31.09 13.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -20.03 66.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.44 -26.01 16.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.688 HD13 HD22 ' A' ' 118' ' ' LEU . 98.2 mt -86.58 -8.73 11.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.991 ' HB ' HG13 ' A' ' 159' ' ' VAL . 62.3 p -103.19 -36.67 8.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.143 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -42.62 -27.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.882 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -80.35 -38.18 31.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.556 ' HB2' HG12 ' A' ' 159' ' ' VAL . 36.1 m0 -84.48 34.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.62 23.61 4.98 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.478 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.991 HG13 ' HB ' ' A' ' 154' ' ' THR . 2.1 p -130.59 143.35 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.86 147.14 52.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 95' ' ' TYR . 12.7 mm -82.91 109.57 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 97' ' ' GLN . 75.9 p -64.55 -43.33 94.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 1.6 ptp180 -165.93 -178.54 4.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.419 ' HB ' ' NH2' ' A' ' 147' ' ' ARG . 38.4 t -141.17 137.5 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -123.34 136.97 54.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.413 HD13 ' CB ' ' A' ' 92' ' ' ALA . 9.9 mm -99.09 140.87 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -95.69 161.68 13.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -47.99 162.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.1 mp -118.75 157.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.503 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.3 t70 -127.16 133.64 25.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 0.0 110.806 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 168.76 20.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.7 2.266 . . . . 0.0 112.362 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.703 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.9 Cg_endo -69.77 163.68 37.36 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.309 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -44.24 145.68 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.805 179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 m -142.68 144.47 32.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 0.0 110.874 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -102.95 -52.86 2.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -87.9 107.91 18.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.9 m -131.34 178.84 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 69' ' ' ARG . 2.9 m-20 -132.02 40.81 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' ASP . 4.0 mm? 35.38 34.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 67' ' ' ASP . 35.1 mtt180 -36.14 109.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -76.91 151.08 35.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -120.55 151.7 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.964 HG12 ' CE1' ' A' ' 95' ' ' TYR . 17.5 m -98.16 156.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.158 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.748 HD11 ' CE1' ' A' ' 111' ' ' PHE . 31.4 mt -118.19 125.02 73.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.27 111.27 18.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 116' ' ' VAL . 85.9 t -120.53 132.19 24.22 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.627 0.727 . . . . 0.0 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.73 152.95 69.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.679 2.252 . . . . 0.0 112.34 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.75 166.93 25.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.662 2.241 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.57 ' NE2' HD11 ' A' ' 123' ' ' LEU . 2.4 tt0 -146.44 117.49 7.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.83 107.03 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 m -121.76 145.22 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.687 ' CD1' HG22 ' A' ' 87' ' ' VAL . 41.0 mm -74.33 109.22 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.35 -174.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -67.34 -45.09 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.15 32.56 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.487 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 3.1 m-20 50.69 44.3 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.48 110.13 30.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 81' ' ' ILE . 6.6 t -70.11 115.19 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.11 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.0 m -142.94 150.0 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.145 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 95.1 m -97.64 130.55 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.946 HG21 HG21 ' A' ' 127' ' ' ILE . 31.3 m -124.34 157.44 31.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 167' ' ' GLN . 18.4 p-10 -160.43 139.53 10.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.86 150.87 28.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -101.29 170.09 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -135.14 131.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.964 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.8 m-30 -91.78 157.95 16.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.572 ' CE1' HG21 ' A' ' 108' ' ' VAL . 13.0 p90 -165.65 158.19 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.1 pt20 -152.3 114.5 4.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.872 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.85 92.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.7 pt -76.05 -18.49 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 11.7 t70 -146.54 106.38 4.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.585 0.707 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.1 Cg_endo -69.73 -18.41 37.14 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.8 t -64.95 -25.75 38.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -101.47 -38.23 8.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -83.78 34.13 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.64 -5.99 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 40.1 p90 -85.13 26.44 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 109' ' ' SER . 14.8 m-80 56.37 37.05 28.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 11.1 p 32.8 36.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 107' ' ' ASN . 7.1 t -93.98 -52.25 4.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -51.4 -46.33 62.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.88 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.748 ' CE1' HD11 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -58.67 -37.45 76.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 73' ' ' ILE . 39.5 mt -63.63 -66.68 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 ptp -57.04 -26.08 59.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.23 -65.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG13 ' CE2' ' A' ' 111' ' ' PHE . 11.9 mm -39.63 -64.24 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.586 ' HA ' HG22 ' A' ' 75' ' ' VAL . 49.1 t -36.22 -40.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -80.03 -55.0 5.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.8 mt -45.69 -49.63 14.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.57 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.544 ' HA ' HD21 ' A' ' 123' ' ' LEU . 36.2 mm-40 -51.87 -39.53 59.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -76.71 -56.84 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -53.38 -57.42 10.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 124' ' ' ARG . 3.1 pp -51.21 -43.12 61.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.71 ' N ' HD12 ' A' ' 123' ' ' LEU . 32.2 ttt85 -49.84 -38.69 36.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.85 -54.28 41.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.68 -62.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.946 HG21 HG21 ' A' ' 90' ' ' VAL . 43.6 mm -48.7 -39.21 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.36 -30.14 24.85 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -122.02 114.02 20.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtp -172.19 -175.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 26.2 mt-10 -119.08 132.96 56.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.473 HD13 ' HD3' ' A' ' 172' ' ' PRO . 48.8 tp -35.81 -30.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 21.6 t70 -90.21 -53.43 4.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.845 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -45.38 -37.51 5.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.32 -65.76 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.122 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -67.83 -28.85 67.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.0 p -103.15 39.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.2 60.18 0.26 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -89.97 -33.35 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.7 -43.35 99.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.0 mt -67.23 -50.7 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 74.7 mt -57.51 -50.5 76.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.504 ' OD1' HD11 ' A' ' 166' ' ' ILE . 82.2 m-20 -57.57 -55.33 36.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -45.43 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 145' ' ' ARG . 5.1 mmp_? -53.93 -69.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.5 mt -55.64 -62.71 1.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 38.8 ttt-85 -41.69 -34.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.8 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.59 -56.47 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.581 ' O ' HG23 ' A' ' 154' ' ' THR . 94.4 mt -54.29 -35.86 63.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -15.82 61.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -84.57 -44.34 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 153' ' ' ILE . 8.7 mt -72.03 -5.36 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.109 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.769 ' HB ' HG13 ' A' ' 159' ' ' VAL . 60.5 p -102.55 -37.66 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -48.51 -20.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.2 ptp180 -87.34 -34.09 18.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.577 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.4 m0 -86.11 19.25 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.77 19.12 62.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.4 p -124.55 148.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 111.144 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -128.66 148.46 50.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.9 mm -88.61 100.86 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -51.66 -51.17 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.203 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -163.98 -176.56 4.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 69.6 t -140.43 143.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.19 137.44 54.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.504 HD11 ' OD1' ' A' ' 143' ' ' ASN . 7.5 mm -107.24 123.22 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.437 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.5 mm-40 -78.11 157.71 29.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 39.9 mmm-85 -42.43 157.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -110.8 155.72 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.6 m-20 -113.23 120.49 40.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.552 0.691 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 170.04 17.44 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.667 2.244 . . . . 0.0 112.358 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.473 ' HD3' HD13 ' A' ' 132' ' ' LEU . 54.0 Cg_endo -69.73 123.95 10.61 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.711 2.274 . . . . 0.0 112.379 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -64.9 168.05 6.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.2 p -128.73 120.33 26.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.362 . . . . 0.0 110.861 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.72 164.28 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -74.66 165.64 24.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -136.51 154.6 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.2 175.28 5.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 29.17 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 -74.29 125.9 29.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.09 148.15 24.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 96' ' ' TYR . 16.0 m-70 -115.62 143.83 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.1 145.63 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 115' ' ' ILE . 54.8 mt -109.02 129.2 64.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.58 100.11 12.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 116' ' ' VAL . 19.6 t -106.23 134.78 19.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.664 0.745 . . . . 0.0 111.148 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.9 Cg_endo -69.72 151.28 69.24 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.745 2.297 . . . . 0.0 112.354 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 54.1 Cg_endo -69.67 161.08 47.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.373 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.476 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 5.2 mt-30 -139.67 117.82 11.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.06 110.69 11.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.65 142.95 41.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.985 ' CD1' HG22 ' A' ' 87' ' ' VAL . 49.6 mm -73.45 105.28 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.03 -179.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -66.09 -36.47 83.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.2 29.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 60.1 t30 49.85 51.97 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -122.46 123.47 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.158 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.985 HG22 ' CD1' ' A' ' 81' ' ' ILE . 3.6 t -82.57 116.57 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.57 155.5 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 m -100.71 122.96 44.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 127' ' ' ILE . 34.7 m -114.18 169.09 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -174.93 135.83 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.79 146.85 24.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.095 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -95.66 166.4 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 161' ' ' ILE . 12.9 t -133.23 127.01 53.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -86.64 159.05 19.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 23.0 p90 -165.69 155.07 12.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.773 ' HG2' HG23 ' A' ' 162' ' ' THR . 2.9 pt20 -145.86 123.99 12.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 98' ' ' VAL . 38.0 t -63.97 96.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.4 pt -80.58 -28.39 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 23.3 t0 -135.58 108.53 10.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.707 . . . . 0.0 110.859 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.7 Cg_endo -69.8 -48.49 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.687 2.258 . . . . 0.0 112.371 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.2 p -48.62 -23.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.141 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -103.83 -27.94 11.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -110.82 41.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.096 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 105' ' ' VAL . 10.0 p -94.75 44.89 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 13.6 p90 -117.75 36.4 4.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.444 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.7 m-80 55.88 28.31 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.0 p 33.26 39.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.162 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 107' ' ' ASN . 25.9 m -94.74 -48.19 6.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.2 -46.72 88.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.565 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -61.08 -41.02 95.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.0 -63.26 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.943 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -58.41 -29.17 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.39 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.072 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.75 HG21 HD13 ' A' ' 73' ' ' ILE . 3.1 mm -39.3 -62.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 76' ' ' PRO . 55.8 t -34.86 -48.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -73.82 -50.05 22.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 122' ' ' ASN . 47.9 mt -44.08 -49.12 8.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.76 -43.7 90.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.122 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.476 ' OE1' ' CG ' ' A' ' 78' ' ' GLN . 35.3 mm-40 -48.35 -35.67 12.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.9 m -86.57 -63.31 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 118' ' ' LEU . 69.7 m-80 -42.72 -51.26 5.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.755 HD12 ' N ' ' A' ' 124' ' ' ARG . 2.6 pp -59.25 -43.68 92.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.755 ' N ' HD12 ' A' ' 123' ' ' LEU . 19.4 ttt180 -51.28 -26.96 8.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.08 1.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.653 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.1 mp -76.47 -60.37 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.547 HG21 HG21 ' A' ' 90' ' ' VAL . 3.6 mt -49.78 -41.64 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.06 -23.85 2.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.61 114.21 17.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.575 ' SD ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -172.89 -176.79 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 mt-10 -115.86 119.81 37.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.518 HD13 ' HD3' ' A' ' 172' ' ' PRO . 21.5 tp -36.61 -29.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -86.99 -58.52 2.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.1 tp10 -48.0 -50.32 27.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' GLU . 40.6 p -35.05 -34.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 134' ' ' GLU . 54.3 mt -62.37 -57.78 10.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 m -77.62 -50.7 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.96 70.41 0.59 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.433 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 31.4 ptt85 -112.59 -9.73 13.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.97 -33.78 21.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 141' ' ' ILE . 4.6 mp -73.86 -37.65 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.143 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.575 HD11 ' SD ' ' A' ' 130' ' ' MET . 44.5 mt -60.6 -43.91 95.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.737 ' HB3' HD11 ' A' ' 166' ' ' ILE . 1.8 p30 -79.98 -31.39 39.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.94 -34.12 74.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -79.08 -56.57 4.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.11 -42.67 29.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -53.8 -40.18 66.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.08 -57.16 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -44.36 -62.02 1.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.43 HD23 HD12 ' A' ' 115' ' ' ILE . 9.4 mp -60.17 -36.09 76.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -11.53 3.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.76 -27.27 15.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 153' ' ' ILE . 39.4 mt -96.62 17.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.6 p -125.71 -34.05 2.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.8 -25.22 26.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.537 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 14.3 ptm180 -83.56 -20.11 34.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.537 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 52.9 m0 -96.85 1.57 50.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.97 12.32 77.15 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 160' ' ' LYS . 53.5 t -119.61 154.23 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.926 0.394 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -134.01 151.64 51.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.48 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 32.4 mm -89.81 92.62 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.773 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -49.12 -48.96 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -163.89 -175.98 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 84.2 t -139.74 141.89 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -124.47 135.39 53.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.737 HD11 ' HB3' ' A' ' 143' ' ' ASN . 3.7 mm -105.33 139.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.69 161.14 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -44.4 156.09 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.6 mp -108.96 156.39 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.104 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.6 m-20 -113.01 120.81 39.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.618 0.723 . . . . 0.0 110.9 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.2 31.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.248 . . . . 0.0 112.306 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.518 ' HD3' HD13 ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.7 153.92 68.61 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.676 2.251 . . . . 0.0 112.358 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -93.15 167.44 11.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 18.6 t0 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 64' ' ' ASP . 8.2 t -166.44 170.01 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.875 0.369 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 63' ' ' SER . 9.9 t70 -37.21 151.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -85.05 106.16 16.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.46 126.85 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.26 112.04 16.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 69' ' ' ARG . 4.6 mp -53.74 -21.9 8.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.452 ' C ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -34.37 142.29 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.52 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 2.2 pm0 -115.12 149.42 37.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 88.8 m-70 -106.9 143.73 34.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.79 140.3 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.948 HD13 HG21 ' A' ' 115' ' ' ILE . 26.5 mt -102.92 125.08 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.53 94.0 9.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG23 ' HD2' ' A' ' 76' ' ' PRO . 5.7 p -97.62 133.68 23.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 0.0 111.181 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 144.66 54.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.643 2.229 . . . . 0.0 112.383 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.73 157.82 59.14 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.276 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.451 HE21 HD11 ' A' ' 123' ' ' LEU . 10.3 tt0 -140.94 118.51 11.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -71.45 109.57 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.45 132.52 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.865 ' CD1' HG22 ' A' ' 87' ' ' VAL . 45.5 mm -68.16 109.43 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -54.44 -175.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -69.71 -38.91 77.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -84.53 26.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 37.6 t30 52.83 48.72 21.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 88' ' ' VAL . 43.8 t -113.87 117.83 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.161 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.865 HG22 ' CD1' ' A' ' 81' ' ' ILE . 47.1 t -77.79 113.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.173 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG13 HG12 ' A' ' 86' ' ' VAL . 29.2 m -143.39 157.35 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.434 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 25.5 m -103.62 123.66 47.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 127' ' ' ILE . 10.0 p -103.47 142.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.114 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.11 132.06 17.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.445 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -152.28 164.55 37.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.31 159.73 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.412 ' O ' HD12 ' A' ' 73' ' ' ILE . 74.3 t -133.97 118.94 30.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 7.3 m-30 -79.38 159.64 27.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.5 p90 -165.71 147.89 7.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.954 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.526 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.9 pt20 -140.24 131.72 26.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 98' ' ' VAL . 50.3 t -71.71 91.04 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.095 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.623 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -83.14 -21.5 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.163 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 99' ' ' ILE . 22.3 t70 -134.95 92.85 18.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.593 0.711 . . . . 0.0 110.871 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 -5.18 15.61 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.663 2.242 . . . . 0.0 112.294 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.64 -50.03 42.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -87.39 -18.06 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.554 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -99.44 43.98 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.106 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 105' ' ' VAL . 13.5 p -89.41 14.19 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.143 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 26.5 p90 -97.47 29.8 3.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.942 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.2 m-80 58.75 28.06 16.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.513 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 10.0 m 35.94 38.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.4 p -92.33 -48.74 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -59.25 -42.76 91.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.514 ' CE2' HG13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -61.39 -31.93 71.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.415 ' O ' HG13 ' A' ' 116' ' ' VAL . 33.1 mt -71.62 -54.3 10.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.8 ptp -74.15 -11.01 60.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -93.2 -57.99 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 73' ' ' ILE . 7.7 mm -39.68 -57.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.48 HG12 ' CG2' ' A' ' 73' ' ' ILE . 1.7 m -57.79 -42.08 81.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.463 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 18.4 mtmt -67.4 -18.9 65.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 18.5 mt -88.16 -42.36 12.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.52 -32.23 68.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.426 ' NE2' ' HG2' ' A' ' 76' ' ' PRO . 35.1 mm-40 -57.7 -28.28 63.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.6 m -89.9 -54.69 3.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -55.49 -52.39 63.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.724 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.3 pp -56.1 -40.18 73.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.704 ' N ' HD12 ' A' ' 123' ' ' LEU . 12.8 ttt180 -56.44 -18.14 10.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.68 -61.06 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.3 mp -74.97 -50.8 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 90' ' ' VAL . 34.4 mm -55.99 -38.26 52.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.34 -28.28 27.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.521 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -123.34 114.29 19.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.55 -177.85 1.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.0 mt-10 -122.14 128.85 51.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.1 tp -34.76 -32.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -86.37 -58.27 2.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 136' ' ' LEU . 2.5 tp10 -47.91 -47.05 32.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 134' ' ' GLU . 28.6 p -33.5 -34.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 134' ' ' GLU . 14.1 mt -84.66 -57.78 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.9 t -52.78 -53.12 52.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.84 57.81 3.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -90.92 -36.86 13.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 18.4 t0 -69.1 -20.11 64.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.894 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.93 -58.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 95.1 mt -42.57 -42.18 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.47 ' ND2' ' HA ' ' A' ' 140' ' ' ASP . 1.4 p30 -76.76 -35.89 57.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.427 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -54.68 -48.63 72.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 148' ' ' GLU . 5.0 mmp_? -62.63 -74.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 145' ' ' ARG . 3.7 mm? -38.15 -37.56 0.28 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 40.7 ttt-85 -62.21 -44.11 97.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' ARG . 11.4 tp10 -74.49 -46.29 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.07 -54.09 50.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -7.62 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -97.92 -41.89 7.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.626 HG22 ' O ' ' A' ' 153' ' ' ILE . 17.0 mt -74.93 5.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.8 p -116.61 -28.86 6.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -58.3 -28.88 65.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 8.3 ptp180 -83.98 -16.33 44.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.845 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.561 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 54.7 m0 -98.87 0.63 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 84.78 9.34 81.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.63 141.64 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 0.0 111.171 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.22 129.17 51.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.44 109.57 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.526 HG23 ' HG2' ' A' ' 97' ' ' GLN . 70.1 p -62.06 -44.41 96.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.76 179.67 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 86.8 t -139.32 132.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -116.57 144.2 44.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 mm -109.16 142.26 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -102.14 159.58 15.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -47.53 146.12 2.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.5 mp -96.0 156.57 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.0 m-20 -108.66 119.23 49.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 168.37 21.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 161.14 47.09 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.688 2.259 . . . . 0.0 112.381 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -102.07 -49.08 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 6.8 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.848 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 m -157.72 135.98 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.82 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -57.58 165.17 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -82.58 143.81 30.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.4 t -120.52 121.05 64.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -152.49 168.58 25.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.6 tt -44.56 -26.21 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.904 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 -40.05 95.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -77.77 145.14 36.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.587 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 81.5 m-70 -110.31 142.94 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.45 139.58 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 115' ' ' ILE . 32.5 mt -106.45 119.58 56.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.89 124.26 29.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.5 HG23 ' HD2' ' A' ' 76' ' ' PRO . 14.5 p -121.1 136.84 26.0 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.652 0.739 . . . . 0.0 111.114 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.74 147.98 64.18 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.691 2.26 . . . . 0.0 112.346 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 143.71 51.73 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' OE1' ' CZ ' ' A' ' 124' ' ' ARG . 7.6 tt0 -126.86 126.84 43.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.554 ' OE2' HG23 ' A' ' 89' ' ' THR . 26.4 mp0 -93.37 96.43 9.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.405 ' CG1' ' OE1' ' A' ' 78' ' ' GLN . 15.2 m -108.54 145.27 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 74.3 mt -70.27 106.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.403 ' O ' ' O ' ' A' ' 81' ' ' ILE . 1.6 m -51.36 -175.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -69.54 -39.17 77.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 86' ' ' VAL . 38.9 t70 -86.94 34.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.7 t-20 48.08 45.79 19.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 84' ' ' ASP . 58.3 t -118.5 110.59 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 87' ' ' VAL . 7.3 p -75.25 123.89 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.39 151.4 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.554 HG23 ' OE2' ' A' ' 79' ' ' GLU . 19.7 m -91.71 116.81 29.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.605 HG21 HG21 ' A' ' 127' ' ' ILE . 17.5 m -108.02 160.16 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -166.85 137.0 3.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.85 142.22 20.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 165' ' ' GLU . 15.4 m -93.88 159.36 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 150' ' ' LEU . 25.7 t -135.24 137.67 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 161' ' ' ILE . 4.7 m-30 -97.37 163.27 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.587 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 1.4 p90 -165.59 156.38 13.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.72 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.8 pt20 -152.75 134.21 14.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.94 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.14 99.28 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.3 pt -83.44 -9.35 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.163 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.604 ' OD1' HG22 ' A' ' 102' ' ' VAL . 30.9 t0 -155.96 109.77 2.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.655 0.741 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.35 16.76 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.258 . . . . 0.0 112.36 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.604 HG22 ' OD1' ' A' ' 100' ' ' ASP . 34.2 m -62.52 -14.99 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.158 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -103.58 -26.0 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' A' ' 108' ' ' VAL . . . -104.47 45.8 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -77.83 -2.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.094 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 38.7 p90 -86.49 38.44 0.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.472 ' CG ' ' C ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 49.2 27.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.633 HG22 ' HB1' ' A' ' 104' ' ' ALA . 13.2 t 36.09 40.39 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.8 t -96.85 -50.42 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.91 -40.42 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.538 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.4 t80 -61.51 -40.52 94.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.48 -67.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -55.81 -38.99 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.78 -58.64 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.108 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 73' ' ' ILE . 11.3 mm -46.31 -58.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 t -49.79 -23.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -93.57 -33.18 13.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.44 -51.84 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.26 21.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -67.14 -31.39 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 94.2 m -87.91 -29.4 20.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.141 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.564 ' O ' HD12 ' A' ' 126' ' ' ILE . 78.3 m-20 -78.9 -44.74 22.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 123' ' ' LEU . 1.8 pp -62.63 -40.94 98.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.429 ' CZ ' ' OE1' ' A' ' 78' ' ' GLN . 40.8 mtt-85 -52.15 -24.61 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.0 -57.0 3.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.9 mp -79.74 -63.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.605 HG21 HG21 ' A' ' 90' ' ' VAL . 3.4 mt -51.57 -44.78 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.6 -25.52 1.44 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.543 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -124.18 113.89 18.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.903 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.27 -178.03 1.96 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 132' ' ' LEU . 42.0 mt-10 -120.94 130.5 53.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 131' ' ' GLU . 13.3 tp -34.42 -35.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.2 m-20 -80.83 -51.03 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -54.44 -49.47 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 77.6 p -45.43 -31.18 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.1 mt -73.82 -49.46 25.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.7 m -106.48 37.27 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.3 21.3 5.18 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -74.19 -0.93 18.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.66 -27.38 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.604 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.4 mp -85.32 -41.33 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 38.1 mt -60.42 -58.35 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.626 ' CB ' HG21 ' A' ' 164' ' ' VAL . 14.4 p-10 -59.43 -33.26 71.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.74 -39.31 73.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.062 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -84.69 -58.59 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.13 -53.21 4.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.481 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 24.7 ttp180 -44.33 -40.49 5.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -57.38 3.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -48.66 -23.37 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 94' ' ' VAL . 82.8 mt -102.66 -23.99 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.49 -6.24 58.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.98 -33.28 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.0 mt -79.02 -17.72 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 159' ' ' VAL . 82.0 p -97.18 -38.28 9.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.136 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -42.68 -44.38 4.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 12.5 ptm180 -60.55 -34.65 74.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.583 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 40.5 m0 -85.53 12.96 7.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.32 11.19 84.35 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.512 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 154' ' ' THR . 55.2 t -119.98 140.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 111.115 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.92 145.09 51.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 95' ' ' TYR . 23.7 mm -75.85 106.48 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.72 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -56.12 -41.25 74.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -171.21 178.5 3.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.626 HG21 ' CB ' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -129.97 148.42 33.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.583 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.3 mm-40 -137.82 115.64 11.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.481 HD13 ' HB1' ' A' ' 92' ' ' ALA . 15.4 mm -93.18 141.53 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -100.06 160.54 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.5 mtt-85 -51.52 159.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.0 mp -108.26 156.51 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.499 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 5.7 m-20 -115.72 129.66 24.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 161.93 44.01 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.436 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 54.0 Cg_endo -69.74 122.95 9.63 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.648 2.232 . . . . 0.0 112.375 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -87.11 164.31 16.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.3 m -62.76 137.67 58.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.843 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -55.17 -57.77 10.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -79.55 110.39 14.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -144.2 144.24 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -84.3 146.46 27.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 45.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -77.29 133.74 38.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -115.05 141.6 47.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 96' ' ' TYR . 90.0 m-70 -101.39 159.05 15.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -111.33 144.23 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 115' ' ' ILE . 33.5 mt -106.31 134.79 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.74 108.12 20.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.567 HG23 ' HD2' ' A' ' 76' ' ' PRO . 4.6 p -114.86 136.16 22.5 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.595 0.712 . . . . 0.0 111.132 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.567 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.77 146.12 59.18 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.9 Cg_endo -69.76 159.38 53.64 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.681 2.254 . . . . 0.0 112.369 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 120' ' ' GLN . 27.2 mt-30 -143.99 129.69 19.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.24 94.83 7.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.839 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 140.57 18.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.614 HD13 HG22 ' A' ' 87' ' ' VAL . 31.3 mm -67.18 102.45 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.52 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -59.69 -42.95 94.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.98 30.04 0.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.845 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.478 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 5.7 t-20 51.98 50.62 18.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.06 120.36 63.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.092 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.614 HG22 HD13 ' A' ' 81' ' ' ILE . 24.7 t -77.88 116.36 21.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.63 149.88 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.507 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 8.5 m -91.94 117.09 29.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.761 HG11 HG21 ' A' ' 127' ' ' ILE . 5.2 p -116.1 141.44 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -143.84 141.9 30.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.5 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.25 145.68 23.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.45 166.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.5 t -133.51 131.68 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.49 ' O ' HG23 ' A' ' 161' ' ' ILE . 5.7 m-30 -92.72 157.08 16.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.441 ' CG ' ' CZ ' ' A' ' 111' ' ' PHE . 8.7 p90 -165.84 156.34 13.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.74 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -153.03 121.31 6.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.8 100.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 pt -86.21 -24.14 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 101' ' ' PRO . 19.0 t0 -138.57 105.59 7.66 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 0.0 110.808 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 53.8 Cg_endo -69.79 -43.65 2.51 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.696 2.264 . . . . 0.0 112.307 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.2 m -50.78 -19.23 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -107.91 -34.08 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.919 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -101.91 43.26 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 105' ' ' VAL . 10.1 p -87.25 33.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 34.4 p90 -111.7 27.42 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 109' ' ' SER . 8.1 m-80 58.09 34.76 24.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.56 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 13.3 m 33.52 35.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.5 p -86.13 -60.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.823 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.46 -46.5 48.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -58.54 -39.67 80.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.07 -65.6 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.6 ptp -57.97 -31.66 67.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.59 -66.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 73' ' ' ILE . 16.7 mm -39.04 -63.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.508 HG13 HG23 ' A' ' 75' ' ' VAL . 47.4 t -41.61 -50.57 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.136 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -62.13 -50.5 71.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.14 -60.28 3.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.37 -61.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' CD ' ' CD ' ' A' ' 78' ' ' GLN . 12.8 mm-40 -39.41 -33.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 m -88.1 -53.95 4.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.143 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -56.16 -56.8 16.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.467 ' C ' HD12 ' A' ' 123' ' ' LEU . 2.6 pp -51.53 -41.06 60.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttp180 -55.98 -22.37 26.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.78 -59.58 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.119 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.8 mp -78.17 -60.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.121 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.761 HG21 HG11 ' A' ' 90' ' ' VAL . 11.2 mt -54.97 -47.41 76.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.142 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -42.87 -27.34 0.56 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 130' ' ' MET . 6.8 pt-20 -120.58 113.33 20.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.913 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.4 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -173.12 -174.99 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 135' ' ' THR . 15.8 mt-10 -116.96 127.84 54.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.462 ' C ' ' O ' ' A' ' 131' ' ' GLU . 20.7 tp -33.32 -35.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.1 t70 -84.15 -65.45 1.01 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 135' ' ' THR . 29.6 tt0 -41.69 -47.7 4.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 131' ' ' GLU . 72.9 p -33.18 -40.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.139 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 mt -73.83 -51.14 17.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 m -61.54 -58.36 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.89 65.39 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' C ' ' CD ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -97.06 -45.21 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.467 ' HA ' ' ND2' ' A' ' 143' ' ' ASN . 13.0 t70 -59.07 -29.01 67.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 144' ' ' ALA . 48.3 mt -73.81 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 86.9 mt -39.73 -50.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.474 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 1.5 p30 -69.49 -33.39 72.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 141' ' ' ILE . . . -59.24 -64.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -46.15 -63.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.7 mt -48.11 -51.3 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 163' ' ' ARG . 26.8 ttm180 -44.49 -40.57 5.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.5 -56.35 4.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -42.91 -55.23 3.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.433 HD23 HD12 ' A' ' 115' ' ' ILE . 9.8 mp -68.01 -35.71 78.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -20.87 40.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -82.72 -29.95 29.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 mm -83.71 -17.62 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.944 ' HB ' HG13 ' A' ' 159' ' ' VAL . 64.0 p -93.93 -39.96 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -41.51 -29.87 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.451 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 11.8 ptm180 -79.92 -36.44 36.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.484 ' N ' ' O ' ' A' ' 154' ' ' THR . 35.6 m0 -84.16 30.29 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.26 33.74 39.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.507 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.944 HG13 ' HB ' ' A' ' 154' ' ' THR . 1.5 p -141.49 144.25 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 111.151 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 3.3 tmmm? -127.92 151.08 49.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 95' ' ' TYR . 27.0 mm -89.02 91.09 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.158 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.74 HG23 ' HG2' ' A' ' 97' ' ' GLN . 19.0 p -42.3 -46.68 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.144 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 147' ' ' ARG . 14.5 ptm180 -169.4 -175.03 2.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 143' ' ' ASN . 73.8 t -139.72 147.28 24.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -127.57 137.74 52.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.894 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 28.4 mm -102.92 142.32 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.57 161.88 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.951 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -47.52 156.64 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.918 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -109.81 157.51 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 2.1 t70 -126.09 133.28 24.79 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.63 0.729 . . . . 0.0 110.885 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 170.15 17.25 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.354 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 139.86 41.15 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.678 2.252 . . . . 0.0 112.318 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -56.29 164.09 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 42.1 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.4 p -144.01 150.76 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -70.27 169.07 14.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -75.33 123.33 25.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.34 139.13 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.76 -176.21 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.04 46.35 1.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.1 ptt85 -60.83 123.53 17.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.847 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -104.74 144.33 31.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -111.96 145.66 39.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.858 HG12 ' CE1' ' A' ' 95' ' ' TYR . 34.5 m -94.21 140.39 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.481 HD11 ' CD2' ' A' ' 96' ' ' TYR . 21.0 mt -107.55 119.24 56.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 118.57 20.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 116' ' ' VAL . 88.8 t -117.41 132.68 23.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.729 . . . . 0.0 111.119 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 54.1 Cg_endo -69.75 144.37 53.87 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.69 2.26 . . . . 0.0 112.307 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.85 164.28 35.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.628 2.218 . . . . 0.0 112.316 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.541 ' CD ' HD11 ' A' ' 123' ' ' LEU . 1.3 pt20 -146.67 139.44 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -90.55 129.43 36.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.97 145.19 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.142 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.481 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 78.9 mt -74.73 114.59 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.2 -175.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -68.53 -38.86 81.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.15 23.55 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 27.7 m-20 60.41 50.68 5.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 88' ' ' VAL . 70.7 t -118.82 111.16 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.5 p -75.27 115.41 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.084 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.5 HG13 HG12 ' A' ' 86' ' ' VAL . 15.7 m -140.19 162.2 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.49 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 31.9 m -102.84 125.04 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.196 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 91' ' ' ASP . 11.4 p -105.83 162.21 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 90' ' ' VAL . 2.9 p30 -171.01 134.71 0.97 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.08 35.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 165' ' ' GLU . 17.1 m -102.96 164.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 t -133.93 134.28 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.858 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.2 m-30 -96.77 154.4 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.481 ' CD2' HD11 ' A' ' 73' ' ' ILE . 3.8 p90 -165.65 161.26 18.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' O ' HG23 ' A' ' 99' ' ' ILE . 2.2 pt20 -153.17 114.2 4.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.84 91.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.084 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 97' ' ' GLN . 2.7 pp -89.68 -24.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.596 ' HB2' HD12 ' A' ' 99' ' ' ILE . 29.3 t70 -133.64 90.12 29.16 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.643 0.735 . . . . 0.0 110.898 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -40.61 5.09 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.708 2.272 . . . . 0.0 112.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 103' ' ' LYS . 27.5 m -38.39 -41.52 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 102' ' ' VAL . 23.1 mtpp -91.43 -35.65 14.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.556 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -84.45 41.64 0.85 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.087 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 105' ' ' VAL . 6.1 p -87.66 47.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 23.7 p90 -130.37 32.21 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 108' ' ' VAL . 3.3 m-80 60.93 28.06 17.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 6.4 t 36.1 35.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.113 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 107' ' ' ASN . 54.9 m -89.76 -58.75 2.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -47.46 -54.56 11.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.566 ' CE1' HG13 ' A' ' 115' ' ' ILE . 1.3 t80 -50.13 -48.38 53.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 73' ' ' ILE . 9.1 mt -51.48 -68.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.5 ptp -60.95 -14.91 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.18 -34.51 23.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.068 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.649 HD13 HD12 ' A' ' 150' ' ' LEU . 14.1 mm -72.1 -54.83 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.655 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.0 m -56.68 -22.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.149 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -92.69 -45.21 8.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.0 mt -54.38 -44.1 71.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.11 97.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.479 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 35.2 mm-40 -47.87 -33.09 6.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.1 m -87.0 -50.57 6.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.164 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -58.51 -58.25 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.541 HD11 ' CD ' ' A' ' 78' ' ' GLN . 2.3 pp -51.72 -39.99 59.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -52.93 -31.99 43.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.81 -51.69 31.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.83 -60.12 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.126 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.505 HD11 HG23 ' A' ' 142' ' ' ILE . 47.0 mm -50.61 -38.01 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.136 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.11 -33.83 38.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 130' ' ' MET . 11.9 pt-20 -117.06 113.93 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.404 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.5 OUTLIER -171.8 -177.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.44 121.92 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 131' ' ' GLU . 63.8 tp -33.55 -34.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 131' ' ' GLU . 25.3 t0 -83.96 -51.71 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 135' ' ' THR . 49.1 tt0 -52.99 -47.55 68.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 134' ' ' GLU . 29.8 p -35.82 -50.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.51 -47.12 79.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.4 t -102.47 85.58 2.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 142' ' ' ILE . . . 171.01 37.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.462 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.494 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 28.1 ttp180 -76.62 -31.42 57.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.801 0.334 . . . . 0.0 110.835 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 144' ' ' ALA . 5.1 m-20 -60.18 -38.37 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.4 mt -78.89 -60.11 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 127' ' ' ILE . 20.3 mt -42.95 -51.67 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 139' ' ' ARG . 0.8 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 140' ' ' ASP . . . -57.72 -60.63 3.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.2 mmt-85 -49.63 -68.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 149' ' ' GLU . 4.0 mm? -43.03 -59.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 146' ' ' LEU . 45.5 ttp180 -35.74 -43.25 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.66 -38.7 28.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 146' ' ' LEU . 39.7 mm-40 -62.23 -27.63 69.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.649 HD12 HD13 ' A' ' 115' ' ' ILE . 3.8 mm? -99.42 -29.72 12.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -15.22 60.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.33 -20.56 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.8 mm -91.48 -12.28 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 161' ' ' ILE . 72.0 p -101.31 -33.98 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -50.65 -23.3 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -88.2 -30.23 19.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -88.09 17.6 4.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 100' ' ' ASP . . . 66.71 26.94 73.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.48 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.86 135.75 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 111.148 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.96 139.93 48.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 154' ' ' THR . 42.5 mm -84.98 109.48 18.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -60.54 -55.09 37.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -163.0 -176.16 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.867 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.77 140.47 33.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.169 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 93' ' ' VAL . 2.7 mm-40 -126.3 135.99 52.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 22.0 mm -103.5 141.73 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.14 161.65 13.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -51.59 154.58 1.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -104.53 156.06 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.137 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.48 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.2 m-20 -109.11 120.66 45.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 110.853 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 166.15 28.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.3 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 153.67 68.55 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.642 2.228 . . . . 0.0 112.317 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -58.22 157.91 7.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.1 m -107.29 109.71 21.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -88.18 -70.55 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.526 ' H ' ' CD2' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -118.36 106.76 13.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.818 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' CG2' HD13 ' A' ' 68' ' ' LEU . 14.7 p -175.07 149.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' LEU . 6.0 m-20 -47.31 -75.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.557 HD13 ' CG2' ' A' ' 66' ' ' VAL . 9.9 mp 35.72 34.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' ASP . 29.9 ptt180 -48.59 174.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' A' ' 97' ' ' GLN . 18.4 mp0 -114.59 144.97 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.592 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 65.7 m-70 -117.4 128.73 55.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.853 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -93.77 135.44 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.941 HD13 HG21 ' A' ' 115' ' ' ILE . 21.9 mt -100.69 125.66 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.73 103.96 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 12.7 p -106.06 135.07 19.49 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.78 150.78 68.55 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.627 2.218 . . . . 0.0 112.355 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.485 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.1 Cg_endo -69.69 156.94 62.2 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.262 . . . . 0.0 112.348 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -142.99 121.34 12.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.77 105.66 11.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 127' ' ' ILE . 17.5 m -116.12 148.78 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 69.3 mt -77.12 106.22 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.36 -174.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -64.67 -47.63 77.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 86' ' ' VAL . 26.3 t0 -82.84 37.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.9 m120 47.61 54.8 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.567 HG12 HG13 ' A' ' 88' ' ' VAL . 47.9 t -124.38 110.16 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.4 t -78.35 108.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.567 HG13 HG12 ' A' ' 86' ' ' VAL . 27.5 m -128.46 146.63 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.485 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 1.8 m -80.52 113.52 18.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.899 HG11 HG21 ' A' ' 127' ' ' ILE . 4.8 p -107.41 143.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 15.8 p-10 -151.73 140.8 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.459 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.19 146.92 24.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -97.34 159.11 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 150' ' ' LEU . 40.5 t -131.9 129.12 60.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -93.17 159.82 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.0 p90 -165.56 159.87 17.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.731 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -152.36 128.72 10.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 98' ' ' VAL . 46.5 t -67.32 93.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 100' ' ' ASP . 45.7 pt -73.07 -36.15 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.152 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.426 ' N ' HG13 ' A' ' 99' ' ' ILE . 24.8 t0 -125.4 99.24 33.77 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' O ' HG12 ' A' ' 105' ' ' VAL . 53.9 Cg_endo -69.77 -7.52 21.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.352 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.717 ' O ' HG13 ' A' ' 105' ' ' VAL . 54.2 t -76.88 -47.83 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -82.95 -33.36 26.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -88.2 46.37 1.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 102' ' ' VAL . 16.1 m -89.22 30.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 45.6 p90 -112.66 35.61 3.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m120 47.12 36.68 4.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.563 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 33.2 m 31.08 41.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 107' ' ' ASN . 4.1 m -89.19 -59.27 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.8 OUTLIER -52.81 -34.2 52.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -70.36 -40.16 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.5 mt -62.15 -54.93 34.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 ptp -68.62 -33.64 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -66.87 -59.08 3.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.117 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.941 HG21 HD13 ' A' ' 73' ' ' ILE . 16.2 mm -46.33 -63.68 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.2 t -39.48 -40.64 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -74.04 -49.46 24.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.7 mt -55.72 -57.56 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.32 -51.38 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HA ' HD21 ' A' ' 123' ' ' LEU . 46.4 mm-40 -42.85 -41.46 3.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 84.9 m -75.94 -59.3 2.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -45.77 -57.87 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.3 pp -54.06 -43.65 70.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.657 ' N ' HD12 ' A' ' 123' ' ' LEU . 20.1 ttp180 -53.01 -32.4 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.64 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.2 mp -76.35 -63.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.899 HG21 HG11 ' A' ' 90' ' ' VAL . 2.9 mp -49.62 -45.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.12 -26.18 1.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.47 113.75 17.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.347 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.98 -175.89 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 133' ' ' ASP . 14.3 mm-40 -122.76 123.31 40.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 131' ' ' GLU . 46.3 tp -34.39 -32.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.9 m-20 -83.93 -46.63 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 131' ' ' GLU . 37.0 tt0 -56.31 -50.58 71.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 136' ' ' LEU . 79.1 p -42.17 -56.35 2.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.131 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 135' ' ' THR . 97.4 mt -34.79 -51.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.9 m -117.76 87.21 2.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.81 39.11 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -82.97 -40.28 20.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -51.71 -44.02 63.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.708 HG22 ' NE ' ' A' ' 145' ' ' ARG . 26.5 mt -68.96 -54.85 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.7 mt -54.03 -36.81 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.176 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.497 ' OD1' ' CD1' ' A' ' 166' ' ' ILE . 80.5 m-20 -68.92 -19.14 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.4 -40.85 17.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.073 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.708 ' NE ' HG22 ' A' ' 141' ' ' ILE . 0.5 OUTLIER -66.59 -55.84 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.55 -32.7 67.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 31.6 ttt-85 -79.43 -40.55 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.452 ' CD ' ' O ' ' A' ' 148' ' ' GLU . 9.9 tm-20 -63.28 -25.49 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -91.17 -62.49 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 94' ' ' VAL . 79.4 mt -54.13 -20.72 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 147' ' ' ARG . 21.0 t0 -83.86 13.85 4.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -121.45 -40.87 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 153' ' ' ILE . 22.1 mt -76.93 -8.42 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.089 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.428 ' CG2' HD11 ' A' ' 115' ' ' ILE . 71.6 p -100.65 -38.01 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -45.98 -37.66 6.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.516 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 6.4 ptp180 -66.74 -33.64 76.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.516 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 38.1 m0 -86.19 10.62 14.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.963 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 75.52 17.16 80.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.2 t -122.45 141.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -125.16 150.54 46.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 160' ' ' LYS . 29.3 mm -85.82 113.88 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.731 HG23 ' HG2' ' A' ' 97' ' ' GLN . 25.7 p -68.02 -55.53 12.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 163' ' ' ARG . 4.5 ptp180 -156.01 178.0 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 147' ' ' ARG . 99.4 t -141.41 145.86 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.26 145.1 51.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.497 ' CD1' ' OD1' ' A' ' 143' ' ' ASN . 19.9 mm -106.92 142.29 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.429 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 21.4 mm-40 -94.06 161.79 14.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -54.57 141.72 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.849 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.2 mp -91.22 157.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 3.7 t70 -128.34 133.78 25.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.585 0.707 . . . . 0.0 110.881 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 167.36 24.64 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 154.79 67.14 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.657 2.238 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -80.97 -57.83 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.844 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 64' ' ' ASP . 18.5 p -108.9 -60.56 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.813 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 63' ' ' SER . 7.4 t70 37.05 39.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -116.63 108.5 16.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.854 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 m -154.14 128.01 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -149.58 134.72 18.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.884 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 69' ' ' ARG . 3.3 mp -54.75 -31.75 58.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 68' ' ' LEU . 25.8 mtt-85 -33.62 125.87 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HG3' HG21 ' A' ' 162' ' ' THR . 11.8 mp0 -75.61 140.86 42.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 66.4 m-70 -108.46 134.46 51.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.59 HG12 ' CE1' ' A' ' 95' ' ' TYR . 11.3 m -93.96 151.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.121 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.005 HD13 HG21 ' A' ' 115' ' ' ILE . 20.8 mt -117.56 117.85 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.48 110.38 17.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.1 p -115.89 137.07 23.06 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.643 0.735 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.82 149.53 66.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.314 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 159.11 54.56 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.266 . . . . 0.0 112.335 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -145.4 115.59 7.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.78 117.2 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.74 139.1 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.476 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 49.0 mt -70.29 105.52 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.5 m -50.5 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -64.94 -42.65 94.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.34 30.63 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.476 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.2 OUTLIER 53.46 44.72 29.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.479 HG12 HG13 ' A' ' 88' ' ' VAL . 41.1 t -111.82 114.21 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.8 p -77.18 114.29 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 HG12 ' A' ' 86' ' ' VAL . 27.1 m -142.84 144.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.5 m -87.34 124.48 33.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.103 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 127' ' ' ILE . 28.8 m -114.26 163.98 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -174.86 136.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 166' ' ' ILE . . . -154.07 151.54 29.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.2 m -95.65 164.74 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.1 132.75 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' HG12 ' A' ' 72' ' ' VAL . 4.4 m-30 -91.05 157.6 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 7.7 p90 -165.7 146.23 6.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.827 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.6 pt20 -141.92 123.14 14.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 159' ' ' VAL . 90.5 t -66.54 124.13 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -111.11 -30.07 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 99' ' ' ILE . 34.5 t70 -124.38 101.67 34.07 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.572 0.701 . . . . 0.0 110.908 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 100' ' ' ASP . 54.3 Cg_endo -69.74 -48.12 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.401 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.0 m -41.45 -38.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.185 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -91.6 -37.82 12.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -91.3 45.88 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 105' ' ' VAL . 9.4 p -90.73 40.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.561 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 28.7 p90 -119.99 32.83 5.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' SER . 2.9 m-80 49.8 38.02 14.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 108' ' ' VAL . 13.9 t 34.41 33.39 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.122 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' ASN . 35.6 m -87.98 -51.17 5.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.38 -47.57 75.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.728 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -60.2 -36.32 77.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 12.8 mt -60.79 -60.54 3.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.9 -45.42 89.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.52 -55.14 37.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.005 HG21 HD13 ' A' ' 73' ' ' ILE . 10.9 mm -48.73 -62.96 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 76' ' ' PRO . 49.6 t -42.01 -33.66 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -79.16 -53.97 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 153' ' ' ILE . 14.4 mt -52.35 -58.9 5.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -38.84 -51.96 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -43.73 -41.17 4.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.8 m -78.18 -46.94 19.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -57.11 -61.12 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 127' ' ' ILE . 3.9 pp -55.11 -42.14 72.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.561 ' N ' HD12 ' A' ' 123' ' ' LEU . 15.7 ttm180 -54.59 -25.46 26.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.74 6.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.08 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.446 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.3 mp -79.27 -64.22 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.83 HG21 HG21 ' A' ' 90' ' ' VAL . 2.9 mp -48.7 -42.66 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -46.91 -30.48 5.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -119.38 113.91 21.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.812 0.339 . . . . 0.0 110.925 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.458 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -172.61 -175.19 1.28 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 133' ' ' ASP . 9.2 mt-10 -119.3 123.88 45.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 131' ' ' GLU . 51.8 tp -33.68 -34.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 131' ' ' GLU . 1.3 m-20 -86.17 -54.1 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.459 ' O ' ' C ' ' A' ' 135' ' ' THR . 70.7 tt0 -50.8 -49.81 57.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 134' ' ' GLU . 35.1 p -32.49 -51.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.117 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 mt -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 134' ' ' GLU . 2.2 m -93.86 41.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.871 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.469 ' O ' ' CD1' ' A' ' 142' ' ' ILE . . . -146.84 49.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG2' ' ND2' ' A' ' 143' ' ' ASN . 45.8 ttt180 -95.37 -43.27 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.43 -19.4 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 25.1 mt -95.55 -56.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.198 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 127' ' ' ILE . 46.3 mt -46.82 -41.77 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.489 ' ND2' ' HG2' ' A' ' 139' ' ' ARG . 16.9 p30 -77.69 -20.44 53.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.92 -37.1 40.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -74.15 -66.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.4 mt -42.92 -35.75 1.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -75.71 -41.16 54.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -18.07 63.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.26 -48.53 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 115' ' ' ILE . 65.4 mt -67.88 -35.73 79.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -58.11 -11.85 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -95.88 -45.36 6.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 153' ' ' ILE . 68.8 mt -75.31 -1.45 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.477 HG21 HD11 ' A' ' 161' ' ' ILE . 26.6 p -109.02 -40.62 4.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -45.34 -34.88 3.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 10.2 ptm180 -70.04 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.578 ' CD1' ' HG3' ' A' ' 156' ' ' ARG . 51.4 m0 -88.08 11.88 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 69.87 35.12 72.22 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 99' ' ' ILE . 20.5 t -138.8 136.62 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 0.0 111.165 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -116.3 141.0 48.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.477 HD11 HG21 ' A' ' 154' ' ' THR . 46.9 mm -82.95 96.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.827 HG23 ' HG2' ' A' ' 97' ' ' GLN . 12.0 p -47.75 -55.56 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -163.57 -175.95 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.16 137.07 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.094 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -119.08 143.72 46.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.412 ' HA ' ' CB ' ' A' ' 92' ' ' ALA . 15.3 mm -109.69 142.26 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.42 161.46 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -43.13 158.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 45.4 mt -113.15 154.72 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.438 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 38.2 m-20 -118.68 126.54 27.08 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.586 0.708 . . . . 0.0 110.875 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.93 17.75 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.696 2.264 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 131.56 21.46 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.244 . . . . 0.0 112.326 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.55 165.5 11.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 179.912 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -44.04 -48.73 8.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 110.863 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.33 -58.5 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 65' ' ' HIS . 4.3 p80 -119.78 113.72 21.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.54 171.71 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -109.44 135.71 50.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mp -81.94 39.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -90.25 104.56 17.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 157.84 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 86.4 m-70 -124.37 156.74 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 95' ' ' TYR . 2.7 m -99.69 152.71 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.983 HD13 HG21 ' A' ' 115' ' ' ILE . 20.0 mt -110.03 131.59 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.76 105.99 18.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 92' ' ' ALA . 2.2 p -118.3 127.36 26.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.485 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.3 Cg_endo -69.78 150.24 67.85 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.6 Cg_endo -69.78 164.68 33.64 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 2.264 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -145.26 115.08 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -72.76 100.24 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.8 t -114.73 137.13 49.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 21.8 mt -70.2 105.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.11 -177.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -67.8 -35.94 79.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.91 28.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 13.8 m-20 54.32 45.42 27.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 88' ' ' VAL . 55.6 t -114.82 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.3 p -84.04 108.93 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 86' ' ' VAL . 15.0 m -135.63 152.81 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 3.6 m -88.89 130.87 35.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 127' ' ' ILE . 8.2 p -120.21 132.06 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -141.1 138.33 33.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.427 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -153.78 171.55 18.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' A' ' 165' ' ' GLU . 13.7 m -121.66 159.08 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 73' ' ' ILE . 38.5 t -130.73 130.42 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 72' ' ' VAL . 3.7 m-30 -91.27 160.81 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 2.6 p90 -165.85 157.0 13.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.697 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.9 pt20 -152.17 132.36 13.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 98' ' ' VAL . 20.3 t -73.54 98.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.8 pt -76.55 -19.75 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.082 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -143.91 106.36 4.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.653 0.739 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -10.06 27.6 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.3 t -77.36 -29.65 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.128 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HE2' ' N ' ' A' ' 158' ' ' GLY . 31.2 mtpt -94.65 -34.56 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.568 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -90.92 47.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 105' ' ' VAL . 61.1 t -78.55 -5.57 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.161 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 33.9 p90 -83.11 16.86 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 108' ' ' VAL . 1.5 m120 61.87 38.62 14.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 32.4 m 34.14 36.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 107' ' ' ASN . 8.3 t -89.43 -52.43 5.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.28 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.675 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -62.87 -33.28 74.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.23 -58.45 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 19.5 ptp -64.82 -39.12 93.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -54.59 39.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.983 HG21 HD13 ' A' ' 73' ' ' ILE . 9.4 mm -50.59 -59.73 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.7 t -44.12 -42.86 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -69.15 -48.73 61.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.72 -59.77 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -41.32 -45.12 2.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.111 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 38.4 mm-40 -52.42 -41.59 63.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.2 m -80.08 -50.58 10.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -51.53 -52.81 43.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 124' ' ' ARG . 1.7 pp -60.14 -41.67 93.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.793 ' N ' HD12 ' A' ' 123' ' ' LEU . 57.0 ttt85 -54.31 -21.78 10.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.16 -59.67 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.137 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.513 ' H ' HD12 ' A' ' 126' ' ' ILE . 4.4 mp -76.55 -55.34 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.696 HG21 HG11 ' A' ' 90' ' ' VAL . 50.7 mm -51.07 -38.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.51 -27.31 11.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.449 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -123.24 114.19 19.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.17 -178.34 1.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 133' ' ' ASP . 20.6 mt-10 -122.66 121.56 36.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 131' ' ' GLU . 24.1 tp -33.73 -34.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' GLU . 58.0 m-20 -78.48 -50.38 11.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 tp10 -59.19 -46.98 86.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.9 p -40.57 -36.06 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.172 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.6 mt -64.35 -55.47 21.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -101.54 46.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -132.79 43.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 139' ' ' ARG . 6.4 mtp-105 -87.89 -42.83 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.75 -11.31 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 6.7 mt -100.08 -56.0 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.154 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 47.8 mt -58.37 -44.53 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.529 ' OD1' HD11 ' A' ' 166' ' ' ILE . 67.2 m-20 -56.57 -26.55 55.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.4 -48.59 15.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.064 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 145' ' ' ARG . 5.9 mpt_? -57.01 -64.16 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 146' ' ' LEU . 10.4 mt -52.74 -57.35 10.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HB2' HG21 ' A' ' 164' ' ' VAL . 44.6 ttp180 -45.38 -38.27 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.8 tp10 -82.86 -22.85 33.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.528 ' O ' HD12 ' A' ' 153' ' ' ILE . 32.7 mt-10 -83.31 -12.15 56.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.832 HD12 HD13 ' A' ' 115' ' ' ILE . 2.1 mm? -121.4 -5.87 9.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -24.32 23.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -86.59 -34.37 19.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.841 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 149' ' ' GLU . 22.9 mt -81.54 -11.88 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 1.013 ' HB ' HG13 ' A' ' 159' ' ' VAL . 56.6 p -100.33 -40.44 7.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.176 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -46.59 -21.3 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 156' ' ' ARG . 0.8 OUTLIER -82.6 -37.2 25.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.507 ' HB2' HG12 ' A' ' 159' ' ' VAL . 32.2 m0 -84.04 24.32 0.94 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.412 ' N ' ' HE2' ' A' ' 103' ' ' LYS . . . 65.04 14.26 58.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 1.013 HG13 ' HB ' ' A' ' 154' ' ' THR . 4.2 p -123.24 140.78 45.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 111.149 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HD3' ' C ' ' A' ' 160' ' ' LYS . 3.5 tmtt? -126.78 140.13 52.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.53 93.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.697 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -46.28 -55.04 7.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.159 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 2.8 ptp180 -158.59 -178.9 7.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.501 HG12 ' OD1' ' A' ' 143' ' ' ASN . 92.0 t -141.17 127.96 20.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.164 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.5 mm-40 -115.56 134.14 55.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.529 HD11 ' OD1' ' A' ' 143' ' ' ASN . 17.0 mm -102.52 142.35 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -101.22 159.13 15.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 19.5 mtt85 -45.03 157.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.865 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.8 mp -111.58 155.8 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 6.2 m-20 -111.59 120.07 43.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.596 0.712 . . . . 0.0 110.922 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 169.28 19.29 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.683 2.255 . . . . 0.0 112.337 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.431 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -69.78 151.67 69.02 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 2.249 . . . . 0.0 112.357 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -59.37 -35.19 73.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 173' ' ' LYS . 6.8 t70 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.7 m -109.79 119.69 40.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.902 0.382 . . . . 0.0 110.866 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -63.65 -47.94 79.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.51 121.02 18.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -122.07 44.61 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.3 165.58 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.821 HD23 HE22 ' A' ' 97' ' ' GLN . 2.7 mt -78.6 69.19 4.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.5 mtt-85 -102.36 114.04 27.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 1.2 pm0 -103.96 143.72 32.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -112.53 145.27 40.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 93' ' ' VAL . 2.4 p -94.35 137.02 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.806 HD13 HG21 ' A' ' 115' ' ' ILE . 21.2 mt -103.11 126.92 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.64 108.88 18.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.2 p -112.51 132.01 22.38 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.612 0.72 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 53.5 Cg_endo -69.75 145.92 58.68 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.701 2.267 . . . . 0.0 112.316 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.5 Cg_endo -69.78 162.57 41.58 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.706 2.27 . . . . 0.0 112.322 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -142.97 117.09 9.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -69.04 106.65 2.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.38 142.62 38.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 87' ' ' VAL . 19.5 mm -72.13 109.4 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -56.44 -177.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.6 tptp -65.68 -40.65 92.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -85.51 34.39 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 45.97 47.61 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 -179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ASP . 31.8 t -115.37 122.28 68.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 81' ' ' ILE . 21.8 t -77.23 111.4 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 m -138.48 155.08 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.109 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.6 m -102.19 119.68 39.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.103 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 127' ' ' ILE . 27.5 m -100.64 141.2 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -146.05 133.0 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -153.7 167.39 29.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 165' ' ' GLU . 35.5 m -111.61 172.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.3 t -142.74 123.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HG3' ' A' ' 70' ' ' GLU . 4.6 m-30 -90.39 151.96 21.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -165.8 154.79 11.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.821 HE22 HD23 ' A' ' 68' ' ' LEU . 2.5 pt20 -148.71 112.48 5.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.91 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.2 t -48.88 90.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.765 HD12 ' HB2' ' A' ' 100' ' ' ASP . 2.7 pp -80.64 -26.53 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.765 ' HB2' HD12 ' A' ' 99' ' ' ILE . 28.5 t0 -134.97 97.51 13.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.574 0.702 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 104' ' ' ALA . 53.8 Cg_endo -69.79 -44.74 1.89 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.706 HG23 ' HG2' ' A' ' 103' ' ' LYS . 4.0 m -36.41 -31.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.706 ' HG2' HG23 ' A' ' 102' ' ' VAL . 11.7 mmmt -93.62 -35.54 12.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -82.27 41.73 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.5 p -73.86 4.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.574 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 30.2 p90 -97.34 27.43 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.458 ' O ' ' C ' ' A' ' 108' ' ' VAL . 7.8 m-80 56.87 32.99 22.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.542 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.0 m 32.97 39.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.0 t -96.28 -36.44 10.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.828 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 4.3 m-20 -71.05 -38.59 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.792 ' CE2' HD11 ' A' ' 115' ' ' ILE . 0.5 OUTLIER -67.8 -44.9 76.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.1 mt -48.74 -54.3 15.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.633 ' O ' HG22 ' A' ' 116' ' ' VAL . 7.9 ptp -77.3 -45.01 27.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.873 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -57.4 -14.99 5.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.094 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.806 HG21 HD13 ' A' ' 73' ' ' ILE . 2.0 mm -80.73 -51.55 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 113' ' ' MET . 10.0 m -59.64 -25.48 31.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -82.03 -32.82 30.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 114' ' ' ALA . 16.0 mt -70.5 -36.58 73.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.02 86.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 76' ' ' PRO . 32.3 mm-40 -51.45 -38.17 52.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.1 m -82.88 -57.18 3.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.169 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -54.26 -56.44 18.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 1.005 ' HB2' HD13 ' A' ' 127' ' ' ILE . 1.1 pp -53.72 -41.3 66.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.424 ' N ' HD12 ' A' ' 123' ' ' LEU . 41.5 ttt-85 -53.97 -20.35 6.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.13 -57.9 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.3 mp -79.27 -62.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 1.005 HD13 ' HB2' ' A' ' 123' ' ' LEU . 3.0 mp -50.37 -41.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.3 -26.38 4.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.515 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -124.01 113.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.913 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.98 -175.72 1.54 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' ASP . 13.3 mt-10 -117.0 126.02 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' GLU . 42.5 tp -37.53 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.3 p30 -93.19 -43.39 8.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.829 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' GLU . 2.6 tp10 -63.82 -20.66 65.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.1 p -73.54 -14.24 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 mt -82.17 -40.84 21.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.4 t -120.86 43.09 2.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -134.17 20.24 4.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.494 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.665 ' HA ' HD12 ' A' ' 142' ' ' ILE . 14.6 ptt180 -69.08 -32.08 71.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 0.0 110.848 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -51.72 -47.46 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 mt -75.27 -43.43 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 139' ' ' ARG . 48.9 mt -50.9 -49.9 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.541 ' OD1' HD11 ' A' ' 166' ' ' ILE . 76.0 m-20 -65.44 -52.24 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.442 ' O ' ' CD ' ' A' ' 148' ' ' GLU . . . -42.89 -48.58 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.101 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.6 mmt85 -61.23 -70.1 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.38 -62.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -40.26 -36.4 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 144' ' ' ALA . 0.3 OUTLIER -78.01 -56.98 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.92 -58.37 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 81.8 mt -56.24 -37.23 69.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -11.28 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -92.63 -37.17 12.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -76.13 -19.08 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.791 ' HB ' HG13 ' A' ' 159' ' ' VAL . 73.6 p -93.74 -38.41 11.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -52.11 -16.73 0.84 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.29 -31.75 16.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.465 ' HB2' HG12 ' A' ' 159' ' ' VAL . 40.8 m0 -88.97 11.47 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 76.69 10.98 85.71 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 ' HB ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -113.57 145.42 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 111.128 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -118.48 141.2 48.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 154' ' ' THR . 26.2 mm -79.84 92.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -39.92 -61.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.424 ' NH1' ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -166.49 -178.06 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.41 HG12 ' OD1' ' A' ' 143' ' ' ASN . 62.9 t -135.18 147.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.13 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . 13.7 mt-10 -135.55 143.31 45.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.541 HD11 ' OD1' ' A' ' 143' ' ' ASN . 24.6 mm -105.44 142.24 19.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -106.12 161.25 14.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -42.33 136.95 2.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.943 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.7 mp -95.76 157.22 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.496 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 9.6 m-20 -107.87 120.93 45.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.603 0.716 . . . . 0.0 110.843 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 169.14 19.58 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.67 2.247 . . . . 0.0 112.357 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.451 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 54.1 Cg_endo -69.75 128.49 16.11 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.251 . . . . 0.0 112.379 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -118.0 166.31 12.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 174' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 18.6 m -55.48 127.62 30.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.35 -55.93 23.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -82.29 122.0 27.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.49 132.77 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -154.48 156.73 37.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 mp -85.88 39.74 0.82 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -54.87 118.59 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -119.75 152.36 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.878 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 85.5 m-70 -121.86 143.85 49.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.35 139.66 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.71 HD11 ' CE1' ' A' ' 111' ' ' PHE . 27.4 mt -108.26 124.56 64.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.46 127.49 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.815 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HD2' ' A' ' 76' ' ' PRO . 2.3 p -120.75 135.32 24.61 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.627 0.727 . . . . 0.0 111.139 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 116' ' ' VAL . 53.3 Cg_endo -69.78 150.29 67.89 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.2 Cg_endo -69.71 149.84 67.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.736 2.291 . . . . 0.0 112.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.73 HE21 HD11 ' A' ' 123' ' ' LEU . 12.9 tt0 -137.59 113.71 9.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -74.81 101.92 4.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG11 ' HA2' ' A' ' 128' ' ' GLY . 15.1 t -111.05 137.66 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 65.2 mt -68.16 104.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -49.78 -179.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -65.12 -41.02 95.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 84' ' ' ASP . 19.2 t70 -84.96 33.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.836 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 51.07 47.89 24.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 172' ' ' PRO . 94.0 t -118.93 114.76 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.4 p -80.38 120.18 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -145.89 148.91 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 11.4 m -81.16 125.98 30.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.951 HG11 HG21 ' A' ' 127' ' ' ILE . 9.8 p -121.76 130.93 74.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.109 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 13.5 p-10 -140.95 145.47 36.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB1' HD13 ' A' ' 166' ' ' ILE . . . -153.82 150.34 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 165' ' ' GLU . 0.4 OUTLIER -100.33 155.15 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.097 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.77 141.76 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.39 162.53 13.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 6.1 p90 -165.9 157.53 14.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.517 ' NE2' HG21 ' A' ' 162' ' ' THR . 3.0 pt20 -153.31 116.4 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 98' ' ' VAL . 34.4 t -53.79 94.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.132 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.27 3.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -165.17 112.64 0.83 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.64 0.733 . . . . 0.0 110.841 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -51.22 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.667 2.244 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 p -44.68 -37.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -81.16 -37.08 29.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.49 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . . . -96.73 56.01 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.082 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 105' ' ' VAL . 12.8 p -92.66 3.25 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.166 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.572 ' CE2' ' HA ' ' A' ' 108' ' ' VAL . 31.0 p90 -87.94 24.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.939 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 108' ' ' VAL . 23.4 m-80 61.97 27.4 16.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.572 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . 3.3 t 36.66 40.7 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.6 t -96.16 -52.33 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.472 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -57.22 -39.2 74.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.71 ' CE1' HD11 ' A' ' 73' ' ' ILE . 1.0 OUTLIER -62.88 -35.01 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.8 mt -65.45 -64.5 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 ptp -61.64 -32.74 72.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -67.13 -57.22 7.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.121 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.533 HD11 ' CG2' ' A' ' 154' ' ' THR . 8.1 mm -44.69 -56.64 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 76' ' ' PRO . 87.6 t -53.79 -24.93 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -85.91 -37.77 18.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 121' ' ' THR . 10.4 mt -67.55 -57.07 7.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.73 -36.41 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.123 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -63.41 -40.85 98.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 118' ' ' LEU . 88.6 m -78.74 -38.77 38.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 72.2 m-80 -69.26 -56.38 7.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.73 HD11 HE21 ' A' ' 78' ' ' GLN . 2.1 pp -53.19 -44.18 67.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.72 ' N ' HD12 ' A' ' 123' ' ' LEU . 45.5 ttt-85 -52.46 -22.04 4.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 122' ' ' ASN . . . -73.92 -60.59 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 126' ' ' ILE . 3.0 mp -78.91 -60.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.951 HG21 HG11 ' A' ' 90' ' ' VAL . 1.9 mp -49.98 -38.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.472 ' HA2' HG11 ' A' ' 80' ' ' VAL . . . -51.62 -23.89 10.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.06 114.05 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.844 0.354 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.79 -175.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 133' ' ' ASP . 22.2 mt-10 -120.84 137.07 54.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 59.0 tp -38.29 -26.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.757 ' HA ' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -97.83 -59.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -41.93 -25.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 133' ' ' ASP . 1.5 p -64.2 -50.58 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.757 HD21 ' HA ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -79.29 -13.95 59.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.935 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 m -92.78 -29.58 15.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.477 ' CA ' HD13 ' A' ' 141' ' ' ILE . . . -114.56 85.53 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.499 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -103.03 -43.45 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.809 0.338 . . . . 0.0 110.839 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -16.84 63.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.639 ' H ' HD12 ' A' ' 141' ' ' ILE . 3.8 mp -85.11 -48.73 16.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.613 ' CG2' HD11 ' A' ' 127' ' ' ILE . 70.8 mt -55.48 -61.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -50.46 -37.67 39.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.97 -59.02 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -48.77 -66.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 tp -42.81 -48.77 5.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -55.31 -42.94 74.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.32 -9.83 50.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.701 ' O ' HD12 ' A' ' 153' ' ' ILE . 13.2 mt-10 -98.35 -53.35 3.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.2 mt -64.6 -34.7 78.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -13.67 35.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -88.58 -49.84 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 149' ' ' GLU . 4.4 mp -72.92 -21.61 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.533 ' CG2' HD11 ' A' ' 115' ' ' ILE . 60.0 p -91.21 -35.35 14.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -25.65 21.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CB ' HH11 ' A' ' 156' ' ' ARG . 0.0 OUTLIER -80.15 -34.94 37.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -82.57 15.91 2.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 71.37 18.54 76.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.45 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.77 128.07 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 0.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.94 145.29 41.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.0 mm -84.08 116.31 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.517 HG21 ' NE2' ' A' ' 97' ' ' GLN . 30.3 p -70.37 -62.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -146.65 167.13 24.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.96 115.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.677 ' HB2' HG23 ' A' ' 93' ' ' VAL . 20.0 mm-40 -99.16 147.21 25.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.559 HD13 ' HB1' ' A' ' 92' ' ' ALA . 22.6 mm -107.62 137.21 39.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 91' ' ' ASP . 24.9 mt-30 -88.74 159.61 17.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -50.58 156.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 3.0 mp -110.99 157.26 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.124 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 10.0 t70 -125.45 133.26 24.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 168.47 21.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.341 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.509 ' HG3' HG13 ' A' ' 86' ' ' VAL . 53.5 Cg_endo -69.8 170.62 16.2 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.683 2.256 . . . . 0.0 112.316 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 174' ' ' ASP . 31.9 pttt -95.45 -52.12 4.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.41 ' N ' ' CG ' ' A' ' 173' ' ' LYS . 41.2 m-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.9 m -148.94 157.14 43.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 110.895 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -82.91 166.74 18.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -89.23 112.69 23.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 66' ' ' VAL . 17.4 m -92.1 123.66 44.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.77 156.78 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.78 HD12 HE22 ' A' ' 97' ' ' GLN . 5.1 tp -84.81 -21.56 29.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 68' ' ' LEU . 25.2 ptt-85 -36.58 137.81 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.833 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.38 152.87 41.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 96' ' ' TYR . 35.5 m-70 -113.85 149.26 35.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.2 p -96.49 145.31 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.966 HD13 HG21 ' A' ' 115' ' ' ILE . 18.7 mt -105.35 130.68 56.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.124 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.38 95.11 7.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.905 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.658 HG23 ' HD2' ' A' ' 76' ' ' PRO . 6.1 p -100.93 138.42 20.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.679 0.752 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.658 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.9 Cg_endo -69.74 150.48 68.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.676 2.251 . . . . 0.0 112.327 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.498 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 53.2 Cg_endo -69.8 171.0 15.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.47 ' NE2' ' HG2' ' A' ' 120' ' ' GLN . 1.6 mp0 -142.97 145.88 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -103.37 101.22 11.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.625 HG12 ' NH1' ' A' ' 124' ' ' ARG . 28.9 m -117.05 145.83 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 66.9 mt -77.55 106.75 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.33 -178.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -62.87 -48.59 78.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.3 t0 -81.45 37.98 0.48 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 2.5 m120 46.67 44.84 14.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG12 HG13 ' A' ' 88' ' ' VAL . 76.6 t -111.23 110.03 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.61 120.86 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG13 HG12 ' A' ' 86' ' ' VAL . 28.7 m -144.83 150.3 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.498 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 6.9 m -93.52 125.05 37.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 127' ' ' ILE . 34.4 m -112.9 148.98 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.156 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 92' ' ' ALA . 0.6 OUTLIER -152.81 138.45 17.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.831 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.493 ' O ' ' CG1' ' A' ' 75' ' ' VAL . . . -154.08 153.44 31.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 165' ' ' GLU . 24.2 m -101.22 163.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.1 t -135.39 132.69 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 161' ' ' ILE . 3.6 m-30 -94.26 161.31 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 71' ' ' HIS . 11.6 p90 -165.91 152.37 9.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.886 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.78 HE22 HD12 ' A' ' 68' ' ' LEU . 4.3 pt20 -143.11 126.06 16.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.91 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.0 t -70.83 91.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.408 ' O ' HG11 ' A' ' 66' ' ' VAL . 12.2 pt -71.7 -31.89 43.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -132.07 102.6 14.49 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.846 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -10.14 27.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.637 2.224 . . . . 0.0 112.393 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.12 -50.8 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -77.02 -38.09 53.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -86.63 47.82 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.34 4.74 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 36.3 p90 -85.26 30.83 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 108' ' ' VAL . 2.3 m-80 49.63 37.07 11.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 23.6 m 32.57 41.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.4 m -94.96 -41.58 9.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.76 -46.8 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.704 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -57.05 -30.4 64.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 116' ' ' VAL . 14.0 mt -60.31 -60.67 3.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.4 ' O ' HG22 ' A' ' 116' ' ' VAL . 20.0 ptp -67.75 -46.22 72.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.26 -35.93 63.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.052 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.966 HG21 HD13 ' A' ' 73' ' ' ILE . 5.2 mm -67.76 -64.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.501 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 2.7 m -52.29 -15.88 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -94.83 -34.32 12.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 150' ' ' LEU . 10.8 mt -73.2 -54.23 8.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -47.08 -45.29 21.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 68.9 mt-30 -62.02 -36.13 80.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.5 m -74.16 -22.12 59.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 146' ' ' LEU . 71.7 m-80 -91.53 -61.56 1.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 124' ' ' ARG . 4.1 pp -47.63 -39.83 18.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.625 ' NH1' HG12 ' A' ' 80' ' ' VAL . 25.4 mtt-85 -52.72 -33.09 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.88 -54.43 15.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mp -77.56 -59.52 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 90' ' ' VAL . 3.7 mt -50.25 -44.24 22.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -44.86 -24.02 0.68 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 130' ' ' MET . 10.4 pt-20 -125.86 112.76 16.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -175.54 -175.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 135' ' ' THR . 10.2 mm-40 -122.44 129.39 52.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.99 -23.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' GLU . 74.9 m-20 -85.74 -64.89 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.898 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 136' ' ' LEU . 15.2 pt-20 -53.33 -46.02 69.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 131' ' ' GLU . 25.3 p -33.3 -33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 134' ' ' GLU . 39.6 mt -70.85 -69.33 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 t -54.14 -46.29 72.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.72 57.64 2.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -99.75 -26.41 14.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -78.12 -26.13 47.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.7 mt -78.73 -52.34 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 77.0 mt -43.88 -50.51 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.562 ' HB3' HD11 ' A' ' 166' ' ' ILE . 0.9 OUTLIER -68.47 -41.01 80.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' N ' ' OD1' ' A' ' 143' ' ' ASN . . . -50.86 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -55.09 -56.76 16.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.505 HD21 ' HB1' ' A' ' 119' ' ' ALA . 7.2 tp -47.51 -62.12 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB2' ' CG1' ' A' ' 164' ' ' VAL . 25.9 ttp85 -43.85 -50.25 7.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -53.54 -31.37 46.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -79.58 -60.18 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.948 HD12 HD13 ' A' ' 115' ' ' ILE . 3.3 mm? -54.82 -31.75 59.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 151' ' ' ASP . 0.0 OUTLIER -66.85 -3.75 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -97.59 -43.84 7.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.5 mp -75.16 -18.78 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 68.8 p -92.04 -35.33 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -49.16 -38.62 26.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.578 ' HG3' ' CD1' ' A' ' 157' ' ' TRP . 4.6 ptp180 -69.93 -32.53 70.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.672 ' O ' HG23 ' A' ' 159' ' ' VAL . 31.7 m0 -88.23 34.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 49.57 23.39 4.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 157' ' ' TRP . 91.2 t -126.72 143.32 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.89 0.376 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.75 141.92 48.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 95' ' ' TYR . 26.9 mm -77.54 97.56 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.18 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 97' ' ' GLN . 62.6 p -51.27 -38.57 53.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -170.99 -179.93 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.846 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.478 HG23 ' OD1' ' A' ' 143' ' ' ASN . 1.7 m -141.32 134.53 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.102 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.445 ' HB2' HG23 ' A' ' 93' ' ' VAL . 4.7 mt-10 -121.07 139.42 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 143' ' ' ASN . 9.0 mm -104.12 142.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.171 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -99.48 161.95 13.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -49.32 145.38 4.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 170' ' ' ASP . 3.3 mp -98.27 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' N ' HG22 ' A' ' 169' ' ' ILE . 2.2 m-20 -112.72 120.46 40.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 0.0 110.87 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 170.23 17.12 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.629 2.22 . . . . 0.0 112.358 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 136.16 32.29 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.69 2.26 . . . . 0.0 112.318 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -102.6 173.29 6.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.822 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.499 -0.241 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.7 t -133.93 118.12 17.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.63 -60.25 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -71.69 126.02 28.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.18 128.29 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.179 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -155.87 176.19 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.23 36.49 2.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -65.04 141.11 58.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.29 138.6 38.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 96' ' ' TYR . 99.1 m-70 -108.57 126.73 53.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -93.1 135.26 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 115' ' ' ILE . 20.4 mt -99.1 128.11 51.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.32 97.97 9.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.849 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.688 HG22 ' HA ' ' A' ' 116' ' ' VAL . 48.2 t -102.89 126.78 31.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.638 0.732 . . . . 0.0 111.128 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 149.86 67.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.352 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.496 ' HB2' ' CG2' ' A' ' 89' ' ' THR . 54.0 Cg_endo -69.79 147.58 63.02 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.348 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -128.17 116.95 20.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -68.53 116.86 9.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.62 147.52 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' CG2' ' HA ' ' A' ' 85' ' ' ASN . 46.6 mm -83.56 108.67 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.4 m -53.11 -174.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -67.32 -45.09 77.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 84' ' ' ASP . 25.8 t70 -82.89 36.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.49 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 4.6 m-20 47.26 51.07 13.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG12 HG13 ' A' ' 88' ' ' VAL . 87.1 t -118.15 109.48 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 87' ' ' VAL . 6.4 p -78.14 114.28 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 86' ' ' VAL . 18.1 m -140.15 142.06 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.496 ' CG2' ' HB2' ' A' ' 77' ' ' PRO . 32.3 m -81.93 126.24 31.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 91' ' ' ASP . 7.2 p -119.64 160.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -162.57 143.5 10.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.76 153.52 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 165' ' ' GLU . 18.0 m -101.19 164.48 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 80.8 t -137.42 134.43 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 3.4 m-85 -96.59 157.02 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 71' ' ' HIS . 4.7 p90 -165.92 150.94 8.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.762 ' HG2' HG23 ' A' ' 162' ' ' THR . 3.0 pt20 -147.95 110.01 4.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.417 HG21 HG21 ' A' ' 108' ' ' VAL . 92.0 t -51.68 95.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.2 pt -81.55 -8.26 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -161.22 109.59 1.25 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.569 0.699 . . . . 0.0 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -47.84 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 101' ' ' PRO . 2.2 t -34.83 -39.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt -90.71 -37.86 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.565 ' HA ' ' CE2' ' A' ' 106' ' ' TYR . . . -94.23 49.83 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.8 m -86.12 8.17 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 108' ' ' VAL . 35.7 p90 -90.47 26.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 108' ' ' VAL . 14.5 m-80 56.56 33.97 23.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' TYR . 16.5 t 33.65 41.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.121 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.3 m -97.45 -50.18 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' O ' ' CB ' ' A' ' 114' ' ' ALA . 6.3 m-20 -57.6 -45.09 85.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.922 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 73' ' ' ILE . 1.1 t80 -61.09 -44.39 97.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.527 HD23 HG12 ' A' ' 73' ' ' ILE . 19.0 mt -53.16 -64.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.786 ' O ' HG22 ' A' ' 116' ' ' VAL . 21.0 ptp -62.24 -45.07 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 110' ' ' ASP . . . -56.92 -32.31 65.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 73' ' ' ILE . 3.9 mm -70.92 -59.81 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.184 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 113' ' ' MET . 8.7 m -44.06 -22.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 115' ' ' ILE . 77.1 mttt -94.77 -46.86 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.09 -53.04 62.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.46 -45.78 47.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.115 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 116' ' ' VAL . 78.3 mt-30 -57.96 -37.9 75.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 87.7 m -70.17 -35.49 74.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.428 ' CG ' ' HB3' ' A' ' 149' ' ' GLU . 71.0 m-80 -80.31 -62.92 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.721 ' HB3' HD21 ' A' ' 146' ' ' LEU . 4.0 pp -46.59 -43.79 17.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.596 ' N ' HD12 ' A' ' 123' ' ' LEU . 9.7 ttm180 -47.73 -39.09 16.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.15 -52.03 66.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.081 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 126' ' ' ILE . 5.1 mp -80.42 -62.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.169 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.558 HD12 HD13 ' A' ' 123' ' ' LEU . 5.2 mt -51.17 -43.28 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -45.61 -31.58 3.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.524 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 130' ' ' MET . 8.2 pt-20 -116.52 113.39 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.411 ' CG ' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -172.55 -175.09 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.842 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 133' ' ' ASP . 35.0 mt-10 -116.5 121.34 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 131' ' ' GLU . 57.5 tp -33.89 -33.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 131' ' ' GLU . 4.2 m-20 -83.45 -50.75 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 131' ' ' GLU . 24.8 tt0 -56.45 -48.58 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.886 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.0 p -40.1 -50.11 2.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.147 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.3 mt -47.02 -39.17 12.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -127.61 82.36 2.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -175.27 25.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 5.0 ptt-85 -72.6 -35.33 67.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.917 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 139' ' ' ARG . 1.5 m-20 -46.94 -32.21 3.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.09 -35.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.124 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 139' ' ' ARG . 71.4 mt -60.81 -50.64 79.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 139' ' ' ARG . 2.3 p30 -61.77 -52.78 62.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.439 ' HA ' ' NH1' ' A' ' 147' ' ' ARG . . . -39.29 -49.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -58.8 -60.6 3.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 123' ' ' LEU . 3.9 mm? -54.37 -61.96 1.96 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 144' ' ' ALA . 23.6 ttp-105 -36.19 -36.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -81.51 -55.5 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 152' ' ' LYS . 70.2 mm-40 -50.24 -17.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.87 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.6 mt -107.11 -40.07 5.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -65.1 -8.31 16.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 149' ' ' GLU . 5.2 ptmt -100.83 -18.24 16.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 153' ' ' ILE . 7.2 mt -107.3 18.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.186 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.993 ' HB ' HG13 ' A' ' 159' ' ' VAL . 39.7 p -120.99 -32.29 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -25.56 11.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -84.1 -25.82 29.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TRP . . . . . 0.446 ' HB2' HG12 ' A' ' 159' ' ' VAL . 54.4 m0 -92.84 17.41 10.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 66.79 15.44 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.445 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.993 HG13 ' HB ' ' A' ' 154' ' ' THR . 5.0 p -124.94 155.94 33.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.178 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -137.52 151.7 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.477 ' N ' ' HD3' ' A' ' 160' ' ' LYS . 31.7 mm -88.94 98.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.762 HG23 ' HG2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -52.66 -48.84 66.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -166.15 -176.38 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.08 147.93 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.549 ' HB2' HG23 ' A' ' 93' ' ' VAL . 3.2 mm-40 -133.81 141.66 47.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 13.9 mm -108.55 142.07 22.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -101.44 161.87 13.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.56 160.95 0.23 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 170' ' ' ASP . 2.9 mp -113.84 157.06 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.501 ' N ' ' CG2' ' A' ' 169' ' ' ILE . 4.6 m-20 -111.42 123.54 34.75 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.666 0.746 . . . . 0.0 110.85 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 164.44 34.55 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.322 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.64 40.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 0.0 112.385 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.36 153.4 24.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 28.1 t0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.884 . . . . . . . . 0 0 . 1 stop_ save_